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Abstract
Ultraviolet (UV) irradiation causes non-melanoma skin cancers, the
incidence of which have dramatically increased. UV irradiation can damage
the skin in many ways, it induces DNA damage, inflammation, immune
suppression, oxidative damage and can lead to cell death.
Selenium (Se) is a trace element found in many food sources, it is
incorporated into specific selenoproteins. These include glutathione
peroxidase and thioredoxin reductase which have strong antioxidant
functions. In mice Se supplementation can reduce the number of skin
tumours formed after UV irradiation. The aim of this thesis was to
characterise how Se can act in the skin to prevent ultraviolet- B radiation
(UVB)-induced cellular damage.
To assess the effect of Se supplementation on UV irradiation of the skin,
human skin cells were grown in vitro and supplemented with Se.
Selenoprotein profiles were characterised using [75Se]-labelling. It was
shown that primary human fibroblasts, melanocytes and keratinocytes
express unique patterns of selenoproteins. Se was found to diminish the
amount of cell death induced by UVB, Se also decreased the level of UVB-
induced apoptotic cell death. Following UVB irradiation keratinocytes
produce cytokines. In primary human keratinocytes Se diminished the
induction of mRNA for IL-8, IL-6 but not the protein levels of these
cytokines. However Se supplementation did decrease both the mRNA and
protein levels of human TNF-a. In mouse keratinocytes the UVB-induction
of the mRNA for TNF-oc and IL-10 were decreased as were the IL-10 protein
levels.
The effect of Se on the UVB-induced DNA damage was assessed by the
comet assay. The formation and rate of repair of cyclobutane dimer sites
was not affected by Se. However the formation of oxidative DNA damage
was decreased. The p53 protein is also induced following UVB irradiation of
keratinocytes, Se did not affect this induction. Se was also found to decrease
the production of lipid peroxides in keratinocytes following exposure to
UVB. Finally mice were fed diets containing different levels of Se for six
weeks which resulted in increased GPX activity in Lymph nodes, skin and
livers. The mice were then exposed to UVB. It was found that the number of
epidermal Langerhans' cells were higher in Se replete animals and remained
higher even after UVB treatment.
Overall it would appear that Se supplementation can decrease many forms
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The skin is the largest organ of the body. It is in continual contact with the
external environment and therefore, in addition to controlling water loss and
temperature regulation, it encounters a wide range of potentially damaging
factors such as ultraviolet (UV) radiation, chemicals and micro-organisms.
The skin was originally considered to function purely as a physical barrier;
however it is now known to be a highly immunoreactive organ, which
defends the body from invading pathogens. The skin is also capable of self
repair. The skin as an immunoreactive entity complete with its associated
lymphoid tissues, was first described nearly 20 years ago (Streilein, 1978).
The skin is divided into two main compartments they are: the epidermis and
dermis, and are separated from each other by the basement membrane (Fig
1.11).
1.1.1 Keratinocytes.
Keratinocytes constitute 92% of the cells in the epidermis forming a stratified
multi-layered epithelium. Keratinocytes provide the physical barrier
properties of the epidermis and accomplish its repair and regeneration. The
keratinocytes situated adjacent to the basement membrane are
predominately undifferentiated, rapidly proliferating stem cells. As
keratinocytes become committed to differentiate, they detach from the
basement membrane, lose their capacity to proliferate and migrate from the
basal layers towards the stratum corneum. Terminally differentiated
keratinocytes are finally shed from the stratum corneum as dead cornified
squames (reviewed in Watt, 1989). In addition to forming a physical barrier,
keratinocytes have an important immunoregulatory role and keratinocytes
in culture can be stimulated to secrete many cytokines. The functions of
some of these cytokines will be discussed later in the chapter.
1-1
1.1.2 Langerhans' cells and other immune cell types of the skin.
In addition to keratinocytes, the other components of the skin include
Langerhans' cells (LCs), leukocytes, endothelial cells, melanocytes and mast
cells. Langerhans' cells are cluster of differentiation (CD) la+, major
histocompatibility (MHC) Class II dendritic cells derived from the bone
marrow. They form a semi-continuous network between epidermal
keratinocytes and are the main antigen presenting cell (APC) of the skin.
Langerhans' cells are defined by their dendritic morphology and possession
of a unique intracytoplasmic organelle called a Birbeck granule, the function
of which remains unclear (Birbeck et al, 1961). Unlike keratinocytes, LCs are
a migratory population of cells and do not permanently reside in the
epidermis. Immature LCs in the epidermis develop the capacity to become
potent APCs, after migration from the skin to the draining lymph nodes
where they process and present antigens to naive T cells (Streilein et al, 1990).
In a secondary immune response, antigen presentation to memory T cells
may then occur within the skin by LCs or macrophages (Streilein et al, 1990).
Invading pathogens, contact sensitisers or exposure to ultraviolet light can
all induce LCs to migrate from the epidermis.
T cells, macrophages and other leukocytes enter the dermal and epidermal
compartments from dermal blood vessels. The majority of T cells within the
dermis comprise equal numbers of T helper cell (CD4+) and cytotoxic T cell
(CD8+) subsets and are located in the perivascular region. In contrast, only
2% of the T cells in normal skin are found in the epidermis and they are
predominately CD8+ (Bos et al, 1987).
1.1.3 Melanocytes.
Melanocytes are highly differentiated neural crest-derived cells which are
present in the basal layer of the epidermis. Melanocytes are responsible for
basal skin pigmentation and for tanning. However their primary function is
to protect the skin from UV irradiation, they do this by the production and
transfer of melanin to keratinocytes (reviewed by Gilchrest and Eller, 1999).
Melanin consists of two types, eumelanin and phaeomelanin. Melanin is
produced in specialised intracellular organelles called melanosomes,
following production; the melanin is transported through the dendritic
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processes of the melanocytes to the surrounding keratinocytes. Following
exposure to UV radiation, the number of melanosomes and their production
of melanin greatly increases (Yaar and Gilchrest, 1991). Melanin can directly
absorb UV photons thereby dissipating the otherwise injurious energy as
heat. Melanin can also absorb free radical species generated by the
interaction of UV photons with cellular lipids. When stimulated,
melanocytes respond to many cytokines and can also secrete several
cytokines including; Interleukin (IL)-la and IL—(3, transforming growth
factor-(3 (TGF-(3), IL-8 and monocyte chemotactic protein-1 (reviewed by
Thody, 1995). In addition, intracellular adhesion molecule-1 (ICAM-1) can
be induced on the surface of melanocytes, thus promoting cell-cell
interactions.
1.2 Sunlight and skin cancer.
1.2.1 Historical note.
Solar radiation has been worshipped since ancient times for its health
inducing properties. The Egyptians believed that the sun's energy was from
Aton Ra, the sun god dating from the Fifth Dynasty 2750 BC. Helios the
Greek god of sun and light has given his name to heliotherapy, which means
healing by exposure to natural sunlight. Herodotus, in 525 BC, observed
that the strength of the skull was related to sunlight exposure. Sunbathing
was recommended at this time for a range of conditions such as epilepsy,
jaundice and obesity. During the eighteen and nineteenth centuries
heliotherapy was used in the treatment of rickets (Diffey, 1984). Sunlight is
essential for the photochemical formation of vitamin D3 in the skin, which is
necessary for bone formation. It is still used for the treatment of certain skin
diseases such as psoriasis.
The Danish physician Niels Finsen (1860-1904) realised the importance of the
UV component of sunlight, with respect to skin disease in the late nineteenth
century. In his 1893 publication 'On the influence of light and the skin1 and in
later published articles Finsen stressed that it was the UV radiation not heat,
from the solar spectrum that was responsible for sunburn. Finsen went on to
win the Nobel Prize for Medicine for his work on the treatment of lupus
vulgaris with UV radiation.
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The advent of cheap air travel and increased leisure time has meant that
more people can now travel to sunny climates on a regular basis. There has
been a gradual increase in the availability and popularity of artificial tanning
devices. It is thought that this 'suntan seeking' behaviour is largely
responsible for the rapidly rising incidence of skin cancer in Europe and
North America.
1.2.2 The electromagnetic spectrum.
The sun is the major source of human exposure to UV radiation.
Approximately 50% of the sun's energy that reaches the earth's surface,
comes from the visible portion of the electromagnetic spectrum and only 5%
is from the UV component of the electromagnetic spectrum. The UV part of
the spectrum is subdivided into UVC (200-290 nm), UVB (290-315 nm) and
UVA (315-400 nm) (Fig 1.1). UVC radiation is absorbed completely by the
stratospheric ozone layers and is therefore not of biological relevance
(Diffey, 1984). UVB radiation is only partly absorbed by the ozone layer and
UVA radiation is not absorbed at all. The UV spectrum of the sun at ground
level is dependent on geographical location, the time of day, month of year
and also on the weather conditions, level of air pollution and reflection from
the Earth's surface. An example of the solar spectrum in the UK on a clear
summer day, shows that UVB and UVA can be measured only (Fig 1.2).
1.2.3 Environmental considerations.
There is concern regarding the depletion of the stratospheric ozone and the
concomitant increase in levels of genotoxic UVB radiation, which is
predicted to increase the risk of skin cancer in the future (Slaper et al, 1996).
Ozone is the primary absorber of UV light in the atmosphere. It blocks all
UVC from reaching the Earth's surface, 90% of UVB, but very little UVA.
Inert gas propellants from aerosol cans (chlorofluorocarbons) and high¬
flying jets have been blamed for the depletion of the ozone layer. Since 1985
seasonal fluctuations in the ozone layer have been observed regularly in
Antarctica.
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Figure 1.2: Typical solar spectral output in the UK on a clear,
summer day.
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and in some parts of the Northern hemisphere where there is minimal air
pollution (Kerr, 1992; Hilsenrath et al, 1992). It is believed that any reduction
in the atmospheric ozone layer will lead to increased environmental
exposure, in particular to UVB which reaches the Earth's surface in amounts
inversely proportional to the concentration of atmospheric ozone
(Longstreth et al, 1998). International commitment has resulted in a decrease
in the production and emission of ozone-damaging chemicals, which may
eventually lead to a recovery of the ozone layer.
1.2.4 Chromophores present in the skin.
The longer the wavelength of light, the deeper into the skin it can penetrate.
Therefore, UVA can penetrates more deeply into the dermis than UVB.
Chromophores in the skin absorb the UV radiation and are altered or
damaged by the energy they absorb. The major chromophores present in the
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skin are DNA, proteins and urocanic acid. The effect of UV on
deoxyribonucleic acid (DNA) is discussed in detail later in the chapter.
Absorption of photons by proteins can lead to the formation of protein-
protein cross-links and protein-DNA cross-links.
Urocanic acid is produced by the de-amination of the essential amino acid
histidine. The skin does not contain the enzyme urocanase to catabolize
urocanic acid, therefore the skin contains a high level of the latter. In the
epidermis, urocanic acid exists as a trans-form. Exposure to UV radiation
isomerises urocanic acid from the trans-form to the cis-form, which is
thought to be an important mediator of UV-induced regulation of cellular
responses and immunosuppression in the skin (reviewed in Beissert and
Granstein, 1995; Norval et al, 1995; Kondo et al, 1995).
When the skin is exposed to UV radiation there is an increase in the release
of arachidonic acid from membrane bound phospholipids, through the
activation of phospholipase A2 and phospholipase C. The subsequent
increase in prostaglandin, is thought to be involved in the erythema reaction
following exposure to UV.
1.3 Epidemiology of skin cancer.
It is widely accepted that UV radiation is carcinogenic in humans and can
produce photochemical changes in superficial tissues, resulting in acute and
chronic adverse health effects. In 1894 the dermatologist Unna Firt
recognised the relationship between skin cancer and exposure to sunlight
(reviewed in Diffey, 1984). Acute effects of exposure to sunlight include;
erythema resulting from vasodilatation of the blood vessels in the skin,
sunburn, blistering, photokeratitis and conjunctivitis. Chronic effects
include; premature photoaging, lens cataracts, malignant and benign
tumours, and immunosuppression.
UVB has long been recognised as carcinogenic in experimental animals, and
there is increasing evidence that UVA, which penetrates more deeply into
the skin also contributes to photocarcinogenesis. The wavelength
dependence (action spectrum) of UV-induced skin cancers has been
estimated (de Gruijl, 1993). These studies on wavelength dependence,
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demonstrate that the UVA contribution to the carcinogenicity of sunlight is
approximately 20% with UVB causing 80%.
The majority of experimental models of UV-induced carcinogenesis have
been carried out using hairless mice, which mainly develop squamous cell
carcinomas (SCC) (de Gruijl and Forbes, 1995). The action spectrum for the
development of SCCs in the hairless mouse, as well as that for non-
melanoma skin cancer development in human skin, closely resemble the
human erythemal action spectrum (Parrish et al, 1982). The action spectra
show that UVB radiation is the most efficient wavelength at inducing skin
tumours, however a deleterious role for UVA in skin carcinogenesis has also
been demonstrated. This is an important factor to consider, due to the high
intensity of UVA in sunlight and the inability of some sunscreens to block
UVA wavelength effectively.
The incidence of the three main types of cutaneous malignancies; basal cell
carcinoma (BCC), SCC, and malignant melanoma, has nearly doubled
between 1980-1990 (Devessa et al, 1995). The number of skin cancer-related
deaths has risen by around 50% over the last 15 years.
Non-melanoma skin cancers (NMSC) are the most common type of skin
tumours to occur, they are generally curable, and death is uncommon. The
occurrence of NMSC is related to chronic UV exposure and it is therefore
commoner in fair skinned individuals (Stern and Momtaz, 1984), albinos and
individuals with DNA repair defect disease xeroderma pigmentosum. Some of
the apparent increased incidence of skin cancers are thought to be due to
better reporting of cases.
1.3.1 Basal cell carcinoma.
BCCs are slow-growing, locally invasive malignant epidermal skin tumours.
BCCs, represent the most common type of skin cancer. It is estimated that
40,000 are currently annually diagnosed in the UK. The most significant
etiologic factor is chronic exposure to UV radiation, consequently the head
and neck are the most commonly involved sites (Cheronsky, 1978). The
clinical appearance and morphology of BCCs are diverse ranging from;
nodular to cystic, ulcerated, superficial, keratotic and pigmented. They are
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rarely fatal and metastasis is rare (Lo et al, 1991). However, BCCs can result
in significant morbidity from local tissue destruction, particularly on the
head and neck if not detected early. A 5% increase in incidence of these
tumours per annum has been detected. The incidence of BCC rises with
increasing age. With an ageing population it is estimated that the incidence
of BCC in the UK will rise further over the next decade. This could have
major economic implications.
1.3.2 Squamous cell carcinoma.
SCCs are malignant tumours arising from keratinocytes in the epidermis or
from mucous membranes. SCC's are locally invasive and have the potential
to metastasise to other organs of the body. SCC's represent the second most
common skin cancer. Approximately, 10,000 are diagnosed annually in the
UK at present. In many countries as well as the UK the incidence is rising.
SCC's are more common and more aggressive in patients who are
immunosuppressed, such as those receiving immunosuppressive medication
following renal or other organ transplants. SCC's usually present as an
indurated nodular warty, keratinising tumour which can become ulcerated,
typical sites being the ears, head and neck.
1.3.3 Malignant melanoma.
Malignant melanomas are malignant tumours derived from melanocytes,
they are the leading cause of death from skin disorders. Melanomas
typically arise from pre-existing melanocyte naevi. They are usually, but not
always, dark brown/black, with irregular pigment and borders. Patients
usually notice change in shape, size or colour of pre-existing naevi. The
mortality rates from melanoma have been rising over the last 50 years,
(Weinstock, 1993) with a rapidly rising incidence of 7% per annum in the UK
in the past decade. 5,000 cases are diagnosed annually in the UK.
Unfortunately the past decade has also seen an increase mortality from
malignant melanomas, of 2% per annum in England and Wales. It is thought
that the risk of melanoma may be associated with short periods of intense
exposure to UV radiation and possibly acute episodes of sunburn especially
in childhood (Elwood, 1992a and b).
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1.4 Adverse effects of UV radiation exposure on the skin.
1.4.1 Induction of cell death.
Exposure to UV can induce cell death in the skin. There are two distinct
forms of cell death, termed necrosis and apoptosis. Necrosis is a passive
form of cell death resulting from acute cellular injury, in which cells tend to
swell and then lyse. Apoptosis in comparison is an active form of cell death,
with specific morphological features which differ from necrosis (Kerr et al,
1972). The nucleus and cytoplasm shrink (condensation of the chromatin
occurs), the nucleus becomes pyknotic and the cell fragments into membrane
-enclosed fragments called apoptotic bodies (Kerr et al, 1994). Within tissues
the apoptotic bodies are rapidly recognised and phagocytosed by
neighbouring cells. Then the apoptotic bodies are degraded within the cells
lysosomes, resulting in their effective removal. As the cells are removed
quickly and do not lyse, no cellular contents leak and there is no
inflammatory response, unlike necrotic cell death. Apoptosis is often
labelled programmed cell death, as it occurs during development and
differentiation of tissues and mediates the changes in organ structure and
function (Sen, 1992). It is also the major mechanism by which homeostasis of
a number of physiological systems in the body can be regulated. In the skin
it is thought that apoptosis is a ubiquitous process, that is important in
regulating epidermal growth (Weedon, 1990). Apoptosis usually effects
individual cells and not whole populations, unlike necrosis.
There are many factors which induce apoptosis in different cell types they
include; tumour necrosis factor (TNF)-a, tumour growth factor (TGF)-(3,
retinoids, calcium, growth factor withdrawal, heat, cold, UV radiation and
oxidative stress. Other factors can inhibit apoptosis including; growth
factors, interleukin (IL)-2, IL-3, IL-4, IL-6, CD40 ligand, zinc, antioxidants
and calpain inhibitors. Reactive oxygen species (ROS) such as hydrogen
peroxide (H2O2) can induce cells to undergo apoptosis (Lennon et al, 1991).
The intensity of stimuli is thought to be important in the induction of
apoptosis, above a certain threshold of stimulus and cells undergo cell death
by necrosis. This has been demonstrated with H2O2 (Lermon et al, 1991).
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Biochemical changes specific to apoptotic cells also occur, these involve the
activation of catabolic enzymes. A class of highly specific proteases also
appear to have an important role in apoptosis. Proteases of this class are
related to mammalian interleukin-l(3 converting enzyme (ICE) and to cell
death gene (CED)-3. All of these proteins possess the amino acid cysteine in
their active site and cleave their target proteins at specific aspartic acids and
are called caspases. The caspase proteins can activate other members of the
family, so that a network of caspase activation occurs. The caspases have
different activation signals for example, caspase-8 activates caspase-1 which
in turn activates caspase-3 during Fas-induced apoptosis (Fig 1.3).
There are two main pathways of apoptosis. One of these is the Fas pathway;
Fas is a transmembrane receptor and a member of the TNF receptor
superfamily. FasL the ligand for Fas, is a transmembrane protein that
belongs to the TNF family. When FasL binds to Fas at the cell surface, Fas
trimerises and then Fas-associated protein with death domain (FADD)
associates with the receptor trimer via a homotypic death domain interaction
(Takahashi et al, 1994). Other death domain containing-proteins which
interact with the Fas receptor are MORT1 and RIP. Other ICE-like proteases
are then recruited i.e. FLICE or MACH. Exposure to UVB can also lead to
Fas trimerisation without FasL binding (Aragane et al, 1998) (Fig 1.4).
Another apoptosis pathway related to the one mediated by Fas involves the
TNF receptor, it associates with TRADD (TNF receptor 1-associated death
domain), which then recruits FADD (Greenblatt and Elias, 1992). Then
FADD concomitantly recruits caspase-8 in both pathways; once activated it
can cleave a number of nuclear protein substrates, resulting in DNA
fragmentation and the activation of other caspases.
The final pathway for induction of apoptosis is via p53. The human p53
gene encodes a nuclear phosphoprotein, with a molecular mass of 53,000. It
is one of the most frequently mutated genes known, with more than 50% of
human malignancies containing altered p53 genes (Hollstein et al, 1991).
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Degradation of Chromosomal DNA)
The cell receives the apoptotic-inducing signal and either the Fas, TNF or p53
pathway leading to apoptosis is activated. This leads to the activation of
caspases within the cell and cleavage of cellular DNA and proteins until the
cell is divided into apoptotic bodies which are phagocytosed by other cells
(adapted from Teraki and Shiohara, 1999).
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Either FasL binds to Fas or UV radiation activates Fas thus leading to the
trimerisation of Fas. This leads to the recruitment of FADD or MORT1
which in turn leads to the activation of caspases and fragmentation of the cell
into apoptotic bodies (adapted from Teraki and Shiohara, 1999).
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The p53 tumour suppressor gene is mutated in the germline of individuals
with Li-Fraumeni syndrome. These individuals have a high risk of
developing cancerous growths/ greater than 50% Li-Fraumeni patients will
develop tumours by age 30 (Malkin et al, 1990). The p53 protein functions as
a tumour suppressor by inducing growth arrest, senescence, or apoptosis in
response to a variety of cellular stresses. These cellular stresses include;
exposure to DNA damaging agents, hypoxia, nucleotide depletion, and
oncogene activation. Apoptotic responses protect the cell from uncontrolled
proliferation and neoplastic transformation. The N-terminal transactivation
domain of p53 is important for the stability of the protein in the cell. The
regulatory protein mouse double minute 2 (MDM2) can bind to this region
and block p53 transactivation, by preventing phosphorylation of this region
(Momand et al, 1992), as a result p53 is degraded (Midgley and Lane, 1997).
The basic C-terminal region of p53 is able to bind single stranded DNA. The
half life of wild type p53 in unstressed cells is very short 20-30 minutes only.
Within stressed cells the p53 protein is stabilised and it's DNA binding
activity increases, allowing it to mediate cell cycle arrest or apoptosis. The
protein MDM2 is thought to destabilise p53 and when it dissociates from the
p53 protein, p53 has a longer half life (Fig 1.5). After DNA damage p53
becomes phosphorylated and MDM2 binding is decreased (Shieh et al, 1997,
reviewed in Burns and El-Deiry, 1999). Phosphorylation at serine 389 and
acetylation of the C-terminal region of p53 increases it's DNA binding
activity, this is thought to occur due to allostearic alteration of the p53
protein allowing it to bind DNA (Hupp and Lane, 1994) (Fig 1.6). Damage to
DNA induced by exposure of cells to UV has been demonstrated to lead to
phosphorylation of serine 389 (Lu et al, 1998). The UV-induced protein
kinase JNK-1 phosphorylates p53 at serine 34, this is within the region where
MDM2 binds (Milne et al, 1995). The levels of protein for p53 do not
correlate with p53 activity, the p53 protein appears to have to be activated.
Other kinases can also phosphorylate p53 at various serine residues, these
include; at the C-terminus, protein kinase C (PKC) which phosphorylates
serine 378 and cyclin dependent kinase 2 (CDK2) which modifies the
tetramerisation domain. DNA protein kinase (DNA-PK) which
phosphorylates serine 37 and 15 in the N terminal binding domain.
Therefore activation of specific kinases can stimulate p53 towards different
functions (reviewed in Burns and El-Deiry, 1999).
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p53 binds to MDM2 and is constantly degraded, if p53 is phosphorylated
this prevents MDM2 binding and so stabilises the protein. The stabilised p53
is then phosphorylated or acetylated again which results in a conformation
change and allows the protein to bind DNA and activate downstream genes
(adapted from Burns and El-Deiry, 1999).
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MDM2 binds p53 at the N-terminal transactivation domain (TA), several
phosphorylation sites are present which can be phosphorylated to prevent
MDM2 binding. The protein also contains a proline rich region (PxxP) and a
tetramerization domain (TETRA). Phosphorylation of the C-terminal
domain (CTD) can alter the shape of the protein to uncover the central DNA
binding domain. Most of the mutations found within tumour cells occur in
the DNA binding domain (adapted from Burns and El-Deiry, 1999).
If the intensity of UV radiation is low then there is limited DNA damage and
p53 activates growth arrest genes, the cell then undergoes cell cycle arrest at
Gl, the damaged DNA is repaired and the cell is allowed to progress
through the cell cycle (Lane, 1992; Cox and Lane, 1995). If the intensity of
irradiation is high then a substantial level of DNA damage results and p53
signals the cell to undergo apoptosis, which will prevent the mutated DNA
from being passed on to subsequent generations of daughter cells. Cells
which are actively replicating during the exposure to UV are more likely to
undergo apoptosis, this appears to be due to p53 DNA proof-reading
capability (Danno and Horio, 1987). Once activated p53 can bind directly to
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single stranded DNA and interact with the DNA replication machinery (Cox
et al, 1995). In this situation p53 can then regulate the transcription of genes
involved in cell cycle arrest (Lui and Pelling, 1995) and apoptosis
(Selvakumaran et al, 1994). Examples of the genes which p53 can control the
transcription of are p21WAFVClPl (EL-Deiry et al, 1994), GADD45 (Zhan et
al, 1994) and MDM2 (EL-Deiry et al, 1994) these genes appear to be involved
in the p53 response to DNA damage. The protein p21WAF1 is a potent
inhibitor of cyclin dependent kinase activity (Xiong et al, 1993), it can also
interfere directly with DNA synthesis (Waga et al, 1994). The protein
GADD45 can also suppress the cell cycle and stimulate nucleotide excision
repair (Smith et al, 1995, Li et al, 1997). It is known that p53 can down
regulate Bcl-2 (B-cell leukaemia-2) expression and increases Bax expression,
these actions could increase the rate of apoptosis (Miyashita et al, 1994,
reviewed in Hoffman and Liebermann, 1994).
Many proteins of the Bcl-2 family can prevent apoptosis e.g. Bcl-2, Bcl-Xl,
Bcl-w. Other members of the Bel family can drive apoptosis such as Bax, Bik,
Bak, Bad, Bid. All of these proteins commonly co-exist within cells and it is
thought that the ratio of these proteins (e.g. Bcl-2 to Bax) regulates the cells
susceptibility to undergo apoptosis (Chao and Korsmeyer, 1998). Bcl-2 has
been demonstrated to respond to the redox potential of cells and may have
antioxidant actions (reviewed in Kroemer, 1997).
The importance of UVB as an initiator of tumourogenesis, is thought to
result from its ability to cause mutations in genes which control the cell cycle
such as; proto-oncogenes for example Ras and tumour suppressor genes
such as p53. Cells in the epidermis accumulate mutations over years of
exposure to sunlight and the resulting dysfunctional genes can eventually
lead to a malignant transformation. The majority of the mutations in p53
which are found in human tumours are located in the DNA binding region
of the protein. This region contains ten cysteine residues, eight of which are
conserved, implying that they are important for the function of p53. The
cysteine residues form a loop-sheet-helix motif around a zinc atom, which
forms the DNA-binding surface of the p53. Mutations can either replace or
alter the cysteine residues, which will disrupt the correct conformation of
p53, thus abolishing wild type p53 activity. Over 90% of SCC's in the USA
were found to have mutations within the p53 gene (Brash et al, 1991). In
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BCC's mutations in p53 are also found but only in 50% of tumours (Rady et
al, 1992; Zeigler et al, 1993). BCCs have been demonstrated to over express
p53 protein, it is thought that the p53 is mutated and has an extended half
life. The mutation is thought to prevent cells from halting in cycle arrest and
proceeding through apoptosis, as p21waf/cipl is expressed in normal
epidermis following exposure to UVB, but not in neoplastic epidermis
(Urano et al, 1995; Inohara et al, 1996). The absence of p21waf/cipl will allow
tumour cells to grow in a unregulated manner and also escape the apoptotic
pathway (reviewed in Brash et al, 1996). Therefore sunlight can promote
skin cancer by first of all initiating a mutation in the DNA coding for p53,
then by promoting the growth of the altered cells by inactivating the p53
protein. As a result altered cells do not undergo apoptosis on exposure to
sunlight and do not halt in growth arrest to repair their DNA.
Terminal differentiation of keratinocytes is thought to be a specialised form
of apoptosis (Maruoka et al, 1997), because there are similarities between
terminally differentiating keratinocytes and apoptotic cells; for example,
granular keratinocytes show signs of endonuclease activation and DNA
fragmentation (McCall and Cohen, 1991). Recently however it has been
suggested that terminal differentiation, whilst similar to apoptosis is a
distinct mechanism. The differences include: the extended time needed for
keratinocytes to differentiate (days instead of hours), differentiating
keratinocytes do not fragment, unlike apoptotic cells and finally
differentiation specific keratin genes are turned on, which are not expressed
within apoptotic cells (Gandarillas et al, 1999) Apoptotic keratinocytes are
characterised by a condensed and basophilic nucleus and eosinophilic
homogenisation of the cytoplasm, they are often referred to being
dyskeratotic cells or sunburn cells (Young, 1987). Apoptotic cells in culture
also loose their cell-cell contacts, round up and develop cell surface blebs
before detaching from the cell monolayer (Malorni et al, 1994). Surface
blebbing and rounding up can be decreased by the addition of antioxidants
such as a-tocopherol (Malorni et al, 1996) and glutathione (Godar, 1999).
Keratinocytes can express Fas, FasL, TNF receptor, TNF and p53 so can
undergo apoptosis through all these described pathways.
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1.4.2 Ultraviolet Radiation induced DNA damage.
As discussed earlier in this chapter the effects of UV radiation are based on
the absorption of the radiant energy by an appropriate molecule
(chromophore). The many of the biological effects of UV exposure are
thought to be causally related the absorption of UV by DNA. The role of UV
radiation in initiation of skin carcinogenesis is well established and results
from photochemical modification of DNA. The wavelengths of UV that are
carcinogenic for human cells correspond to the absorption spectrum of DNA
(Sutherland etal, 1980).
DNA is constantly damaged by a variety of chemical and physical agents
such as UV radiation. All cells possess mechanisms for repairing DNA
damage. Most UV radiation-induced DNA damage is efficiently repaired,
but if the damage burden is too great these DNA repair mechanisms become
overwhelmed and some damage becomes fixed in the form of permanent
mutations.
Absorption of UV photons by a DNA molecule produces an excited state,
that is followed by a rearrangement of electrons to form a variety of
photoproducts. DNA absorbs UV radiation in the range 230-300nm. The
main mechanisms of UV radiation-induced DNA damage are wavelength-
dependent. Ultraviolet radiation may damage DNA directly as detected
with shorter wavelengths of UVC or UVB, or indirectly; longer wavelength
UVA acting through the formation of reactive oxygen species (ROS). The
most superficial keratinocytes of the epidermis, which receive the greatest
UV exposure, are committed to terminal differentiation as they move into
the stratum corneum. Therefore injury to these cells is not highly significant.
However, mutation of the basal-layer stem cells may result in the
development of malignancy. The process of excision repair is essential for
the repair of these lesions.
Direct DNA damage.
Cyclobutane pyrimidine dimers (CPDs) are the predominant UV
photoproduct, accounting for approximately 85% of DNA damage induced
by UVC and UVB.
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The formation of CPD involves redistribution of electrons in adjacent
pyrimidines and single-bond ring closures at the 5- and 6- positions, giving
rise to covalent cyclobutane linkage (Fig 1.7). CPDs are bulky DNA lesions
involving the chemical bonding of adjacent thymine or cytosine base pairs to
form cyclobutane rings using energy from UV radiation. Approximately
50% are found at TT sequences, 40% at TC/CT, and 10% at CC sequences.
The 6-4 pyrimidine-pyrimidone photoproduct is the second most common
UVB photoproduct, accounting for between 10-30% of UV induced lesions.
It is formed by reaction of the carbon-carbon double bond at the 5-position of
one pyrimidine with the carbon-nitrogen double bond of an adjacent
pyrimidine, resulting in covalent linkage between the 6- and 4- positions of
the respective pyrimidines (Fig 1.7).
Dewar isomers are formed through the photoisomerization of 6-4
photoproducts. This is stimulated most efficiently by UV wavelengths of
around 320 nm. Consequently it has been suggested that the majority of 6-4
photoproducts will be converted to Dewar isomers upon exposure to solar
UV radiation (Clingen et al, 1995).
Direct types of DNA damage are found in the DNA from human BCCs and
SCCs. Also patients with the hereditary condition xeroderma pigmentosum are
2000 times more likely than normal individuals to develop skin carcinomas
(Lambert et al, 1995). These patients are classically defective in the repair of
direct DNA damage (Cleaver, 1968), providing additional evidence of the
strong link between this type of DNA damage and skin cancer.
In contrast to CPDs and 6-4 photoproducts there is relatively little
information regarding the biological effects of Dewar isomers (Mitchell and
Nairn, 1988). The mutagenicity of Dewar isomers has not yet been
established in mammalian cells. However, transfecting single-strand DNA
vectors containing a single site-specific photoproduct into Escherichia coli or
Saccharomyces Cerevisae has shown the TC Dewar isomer to be more
mutagenic that the TC 6-4 photoproduct.
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The CPD (top right) is formed when the energy from UV opens the double
bonds between Carbon (C) atoms 5 and 6 of two neighbouring pyrimidine
rings and forms new bonds between them. The second major photoproduct
is the 6-4 photoproduct (bottom right). Again the double bonds of two
adjacent pyrimidines are broken however when the new bonds are being
formed one pyrimidine rotates and the new bonds form between position C4




Indirect forms of DNA damage induced by UV radiation include: oxidised or
hydrated pyrimidines (cytosine photohydrates and thymine glycols),
oxidised purines (8-hydroxyguanosine), single-strand breaks and DNA
protein cross-links (Jen et al, 1997).
Once a non-DNA chromophore is excited by the absorption of a photon, it
must transfer its energy to DNA in order to produce chemical modification
of DNA. This process may involve direct energy transfer between the
sensitiser and one of the DNA bases, which results from absorption of short
wavelength UVB and UVC or via the production of chemically reactive
intermediates such as reactive oxygen species, as is the case with longer
wavelength UVA. The main target of reactive oxygen species is the purine
base guanine. Modification of this base produces 8-hydroxyguanine which
mispairs with adenine, leading to the formation of a T-A base pair from an
original G-C base pair.
Single strand breaks.
Breaks in the sugar-phosphate backbone of DNA producing single strand
breaks can be induced by both short and longer wavelength UV radiation.
These types of DNA damage are rapidly repaired in vitro and the biological
significance in vivo is unclear.
1.4.3 Repair of UV-induced DNA lesions.
DNA photoproducts will lead to skin cancer only if they persist long enough
in basal cell keratinocytes to be fixed as mutations in subsequent rounds of
cell division. Therefore accurate DNA repair mechanisms are critical for cell
survival. The importance of accurate DNA replication has lead to the




Excision repair removes areas of damaged DNA either as single bases or
incorporated into small oligonucleotides. In both cases the repair process
consists of four biochemically co-ordinated steps. These are:
1. Excision of the damaged base by a DNA glycosylase.
2. Incision of DNA at or near the damaged site by an endonuclease.
3. Resynthesis ofDNA removed during repair using the complementary
strand as a template, by the DNA polymerase.
4. Ligation of the newly synthesised DNA to the existing strand, by a DNA
ligase.
Regardless of the mechanism by which damage is removed from DNA,
excision repair generates single stranded gaps. Repair is not complete until
the missing nucleotides are resynthesised by DNA polymerases and the
repair gaps sealed by DNA ligase (Friedberg, 1995) (Fig 1.8).
There are two sub pathways of nucleotide excision repair (NER).
Transcription-coupled repair is responsible for the rapid repair of the
transcribed strand of actively expressed genes and global genomic repair is
for the slower, less efficient repair of the bulk of untranscribed DNA
(Friedberg, 1996).
Post replication repair.
Post-replication repair pathways may be induced in response to DNA
damage and allow cells to survive large damage burdens, often at the
expense of increased mutation. Damage may still be present in the
replicating DNA and such sites could block the progress of DNA polymerase
synthesising the daughter strand. In order to avoid this, the cell activates
one or more alternative pathways that allow DNA polymerase to bypass
lesions in the parent strand, with consequent loss of information (gap) in the
daughter strand, resulting in possible mutation. These gaps can be repaired
in two different ways.
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1. A gap filling mechanism that is based on repair synthesis (error prone
repair)
2. Accurate post-replication repair when recombination is involved in filling
the gap, called post-replicative recombinational repair. In this repair
process the area ofDNA damage in one double-stranded DNA molecule
is replaced by the corresponding but undamaged sequence from the other.
Figure 1.8: Base excision repair.
Modification
DNA












The damaged base is excised by a DNA glycosylase enzyme, then the site is
incised by an endonuclease, and the gap in the DNA is filled by a DNA
polymerase enzyme and the new strand ofDNA is rejoined by a DNA ligase
enzyme.
1.4.4 Reactive Oxygen Species.
Reactive oxygen species, are thought to be involved in cancer, ageing and
various inflammatory disorders. In normal circumstances ROS usually have
a short half life, however they can react with DNA, proteins and unsaturated
fatty acids (Engelhardt, 1999). A reaction of this type can result in DNA
strand breaks, oxidative DNA damage, protein-protein and protein-DNA
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cross-linking. In their reactions with lipids, ROS can produce lipid peroxides
which persist within the cell and can lead to the initiation of free radical
chain reactions in membranes with resulting membrane destruction.
In the body ROS are generated during respiration and during the
inflammatory response. One exception is in the skin where the most
important source of reactive oxygen species is UV-radiation. In the skin ROS
can be formed directly or through (endogenous) photosensitisation reactions.
During UV exposure in the skin a wide range of reactive species can be
formed including singlet oxygen, superoxide anion, H2O2, nitric oxide,
peroxynitrite and hydroxyl radicals. The ROS formed in the skin are
thought to be involved in skin cancer, UV-induced immunesuppression and
premature skin ageing.
Hydrogen peroxide is a dangerous molecule, due to it's small size and lack
of charge it can diffuse a considerable distance and cross biological
membranes. It is formed via the reaction of superoxide and hydrogen and
this reaction is catalysed by superoxide dismutase (SOD).
SOD
2 02 + 2H+ ► H2°2 +°2
Superoxide Hydrogen
anion peroxide
The hydroxyl radical is also dangerous as it is a highly reactive and largely
indiscriminate oxidant (Darr and Fridovich, 1994). The hydroxyl radical is
formed when superoxide reacts with H2O2 in the presence of transition
metals such as iron via the reaction:
Fe2+ ► Fe3+ •
H702 + °2 ► OH + 02 + OH
Hydroxyl
radical
Singlet oxygen is also very reactive and will rapidly attack the double bonds
found in unsaturated lipids. Superoxide anion is also very reactive and is
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formed as a by product of respiration or directly by energy transfer via
exposure to UV.
O0 + e ^ o2
Superoxide
anion
Nitric oxide is generated by nitric oxide synthetases from L-arginine. Nitric
oxide can react with superoxide to form peroxynitrite, which is a potent
oxidant, which is capable of causing damage in a wide range of biological
systems. It can nitrate proteins, attack lipids and cause DNA single strand
breaks.
Fortunately the skin possesses a wide range of antioxidant defence
mechanisms to protect itself from UV-induced ROS (Fig 1.9). Flowever the
capacity of these antioxidant systems is not infinite and they can become
overwhelmed by extensive exposure to UV radiation. The limited capacity
of the antioxidant systems is supported by the fact that, following UV
exposure most of the antioxidant systems in the skin are decreased.
Therefore, following chronic exposure to UV, ROS can reach a damaging
level.
One strategy to provide photoprotection would be to supplement or enhance
the antioxidant systems.
1.4.5 Antioxidant systems in the skin.
Selenoproteins.
The family of glutathione peroxidases (GPXs) consist of four family
members. They are all antioxidant selenoproteins. Selenoprotein P and the
thioredoxin reductase are also antioxidant selenoproteins which will be
covered in depth later in the chapter.






Catalase scavenges H2O2. Following exposure to UVA and UVB the level of
catalase present in the skin is greatly reduced (Fuchs et al, 1989a and b;
Hasegawa et al, 1992; Punnonen et al, 1991). The decrease in catalase is
probably due to the irreversible oxidative damage of the enzyme. Catalase is
thought to be a less important antioxidant enzyme than GPX, as catalase-
deficient fibroblasts do not show decreased viability following exposure to
UVB (Shindo and Hashimoto, 1995). It is interesting however to note that
catalase can decrease the damage to other antioxidant enzymes during
chronic UVB exposure (Shindo and Hashimoto, 1995). When added
exogenously to tissue culture media, catalase can decrease the formation of
sunburn cells in mouse skin explants following exposure to UVB (Miyachi et
al, 1983).
Superoxide dismutase.
Superoxide dismutase catalyses the reduction of superoxide anions to the
less reactive H2O2, which in turn can be converted via the Fenton reaction, in
the presence of transition metals to produce the very reactive hydroxyl
radical. Two forms of SOD exist, with different subcellular distributions.
They are Cu/Zn SOD (Sherman et al, 1983) which resides in the cytoplasm
and MnSOD (Ho and Crapo, 1988) which is expressed solely within the
mitochondria. The level of SOD in the skin decreases following exposure to
UVB (Fuchs et al, 1989a and b; Hasegawa et al, 1992; Punnonen et al, 1991;
Miyachi et al, 1987). As seen with catalase the damage to SOD is probably a
result of direct oxidative damage to the enzyme. When added exogenously
to tissue culture media, SOD prevents the formation of sunburn cells
(Miyachi et al, 1983). However the H2O2 formed by the action of SOD is
itself damaging to cells, therefore to be protective any increase in SOD
should be ideally accompanied with an increase in CAT or GPX (Yohn et al.
1991).
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1.4.6 Non-enzymatic antioxidant systems.
Glutathione.
Glutathione is an endogenous tripeptide, it is the most abundant thiol-
containing protein in the majority of tissues. Glutathione depletion makes
cells more susceptible to cell killing by exposure to UV (Tyrrell and Pidoux,
1988). Glutathione can act directly as an antioxidant, it quenches free
radicals by donating a hydrogen atom. Glutathione is also essential as it acts
as the hydrogen donor for GPX and ascorbate. Therefore it is important in
the maintenance of several antioxidant pathways.
Glutathione is itself recycled by glutathione reductase with nicotinamide
dinucleotide phosphate (NADPH) as a cofactor. The skin contains very high
levels of glutathione reductase and it is estimated that it can successfully
recycle all the glutathione present in the skin in less than one minute. This
indicates how vital glutathione is in the skin (Conner and Wheeler, 1987).
Cysteine derivatives such as N-acetylcysteine increase the intracellular levels
of glutathione (Steenvoorden and van Henegouwen, 1997). In cultured
fibroblasts N-acetylcysteine suppresses UVB-induction of p53 but not DNA
single strand breaks (Renzing et al, 1996). It also prevents UVB induced
immunesuppression in mice (van der Broeke and Beijersbergen, 1995).
Glutathione derivatives such as glutathione-isopropylester decreases the
sensitivity of cultured cells to UVB (Kobayashi et al, 1996a) and decrease
photocarcinogenesis in mice (Kobayashi et al, 1996b).
a-tocopherol.
Alpha-tocopherol (Vitamin E) is a lipophillic endogenous antioxidant. It
provides protection against UV-induced oxidative membrane damage
(Burton and Traber, 1990). It functions as a chain breaking antioxidant in
lipid peroxidation. Alpha-tocopherol is effective against UV-induced,
immunesuppression (Yuen and Halliday, 1997; Gensler and Magdaleno,
1991; Clement-Lacroix et al, 1996), tumourigenesis (Gensler and Magdaleno,
1991), lipid peroxidation (Yuen and Halliday, 1997; Morliere et al, 1990),
sunburn cell formation (LaRuche and Cesarini, 1991), depletion of epidermal
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LCs (Yuen and Halliday, 1997), and oxidative DNA damage (Stewart et al,
1996).
Figure 1.9: Antioxidant systems in the skin.
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Antioxidant systems in the skin, phospholipid glutathione peroxidase
(PHGPX), cytoplasmic glutathione peroxidase (cGPX), lipid peroxides
(LOOH), glutathione (GSH).
1.5 Effects of UV radiation on the skin immune system.
It is thought that the skin immune system is important in the control of
certain tumours by performing an immune surveillance role, monitoring for
changes associated with cellular transformation. In order for the
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transformed cell to evade the immune system, the immune system itself
would have to be weakened in some way. The phenomena of UV-induced
modulation of tumour immunity was first reported by Kripke and co¬
workers in 1977. They discovered that UV-induced murine skin tumours are
highly immunogenic and are therefore rejected upon inoculation into naive
syngenic hosts. However the tumours grew progressively if the recipient
had been UV-irradiated prior to receiving the tumour, with subcarcinogenic
doses of UV radiation (Kripke and Fisher, 1976; Fisher and Kripke, 1977;
Kripke, 1994). Further evidence that immunesuppression plays a role in skin
carcinogenesis, comes from data on renal allograft recipients receiving
immunosuppressive drugs. These individuals have a highly increased risk
of developing SCCs, which are generally found on sun-exposed sites
(Hartevelt et al, 1990). Therefore UVB appears to have a role in both tumour
initiation by causing DNA damage and as a tumour promoter by inhibiting
tumour surveillance and hence can be described as a complete carcinogen
(Brash et al, 1996).
It has been suggested that DNA damage can itself induce immune
suppression via the production of immunoregulatory cytokines (Kripke et al,
1992). Application of the DNA repair enzyme T4 endonuclease V
encapsulated in liposomes, onto UV-irradiated skin of mice prevents the loss
of LC from the skin and reduces local immune suppression (Wolf et al, 1995).
It has also been demonstrated that DNA damage in keratinocytes induces
the release of immunomodulatory cytokines (O'Connor et al, 1996), resulting
in immune suppression respectively.
Although cytokines are not expressed constitutively by keratinocytes in vivo
they can be induced by a variety of stimuli. Furthermore, expression of cell
surface molecules such as, MHC class II antigens or ICAM-1 are induced on
keratinocytes in inflammatory reactions of the skin (Barker et al, 1990). MHC
class 11+ keratinocytes can also present bacterial superantigens,
Mycobacterium leprae and herpes simplex virus antigens to T cells in vitro
(Nickoloff et al, 1994; Cunningham et al, 1989), thus emphasising the
potential role of keratinocytes in regulating the skin immune system.
Many cytokines are released from keratinocytes following exposure to UVB
these include, IL-la which is involved in the pro-inflammatory reaction and
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induces fever, inflammation, erythema and the release of other cytokines
from both keratinocytes and fibroblasts (Sauder et al, 1982). Another pro¬
inflammatory cytokine which is released following exposure to UV is IL-6, it
can induce acute phase proteins, fever and keratinocyte proliferation (DeVos
et al, 1994). IL-8 is also induced following exposure to UV radiation, it
functions as a chemoattractant for neutrophils (Kondo et al, 1993).
Other cytokines which are induced following exposure to UV have
immunosuppressive functions. IL-10; has been shown to be
immunosuppressive and can suppress inflammatory cytokine synthesis. IL-
12 is important in mediating cell-mediated immune responses (reviewed in
Duthie et al, 1999).
TNF-a is also upregulated following exposure of the skin to UV, it has been
proposed to initiate the movement of LCs from the skin to the draining
lymph nodes (Cumberbatch and Kimber, 1995). IL-ip has also been
implicated in the migration of LCs to the draining lymph nodes
(Cumberbatch et al, 1997). It is thought that IL-1 (3 is mainly LC-derived and
can upregulate epidermal TNF-a (Enk et al, 1993). The effects of cytokines
on LCs can be seen in Fig 1.10. TNF-a as well as being involved in LC
migration is also a potent inflammatory cytokine and induces prostaglandin
and collagenase release. Exposure to UV has other effects on LCs: they can
loose their dendrites, show a decreased ability to present antigens and if
badly damaged following exposure can undergo apoptosis (Rattis et al, 1998)
(Fig 1.11). All of these effects lead to a decreased immune response to
antigens.
The main functions of these UV-induced cytokines will be discussed further
in Chapter 6 and 7, however some of the functions of the UV-regulated
cytokines are illustrated in Fig 1.12.
One of the most widely used methods for studying immune suppression in
mice is the contact hypersensitivity method (reviewed in Beissert and
Schwartz, 1999). A sensitising chemical is applied to the skin, the antigen of
choice is taken up and processed by the LCs, which migrate to the draining
lymph nodes, were they present the antigen to T cells. The T cells proliferate
and differentiate into an effector population. When the antigen is applied a
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second time either to the same site or a different one, an immune response
occurs to clear the antigen and tissue swelling occurs. The swelling can be
measured, if the site of application is the ears, ear swelling can be measured.
If the mice are irradiated prior to the first exposure of antigen then the
observed immune response is greatly decreased, this is accounted for by
immunosuppression caused by UVB (Moodycliffe, 1994, Toews et al, 1980).
The use of contact hypersensitivity is a versatile method for studying the
immunosuppression induced by UV. TNF-a is thought to be involved in
local immunosuppression by UV, perhaps by inducing LC to migrate from
the epidermis (Moodycliffe et al, 1994,). The cytokine IL-10 is an important
mediator of systemic immune suppression following exposure to UV (Rivas
and Ullrich, 1992).
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Effects of keratinocyte cytokines on LCs (adapted from Kondo, 1999).
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Figure 1.11: Effect of UVB on LCs in the skin.
UVB
LCs once irradiated; migrate from the epidermis, thus leaving a reduced LC
population to provide antigen presentation. Also LCs can be damaged by
LTV and show a decreased ability to present antigens. Antigen presenting
cells (APCs) present antigens to T cells in the draining lymph-nodes. Finally
soluble factors produced by keratinocytes (KCs) following exposure to UVB
can lead to systemic immunesuppression (adapted fromMeunier, 1999).
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Figure 1.12: Cytokines released from keratinocytes following
exposure to UV radiation.
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their receptors on immune cells
Autocrine and paracrine effects of some the cytokines released from
keratinocytes (KC) following exposure to UV radiation (adapted from
Kondo, 1999).
1.6 Transcription factor activation by UV radiation.
Many transcription factors are also activated by exposure to UV radiation.
The c-jun and c-fos proto-oncogenes are both rapidly induced following
exposure to UV. The jun and fos gene products form heterodimers called
activator protein-1 (AP-1), a transcriptional activator that binds to either the
TPA response element or the AP-1 sites on genes and subsequently up
regulates many other UV inducible genes (reviewed by Foletta et al, 1998)
(Fig 1.13). AP-1 activates many genes including; IL-4, -5, -3, -6, -8, -ip, TNF-
Another transcription factor nuclear factor kappa B (NFkB) is found in the
majority of cell types. It is composed of a family of five different proteins,
which form dimers in the cytoplasm of cells, examples of this family are p50
a.
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and p65. Within the cytosol, NFkB is kept inactive by binding to the
inhibitory complex IkB. On receiving an activation signal NFkB dissociates
from IkB and moves into the nucleus, where it can activate gene
transcription of many genes including; IL-la and (3, IL-2, -3, -6, - 8, -12 and
TNF-a to name a few (reviewed in May and Ghosh, 1998; Ghosh et al, 1998)
(Fig 1.14). NFkB can also be activated in enucleated cells, this suggests that
the activation signal occurs at the cell membrane.
Other signal transduction proteins which are activated by UV include: Src
tyrosine kinases (Devary et al, 1992), Ras (a small GTP binding protein)
(Engelberg et al, 1994), JNK-1 (Derijard et al, 1994), GADD and MAP kinases.
Exposure to UV can also lead to the activation of phospholipase A2 (Hawk et
al, 1983; Hanson and Deleo, 1989,1990). Phospholipase A2 activation leads
to the release of archadondic acid from membrane phospholipids and plays
an essential role in the generation of inflammatory intermediates such as,
leukotrienes and prostaglandins (Tyrrell, 1996). Furthermore, there is
considerable evidence that UVB radiation can lead to prostaglandin E2
synthesis via pathways which can be inhibited by antioxidants (Miller et al,
1994).
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Figure 1.13: Transcriptional activation following exposure to
UVB.
UVB
AP-1 and NFkB activation following exposure to UVB. c-fos and c-jun are
activated and form a dimer which can then bind DNA and activate the
transcription of other genes. IkB is phosphorylated, IkB dissociates and




The trace element Selenium (Se) was discovered by Jacob Berzelius in 1817
and was named after Selene the Greek goddess of the moon. It is in group
VI of the periodic table, below sulphur and has an atomic weight of 78.96. It
shares many properties with sulphur, they are both of similar atomic size,
bond energy and electron affinities. It is a metalloid and has semi¬
conducting properties. Se exists naturally in a range of oxidation states as
volatile species or analogues of organic sulphur compounds, the properties
of which are described in Table 1.1.
Table 1.1: Oxidative states in which Se is found (adapted from
Foster and Sumar, 1997).
Form Occurrence Properties
Selenate (SeC>4) Alkaline waters, soils, Soluble, stable in
plants, food chain alkaline /oxidising
conditions.
Selenite (SeC>3) As above Readily oxidised by
alkali pH, oxygen.
Readily reduced by SO2,
ascorbic acid.








Elemental Se (Se) Unavailable to plants Forms complex bonds





Selenium is widely used in industry in photocopying machines, light meters,
it is used in stainless steel production, vulcanising rubber and it is added to
many anti-dandruff shampoos.
At low levels it is an essential element necessary for the growth of animals
and humans. However at higher concentrations it can be toxic. Selenium's
nutritional value was first discovered in 1957 when it was found to prevent
liver necrosis in vitamin E-deficient rats (Schwartz and Foltz, 1957). In 1973
the role of Se in the antioxidant enzyme glutathione peroxidase (GPX) was
discovered (Rotruck et al, 1973).
Se is mainly ingested as selenoamino acids (selenomethionine and
selenocysteine) from plants and animals (Spallholz, 1994) or as
methylated/non-methlylated Se (Table 1.2). Selenoamino acids are then
transported across the gut via amino acid transport proteins. Most forms of
Se are then converted to hydrogen selenide in the body then incorporated in
to selenoproteins (Fig 1.14). Excess Se can be methylated to mono, di or
trimethyl, Se. Trimethly Se is excreted by the kidneys through the urine, and
the dimethyl form is exhaled.
In Se supplementation trials, both organic and inorganic forms of Se are
rapidly absorbed. However organic forms are retained for longer, and reach
higher concentrations. This maybe due to the incorporation of
selenomethionine into non-specific cellular proteins, instead of methionine
(Waschulewski and Sunde, 1988). Inorganic forms of Se increase the level of
platelet GPX more rapidly than organic forms (Neve, 1995; Brown et al,
2000).
The bioavailability of Se can be dependent on the levels of methionine in the
diet, total protein content, restricted diet intake, presence of heavy metals
and the levels of some sulphur compounds.
Se occurs in all human tissues especially the liver and kidney at an average
level of about 0.2 pg/g. It can be either be incorporated covalently into
selenoproteins whose active sites contain Se as selenocysteine. Alternatively
Se may be loosely bound into Se-binding proteins, or incorporated non-
specifically as selenomethionine instead of methionine.
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Table 1.2: Most common Se compounds (adapted from Foster
and Sumar, 1997).
Form Dietary Se compounds Characteristics
Inorganic Sodium selenite, Readily absorbed




Sodium selenate, selenic More stable
acid











Se status is usually assessed by measurement of Se in whole blood or it's
fractions. GPX activity can also be measured in erythrocytes. However GPX
expression in erythrocytes reaches a plateau and so it is of little use for
assessing high Se intake. In practice measurement of plasma Se is the most
commonly used method to assess Se status (Neve, 1995). Se is mainly
excreted in urine, so urine measurements can be of use in the assessment of
Se status. Many studies have used nail and hair samples as a measure of
long term Se status, since the amount of Se in the nails increases after Se
supplementation.
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(adapted from Ip and Ganther, 1990).
Excreted in Urine
The levels of Se in foodstuffs varies considerably depending on the
concentration of Se found in the underlying soil. Regions of the world with
very low soil Se (<0.05 ppm) include, Denmark, Eastern Finland, North East
and Southern central China. Less severe deficient areas have been reported
in Western Australia, New Zealand and the USA. The average daily intake
of Se also varies depending on the Se levels in general food products. In the
USA the daily average intake is 132 pg/day, whereas in Britain it ranges
from 34 pg- 43.7 pg/day and in Scotland is about 48.7 pg. The average daily
intake of Se in the UK has been decreasing over the last 30 years and in the
1970s it was around 60 pg/day (Rayman, 1997). The recommended daily
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intake in the USA is 70 jag/day (Levander, 1997). This level is aimed to be
sufficient to increase the level of GPX in the plasma to plateau levels.
However this may be an underestimate of how much Se is required for
optimal health and for other selenoproteins to reach their maximal
expression (Neve, 1995). The Food and Nutrition Board of the US National
Research Council estimate the safe and adequate Se intake for adults is 50-
400 pg/day (Levander, 1983). The highest levels of Se in the diet are found
in Brazil nuts (124 pg/lOOg), kidney (146 pg/lOOg) and crab meat (84
pg/lOOg), whereas levels in dairy products were lower (below 2 pg/lOOg).
1.8 Selenium deficiency.
Se deficiency in cattle and livestock is associated with white muscle disease
(Oldfield, 1987). It is a localised myopathy associated with depigmentation
and calcification. Se deficiency in humans (<11 pg/day) is associated with
Keshan disease, a myocardiopathy associated with children and young
adults. In Heilongjiang province in China the disease was rampant in the
1930-1960s. During the 1960s task groups were set up to study the problem
and Se deficiency was found to be a major factor. The disease occurred in
focal patches in a belt from the Northeast to the Southeast of China. The
disease primarily struck children under five. One factor which suggests that
Se deficiency was not the only causal factor, was the seasonal occurrence of
the disease. The disease peaked in the Northeast in winter and in the
Southeast in summer. Features of the disease include chronic cardiac
insufficiency, heart enlargement, gallop rhythm, arythmia, multifocal
necrosis and fibrous replacement of the myocardium. Since 1974 table salt
has been supplemented with selenite in areas of China with low soil Se levels
and the disease has virtually been eradicated, with only 45 cases reported in
1990 in the whole of China (Yang et al, 1984). It is thought that low Se intake
and oxidative stress are causal factors in this disease. Lack of other
antioxidant nutrients are also thought to play a role as well. Exposure to
coxsackie virus is thought to be a factor in the pathogenesis of Keshan
disease; the virus causes more damage to Se-deficient heart tissue. It has also
been demonstrated that the non-virulent form of the virus, can become
virulent when passaged through a Se-deficient host. The mechanism for this
is not presently known, however it has been hypothesised that the viral RNA
may undergo free-radical induced alteration in the Se-deficient host
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(Levander and Beck, 1997). Indeed the nucleotide sequence of the non-
virulent virus closely resembles the virulent form following passage through
a Se-deficient host (Beck and Levander, 1998). There have been further
suggestions that Se deficiency may exacerbate other viral infections
including; influenza, hepatitis and human immunodeficiency virus (Baum et
al, 1997).
Another disease found in areas with low levels of Se in the soil is Kasin-Beck
disease (osteoarthritis deformans endemica) or enlarged joint disease. It
occurs in northern China, North Korea and eastern Siberia. It affects mainly
children aged 5-13 years. It starts as limb weakness, stiffness of the joints,
swelling of the joints and progresses to joint enlargement and dysfunction by
30 years of age (reviewed in Levander, 1987). Again the disease can be
prevented by Se supplementation.
Se deficiency has been linked to an increased risk of artherosclerosis and
other forms of cardiovascular disease. This maybe due to increased levels of
free radicals, oxidised low density lipoprotein and lipid peroxidation.
Selenium deficiency also leads to abnormal sperm structure and reduced
fertility (Becvana and Bahuguna, 1994). Children fed intravenously long
term also show signs of Se deficiency including hair loss, myopathy and
macrocytosis.
Epidemiological studies have suggested that there is a higher incidence of
colon, stomach, bladder, ovarian, pancreas, oesophagus, breast and other
types of cancer in areas with low Se in the soil (Shamberger and Willis, 1971;
Schrauzer et al, 1977a and b; Yu et al, 1991; Knekt et al, 1990).
1.9 Selenium supplementation trials.
Following publication of experimental evidence in animal models which
suggested that Se supplementation decreased tumourigenesis, several
human trials have been carried out. The largest trial was carried out by
Clark et al, 1996 who reported a lower incidence of colorectal, lung, and
prostate cancer rates in patients supplemented with Se. The trial was carried
in Se-poor regions of the USA. In the study 1300 patients with a history of at
least 2 skin cancers, were given either placebo tablets or Se tablets in the
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form of 200 pg Se/day of a Se enriched brewers yeast. The trial was fully
randomised and was carried out over a 10 year period. During the trial the
average plasma Se level had increased by 67% with no signs of toxicity.
They found a 37% reduction in the incidence of total cancers, a 50% decrease
in cancer mortalities and a 17% decrease in total deaths. There were
significant reduction in the numbers of patients with prostate (63%),
colorectal (58%), and lung cancers (46%) in the Se supplemented group
(Clark et al, 1996). They found no effect on the levels of skin cancers. An
earlier trial in China had shown a 35% decrease in hepatoma incidence in
patients receiving Se supplements (Yu et al, 1990).
Another large scale supplementation trial was started in 1994 in France
(SUVIMAX trial). The trial is to be carried out for 8 years on 15,000 people to
investigate whether Se and Zinc supplementation reduces the incidence of
cancer and heart disease. The PRECISE trial is the most recent Se
supplementation trial, it is about to begin in the UK, Denmark, Sweden,
Finland and the USA. There will eventually be 40,000 patients recruited and
they will receive either 100, 200 or 300 pg of Se a day, the trial will last for 5
years and will study the mortality rate in all of the groups.
Se supplementation has been suggested for many medical conditions,
including, cataracts, malaria, alopecia areata, muscular dystrophy, and male
infertility. It has also been suggested that Se supplementation can improve
arthritis (Tarp et al, 1985,1995).
Several theories have been offered to explain the protective effects of Se in
human health. They include prevention of carcinogen-induced oxidative
damage, alterations in carcinogen metabolism and selective toxicity to
rapidly dividing tumourogenic cells. It has been demonstrated that selenite
and selenomethionine at high levels (pM) protect against tumourogenesis. A
whole range of new synthetic forms of Se compounds are presently being
produced and tested for their anti-tumourogenesis effects. One such
compound is l,4-pheylenebis(methylene)selenocyanate (p-XSC). This
compound has low toxicity and can inhibit tumourogenesis in mammary
glands, the colon and the lungs in experimental animals (El-Bayoumy et al,
1995).
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The longest wide scale Se supplementation programme is running in
Finland, where a program of nation-wide Se supplementation (as sodium
selenate) in fertilisers has been ongoing since 1984. It was decided to
supplement fertilisers in Finland with Se due to the very low levels of Se in
the soil, which lead to food products containing low levels of Se. The plasma
Se levels in the Finnish population were very low in the 1970s and there was
a high prevalence of heart disease and cancer. The Se content of plasma in
Finland was between 0.63-0.76 pM in 1970 and has now risen to 1.40 pM
(Varo et al, 1993).
1.10 Selenium toxicity.
Although Se is an essential element at high levels it can become toxic. Se
toxicity is dependent on the type of Se, and species of animal. In humans the
symptoms are garlicky breath odour which is due to exhaled dimethly
selenide, brittle nails, discolouration of the nails and hair loss (Bedwal et al,
1993). Some parts of China have very high levels of Se in the soil, where
daily intake can be as high as 900 pg/day. In Britain the recommended
maximum safe amount of Se is 450 pg/day. Selenosis in animals can result
in hoof rot, blind staggers due to weakness of the forelimbs, alkali disease
and alopecia. Certain plants from the Astragalus genus can be toxic to cattle
due to their ability to accumulate Se.
The toxicity of high levels of Se, is thought to be due to its prooxidant ability
to catalyse the oxidation of thiols and simultaneously generate superoxide
(Spallholz, 1994). Cytotoxic Se compounds include; selenite and
selenocysteine, which can generate superoxide and lead to an increase in
oxidative DNA damage in the cell leading to apoptosis (Stewart et al, 1999).
Selenite can also react with glutathione to produce selenodiglutathione, a
very reactive compound, which has antiproliferic and apoptosis inducing
properties (Wu et al, 1995a). Selenomethionine is not cytotoxic to cells even
at high concentrations as it is a non-redoxing, Se compound which does not
produce superoxide (Stewart et al, 1999). High levels of cytotoxic Se
compounds have been shown to be anticarcinogenic in some animal models
(Medina, 1986 and 1988; Ip, 1986). The mechanism of this anticarcinogenic
effect is unknown but many theories have been suggested. One such
hypothesis is that the high levels of some Se compounds, for example
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selenite, inhibits the growth of tumour cells. Another possibility is that
methylated Se derivatives inhibit crucial redox enzymes or can metabolise
chemical carcinogens (Lanfear et al, 1994). Selenite and selenodiglutathione
have also both been shown to inhibit ribonucleotide reductase activity at
high levels (10 pM), inhibition of de novo synthesis of deoxyribonucleotides
prevents cell cycle progression and leads to an accumulation of cells in S
phase. This accumulation of cells in S phase does occur at high levels of
selenite (Spyrou et al, 1996).
1.11 Selenoproteins.
It is now recognised that Se exerts many of its actions through the expression
of a number of selenoproteins, in which Se is covalently linked within the
protein, as selenocysteine (Cone et al, 1976). Replacing selenocysteine with
cysteine results in a sharp decline in activity of selenoproteins (Axley et al,
1991; Rocher et al, 1992). Thus the effective function of these enzymes
depends on insertion of the selenocysteine residue. The Se atom of
selenocysteine is more reductive than the sulphur atom of cysteine, in part
because it is fully ionised at physiological pH in contrast to cysteine
containing sulphur. At least 30 selenoproteins have been identified by SDS-
polyacrylamide electrophoresis of 75Se-labelled tissue. However only
approximately fourteen have been characterised.
1.11.1 Selenoprotein synthesis.
The synthesis of selenoproteins in prokaryotes is dependent on the products
of 4 genes Sel A, Sel B, Sel C, and Sel D (Burk and Hill, 1993; Burk, 1991).
The Sel C gene product is a unique form of transfer RNA (tRNA) which acts
as a serine/phosphoserine carrier and recognises the UGA stop codon for
selenocysteine insertion. The Sel A gene codes for a pyridoxal phosphate
-containing, selenocysteine synthetase enzyme which converts the serine on
the tRNA, specified by the Sel C product to selenocysteine in the presence of
the product from the Sel D protein. The Sel D product requires ATP and
magnesium for it's activity, and is thought to produce phosphoselenoate.
The serine is first phosphorylated to phosphoserine before the phosphate
group is substituted with Se, as phosphoselenoate to produce selenocysteine
tRNA. The Sel B product is required for co-translation and insertion of
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selenocysteine into proteins and is similar to the elongation factor-Tu which
transports amino acid tRNAs to the ribosome.
In addition to a UGA codon a specific 3'-untranslated segment referred to as
the selenocysteine insertion sequence (SECIS), needs to be present in the
mRNA to allow the UGA codon to read for selenocysteine and not for
termination of translation (Berry et al, 1997; Low and Berry, 1996). The
sequences are variable for different selenoproteins, however they are
thought to serve a common purpose. The insertion sequences create a stem
loop structure, which allows recognition of the UGA codon as a
selenocysteine instead of a termination codon. In prokaryotes the SECIS is
adjacent to the UGA codon, however in eukaryotes it is located in the 3'
untranslated region (Stadtman, 1996). Parts of the mechanism for insertion
of selenocysteine into selenoproteins has been characterised and it appears to
be similar to that in prokaryotes. A specific tRNA has been isolated, SECIS
elements are present and elongation factors have been isolated in the
mammalian system.
1.11.2 Hierarchy of selenoproteins.
There is an important hierarchy of Se supply to tissues during Se deficiency,
the thyroid, brain, skin and lymph nodes retain the element, whilst it is
rapidly lost from liver, kidneys and muscle (Arthur et al, 1993; Beckett et al,
1993; Bermano et al, 1995; Calomme et al, 1995; Thompson et al, 1995). In
addition there is a an important hierarchy of Se supply to different
selenoenzymes within tissues, such that loss of expression of cyGPX occurs
before most other selenoproteins..
1.11.3 Selenoprotein P.
Selenoprotein P is an extracellular glycoprotein, that makes up one third of
the total Se in human plasma and it is thought to have an antioxidant
defence role (Burk et al, 1995). Selenoprotein P can protect the liver from
diquat-induced liver necrosis in mice (Burk et al, 1991). Selenoprotein P is
secreted into the plasma by the liver (Burk and Hill, 1999). There is evidence
to suggest that one possible function of selenoprotein P is to protect
endothelial cells from oxidative damage (Burk et al, 1997). The protein has a
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molecular mass of 55 kDa and has been shown to contain 10 in-frame
selenocysteine residues (Hill et al, 1991). It also contains two SECIS motifs in
the 3' untranslated region. The protein can exists as several isoforms, one
isoform being formed by termination of translation after insertion of 2
selenocysteines (45 kDa). Another isoform is formed following termination
after insertion of all 10 selenocysteine (55 kDa) (Chittum et al, 1996). The
expression of the protein is modulated by Se status (Yang et al, 1989).
1.11.4 Iodothyronine 5-deiodinases.
The family of iodothyronine deiodinases (Types I, II and III) are all
selenoenzymes. Type 1 iodothyronine 5-deiodinase (IDI) is responsible for 5'
monodeiodination and thus conversion of the prohormone thyroxine to the
active hormone triiodothyronine. Type -I IDI can also catalyse 5-
monoidination and thus convert thyroxine to the inactive isomer of reverse
triiodothyronine. The enzyme is a homodimer and each 27 kDa subunit
contains one selenocysteine (Arthur et al, 1990; Berry et al, 1991). Type I-IDI
is found in high levels in the liver, kidney, thyroid and muscles, it carries out
local 5 and 5' deiodination. During Se deficiency the levels of thyroidal IDI
are conserved, whereas hepatic IDI levels decrease (Arthur et al, 1993;
Beckett et al, 1993). Type II-IDI in comparison to type I-IDI carries out only 5'
deiodination, whilst Type III-IDI catalyses only 5-deiodination (St. Germain
and Galton, 1997).
1.11.5 Selenoprotein W.
Selenoprotein W was first found as a component of skeletal muscle protein
(Vendelandef al, 1993), loss of selenoprotein W expression occurs prior to the
onset of white muscle disease in Se deficient cattle. Four isoforms have been
found, each having one Se atom per molecule. The molecular weights are
9550, 9596, 9858 and 9898 daltons. Selenoprotein W expression is found in
greatest quantities in the brain, muscle, testis and spleen. It may have a
redox function as it has been isolated with glutathione (Burk and Hill, 1999).
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1.11.6 Novel Selenoproteins.
Recently a novel 15 kDa selenoprotein has been discovered which is found at
high levels in the prostate (Gladyshev etal, 1998).
1.11.7 Selenium-binding proteins.
These proteins covalently bind Se in an unknown form which is not
selenocysteine. The biological significance of the Se is unknown and the
activity of these proteins are not regulated by Se status (Wu et al, 1995b).
Proteins of this type include protein disulphide isomerase, which is involved
in protein folding (Sinha et al, 1993), a 15 kDa protein called fatty acid
binding protein (Bansal et al, 1989), and a 56 kDa protein (SP56) which is
closely related to acetaminophen-binding protein (Lanfear et al, 1993).
1.11.8 Glutathione peroxidases.
Several forms of GPX have been discovered these include cytoplasmic GPX
(cGPX), phospholipid hydroperoxide GPX (PHGPX) (Ursini et al, 1985),
plasma or extracellular GPX (EGPX) (Takahashi and Cohen, 1986) and
gastrointestinal (gGPX) (Wingler et al, 1999)
The family of GPXs detoxify a wide range of lipid peroxides and hydrogen
peroxide to produce water and the corresponding alcohol in the presence of
reduced glutathione (Roetruck et al, 1973; reviewed in Brigelius-Flohe, 1999).
Cytoplasmic GPX.
The first functional selenoprotein to be discovered was cytoplasmic GPX, it
compromises of four identical subunits, each with a molecular weight of 21-
26 kDa (Gladyshev and Hatfield, 1999) and containing one selenocysteine
residue (Roetruck et al, 1973). Cytoplasmic GPX may also acts as a reservoir
for Se (Burk, 1991; Sunde, 1990). Cytoplasmic GPX is expressed by most
tissues in the body. The importance of cGPX is unclear as mice which are
deficient in cGPX develop normally and appear to cope with hypoxia (Ho et
al, 1997). However other groups have reported that cGPX knockout mice are
more susceptible to oxidative stress (Cheng et al, 1999; Fu et al, 1999).
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The mRNA for cGPX has a guanine base immediately following the UGA
coding for insertion of Se into the protein (Low and Berry/ 1996). This
terminator purine has been proposed to favour termination when
selenocysteine-tRNA is limiting (McGaughan et al, 1995; Allan et al, 1999). It
has also been proposed that cysteine substitutes for selenocysteine and is
incorporated into the protein during periods of Se deprivation. The cysteine
containing protein is less active than the Se containing form of the protein
(Berggren et al, 1997). Se depletion in some cell types leads to a decreased
half-life of cGPX mRNA but not PHGPX mRNA (Bermano et al, 1995;
Bermano et al, 1996a).
Phospholipid hydroperoxide GPX.
PHGPX is monomeric and has one Se atom per molecule, it has a molecular
weight of 20-23 kDa (Ursini et al, '1985; Schuckelt et al, 1991). It occurs in
plasma, breast milk, the heart, liver and lung levage. The protein PHGPX
has been suggested to have an antioxidant activity in extracellular fluids.
The protein may have a role in protection against cardiomyopathy and
Keshan disease. Unlike cGPX, PHGPX can metabolise phospholipid
hydroperoxides, lipid peroxides and low density lipoprotein and is believed
to prevent damage to membranes (Ursini et al, 1985; Maiorino et al, 1991).
PHGPX would appear to have a role in modulating leukotriene biosynthesis
(Weitzel and Wendel, 1993; Schnurr et al, 1996; Imai et al, 1998; Huang et al,
1998). During Se depletion the activity of PHGPX is decreased, however the
rate of this decrease in activity is significantly slower than that for cGPX
(Weitzel et al, 1990). When PHGPX is transfected into cells it provides
protection from lipid hydroperoxide-mediated cell injury (Sun et al, 1997).
The expression of the protein and it's activity increase on addition of Se.
PHGPX also plays an important role in spermatogenesis. The protein for
PHGPX is present in spermatids as a soluble enzyme exhibiting high
activity, however during spermatogenesis the PHGPX polymerises. The
PHGPX becomes an inactive cross-linked insoluble protein which is bound
to the mitochrondrial capsule (Ursini et al, 1999).
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Extracellular GPX and gastrointestinal GPX.
Extracellular GPX was recognised as an enzyme distinct from cGPX in 1986
(Takahashi and Cohen, 1986). EGPX is also referred to as plasma GPX, and
it consists of four identical 23 kDa subunits, each of which contains one
selenocysteine. The function of EGPX is currently unknown, however it is
known to be secreted by the kidneys, heart and lung.
Gastrointestinal GPX is found in the liver and gastrointestinal tract in
humans. It is thought to decrease the absorption of hydroperoxides (Chu et
al, 1993; Wingler et al, 1999). During Se deficiency the mRNA and the
protein levels for GI-GPX remain stable, therefore Se is preferentially
channelled to this selenoprotein (Wingler et al, 1999).
Skin GPX.
Recently a novel form of GPX has been found in the skin (Frank et al, 1997),
this protein is upregulated by keratinocyte growth factor and is thought to
be produced by fibroblasts and keratinocytes. It is thought that the protein is
involved in wound repair, however this protein is not an selenoenzyme
(Munz et al, 1997). The gene for this novel form of GPX has only slight
identity to other GPX genes.
1.11.9 Thioredoxin Reductase.
Thioredoxin reductase is a flavin adenine dinucleotide-containing enzyme
found in all organisms which, in conjunction with it's substrate thioredoxin,
forms a redox system which has multiple functions including detoxification
reactions (Holmgren and Bjornstedt, 1995; Tamura and Stadtman, 1996;
Gladyshev et al, 1996). Thioredoxin reductase is a member of a larger family
of pyridine nucleotide-disulphide oxidoreductases, which include lipoamide
dehydrogenase, glutathione reductase (GR) and mercuric ion reductase
(Zhong et al, 1998). The molecular mass of TR is 58 kDa and it has a dimeric
structure, with each subunit containing a selenocysteine residue near the
carboxyl terminus. (Gladyshev et al, 1996). Thioredoxin reductase reduces
oxidised thioredoxin (a small multifunctional and ubiquitous protein) to
reduced thioredoxin using NADPH as a cofactor. Protein disulphide
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isomerase is also a substrate for TR (Lundstrom and Holmgren, 1990). The
selenocysteine residue in the protein is essential for the reduction of
thioredoxin (Gasdaska et al, 1996; Marcocci et al, 1997). Furthermore TR and
thioredoxin have been shown to have growth regulating effects on cells
(Berggren et al, 1996; Gallegos et al, 1996; Gasdaska et al, 1999). Thioredoxin
and TR catalyse the transport of electrons to ribonucleotide reductase and
other reductive enzymes. Ribonucleotide reductase is involved in the direct
reduction of ribonucleotides to deoxyribobonucleotides, this is the rate-
limiting step in DNA synthesis (Thelander and Reichard, 1979). Thioredoxin
reductase can also detoxify lipid hydroperoxides and hydrogen peroxide
(Bjornstedt et al, 1995a) (Fig 1.15). Thioredoxin reductase appears to have
greater capacity to detoxify H2O2 and lipid peroxides than GPX. This
suggests that one important function of TR is to protect cells from the
oxidative damage of H2O2 and lipid hydroperoxides.
A number of TR enzymes have been sequenced from human placenta
(Gasdaska et al, 1995), Jurkat cells (Gladyshev et al, 1996) and lung
adenocarcinoma cells (Tamura and Stadtman, 1996). Recently it has been
reported that three isoforms of TR exists. Two isoforms from rat liver have
recently been cloned and sequenced.
As for other selenoproteins Se status can modify TR expression and activity
(Berggren et al, 1997; Gallegos et al, 1997). A 3-untranslated region, stem-
loop sequence has been identified that may function as a putative SECIS
(Brigelius-Flohe et al, 1994; Powis et al, 1997). Selenium deficiency can lead
to a decrease in the levels of mRNA for TR and to incorporation of cysteine
instead of selenocysteine into the protein (Gallegos et al, 1997). During Se
deficiency in rats TR activity in the liver was found to decrease, whilst TR
levels in the brain remain unchanged (Hill et al, 1997). Also in vivo, TR
activity in rat liver, lung and kidney undergoes transitory increased
expression when these animals are fed a high Se diet (Berggern et al, 1999).
Changes in Se status, therefore result in altered expression of TR enzyme,
which in turn may alter the growth characteristics or change the detoxifying
capacity of the cell, leaving cells exposed to oxidative damage.
Thioredoxin reductase may also have effects on other antioxidant systems, it
can induce manganese superoxide dismutase (Das et al, 1997) and regenerate
1-51
ascorbate from dehydrascorbate (May et 1997). The regenerated ascorbate
can itself regenerate a-tocopherol from a-tocopherol semiquinone (Tamura
et al, 1995), TR can also act as an electron donor to plasma GPX for the
reduction of hydroperoxides (Bjornstedt et al, 1994).
Figure 1.15: Thioredoxin reductase and glutathione peroxidase
activity in the skin.
High levels of selenite and selenodiglutathione are efficient oxidants of
thioredoxin and can inhibit the function of the thioredoxin system
(Bjornstedt et al, 1992; Kumar et al, 1992; Bjornstedt et al, 1995b). The
inhibition of the thioredoxin system then leads to an inhibition of its many
functions, such as the inhibition of ribonucleotide reductase and general
protein disulphide reductase activity. These effects of the thioredoxin
system may help to explain the growth inhibitory functions of high levels of
some Se compounds (Bjornstedt et al, 1992; Ganther, 1999).
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Extensive work has been carried out on the importance of the
thioredoxin/TR system within the epidermis. Thioredoxin reductase is
present on the plasma membrane of keratinocytes and melanocytes and it
can protect the epidermis from the damaging effects of reactive oxygen
species (Schallreuter and Wood, 1986; Schallreuter et al, 1986a). There is a
link between reduction of free radicals by TR and melanin biosynthesis by
melanocytes (Schallreuter and Wood, 1986). Schallreuter and Wood
reported a direct correlation between TR activity and skin pigmentation.
Thioredoxin reductase activity in patients with skin type VI (highly
pigmented) is five fold higher than that found in patients with skin type I
(fair skin) (Schallreuter et al, 1987). Thioredoxin reductase and thioredoxin
levels increase in the skin following exposure to oxidative stress
(Schallreuter et al, 1994). Furthermore TR can reduce superoxide to water
and H2O2 (Schallreuter and Wood, 1986). Subsequently TR can reduce H2O2
to water (Schallreuter and Wood, 1989).
1.12 Selenium and the immune system.
Selenium can augment the activity of the immune system (reviewed in
Spallholz et al; 1990; McKenzie et al, 1998). Mice maintained on Se
supplemented diets, show an increased capacity for T cells to proliferate in
response to stimulation with antigen or mitogen and to differentiate into
cytotoxic effector cells (Meeker et al, 1985; Roller et al, 1986; Kiremidjian-
Schumacher et al, 1992; Roy et al, 1992). The effects of Se on murine T cells
have been reproduced in humans, with an increase in the levels of IL-2
receptor protein and natural killer cell function also detected (Kiremidjian-
Schumacher and Roy, 1998). Human patients given 200 pg sodium selenite
for 8 weeks, express more IL-2 receptor on the surface of their T cells than
the unsupplemented control group (Roy et al, 1994). During Se deficiency
antibody titres in mice decrease (Spallholz et al, 1973, 1975). This was also
found to be the case in a more recent study, were Se-deficient rats where
found to have lower antibody titres and a decreased delayed type
hypersensitivity reaction (Kukreja and Khan, 1998).
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1.13 Selenoproteins and the skin.
There is much evidence to suggest that Se has an important role in protecting
skin from the harmful effects of UVB. In mice Se supplementation can
substantially decrease the level of skin damage, tumour formation and
overall mortality following UVB exposure (Overvad et al, 1985; Pence et al,
1994; Stewart et al, 1996). In man subnormal Se status is associated with up
to a 4-fold increased risk of developing skin cancer (Reinhold et al, 1989;
Clark et al, 1984; Deffaunt et al, 1994). Topical Se application, as
selenomethionine, has been shown to protect human subjects and mice from
acute skin damage and decrease sunburn cell formation following UVB
exposure (Thorling et al, 1983; Burke et al, 1992a and b; LaRuche and
Cesarini, 1991). In Se deficiency there is an increase in UVA-induced lipid
peroxidation in cultured fibroblasts (Moysan et al, 1995). In keratinocyte
cultures, selenite decreases UV-induced oxidative damage to DNA when
added to the growth medium (Stewart et al, 1996). Leccia et al, have shown
that incubation with selenite increases GPX activity and decreases UVA-
induced lipid peroxidation in human skin fibroblasts (Leccia et al, 1993;
Emonet-Piccardi et al, 1998). Furthermore, dietary supplementation in mice
with sodium selenite, has been reported to increase GPX levels and decrease
the incidence of chemically induced skin carcinogenesis (Perchellet et al,
1987). Topically applied thermal water from natural spas, containing a high
level of Se decreases the level of UVB-induced lipid peroxidation and skin
carcinogenesis in hairless mice (Overvad et al, 1985). Moreover, Se
supplementation in patients diminish the levels of lipid peroxidation
induced by exposure to UVB (Pietschmann et al, 1992). These studies will be
discussed in more detail in the relevant result chapters of this thesis
(reviewed in McKenzie, 2000).
1.14 Aims.
In this thesis the effect of Se on UVB-induced damage to the skin will be
investigated. There is a great deal of evidence to suggest that Se is crucial in
protecting the skin from the harmful effect of UVB. Se supplementation has
been shown to prevent UVB-induced tumourogenesis and
immunosuppression in the skin. Therefore the aim of this thesis was to
investigate how Se affects the skin. To achieve this aim the effect of Se on
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many different UVB-induced types of damage in the skin have been studied,
including:
• Necrotic cell death
• The formation of lipid peroxides
• Apoptotic cell death








General Materials and Methods
2.1 Materials.
Cell Culture Reagents.
Dulbecco's modified Eagle's media (DMEM), penicillin-streptomycin (pen-
strep), glutamine, dispase, trypsin, sodium pyruvate, keratinocyte serum-
free media (K-SFM), Earle's balanced salt solution (EBSS), lymphocyte
separation media and fungizone were purchased from Gibco Life
Technologies BRL, Paisley, Renfrewshire, UK. The melanocyte culture
media was purchased from Sigma-Aldrich, Poole, Dorset, UK. Tissue
culture plastics were supplied by Corning, High Wycombe, UK.
Radioisotopes.
The [75Se]-selenite (33 MBq/mg) was purchased from the University of
Missouri, Columbia, USA. Adenosine triphosphate (ATP) [gamma 32P] was
purchased from ICN Biomedicals, Basingstoke, UK.
Immunochemicals.
Antibodies to rat TR and rat PHGPX were raised in rabbits using proteins
purified as described previously (Holmgren and Bjornstedt, 1995; Roveri et
al, 1994). The antibody for human p53 (D07) was purchased from TCS
Biologicals Ltd, Buckingham, UK). The avidin-biotin complex (ABC)-
Horseradish peroxidase (HRP) was obtained from DAKO, High Wycombe,
UK. Enzyme-linked immunosorbent assays (ELISA) kits were purchased
from Genzyme, Cambridge, USA. Monoclonal rat anti-mouse IL-10
antibody was purchased from Harlan Sera-Lab, Belton, UK. Biotinylated
anti-rat IgG raised in rabbit was obtained from Vector, Burlingham, USA.
Enhanced chemiluminescence reagents (ECL) were obtained from
Amersham Life Science, Chalfont, UK. Anti-mouse IgG-HRP conjugate was
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purchased from Autogen Bioclear, Wiltshire, UK. Slide mounting solution
DePeX, was from Merck, Poole, UK.
General materials.
Aprotinin and bovine serum albumin (BSA), were purchased from
Boehringer Mannheim, Germany. All primers, the oligo dt(is), RNA guard,
nitrocellulose and dinucleotide triphosphates (dNTPs) were purchased from
Pharmacia Biotech, St Albans, UK. Thermus icelandicus red hot DNA
polymerase was purchased from Advanced Biotechnologies, Epsom, UK.
AGFA film developer and fixer were from F1A West (X-ray) Ltd, Edinburgh,
UK. The T4 polynucleotide kinase (PNK) was obtained from New England
Biolabs, Hitchin, UK. Agarose, guanidine isothiocyanate, HEPES,
dithiolthreitol (DTT) and Molony murine leukaemia virus reverse
transcriptase (MMLV) were purchased from Gibco Life Technologies BRL,
Paisley, Renfrewshire, UK. All other chemicals and reagents were purchased
from Sigma-Aldrich, Poole, Dorset, UK.
2.2 General methods.
Specific methods will be covered in the individual results chapters.
2.2.1 Culture conditions for cell lines.
Cultures of the spontaneously transformed human keratinocyte line HaCaT
(Boukamp et al, 1988) (gift from Professor N Fusenig, Differenzierung und
Carcinogenese, Deutsches Krebsforschungszentrum), were grown in DMEM,
supplemented with 5% foetal calf serum (FCS), 100 units/ml penicillin -100
pg/ml streptomycin in a humidified 5% carbon dioxide (CO2) atmosphere at
37°C. Cultures of the spontaneously transformed mouse keratinocyte cell
line PAM 212 (Yuspa et al, 1980), the human epithelial carcinoma cell line
A431 (Giard et al, 1973), human epithelial cell line HeLa (derived from a
carcinoma of the cervix) (Scherer et al, 1953) and the human epithelial cell
line SiHa (derived from a squamous cell carcinoma of the uterus) (Friedl et
al, 1970) were also grown in the same conditions as FlaCaT cells.
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2.2.2 Primary fibroblasts.
Primary fibroblasts were cultured from forearm biopsies (Sly and Grubb,
1979). The dermis was isolated and dissected into 1 mm2 sections. The small
sections were placed underneath sterilised glass coverslips in 10 cm2 petri
dishes. The petri dishes were flooded with DMEM containing 10% FCS, 2.5
jag/ml fungizone and Pen-Strep (as section 2.2.1) and placed in a humidified
5% CO? atmosphere at 37°C. The dishes were left undisturbed for 2 weeks,
after which time the media in the dishes was changed every 2 days. After 4-
6 weeks the fibroblasts began to migrate out from beneath the coverslips, the
coverslips were then removed and the fibroblasts cultured until confluent.
Fibroblasts will grow indefinitely, however in this project they were used
between passages 3-6 only.
2.2.3 Primary keratinocytes.
Primary human keratinocytes were cultured from neonatal foreskins,
obtained from the Royal Hospital for Sick Children, Edinburgh (Kondo et al,
1993). The foreskin samples were incubated overnight in 0.1%
dispase/DMEM solution. The epidermis was removed and dispersed in
trypsin (0.5 g/L) and 0.68 mM tetrasodium ethylenediaminetetracetic acid
(EDTA) for 15 minutes. Cells were then plated out on fibronectin-coated
plates (5 pg/cm2) and grown in K-SFM containing Pen-Strep (as in section
2.2.1). After 2 passages the cultures were composed predominantly (>95%)
of keratinocytes. The cells were used at passage 3 or 4.
2.2.4 Primary Melanocytes.
Primary melanocytes were isolated from neonatal foreskins also. The
foreskin samples were treated as for keratinocyte isolation, however
following treatment with trypsin to disperse the epidermis, the cells were
plated into melanocyte media (Sigma-Aldrich, Poole, Dorset, UK ),
containing pen-strep (as in section 2.2.1). The cultures were incubated
overnight and then trypsinised for 1 minute only, this was sufficient time to
dislodge the melanocytes, which were then plated into fresh flasks and
maintained in melanocyte media. The melanocytes were also used at
passage 3 or 4.
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2.2.5 Measurement of Se content of individual cell culture media, skin
samples and plasma.
The Se contents of each culture media were determined by acid digestion
followed by fluorimetric analysis (Olsen etal, 1975; Boyne and Arthur, 1986)
this was carried out by Dr J Arthur, Rowett Research Institute, Aberdeen,
UK. The samples were digested overnight in 2 ml of concentrated nitric acid.
The samples were then heated slowly to boiling point and held at boiling
point for 5 minutes. Concentrated perchloric acid (2 ml) was then added
dropwise to the samples and the samples were boiled again for 30 minutes.
Then 2 ml of 10% volume/volume (v/v) hydrochloric acid (HC1) was added
to convert Se as selenate to selenite. The samples were then cooled and 5 ml
hydroxylamine/EDTA solution (25 g hydroxylamine and 9.24 g EDTA/L
distilled water) was added to each sample, followed by 5 drops of cresol red
(50 mg cresol red dissolved in distilled water (250 ml) containing 1 ml of 40%
(v/v) ammonia). Ammonia solution 40% (v/v) was added to each sample
until the sample colour changed from red to green (approximately 3 ml),
then 10% (v/v) HC1 was added until the colour of samples changed from
green to orange. This brought the pH of the samples to 1.5-2.5 which allows
the formation of the diaminonaphthaline-Se complexes. The samples were
then diluted to 50 ml with distilled water and 5 ml of diaminonaphthaline
solution was added, the samples were then incubated for 30 minutes at 50°C.
The samples were then cooled and 6 ml cyclohexane added, the samples
were then shaken for 20 seconds to extract the daminonaphthaline-Se
complexes. The samples were left to stand to allow the diaminonaphthaline
layer to separate. The top layer containing the Se-complexes was then
removed and the fluorescence measured. Dilution's of selenous acid were
used to form a standard curve.
2.2.6 Ultraviolet irradiation.
Before all exposures to ultraviolet radiation cells were grown to 70%
confluence and the media was removed, set aside and the monolayer was
covered with phosphate buffered saline (PBS). With the exception of the
experiments described in Chapter 5, cells were irradiated with broadband
UVB from a bank of two TL-20W/12 lamps (Philips, Croydon, UK) with an
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Figure 2.1: Emission Spectrum for TL-20W/12 UVB Lamps.
The output of the lamps was determined by Dr Neil Gibbs (Photobiology
Unit, Ninewells Hospital, Dundee) using a spectroradiometer (model 742,
Optronic Laboratories) across the spectral range 250-400 nm. The tube target
distance was 16 cm.
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output range of 270-350 nm (peak 308 nm) (Fig 2.1). The irradiance was 80
mW/cm2 at a distance of 30 cm (Kondo et al, 1993).
The experiments in Chapter 5 where carried out in the MRC Cell Mutation
Unit, Sussex University, Brighton and the lamps used have a similar spectral
output to the TL-20W/12 lamps, however they have emit less UVC than the
TL-20W/12 lamps. They emit broadband UVB, from a bank of four FS-20
Westinghouse lamps (Clingen et al, 1995). For some experiments the lamps
were shielded with plastic petri dishes, to decrease the output to allow very
low doses of UV radiation to be given accurately (Fig 2.2).
During all experiments an IL-1400A radiometer, equipped with a
SEL240/UVB 1/TD UVB detector with a spectral sensitivity in the range of
280-320 nm (International light Inc, Montreal, Canada) was used to quantify
the UVB joules/ metre2 (J/m2) output that the cells or mice were exposed to.
2.2.7 Solutions of Se compounds.
Stock solutions of sodium selenite and seleno-DL-methionine were made in
PBS, at concentrations 100-1000 fold of the working concentrations. The
solutions were stored at -20°C after being filter sterilised.
2.3 Methods for measuring cell survival and lipid peroxidation.
2.3.1 Trypan blue exclusion assay.
Following exposure of the cells to the toxic insult, the original media was
replaced. Cell viability was determined by cell counts 48 hours later. The
cells were trypsinised and resuspended in 50 pi PBS and 50 pi trypan blue,
0.4% weight/volume (w/v) then the cells were counted on a
haemocytometer. At least 100 cells were counted for each point, n=3.
2.3.2 Effect of Se supplementation on cell viability and growth.
Growth stimulation by Se was assessed by counting cells using a Coulter
counter, model: DN (Coulter electronics Ltd, Harpenden, UK). Cell viability
was monitored using the trypan blue exclusion method (section 2.3.1).
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Figure 2.2: Emission Spectra for FS20 UVB Lamps.
Readings were taken using a Bentham Spectroradiometer, double
monochromater with integration sphere.
Source - 4 Westinghouse FS20 lamps 9 cm from light meter
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No Filter culture culture
% UVA 47.79 57.35 60.64
% UVB 51.67 42.65 39.36
%uvc 0.54 0.00 0.01
Total Intensity 8056.82 5024.99 3989.25
Tissue culture dishes allowed 62.37% of the total lamp output through.
Bacterial culture dishes allowed 49.51% of the total lamp output through.
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2.3.3 Colony-formation assay.
Keratinocytes and fibroblasts in logarithmic growth phase were counted on a
haemocytometer. Cells were plated at lxlO3 cells in 10 cm tissue culture
petri dishes. Cells were allowed to attach for 24 hours before being exposed
to the damaging agent. If the cells were exposed to UVB, the media was
removed and replaced with PBS during the irradiation. The original media
was then replaced for 48 hours, the media was then replaced again and the
cells and left for 7-14 days until colonies had formed on the control plates.
The media was then aspirated, the cells washed in PBS, and stained with 1%
(w/v) crystal violet reconstituted in 20% (v/v) ethanol for one minute. The
plates were then washed extensively in water and the number of colonies
with >25 cells counted on a See-scan image analysis system (Seescan,
Cambridge, UK). Triplicate dishes were counted for each point.
2.3.4 Lipid peroxidation assay.
The cells were harvested into PBS, then lysed by repetitive freeze thawing,
prior to level of lipid peroxidation being measured using a kit from
Calbiochem-Novabiochem Ltd, Nottingham, UK. Samples were analysed
according to the manufacturer's instructions. The principal of the kit is that
the malondialdehyde (MDA) in the samples, reacts with reagent R1 in the kit
to form a stable chromophore with maximal absorbance at 586 nm (Philips
spectrophotometer model PU8625) (Fig 2.3). A standard curve was
constructed using dilution's of pure MDA.
Figure 2.3: Lipid Peroxidation Assay Kit Reaction.
<Lh3
Reagent R1 Abs. max = 586 nm
MDA : R= OH
4-HNE: R= CH(OH)CH2CH2CH2CH2CH3
MDA : R-) = H
4-HNE: Ri = CH2CH2CH2CH2CH2CH3
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Two molecules of chromogenic reagent Rl, react with one molecule of MDA
or 4-hydroxyalkenal, at 45°C yielding a stable chromophore with maximal
absorbance at 586 nm.
2.4 Methods used to study apoptosis and p53 expression.
2.4.1 Morphological detection of apoptotic cells using acridine orange.
Cells were cultured in 6 well dishes, then the monolayers and culture media
supernatants were harvested separately and centrifuged at 800 g for 10
minutes. Cells were resuspended in 20 pi PBS and initial cell counts carried
out using a haemocytometer. Apoptotic cells were identified by staining
with an equal volume of the DNA binding fluorophore, acridine orange (5
pg/ml in physiological saline) and visualised using fluorescent microscopy
(Leitz, Otholux II), with a FITC-3 fluorescent filter (excitation filer, Wratten
47B and barrier filter, Wratten 12, Kodak). The number of apoptotic cells in
samples were counted over 20 microscope fields and calculated as the
percentage of the total number of cells present in both the supernatants and
in the monolayers, n=3.
2.4.2 Electron microscopy.
The cells were fixed in 3% glutaraldehyde diluted in 200 mM sodium
cacodylate buffer (pH 7.4) for 30 minutes, before being washed in 200 mM
sodium cacodylate buffer (pH 7.4) for 15 minutes (between each wash and
all subsequent treatments the cells were centrifuged at 2000 rpm for 5
minutes). The cells were then fixed in 1% osmium tetroxide prepared in 200
mM sodium cacodylate buffer (pH 7.4) for 30 minutes, then washed in 200
mM sodium cacodylate as previously. The cells were dehydrated in 10%
ethanol for 5 minutes, this was repeated 3 times. The cells were further
dehydrated in absolute ethanol for 20 minutes, again this was repeated three
times. Finally the cells were treated with epoxy propane twice for 10
minutes, before being embedded in araldite.
Thin sections (1 pm) were then cut from the embedded cells and examined
using an electron transmission microscope (Philips, model: CM12, Croydon,
UK).
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2.4.3 Detection of internucleosomal cleavage during apoptosis.
Cells (IxlO6) were suspended in 20 pi of lysis buffer (10 mM EDTA, 50 mM
Tris-HCl pH 8.0, 0.5% (w/v) sodium lauryl sarcosinate and 0.5 pg/ml
proteinase K) and incubated at 50°C for 1 hour. After which time 10 pi of 0.5
mg/ml RNase A was added and the cells incubated for a further hour at
50°C. Cell samples were then incubated with 10 pi of 10 mM EDTA (pH 8.0)
containing 1% low melting point agarose for 5 minutes at 70°C, prior to
loading on a 2% agarose gel containing 35 pg/ml ethidium bromide. The
samples were allowed to solidify for 5 minutes prior to electrophoresis with
90 mM Tris-phosphate, 2 mM EDTA as buffer, at 40 Volts for 3-4 hours. The
ethidium-stained DNA laddering was visualised using a UV
transilluminator.
2.4.4 Western blot analysis for p53.
2.4.4.1 Preparation of cell lysates.
Primary keratinocytes and A431 cells were lysed using triple lysis buffer (50
mM Tris-HCl (pH 8.0), 150 mM sodium chloride, 0.02% sodium azide, 0.1%
sodium dodecyl sulphate (SDS), 100 pg/ml phenylmethylsulfonyl fluoride
(PMSF), 1 pg/ml Aprotinin, 0.5% (w/v) sodium deoxycholate, 1% (v/v)
IGEPAL) and then centrifuged for 5 minutes at 10000 g to pellet any cellular
debris. Resulting supernatants were aspirated and stored at -20°C. Protein
levels were measured using the microlowry protein assay (Lowry et al, 1951).
2.4.4.2 Gel electrophoresis and western blotting.
Equal amounts of protein (10 pg) for each sample were run on 10% SDS-
polyacrylamide gels (SDS-PAGE) using lx loading buffer (2% SDS, 100 mM
DTT, 60 mM Tris-HCl pH 6.8, 0.01% bromophenol blue), the samples were
boiled for 5 minutes prior to being loaded onto the gel. Electrophoresis was
carried out at 100 Volts, using 25 mM Tris- 250 mM glycine with 0.1% (w/v)
SDS as the electrophoresis buffer. The proteins were then transferred onto
nitrocellulose (Biorad, Herts, UK) at 100 Volts for 1 hour in the presence of
transfer buffer (25 mM Tris, 190 mM glycine and 20% methanol). For p53
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detection, the nitrocellulose was blocked using 4% non-fat Marvel
(powdered milk) dissolved in Tris buffered saline with Tween (TBS-T) (50
mM Tris-HCl, 150 mM NaCl, pH 7.6, 0.2% (v/v) Tween-20) for 1 hour at
room temperature. This was followed by overnight incubation at 4°C with
mouse monoclonal IgG for human p53 primary antibody (D07) diluted
1:1000 in 4% milk/TBS-T. The mouse antibody recognises both wild type
and mutant forms of human p53. The nitrocellulose was subsequently
washed 4 times for 10 minutes in TBS-T, before incubation for 2 hours at
room temperature with a 1:2000 dilution of an anti-mouse IgG-HRP
conjugated antibody in 4% milk/TBS-T. The nitrocellulose was then washed
4 times for 10 minutes in TBS-T, with one final wash in TBS. Blots were then
visualised using ECL and Kodak X-OMAT-XAR autoradiography film.
Films were then quantitated using a Seescan system image analyser
(Seescan, Cambridge, UK) and integrated OD units were obtained using gel
analysis software vl.O ID (Seescan).
2.4.5 Immunostaining for p53.
Cells were grown on sterile glass coverslips in 6 well dishes until 70%
confluent, then treated with either UVB alone or Se and UVB according to
individual methods described in Chapter 4. The cells were then fixed in 4%
paraformaldehyde in PBS for 10 minutes. Following fixation the cells were
washed twice in PBS and treated with 100% ethanol followed by, treatment
with methanol containing 1% H2O2 for 10 minutes, to block endogenous
peroxidase. The coverslips were then rinsed in water and blocked using 20%
rabbit serum for 10 minutes. The mouse monoclonal primary antibody for
human p53 (D07) was incubated with the coverslips at a dilution of 1:200
overnight at 4°C. The cells were then rinsed in PBS twice for 5 minutes and
exposed to a 1:400 dilution of a HRP-conjugated rabbit anti-mouse
polyclonal secondary antibody for 30 minutes, at room temperature. The
coverslips were rinsed in PBS twice before exposure to ABC-HRP for 30
minutes (carried out as per kit instructions, DAKO, High Wycombe, UK).
Cells were rinsed in PBS twice for 5 minutes prior to exposure to
diaminobenzidine for 5 minutes (as per kit instructions, Sigma-Aldrich,
Poole, Dorset, UK). Finally the cells were dehydrated by passing the
coverslips through graded alcohol's and finally into xylene, prior to being
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mounted using the synthetic resin DePeX (Merck, Poole, UK). Positive
staining appeared brown.
2.5 Comet Assays.
2.5.1 Preparation of cells and irradiation.
The comet assay was performed as outlined previously (Singh et al, 1988;
Green et al, 1996). Normal agarose (0.6% in PBS) (85 pi) was layered onto
frosted microscope slides using 22 x 22 mm coverslips. Cells were then
trypsinised (1% trypsin (w/v) and 0.4% EDTA for 3-5 minutes at 37°C) and
resuspended at a density of 4xl05 cells/ml with 0.6% low melting point
agarose prepared in PBS. The cell suspension was added as a second layer to
each slide using 50 pi. Slides were maintained and irradiated on ice
(exposure levels are stated in chapter 5 for each experiment). The slides
were then processed using one of the comet assays as detailed below.
2.5.2 Excision repair.
After irradiation, if excision repair was being studied, 100 pM cytosine
arabino furanoside and 10 mM hydroxyurea in PBS were added to the slides
and incubated at 37°C for 1 hour. The slides, were immersed in lysis
solution (2.5 M sodium chloride, 200 mM sodium hydroxide, 100 mM EDTA,
10 mM Tris, 10% (v/v) dimethyl sulfoxide and 1% (v/v) Triton X-100, pH 10)
at 4°C for at least 1 hour. Slides were then placed in alkali electrophoresis
buffer (300 mM sodium hydroxide, 1 mM EDTA) and left for 40 minutes to
allow the DNA to unwind at 10°C. The slides were then electrophoresed at
20 Volts for 24 minutes at 10°C. Following electrophoresis, slides were
washed with neutralising Tris buffer (400 mM, Tris-HCl, pH 7.5) and stained
with 30 pi of ethidium bromide solution (20 pg/ml). Comet length was
determined using the Casys system (Synoptics, Cambridge, UK).
2.5.3 The T4 endonuclease comet assay.
The cells were prepared as previously described in section 2.5.1 and
irradiated, however following irradiation the slides were immersed in lysis
buffer immediately and incubated as in section 2.5.2. Following lysis the
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slides were neutralised using T4 endonuclease buffer (10 mM Tris-HCl pH
8.0, 10 mM EDTA and 75 mM sodium chloride). For treatment with DNA
repair enzymes, cells which were embedded in agarose, were overlaid with
50 pi of T4 endonuclease V (5-20 pg/ml) (kindly supplied by Applied
Genetics, Freeport, NY). Cover slips were added and the slides incubated for
1 hour at 37°C in a humidified atmosphere. Time course and concentration
dependence studies were performed with all batches of enzyme to ensure
that the amount of enzyme activity was saturating. Control slides were
incubated as above with 50 pi of T4 endonuclease buffer. Following
treatment with enzyme the slides were placed in alkaline electrophoresis
buffer and immediately electrophoresed, neutralised and visualised as in
section 2.5.2.
2.5.4 Foramidopyrimidine-DNA Glycosylase (FaPy-glycosylase) comet
assay.
This assay was carried out almost identically to the T4 endonuclease assay;
except that the T4 endonuclease buffer, was replaced with FaPy glycosylase
buffer (40 mM FFEPES pH 8.0, 100 mM potassium chloride, 0.5 mM EDTA
and 200 pg/ml BSA). Also the FaPy enzyme (kindly supplied by A. Collins,





Following exposure to UVB the cells were incubated for 6, 12 or 24 hours
prior to being washed in PBS and lysed in ice-cold Reagent D (4 M
guanidinium isothiocyanate, 25 mM sodium citrate pFl 7.0, 0.5% sodium
lauryl sarkosinate, 0.1 M 2-mercaptoethanol) and stored at -70°C.
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2.6.1.2 RNA extraction.
Total ribonucleic acid (RNA) was extracted by using a phenol-chloroform
procedure (Chomczynski and Sacchi, 1987). The samples were extracted
with an equal volume of phenol-chloroform-isoamyl alcohol (25:25:1, v/v)
and precipitated with one tenth the volume of 2 M sodium acetate for 1 hour
at -70°C in isopropanol. The RNA was subsequently washed in 70% ethanol,
dried and dissolved in 40 pi distilled water and quantitated by its absorbance
at 260 nm (Philips spectrophotometer model PU8625).
2.6.1.3 Reverse transcription.
To generate the complementary DNA (cDNA) 2 pg of RNA was denatured
at 65°C for 2 minutes. Then lx reverse transcriptase buffer (50 mM Tris-HCl,
pH 8.3, 75 mM potassium chloride, 3 mM magnesium chloride [MgCl2]), 0.5
mM of each dNTP, 30 units of human placental RNase inhibitor, 200 units of
MMLV reverse transcriptase, 1 pg oligo dTqs), and 10 mM DTT and water
were added to give a final reaction volume of 20 pi. The reaction mix was
then incubated at 37°C for 1 hour and then the reaction was terminated by
heating to 95°C for 5 minutes.
2.6.1.4 Primer labelling.
Each primer was end-labelled with y-[32P]-dATP in a 30 pi reaction mix
consisting of 5 pM primer, 5 mM DTT, 100 units T4 PNK, lx PNK buffer (70
mM Tris-HCl, 10 mM MgCl2) and 5 pi of 0.08 mCi/ml y-[32P]-dATP at 37°C
for 1 hour. The labelling reaction was terminated by heating to 95°C for 5
minutes.
2.6.1.5 PCR procedure.
The polymerase chain reaction (PCR) was performed using 2 pi of the
reverse transcriptase reaction in a PCR cocktail containing 0.5 units Red-hot
DNA polymerase, lx PCR buffer (20 mM (NH4)2S04, 75 mM Tris-HCl, 0.01%
Tween), 0.08 mM of a mix of all four dNTPs, 0.375 pM of each primer and 1
pM tetramethylammonium chloride. Each primer set was optimised for
MgCl2 concentration (Listed in Table 2.1) and the volume for each PCR
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reaction was made up to 10 pi with water. PCR reactions were overlayed
with 20 pi of mineral oil to prevent evaporation and were amplified on a
Techne PHC-3 or Gene-E dri block cycler (Techne, Cambridge, UK). The
cycling times were 1 minute at 95°C (denaturation), 1 minute at 60°C (primer
annealing) and 1 minute at 72°C (extension). The number of cycles for each
primer, were calculated by determining the number of cycles which
produced an exponential amount of product without saturating the reaction,
this tended to be between 30-40 cycles. (Primer sequences, MgCl2
requirements and product sizes are found in Table 2.1).
2.6.1.6 Quantitation of PCR products.
Radioactive PCR products were resolved on 12% SDS-PAGE gels (150 Volts)
and identified by size, in comparison to 100 base pair ladder (Gibco Life
Technologies BRL, Paisley, Renfrewshire, UK). The gels were dried and
exposed using a molecular phosphoimager, model: GS-525 (Biorad, Hemel
Hempstead, Herts, UK) and visualised by autoradiography using Kodak X-
OMAT XAR-5 film. The house keeping genes G3pDH and (3-actin were used
when studying human and mouse cells respectively, to control for
differences in the abundance of cDNA. The values for each test cytokine
were normalised using the respective house-keeping gene value for each
sample. All samples and controls were amplified within the same PCR run
and subjected to SDS-PAGE and exposed on the phosphoimager at the same
time.
2.6.1.7 Controls.
The RNA from EL-4 cells (mouse T cell line) stimulated with phorbol-12-
myristate-13-acetate (PMA) (50 ng/ml) served as a positive control for the
mouse cytokines. The RNA isolated from primary human T cells stimulated
with PMA served as the positive controls for the experiments investigating
human cytokine production. The primary human T cells were isolated from
human buffy coat preparations obtained from the Blood Transfusion Service
at the Royal Infirmary, Edinburgh. The white blood cells were isolated by
layering the buffy coats onto lymphocyte separation media and centrifuging
at 1500 rpm for 30 minutes. The white blood cells were then transferred to a
fresh tube and washed three times in RPMI and resuspended in RPMI
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containing 10% FCS. The T cells were subsequently stimulated for 24 hours
with PMA (50 ng/ml) and phytohaemagglutinin (1 pg/ml). After
stimulation the RNA was extracted as described previously. PCR reactions
where distilled water replaced cDNA, were used to check for any
contaminants in the PCR reagents.



































Primer pairs spanned at least one exon to amplify cDNA and not genomic
DNA.
2.6.2 Cytokine quantification of cell supernatants by ELISA.
Cells were grown until 70% confluent and treated with Se for 24 hours prior
to exposure to UVB. The original media was then returned to the cells and
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the cells were incubated for 6, 12 or 24 hours, after which time the cell
supernatants were removed and spun down for 1 minute at 10000 g to pellet
any dead cells that may be present. The supernatant was aliquoted and
stored at -70°C until required. The samples were analysed in triplicate using
Predicta ELISA kits (Genzyme Corporation, Cambridge, MA, USA)
according to the manufacturers instructions.
2.6.3 Immunostaining for IL-10.
Immunostaining for IL-10 was carried out as described in Section 2.4.5.
Immunostaining was performed using a rat monoclonal anti-mouse IL-10
antibody, diluted 1:100 before overnight incubation at 4°C. In these
experiments, the secondary antibody used was a biotinylated anti-rat IgG
raised in rabbits, used at a 1:100 dilution for 30 minutes at room temperature.
2.7 Mouse Experiments.
2.7.1 Composition of Se diets.
The mouse diets were provided by Dr. J. Arthur, Rowett Research Institute,
Aberdeen, UK. The composition of the experimental mouse diet was as
described below in Table 2.2 (Arthur et al, 1987):
The basal diet contained either no Se, 0.1 ppm or 2 ppm Se added as sodium
selenite where appropriate.
Table 2.2 : Composition of basal experimental mouse diet.




Cod liver oil 1.5




* The amino acid mixture contained the following per 113.0 g of mix : L-
alanine, 5.0 g, L-arginine hydrochloride, 6.0 g, L-asparagine, 4.0 g, L-aspartic
acid, 5.0 g, L-cysteine, 2.0 g, glycine, 5.0 g, L-histidine, 3.0 g, L-isoleucine, 5.0
g, L-leucine, 7.5 g, L-lysine hydrochloride, 7.0 g, L-methionine, 4.0 g, L-
monosodium glutamate, 30.0 g, L-phenylalanine, 5.0 g, L-proline, 4.0 g, L-
serine, 5.0 g, L-threonine, 5.0 g, L-tryptophan, 1.5 g, L-tyrosine, 3.0 g and L-
valine, 6.0 g.
t The Vitamin mix contained (g/50 g mix): thiamin, 0.5 g, pyridoxine, 0.5 g,
riboflavin, 0.5 g, p-aminobenzoic acid, 0.5 g, nicotinic acid, 1.5 g, calcium-
pantothenate, 1 g, folic acid, 0.25 g, biotin, 0.25 g, inositol, 20 g, and sucrose,
25 g. The trace elements mix contained (g/250 g mix): KIO3, 0.84 g, NaF,
0.277 g, NH4VO3, 0.023 g, NiCl2-6H20, 0.23 g, Cr(S04)3K2S04-24H20, 2.4 g,
SnCl4-5H20, 0.029 g and sucrose, 246.71g and omitted sodium selenite where
appropriate (Abdel-Rahim et al, 1986).
2.7.2 Source of mice.
The mouse strain used were C3Fl/HeN female mice obtained from the
specific-pathogen-free animal breeding facility at the department of Medical
Microbiology Transgenic Unit, University of Edinburgh. Mice were weaned
at the start of the experiment and were immediately transferred onto one of
the Se diets for 6 weeks, prior to experimental procedures being carried out.
2.7.3 ATPase staining of epidermal sheets for LCs.
Twenty four hours following irradiation the mice were sacrificed and the
ears collected. The ears were divided in two and were floated dermal side
down in 0.76% EDTA pH 7.2 at 37°C for 2 hours. The ears were then rinsed
three times in saline and the epidermal sheets were removed. The epidermal
sheets were fixed in 1.28% sodium cacodylate/4% formaldehyde/6.85%
sucrose at 4°C for 1 hour before being rinsed three times in saline. The
epidermal sheets were then stained with adenosine diphosphate (ADP)-lead
(0.6 mg/ml ADP, 0.125% lead nitrate, diluted in 1.2% magnesium sulphate,
5% glucose and 40% Tris-Mal buffer) (3% Tris, 2.9% maleic acid and 1%
sodium hydroxide) at 37°C for 70 minutes and then rinsed in Tris-Mal buffer
three times before treatment with 2% ammonium polysulfide for 20 minutes
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at room temperature. Finally the epidermal sheets were rinsed in water and
mounted on slides in 50% glycerol (Juhlin and Shelley, 1977; Chaker et al,
1984). The number of LCs were counted in 10 fields/epidermal sheet.
2.7.4 Protein Determination.
Mouse tissue samples, cellular extracts for analysis of selenoprotein profiles
and enzyme activities were sonicated and the protein levels determined
using the Bradford dye-binding method (Bradford, 1976) adapted for use on
a Cobras Fara centrifugal analyser (Roche Diagnostics, Welwyn Garden City,
UK). Bradford reagent was made by dissolving 0.01% comassie brilliant blue
G-250 in 5% ethanol and 8.5% phosphoric acid, the solution was then filtered
through a Whatman grade 1 filter paper.
Bradford reagent (265 pi) and 25 pi of the sample and 50 pi water were
mixed together and incubated at 37°C for 180 seconds and then the
absorbance at 595 nm was taken. The absorbance values were calibrated
using BSA as standards.
2.7.5 Measurement of GPX activity.
Samples were homogenised in PBS and centrifuged at 10,000 g for 5 minutes
to pellet any cellular debris. The samples were diluted from between 2 to
100 fold to allow accurate measurement. Then 955 pi of reaction mix (5 mg
nicotinamide adenine dinucleotide hydrogen phosphate (NADPH), 46 mg
reduced glutathione, 3 ml distilled water, 24 ml PBS, 1 ml sodium azide
[112.5 mM], and 20 units glutathione reductase), 10 pi sample and 35 pi
PI2O2 (2.2 mM) were added to a cuvette. The rate of change of absorbance
was followed at 340 nm (Arthur and Boyne, 1985). A unit of glutathione is
defined as that which oxidises 1 pM ofNADPH per minute.
2.8 Measurement of selenoproteins.
2.8.1 Determination of selenoprotein profiles.
Profiles of selenoproteins expressed by the various primary skin cells were
determined by radio-labelling with [75Se]-selenite as described previously
2-19
(Howie et al, 1995). Confluent cultures of cells in 75 cm2 flasks, were labelled
with 0.02 MBq/ml of [75Se]-selenite by incubation for 72 hours. Previous
studies have shown that [75Se] uptake and incorporation into selenoproteins
by cells, reaches a plateau at approximately 24 hours. Therefore cells were
labelled for 48-72 hours to ensure a steady state had been reached. Media
was decanted and cells were washed twice with EBSS before being harvested
into EBSS by scraping, followed by centrifugation at 2000g for 10 minutes.
Cells were resuspended in 60 mM Tris-HCl buffer pH 7.8 containing 1 mM
DTT and 1 mM EDTA and lysed by sonication. Equal amounts of protein (25
pg) were loaded onto 12% SDS-PAGE gels and proteins were separated by
electrophoresis, the gels were dried and the labelled selenoproteins
quantified using a molecular phosphoimager, model. GS-525 (Biorad, Hemel
Hempstead, Herts, UK) and visualised by autoradiography using Kodak X-
OMAT XAR-5 film. Selenoprotein profiles were also determined in primary
melanocytes, keratinocytes and fibroblasts which had either been pre-
labelled with [75Se] for 24 hours prior to being exposed to 200 J/m2 UVB and
then harvested 24 hours post exposure. Alternatively cells were exposed to
200 J/m2 UVB, then labelled with [75Se] and harvested 24 hours later.
2.8.2 Western blot analysis to identify TR and PHGPX.
Western blot analysis was used to identify TR and PHGPX, the method was
carried out by F. Nicol and Dr J. Arthur at the Rowett Research Institute,
Aberdeen, UK. The proteins were separated by SDS-PAGE and were
transferred to Immobilon polyvinyldifluoride (PVDF) membranes, which
were blocked using 10% (v/v) horse serum in 25 mM Tris, 500 mM sodium
chloride (pH 7.5) containing 0.05% Tween. The blot was probed with affinity
purified polyclonal antibody to rat liver TR at a final dilution of 1:500
(Holmgren and Bjornstedt, 1995) and developed using chemiluminescence or
coupled alkaline phosphatase reagents (McLeod et al, 1997). The blots were
also probed with purified antibodies to rat PHGPX (Roveri et al, 1994).
2.9 Statistical Analysis.
The results discussed are from experiments repeated two or three times.
Each data point was done in triplicate (numbers of replicates of individual
experiments are stated in the text) . Analysis of variance (ANOVA) and the
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posthoc Bonferroni correction were used to analyse the significance of the
results, values for P<0.05 were deemed to be significant. To compare the
differences between sodium selenite and selenomethionine ANOVA and the




The Effects of Selenium on the Survival and
Formation of Lipid Peroxides in UVB Irradiated
Skin Cells.
3.1 Introduction.
The cytotoxic effects of UVB radiation on the skin are well documented.
UVB radiation can damage cells by numerous means and is far more efficient
at causing cell death than UVA. Exposure to UVB can provoke DNA
damage, protein cross-linking and the production of free radicals, which
themselves can damage DNA and induce lipid peroxidation. Further effects
of UVB radiation are discussed in Chapter 1. Cells cultured in vitro which
are exposed to high doses of UVB radiation and thus receive a high level of
damage, exhibit necrotic cell death. However at lower doses of UVB
radiation cultured cells have been reported to undergo apoptotic cell death
(Henseleit et al, 1996). Sunburn cells present in the skin are considered to be
severely damaged keratinocytes that are undergoing apoptotic cell death
(Bayerl et al, 1995), as discussed in detail in Chapter 4. Melanocytes,
keratinocytes and fibroblasts have all been proven to be susceptible to cell
killing by UVB radiation (Dissanayake et al, 1993).
Selenium status and the levels of selenoproteins present in skin cells, appears
to be linked with cell susceptibility to damage by UV radiation. The
introduction of a GPX-like gene, isolated from the dermatotropic poxvirus
molhiscum contagiosum virus, which resides exclusively in the human
epidermis, significantly increased cell survival in cells exposed to UVB
(Shisler et al, 1998).
It has also been reported that supplementing human skin fibroblasts with
sodium selenite (1.2 pM) decreases cell death from 50% to 25%, following
exposure to 120 J/m2 UVB (Richard et al, 1990). Similar results using UVA
radiation and sodium selenite (1.3 pM) reported that cell death in human
skin fibroblasts was decreased from 50% to 10% (Leccia et al, 1993). In a
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further study supplementation with 320 nM sodium selenite decreased cell
death of human skin fibroblasts from 67% to 30% following exposure to
UVA (Moysan etal, 1995). Moreover Se also decreased the incidence of skin
tumours in mice (Overvad et al, 1985; Pence et al, 1994), and inflammation
and sunburn in hairless mice following UVB exposure (Thorling et al, 1983).
Selenium given both orally and topically increases the minimal erythemal
dose (MED) in humans (Burke et al, 1992a; Burke et al, 1992b), and decreases
the number of sunburn cells in human skin following exposure to UVB (La
Ruche and Cesarini, 1991), as discussed further in Chapter 1.
Selenium status can increase the abundance of antioxidant selenoenzymes in
the skin such as members of the GPX and TR families. The catalytic
functions and regulation of the selenoproteins GPX and TR have been
discussed in detail in Chapter 1. However in brief, the GPX family of
proteins can detoxify a wide range of lipid peroxides and hydrogen peroxide
to produce water and the corresponding alcohol's in the presence of reduced
glutathione (Roetruck et al, 1973). Changes in TR expression may have many
effects on the cell including altered growth characteristics or changes in the
ability to detoxify free-radicals. In conditions of Se deficiency, decreased
levels of GPX and TR could diminish the cells capacity to inactivate ROS.
The selenoprotein TR can detoxify lipid hydroperoxides and hydrogen
peroxide. Furthermore thioredoxin reductase has been reported to be
located on the surface of keratinocytes were it is in an ideal position to
detoxify reactive species (reviewed in Schallreuter and Wood, 1989).
Antioxidants other than selenoenzymes can protect human keratinocytes in
vitro from UVB-induced cell death and apoptosis. The antioxidant a-
tocopherol decreases UVB-induced cell death in keratinocytes from 80% to
20% and apoptosis from 80% to 60% (Malorni et al, 1996; Kondo et al, 1990).
Furthermore ascorbic acid also decreases cell death in HaCaT cells (Savini et
al, 1998). In this context it is clear that UVB exposure produces ROS in the
skin. Therefore antioxidants such as selenoproteins can prevent ROS-
induced damage to skin cells by inactivating these molecules.
Several techniques have been utilised in this chapter to study cell growth
and survival. Including the use of a coulter counter to measure total cell
number, therefore allowing the measurement of cell growth following Se
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supplementation in all cell types. The trypan blue assay was employed to
measure: selenium toxicity, cell survival following UVB irradiation, cell
survival following Se treatment and exposure to UVB radiation and cell
death following menadione treatment in keratinocytes and melanocytes.
The trypan blue dye exclusion method was utilised as live cells exclude dye
and dead cells take up the dye. This phenomenon allows the % cell death to
be calculated. Finally, for the fibroblast experiments the colony formation
assay was used as it was found that once a toxic insult was applied to the
fibroblasts any dead cells would adhere to the tissue culture plastic and
could not be removed by trypsin. Therefore to correct for the false survival
rates found with the trypan blue assay, the colony formation assay was used.
One of the mechanisms by which exposure to UVB can damage skin cells is
as mentioned previously, by the production of ROS. Reactive oxygen species
can elicit peroxidation reactions in cell membrane lipids (Punnonen et al,
1991). Reactive oxygen species are difficult to measure directly as they are
very short lived, therefore it is common to measure their presence by the
formation of secondary products (reviewed in Rumley and Paterson, 1998).
Polyunsaturated fatty acids in the plasma membrane are one of the cellular
targets of ROS. The most common by-product of lipid peroxidation is
malondialdehyde (MDA), it arises predominantly from the oxidation of
polyunsaturated fatty acids with three or more double bonds.
Malondialdehyde is formed following exposure of cells to UVB in a dose-
dependant manner (Stewart et al, 1996). Exposure to UVA also causes MDA
formation in a dose-dependent manner (Moysan et al, 1995). Reactive
oxygen species remove the hydrogen atom from the methylene bridges of
unsaturated fatty acids, resulting in lipid hydroperoxides. In the presence of
transition metals, the lipid hydroperoxides then break down to form
aldehydes, including MDA.
The most widely utilised technique for measuring MDA production is the
thiobarbituric acid (TBA) reaction or "TBAR assay". During the TBAR assay
MDA reacts with thiobarbituric acid giving rise to a MDA-TBA adduct
(Asakawa and Matsushita, 1979; Wasowicz et al, 1993). The MDA-TBA
adduct can be measured by using a spectrophotometer (Lefevre et al, 1996),
fluorimeter (Conti et al, 1991) or more specifically by high-performance
liquid chromatography (Wong et al, 1987). However, other substances can
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also react with TBA such as other lipid peroxides, amino acids and sugars.
Consequently, the term thiobarbituric acid reactive substances (TBARS) is
used to describe the results more accurately (Bonnefont et al, 1989).
Although the measurement of TBARS is not a direct measure of MDA, it is
widely used to measure lipid peroxidation of membranes (Moysan et al,
1993; Kobayashi et al, 1996a). Due to a lack of reproducibility with the TBAR
assay, a commercial assay was utilised in this study to measure MDA.
Whilst the commercial assay displays less cross-reactivity with other
substances and the product formed is more stable than the TBA-MDA
adduct, it works by the same principles as the TBAR assay (Fig 2.3).
Lipid peroxidation is inhibited by the use of free radical scavengers,
including topically applied glutathione, which diminishes the formation of
TBARS in irradiated mouse skin (Kobayashi et al, 1996b). Furthermore
ascorbic acid injected intraperitoneally or intracutaneously decreases the
formation of TBARS in mouse skin following exposure to UVB (Kobayashi et
al, 1996a). Finally vitamin E added immediately after exposure to UVB also
decreases the formation of MDA in human skin fibroblasts by at least 50%
(Kondo et al, 1990).
Selenium also decreases the formation of TBARS in patients. Selenium (200
pg/day) given prior to patients exposure to a solar simulator, decreased the
level of TBARS formed by 13% (Pietschmann et al, 1992). Furthermore
cultured fibroblasts given sodium selenite (320 nM) supplementation for 3
days prior to exposure to UVA, displayed a decrease of 50% in the formation
of TBARS (Moysan et al, 1995; Leccia et al, 1993).
Most of the experiments in the present study have been carried out using
primary keratinocytes. Keratinocytes are the most numerous cell type in the
epidermis, they receive the highest exposure to UVB and they are the cell
type that forms basal and squamous cell carcinomas. Basal and squamous
cell carcinomas are accepted to be induced by exposure to UVB radiation
(Stenbach, 1975; reviewed in Elmets and Mukhtar, 1996). A limited number
of studies have been performed on melanocytes and fibroblasts.
Throughout this project two types of Se compounds were used.
Selenomethionine which is an organic form of Se, is widely used in
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supplementation studies as it is the form of Se most commonly available in
the diet. Sodium selenite was also used, it is an inorganic form which again
has been widely used in experiments involving Se supplementation. Sodium
selenite is very reactive and at high concentrations can become an oxidant
itself. These two compounds are described and discussed in Chapter 1.
The aims of this chapter were
• To study the effects of sodium selenite and selenomethionine
supplementation on cell growth and survival, of primary human skin
cells.
• To investigate if sodium selenite and selenomethionine supplementation
protects human primary melanocytes, fibroblasts and keratinocytes in
vitro from UVB-induced cell death.
• To ascertain the mechanism by which Se exerts its protective effect.
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3.2 Methods and Results.
3.2.1 Effect of Se supplementation on cell growth and cell viability.
Cells were grown (Chapter 2, section 2.2) in six-well dishes till 70%
confluent, then treated with sodium selenite or selenomethionine (1 nM-10
pM) and incubated for a further 72 hours. The toxicity of the compounds
were determined by cell viability counts using trypan blue exclusion
(Chapter 2, section 2.3.1). Growth stimulation was assessed by counting cells
using a Coulter counter (Chapter 2, section 2.3.2).
Fibroblasts at a logarithmic growth phase were seeded out at lxlO3 in petri
dishes. The fibroblast were allowed to attach to the dishes for 24 hours,
before Se was added to the media and the cells, incubated for a further 72
hours. The media was then replaced with fresh media and the cells
incubated for 7-14 days. The colonies of cells were visualised with crystal
violet (Chapter 2, section 2.3.3).
Primary human keratinocytes.
Treatment of primary keratinocytes with sodium selenite or
selenomethionine had no apparent effect on growth (Fig 3.1a). Sodium
selenite was toxic at concentrations of 1 pM (24% cell death) or above with
56% cell death found at 10 pM (Fig 3.1b). Selenomethionine was not found
be toxic at concentrations up to 10 pM (Fig 3.1b).
Primary human melanocytes.
Similar results were found in primary melanocytes in that, sodium selenite
and selenomethionine had no growth stimulating activity (Table 3.1a) and
selenomethionine was found to be non-toxic up to 10 pM. Sodium selenite
however was found to be toxic at 10 pM (44% cell death) (Table 3.1b).
HaCaT cells.
Neither of the Se compounds induced growth in HaCaT cells (Table 3.2a).
However, HaCaT cells were found to be more susceptible to the cytotoxicity
of the Se compounds, sodium selenite was toxic to the cells even at 200 nM *
Continued on page 3-12
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Figure 3.1a: Effect of sodium selenite or selenomethionine on














Control 1 nM 1 OnM 5 0 n M 1 OOnM
Selenium Treatment
Primary human keratinocytes were incubated with sodium selenite or
selenomethionine for 72 hours, and the cell growth was measured by
counting the cells using a Coulter counter. Control cells had no Se added to
them. Results are the means of total number of cells ± S.E.M, n=3. No
significant differences from control.
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Figure 3.1b: Effect of sodium selenite or selenomethionine on
the viability of primary human keratinocytes.
Selenium Treatment
Primary human keratinocytes were incubated with sodium selenite or
selenomethionine for 72 hours, and the viable cells counted using a
haemocytometer and trypan blue exclusion. At least 100 cells were counted.
Results are the means of % cell death ± S.E.M, n=3. Control cells had no Se
added to them. Significant differences from control, * = P<0.05, ** = P<0.01.
t = significant differences between the sodium selenite and
selenomethionine, P<0.05.
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Table 3.1a: Effect of sodium selenite or selenomethionine on
the growth of primary human melanocytes.
Total no of cellsflO4) ± S.E.M.






Primary human melanocytes were incubated with sodium selenite or
selenomethionine for 72 hours, and the total number of cells counted using a
Coulter counter. Control cells had no Se added to them. Results are the
means of the total number of cells ± S.E.M, n=3. No significant differences
from control.
Table 3.1b: Effect of sodium selenite or selenomethionine on
the viability of primary human melanocytes.
% Cell Death 1S.E.M.






Primary melanocytes were incubated with sodium selenite or
selenomethionine for 72 hours, and the viable cells counted using a
haemocytometer and trypan blue exclusion. Control cells had no Se added
to them. At least 100 cells were counted. Results are the means of % cell
death ± S.E.M, n=3. Significant difference from control, * = P<0.05, ** =
P<0.01. t = Significant differences between sodium selenite and
selenomethionine treated cells, P<0.05.
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Table 3.2a: Effect of sodium selenite or selenomethionine on
the growth of HaCaT cells.
Total no of cellsdO4) ± S.E.M.






HaCaT cells were incubated with sodium selenite or selenomethionine for 72
hours, and the total number of cells counted using a Coulter counter.
Control cells had no Se added to them. Results are the means of the total
number of cells ± S.E.M, n=3. No significant differences from control.
Table 3.2b: Effect of sodium selenite or selenomethionine on
the viability of cell line HaCaT.
% Cell Death +S.E.M.






HaCaT cells were incubated with sodium selenite or selenomethionine for 72
hours, and the viable cells counted using a haemocytometer and trypan blue
exclusion. Control cells had no Se added to them. At least 100 cells were
counted. Results are the means of % cell death ± S.E.M, n=3. Significant
difference from control, * = P<0.05, ** = P<0.01. t = Significant differences
between sodium selenite and selenomethionine treated cells, P<0.05.
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Table 3.3: Effect of sodium selenite or selenomethionine on the
viability of primary human fibroblasts.
No of Colonies ±S.E.M.








Primary human fibroblasts were incubated with sodium selenite or
selenomethionine for 72 hours, the media was then replaced and the cells left
until colonies had formed on the control plates (7-14 days). Control cells had
no Se added to them. Plates were then stained with crystal violet for 1
minute and the number of colonies with over 25 cells counted on an image
analysis system. Results are the means of total number of colonies ± S.E.M,
n=3. Significant difference from control, * = P<0.05, ** = P<0.01. t =
Significant differences between sodium selenite and selenomethionine
treated cells, P<0.05.
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with 19.9% cell death induced, 20% cell death was observed at 1 pM, which
increased at 10 pM to 81% (Table 3.2b). Selenomethionine was also found to
be slightly toxic towards HaCaT cells with 20% cell death at 10 pM.
Primary human fibroblasts.
The experiments on fibroblasts differ from the other cell types as they were
done using the colony formation assay. However neither Se compound
stimulated the growth of fibroblasts (Table 3.3). Sodium selenite was shown
to be significantly toxic at concentrations of 200 nM and upwards, but
selenomethionine was not toxic at any of the concentrations measured (Table
3.3).
3.2.2 Induction of cell death by exposure to UVB radiation.
To determine the lethal UVB dose for the various cell types, cells were grown
to 70% confluence, the media was removed and retained, then the monolayer
was covered with PBS. The cells were irradiated with broadband UVB
(Chapter 2, section 2.2.6). To determine the UVB dose that killed between
50-80% of the cells, doses of between 480-1440 J/m2 were given. The original
media was replaced and cell viability was determined by cell counts on a
haemocytometer using trypan blue (0.4% w/v) exclusion (Chapter 2, section
2.3.1), 24 and 48 hours after irradiation.
For the fibroblast experiments cells in a logarithmic growth phase were
seeded out at a density of lxlO3 in petri dishes. The fibroblast were allowed
to attach for 24 hours, then the media was replaced with PBS and the cells
were exposed to UVB (100-400 J/m2). The original media was then returned
and the cells were incubated for 7-14 days. The colonies were visualised
with crystal violet (Chapter 2, section 2.3.3).
Primary human keratinocytes.
Primary keratinocytes were found to be relatively resistant to cell death
induced by exposure to UVB radiation. The rate of cell death was found to
be very low at 24 hours (5-25%) however this increased greatly at 48 hours
post exposure to UVB radiation (Fig 3.2a). The dose of UVB which killed




Primary melanocytes were more susceptible to cell death induced by UVB
radiation compared to primary keratinocytes, again the rate of cell death was
higher at 48 hours (Fig 3.2b). The dose required to kill 56% of the cells at 48
hours was 720 J/m2.
HaCaT cells.
HaCaT cells were also susceptible to cell death induced by exposure to UVB,
with more (25-90%) cell death at 24 hours than that observed in keratinocytes
(5-25%) and melanocytes (5-50%). However the dose required to kill 69% of
cells at 48 hours was 960 J/m2 (Fig 3.2c), which was similar to the primary
keratinocytes (65%) (fig 3.2a).
Primary human fibroblasts.
Fibroblast experiments were carried out using the colony formation assay.
The colony formation assay measures the effect of UVB radiation, on cell
division, therefore the results can not be directly compared to those with
trypan blue. However the results do demonstrate that the amount of UVB
required to stop cell division by 50% is 170 J/m2 (Fig 3.2d).
3.2.3 Effect of Se pre-treatment on UVB-induced cell death.
Cells cultured in six-well dishes until 70% confluent were treated with
sodium selenite or selenomethionine (1 nM-1 pM), and incubated for 24
hours. The media was removed and set aside and 1ml of PBS added to each
well immediately prior to the cells being exposed to UVB. Typically the cells
were exposed to UVB for 1.5-2 minutes (720-960 J/m2; the dose given
depended on the cell type used), which resulted in approximately 70-80%
cell death 48 hours post irradiation, in cultures where no sodium selenite or
selenomethionine had been added. After UVB exposure, PBS was removed
and the original culture media was replaced. Viability was determined by
trypan blue exclusion 48 hours post UVB exposure (Chapter 2, section 2.3.1).*
Continued on page 3-18
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Figure 3.2a: Effect of increasing UVB exposure on the viability
of primary human keratinocytes.
Time Post UVB Exposure
24 hrs 48 hrs
720 J/m2
960 J/m2
Media was removed from primary keratinocytes and replaced with PBS
prior to exposure to various doses of UVB radiation. The original media was
then replaced and the cells incubated for 24 or 48 hours before cell counts
were performed using a haemocytometer and trypan blue exclusion. Control
cells received no UVB. At least 100 cells were counted. Results are the
means of % cell death ± S.E.M, n=3. Significant differences from cells not
exposed to UVB, * = P<0.05, ** = P<0.01.
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Figure 3.2b: Effect of increasing UVB exposure on the viability
of primary human melanocytes.
0 24 hrs 48 hrs
Time Post UVB Exposure
480J/m2
720J/m2
Media was removed from primary melanocytes and replaced with PBS prior
to exposure to various doses of UVB radiation. The original media was then
replaced and the cells incubated for 24 or 48 hours before cell counts were
performed using a haemocytometer and trypan blue exclusion. Control cells
received no UVB. At least 100 cells were counted. Results are the means of
% cell death ± S.E.M, n=3. Significant differences from cells not exposed to
UVB, * = P<0.05, ** = P<0.01.
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Figure 3.2c: Effect of increasing UVB exposure on the viability
of HaCaT cells.
"ffl 4 80 J/m 2
"■ 7 2 0 J/m 2
9 6 0 J/ m 2
• 1200J/m2
"I 1 1
0 24 hrs 48 hrs
Time Post UVB Exposure
Media was removed from the HaCaT cells and replaced with PBS prior to
exposure to various doses of UVB radiation. The original media was then
replaced and the cells incubated for 24 or 48 hours before cell counts were
performed using a haemocytometer and trypan blue exclusion. Control cells
received no UVB. At least 100 cells were counted. Results are the means of
% cell death ± S.E.M, n=3. Significant differences from cells not exposed to
UVB, * = P<0.05, ** = P<0.01.
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Figure 3.2d: Effect of increasing UVB exposure on the viability
of primary human fibroblasts.
Dose of UVB(J/m2)
Media was removed from the primary fibroblasts and replaced with PBS
prior to exposure to various doses of UVB radiation. The original media was
then replaced and the cells left until colonies had formed on the control
plates (7-14 days). Plates were then stained with crystal violet for 1 minute,
and the number colonies with over 25 cells counted on an image analysis
system. Control cells received no UVB. Results are the means of total
number of colonies ± S.E.M, n=3. Significant differences from control, * =
P<0.05, ** = P<0.01.
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For the fibroblast and one set of keratinocyte experiments, cells in a
logarithmic growth phase were plated out at lxlO3 in petri dishes. The cells
were allowed to attach for 24 hours, sodium selenite or selenomethionine
was then added to the media for 24 hours. The media was then replaced
with PBS and the cells were exposed to UVB (100-400 J/m2). The original Se-
containing media was then returned and the cells were incubated for 7-14
days. The colonies were visualised with crystal violet (Chapter 2, section
2.3.3).
Primary human keratinocytes.
The dose of UVB used (960 J/m2) produced 76% cell death in primary
keratinocytes 48 hours after exposure (Fig 3.3a), which is slightly higher than
for the previous experiment (65%) (Fig 3.2a). The differences in the levels of
cell death provoked by UVB maybe due to donor to donor variation. The
addition of sodium selenite or selenomethionine 24 hours prior to exposure
to UVB, prevented a marked amount of cell death, but the protective effects
were significantly different between the two compounds (Fig 3.3a). A
protective effect with sodium selenite was seen with concentrations from 1-
200 nM, with an optimal protective concentration of 50 nM.
Selenomethionine was less potent than sodium selenite in protecting cells
from UVB-induced damage, with higher concentrations of selenomethionine
compared to sodium selenite required to produce significant protection from
UVB-induced damage. No significant protective effect of selenomethionine
was observed below a concentration of 10 nM. Maximal protection using
selenomethionine was found at 50 nM, with concentrations in the range of 10
nM-1 pM providing significant protection. As with sodium selenite, the
protection afforded by selenomethionine started to diminish at 1 pM.
The experiments on primary keratinocytes were also repeated using the
colony formation assay with similar results. The optimal protective
concentrations of sodium selenite were 10-100 nM which was a greater range
than observed in the trypan blue experiments (Fig 3.3b). With
selenomethionine the optimal protective concentration was also 10-100 nM
with the protective range of 10-200 nM. Finally the protective effect was lost
at 200 nM sodium selenite, which was a lower concentration than that
observed in the trypan blue experiment and at 1 pM selenomethionine which
is the same concentration as seen in the trypan blue experiments.
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Experiments were also carried out in which sodium selenite or
selenomethionine was omitted from the culture media after exposure to
UVB. Protection from cell death following UVB exposure was still achieved.
Furthermore the protection appeared to be almost identical to that found
when Se was present for the duration of the experiment (Figs 3.3a and 3.4).
Maximal protection was achieved with Se concentrations in the pre-treated
media of 50-200 nM for sodium selenite or selenomethionine.
Concentrations of Se in the range of 1 nM-1 pM of sodium selenite and 50
nM-10 pM selenomethionine offered significant protection.
Primary melanocytes.
Melanocytes were more sensitive to UVB than keratinocytes, and a UVB
dose of 720 J/m2 was sufficient to kill 82% of the cells (Table 3.4). Again the
level of cell death was slightly higher than the previous experiment (56%),
however this may be due to inter-donor differences (Fig 3.2b). In the
experiments with melanocytes, the effects of Se were similar to those seen in
keratinocytes with maximal protection being achieved for sodium selenite
and selenomethionine at concentrations of 10 nM and 100 nM respectively
and little or no protection found at 1 pM (Table 3.4). Concentrations of Se in
the range of 1-200 nM sodium selenite and 10 nM-1 pM selenomethionine
offered significant protection.
HaCaT cells.
In the keratinocyte cell line HaCaT, a dose of 960 J/m2 UVB was required to
kill approximately 80% of the cells (Table 3.4). Again the amount of cell
death at this dose of UVB was higher than found previously (70%), this is
due to inter-experimental differences (Fig 3.2c). The maximal protection
provided by Se was found at 10 nM and 100 nM sodium selenite and
selenomethionine respectively (Table 3.4). Concentrations in the range of 1-
200 nM sodium selenite and 10 nM-200 nM selenomethionine offered
significant protection.
Primary fibroblasts.
Fibroblasts also exhibited a reduction in cell death stimulated by UVB
exposure following pre-treatment with Se compounds. This effect was less *
Continued on page 3-25
3-19
Figure 3.3a: The effect of selenomethionine or sodium selenite
pre-treatment on the viability of primary human











Control 0 1nM 10nM 50nM 1 00 n M 2 00 n M 1uM
Selenium Treatment ^\A Sodium Selenite
11 Selenomethionine
Primary keratinocytes were pre-treated with sodium selenite or
selenomethionine for 24 hours prior to the media being replaced with PBS
and the cells exposed to UVB (960 J/m2). The original Se-containing media
was returned and the cells incubated for 48 hours before cell counts were
performed using a haemocytometer and trypan blue exclusion. Control cells
received no UVB or Se supplement. At least 100 cells were counted. Results
are the means of % cell death ± S.E.M, n=3. Significant differences from cells
not treated with Se, but exposed to UVB, * = P<0.05, ** = P<0.01. t =
Significant differences between sodium selenite and selenomethionine,
P<0.05.
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Figure 3.3b: The effect of selenomethionine or sodium selenite
pre-treatment on the viability of primary human
keratinocytes after exposure to UVB, measured by
the colony formation assay.
E2 Sodium Selenite
Control 0 1nM 10nM 50nM 10OnM 200nM 1 uM
Selenium Treatment
Primary keratinocytes were pre-treated with sodium selenite or
selenomethionine for 24 hours prior to the media being replaced with PBS
and the cells exposed to UVB (200 J/m2). The original Se-containing media
was returned and the cells left until colonies had formed on the control
plates (7-14 days). Plates were then stained with crystal violet for 1 minute
and the number of colonies with over 25 cells were counted on an image
analysis system. Results are the means of % cell death ± S.E.M, n=3.
Significant differences from cells not treated with Se, but exposed to UVB, *
= P<0.05, ** = P<0.01. t = Significant differences between sodium selenite
and selenomethionine, P<0.05.
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Figure 3.4: The effect of selenomethionine or sodium selenite
pre-treatment only on the viability of primary
human keratinocytes after exposure to UVB.
1 25
Control 0 10nM 50nM 1 00nM200nM 1uM 10uM
Selenium Treatment
Primary keratinocytes were pre-treated with sodium selenite or
selenomethionine for 24 hours prior to the media being replaced with PBS
and the cells exposed to UVB (960 J/m2). The original media was replaced
with media from cells of the same passage, with no Se added. Then
incubated for 48 hours before cell counts were performed using a
haemocytometer and trypan blue exclusion. Control cells received no UVB
or Se supplement. At least 100 cells were counted. Results are the means of
% cell death ± S.E.M, n=3. Significant differences from cells not treated with
Se, but exposed to UVB, * = P<0.05, ** = P<0.01. t = Significant differences
between sodium selenite and selenomethionine, P<0.05.
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Table 3.4: The effect of selenomethionine or sodium selenite
pre-treatment on the viability of primary human
melanocytes and the human keratinocyte cell line
HaCaT after exposure to UVB.
% Cell Death ±S.E.M.
Sodium selenite Selenomethionine
Dose (nM) Melanocytes HaCaT's Melanocytes HaCaT's
Control 7.711.6 4.314.3 7.711.6 4.314.3
0 82.611.4 86.811.1 82.611.4 86.8+1.1
1 157.716.4* 157.612.9* 79.311.7 79.413.8
10 110.310.9** 119.511.4** 72.412.3* 64.312.2*
50 22.511.5** 35.411.9** 26.911.5** 23.814.5**
100 129.211.1** 145.212.8* 14.314.9** 11.613.9**
200 34.413.5** 160.412.2* 30.313.4** 39.513.1**
1000 75.413.4 86.712.3 65.613.3* 75.213.4
Primary melanocytes and HaCaT cells were pre-treated with sodium selenite
or selenomethionine for 24 hours prior to the media being replaced with PBS
and the cells exposed to UVB (melanocytes 720 J/m2 and HaCaT cells 960
J/m2). The original Se-containing media was returned and the cells
incubated for 48 hours before cell counts were performed using a
haemocytometer and trypan blue exclusion. Control cells received no UVB
or Se supplement. At least 100 cells were counted. Results are the means of
% cell death ± S.E.M, n=3. Significant differences from cells not treated with
Se, but exposed to UVB, * = P<0.05, ** = P<0.01. t = Significant differences
between sodium selenite and selenomethionine, P<0.05.
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Figure 3.5: The effect of selenomethionine or sodium selenite
pre-treatment on the viability of primary human


















Primary fibroblast were pre-treated with sodium selenite or
selenomethionine for 24 hours prior to the media being replaced with PBS
and the cells exposed to UVB (150 J/m2). The original Se-containing media
was returned and the cells incubated until colonies had formed on the
control plates (7-14 days). Plates were then stained with crystal violet for 1
minute and the number of colonies with over 25 cells were counted on an
image analysis system. Control cells received no UVB or Se supplement.
Results are the means of total number of colonies ± S.E.M, n=3. Significant
differences from cells not treated with Se, but exposed to UVB, * = P<0.05, **
= P<0.01. t = Significant differences between sodium selenite and
selenomethionine, P<0.05.
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than that measured in other skin cell types (Fig 3.5). Exposure to UVB
decreased colony formation by 55% and sodium selenite protected against
the reduction in colony formation by 24% to 79%. Selenomethionine proved
more consistent than sodium selenite at protecting the cells. Significant
increases in colony formation were found with concentrations of 50-200 nM.
The optimal concentration was 200 nM with, a 25% increase in colony
formation.
3.2.4 Effect of Se being added post UVB exposure on UVB-induced cell
death.
In a separate set of experiments primary keratinocytes were grown and
irradiated as in section 3.2.3, however before irradiation, no Se was added to
the media. Selenium was only added following exposure to UVB and the
cells were incubated for 48 hours and then counted using trypan blue
staining as in section 3.2.3.
Protection was still achieved, but the protection was modest and required
higher concentrations of Se compared to protection achieved by adding
sodium selenite or selenomethionine to cells 24 hours prior to UVB exposure
(Fig 3.6). Maximal protection was achieved at 50 nM and 200 nM for sodium
selenite and selenomethionine respectively. The level of protection was
diminished with only a 2-3 fold decrease in cell death for the cells treated
with Se post-UVB. In comparison there was a 5-6 fold decrease in death in
the cells pre-treated with Se for 24 hour (Fig 3.3a and 3.6). Sodium selenite
was more effective in protecting cells with concentrations in the range of 10
nM-1 pM offering modest but significant protection, compared to 100-200
nM for selenomethionine.
3.2.5 Absorbance spectrum of sodium selenite and selenomethionine.
Sodium selenite and selenomethionine were dissolved in PBS at
concentrations of 100 mM. The absorbance of the two solutions was then
measured on a spectrophotometer using a solution of PBS alone to measure
the background absorbance.*
Continued on page 3-28
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Figure 3.6: The effect of sodium selenite or selenomethionine















The media on primary keratinocytes was replaced with PBS, prior to the cells
being exposed to UVB (960 J/m2). The original media was returned, with
either sodium selenite or selenomethionine added and the cells were
incubated for 48 hours before cell counts were performed using a
haemocytometer and trypan blue exclusion. Control cells received no UVB
or Se supplement. At least 100 cells were counted. Results are the means of
% cell death ± S.E.M, n=3. Significant differences from cells not treated with
Se, but exposed to UVB, * = P<0.05, ** = P<0.01. t = Significant differences
between sodium selenite and selenomethionine, P<0.05.
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Figure 3.7: The absorbance spectrums of 100 mM solutions of
sodium selenite or selenomethionine.
1 5 0 200 250 300 350
Wavelength (nm)
- Sodium Selenite (100mM)
Selenomethionine (100mM)
4 0 0 4 5 0
Absorbance of 100 mM solutions of selenomethionine and sodium selenite
were measured on a spectrophotometer. Both chemicals were dissolved in
PBS and the absorption was measured against a PBS only reference.
3-27
Figure 3.7 demonstrates that lOOmM solutions of sodium selenite and
selenomethionine dissolved in PBS had no absorption within the UVA
spectrum. Selenomethionine had a slight absorbance in the UVB spectrum
and sodium selenite had none. They both have a high absorption within the
UVC spectrum. (Fig 3.7).
3.2.6 Effect of varying the pre-incubation times of the Se compounds
prior to UVB exposure.
Primary keratinocytes were treated as in section 3.2.3, however instead of a
24 hour pre-incubation with Se, the Se was added to the cells between 3-48
hours prior to the cells exposure to UVB. The cells were then exposed to
UVB, conditioned media without Se was replaced on the cells and 48 hours
later the cells were counted by trypan blue exclusion as in section 3.2.3.
Varying the time that the Se is on the cells prior to UVB exposure, shows that
both Se compounds have to be present on the cells for at least 24 hours, for
significant protection to be demonstrated (Fig 3.8). Sodium selenite started
to offer the cells protection at 12 hours pre-treatment, compared to 24 hours
for selenomethionine. The protection increased at 48 hours for both
compounds.
3.2.7 Effect of the addition of cycloheximide and Se pre-treatment
on UVB-induced cell death.
Again primary keratinocytes were treated as in section 3.2.2, however at the
same time that the Se was added to the cell media, the protein synthesis
inhibitor cycloheximide (10 pg/ml) was added. Therefore the cells were pre¬
heated for 24 hours prior to exposure to UVB with Se and cycloheximide.
The keratinocytes were exposed to a lower dose of UVB (600 J/m2), and
fresh conditioned media without Se or cycloheximide was returned to the
cells. The cells were counted by trypan blue exclusion 48 hours post
exposure to UVB.
*
Continued on page 3-31
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Figure 3.8: The effect of sodium selenite or selenomethionine
added at various times to primary human
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Sodium selenite or selenomethionine was added to the media of primary
keratinocytes at various time points prior to the media being replaced with
PBS, and the cells exposed to UVB (960 J/m2). The original media was
replaced with conditioned media with no Se, and the cells were incubated
for 48 hours, before cell counts were performed using a haemocytometer and
trypan blue exclusion assay. Control cells received no UVB or Se
supplement. At least 100 cells were counted. Results are the means of % cell
death ± S.E.M, n=3. Significant differences from cells not treated with Se,
but exposed to UVB, * = P<0.05, ** = P<0.01. t = Significant differences
between sodium selenite and selenomethionine, P<0.05.
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Figure 3.9: The effect of sodium selenite or selenomethionine,
and cycloheximide added to primary human
keratinocytes prior to their exposure to UVB.
ne






Sodium selenite or selenomethionine and cycloheximide were added to the
media of primary keratinocytes 24 hours prior to the media being replaced
with PBS, and the cells exposed to UVB (600 J/m2). Fresh conditioned media
(with no Se or cycloheximide) was returned to the cells, and the cells were
incubated for 48 hours before cell counts were performed using a
haemocytometer and trypan blue exclusion. Control cells received no UVB
or Se supplement. At least 100 cells were counted. Results are the means of
% cell death ± S.E.M, n=3. Significant differences from cells not treated with
cycloheximide, but exposed to UVB and Se, * = P<0.05, ** = P<0.01.
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Cycloheximide was utilised to prevent synthesis of selenoproteins. After
exposure to UVB, fresh conditioned media was returned to the cells without
Se or cycloheximide. The removal of cycloheximide was to allow the cells to
produce heat shock proteins and mount a normal cellular response to UVB.
However, as demonstrated in Fig 3.9 this does not appear to have occurred.
Even although a lower dose of UVB was used (600 J/m2), the cells exposed
to UVB and cycloheximide display a higher level of cell death 78%
compared to 48% in cells only exposed to UVB.
3.2.8 Effect of high concentration selenomethionine.
Cells were treated as in section 3.2.1, however higher levels of
selenomethionine were used (10 pM-1 mM) and cell viability was measured
by trypan blue exclusion.
Higher concentrations of selenomethionine were employed to attempt to
answer the question of why higher concentrations of selenomethionine lose
their protective effect. To investigate if the selenomethionine was at sub-
toxic concentrations, higher levels were given to cells. Selenomethionine
was found to be toxic to primary keratinocytes only at 1 mM and on primary
melanocytes at 50 pM (Fig 3.10a and 3.10b). Both of these concentrations are
50-1000 times more concentrated than the levels used in the protection
studies.
3.2.9 Effect of UVB-irradiated sodium selenite or selenomethionine on
primary keratinocytes.
Selenomethionine and sodium selenite dissolved in PBS were exposed to
1000 J/m2 UVB. The toxicity of the irradiated solution were compared to
unirradiated solutions. The toxicity was compared by treating primary
keratinocytes with the solutions for 72 hours. The cells were then counted
by trypan blue exclusion as in section 3.2.1.
*
Continued on page 3-35
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Figure 3.10a: Effect of high levels of selenomethionine on the
viability of primary human keratinocytes.
Selenomethionine Concentration
Primary human keratinocytes were incubated with selenomethionine for 72
hours, and the viable cells counted using a haemocytometer and trypan blue
exclusion. At least 100 cells were counted. Results are the means of % cell
death ± S.E.M, n=3. Control cells had no Se added to them. Results are the
means of % cell death ± S.E.M, n=3. Significant differences from control, * =
P<0.05, ** = PcO.Ol.
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Figure 3.10b: Effect of high levels of selenomethionine on the
viability of primary human melanocytes.
1 o o
Control 2 0 u M 5 0 u M
Selenomethionine Concentration
Primary human melanocytes were incubated with selenomethionine for 72
hours, and the viable cells counted using a haemocytometer and trypan blue
exclusion. At least 100 cells were counted. Results are the means of % cell
death ± S.E.M, n=3. Control cells had no Se added to them. Significant
differences from control, * = P<0.05, ** = P<0.01.
3-33
Figure 3.11: Effect of irradiated sodium selenite or























Control 2 0 0 n M 1 uM 1 OuM
Selenium Treatment
Primary human keratinocytes were incubated with irradiated sodium
selenite or selenomethionine (1000 J/m2) for 72 hours, and the viable cells
counted using a haemocytometer and trypan blue exclusion. At least 100
cells were counted. Results are the means of % cell death ± S.E.M, n=3.
Control cells had no Se added to them. Significant differences from control, *
= P<0.05, ** = P<0.01. t = Significant differences between sodium selenite
and selenomethionine, P<0.05.
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It was found that pre-irradiation did not alter the toxicity of the Se solutions
(Fig 3.11).
3.2.10 Effect of Se pre-treatment on menadione-induced cell death.
To demonstrate if the protective effect of selenomethionine was lost at high
concentrations with other toxic assaults, menadione was utilised. This
compound induces oxidative stress in cells. First the level of menadione to
induce cell death in keratinocytes was investigated. In the literature, cells
are usually pulsed with menadione for 2-4 hours to induce cell death,
therefore it was decided to use a 3 hour treatment. Cells were cultured to
70% confluence and then pulsed for 3 hours with various concentrations of
menadione made in PBS. The cells were then washed well with PBS and
fresh media returned, 48 hours later the cell viability was counted using
trypan blue exclusion.
Preliminary experiments indicated that menadione was non-toxic at 50 pM,
but was toxic at 100 pM, killing most of the cells (98%) (Fig 3.12).
Subsequent experiments were performed by pulsing the cells for 3 hours
with 100 pM menadione to induce cell death.
Primary keratinocytes were treated as above, however the cells were also
pre-treated for 24 hours with sodium selenite or selenomethionine. The cells
were then exposed to menadione and survival quantitated by trypan blue
exclusion.
Selenium treatment for 24 hours prior to exposure to menadione protected
the cells from cell death (Fig 3.13). Sodium selenite was markedly better at
affording this protection than selenomethionine. Sodium selenite was
protective at 10-100 nM, much the same concentrations (1-200 nM, Fig 3.3a)
as when UVB is the toxic insult. Selenomethionine was found to be
protective at 50 nM only, unlike when UVB was used, where concentrations
of 10nM-l pM offered protection (Fig 3.3a). The protection was lost at higher
concentrations of Se, much like with UVB response. However, the level of
protection was lower than that seen using UVB exposure. *
Continued on page 3-38
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Figure 3.12: Effect of menadione on the viability of primary
human keratinocytes.
1 2 5
Control 10uM 50uM 1 OOuM
7*-—*
2 0 0 u M 5 0 0 u M
Menadione Treatment
Primary human keratinocytes were incubated with menadione prepared in
media for 3 hours, then washed with PBS and fresh media returned. The
cells were then left for 48 hours, and the viable cells counted using a
haemocytometer and trypan blue exclusion. At least 100 cells were counted.
Results are the means of % cell death ± S.E.M, n=3. Control cells had no




Figure 3.13: The effect of selenomethionine or sodium selenite
pre-treatment on the viability of primary human











Control 1n M 1 0n M 50nM 100nM 200nM 1uM
Selenium Treatment
Primary keratinocytes were pre-treated with sodium selenite or
selenomethionine for 24 hours prior to the media being replaced with media
containing 100 pM menadione for 3 hours. The original media was returned
and the cells incubated for 48 hours before cell counts were performed using
a haemocytometer and trypan blue exclusion. Control cells received no
menadione or Se treatment. At least 100 cells were counted. Results are the
means of % cell death ± S.E.M, n=3. Significant differences from cells not
treated with Se, but exposed to UVB, * = P<0.05, ** = P<0.01. t = Significant
differences between sodium selenite and selenomethionine, P<0.05.
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3.2.11 Effect of increasing the level of UVB exposure to cells pre-treated
with Se.
Primary keratinocytes were treated as in section 3.2.3, however increasing
doses of UVB were given to the cells.
When the level of UVB that the cells were exposed to was increased, the
protective effect of the Se was gradually lost. The protection is displayed in
Fig 3.14. When the UVB dose was over 1000 J/m2 protection diminished
when using both compounds. However below 1000 J/m2 protection was
afforded by both seleno-compounds.
3.2.12 Effect of UVB and Se on the formation of MDA.
HaCaT cells were grown in petri dishes until they were 70% confluent, the
media was replaced with PBS and the cells were exposed to 1000 J/m2 UVB.
The original media was returned to the cells and they were incubated for 0-
24 hours following exposure to UVB. The cells were then harvested and the
levels of MDA measured using a commercial assay (Calbiochem,
Nottingham). The method is described further in Chapter 2, section 2.3.4.
The levels of MDA present were found to decrease slightly immediately
following exposure to UVB (Fig 3.15). However 3 hours after exposure to
UVB the levels begin to increase slowly over the next 12 hours. Between 12
and 24 hours after exposure to UVB the levels of MDA increased sharply.
To investigate the influence of Se on the formation of MDA following
exposure to UVB, HaCaT cells were grown in petri dishes until they were
70% confluent, the cells were then treated with either sodium selenite or
selenomethionine for 24 hours. The media was then replaced with PBS and
the cells were exposed to 1000 J/m2 UVB. The original Se-containing media
was returned to the cells and they were incubated 24 hours following
exposure to UVB. The cells were then harvested and the levels of MDA
measured.
Selenium was found to decreases the formation of MDA (Fig 3.16). Sodium
selenite decreased the formation of MDA at concentrations in the range of 1 -
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50 nM, and selenomethionine at concentrations between 50-200 nM. HaCaT
cells were used in the experiments measuring MDA because a large of
volume of cells (at least 1x10^) were required to obtain levels ofMDA which
were detectable. Due to the amount of cells required for each treatment a
limited number of concentrations of Se were tested. However the
experiments were reproducible and were carried with duplicate samples,
twice and with triplicate samples once with similar results.
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Figure 3.14: The effect of sodium selenite or selenomethionine
added to primary human keratinocytes prior to











1! 50nM Sodium Selenite
0 200nM Selenomethionine
UVB(J/m2)
Sodium selenite or selenomethionine was added to the media of primary
keratinocytes 24 hours prior to the media being replaced with PBS, and the
cells exposed to a range of doses of UVB (200-1200 J/m2). The original Se-
containing media was returned, and the cells were incubated for 48 hours,
before cell counts were performed using a haemocytometer and trypan blue
exclusion. Control cells received no Se supplement. At least 100 cells were
counted. Results are the means of % cell death ± S.E.M, n=3. Significant
differences from unirradiated cells, * = P<0.05, ** = P<0.01. t = Significant
protection by Se compared to irradiated control cells.
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Figure 3.15: The Effect of UVB at inducing MDA in HaCaT
cells.
0 "" 1 1 1 1 1 1
Control 0 3 6 1 2 2 4
Time Post Exposure to UVB (hours)
HaCaT cells were grown to 70% confluence, the media was replaced with
PBS and the cells exposed to UVB (1000 J/m2). The original media was
replaced and the cells were incubated for 0-24 hours. The cells were then
harvested and the levels of MDA present measure by commercial assay.
Control cells were not exposed to UVB. The results are the means of the
levels of MDA present ± S.E.M, n=2. Significant increase in MDA compared
to control cells, * = P<0.05.
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Figure 3.16: The Effect of Se on the UVB-induction ofMDA in
HaCaT cells.
2
Control 0 1nM 10nM 50nM 50nM 100nM 200nM
Sodium Selenite Selenomethionine
Selenium Treatment
HaCaT cells were grown to 70% confluence, sodium selenite or
selenomethionine was added to the media and the cells incubated for 24
hours. The media was replaced with PBS and the cells exposed to UVB (1000
J/m2). The original Se containing-media was replaced and the cells were
incubated for 24 hours. The cells were then harvested and the levels ofMDA
present measure by commercial assay. Control cells were not exposed to
UVB and Se. The results are the means of the levels of MDA present ±
S.E.M, n=2. Significant decrease in MDA compared to irradiated cells not
treated with Se, * = P<0.05.
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3.3 Discussion.
3.3.1 Toxicity of Se compounds.
Selenite was considerably more toxic to cells than selenomethionine. Thus
treatment with 1 |xM selenite, killed approximately 25% of primary
keratinocytes and at a concentration of 10 |xM, more than 50% of the cells
were destroyed. In comparison selenomethionine showed no toxicity at any
of the concentrations used in the study (Fig 3.1b). Indeed selenomethionine
had to be added at 1 mM before any toxic effect could be observed (Fig
3.10a). Melanocytes were more resistant to the harmful effects of sodium
selenite, with toxicity observed at concentrations of 10 |xM (44% cell death).
As with the keratinocyte study, selenomethionine was not found to be toxic
with concentrations as high as 20 |xM (Table 3.1b and Fig 3.10b). HaCaT cells
were susceptible to cell damage by sodium selenite, with a significant effect
on cell viability being found at concentrations of 200 nM. Selenomethionine
also appeared to be toxic in HaCaT cells at concentrations of 10 |xM (Table
3.2b). The increased toxicity of the seleno-compounds suggests an increased
susceptibility to toxic insult in the HaCaT cell line, which may be due to
deficiencies in a range of antioxidant enzymes, as a consequence of the
HaCaT cells being a spontaneously transformed cell line. Primary fibroblast
cells were also found to be susceptible to cell destruction after treatment
with sodium selenite at 200 nM but the cells proved resistant to
selenomethionine up to 10 (xM (Fig 3.30). The results demonstrate a clear
difference in how various cells react to treatment with sodium selenite and
selenomethionine. In summary, primary keratinocytes were the least
susceptible to the harmful effects of sodium selenite, followed by
melanocytes, HaCaT cells and finally the most sensitive, fibroblasts. When
using selenomethionine all of the cells were unaffected by treatment with
concentrations of 10 fxM, except the HaCaT cells. The data also show that
sodium selenite was more toxic than selenomethionine.
3.3.2 Protective effect of Se on skin cells exposed to UVB.
The results presented in this chapter show that pre-incubation of primary
cultures of keratinocytes, melanocytes, fibroblasts and the HaCaT cell line
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with Se for 24 hours can provide all cell types with significant protection
from UVB-induced cell death (Fig 3.3a, Table 3.4 and Fig 3.4). The chemical
form of Se added to cells was an important factor in determining the
minimal and optimal concentrations of Se, required to provide protection
from UVB. Selenite was more potent than selenomethionine at conferring
protection, illustrated by the finding that in melanocytes, keratinocytes and
HaCaT cells, significant protection was achieved with a concentration of
selenite as low as 1 nM, whilst no significant protection was achieved with
selenomethionine below concentrations of 10 nM. Concentrations of Se
which conferred maximal protection to cells also varied with the chemical
form of Se. With selenite, maximal protection was achieved using a
concentration of 10-50 nM in all cell types. However when using
selenomethionine, maximal protection was achieved at concentrations of 50
nM, for keratinocytes, and 100 nM for HaCaT's, fibroblasts and melanocytes
(Fig 3.3a, Table 3.4 and Fig 3.4). The observation that a similar degree of
protection from UVB-induced cell death by Se addition was found with the
HaCaT keratinocyte cell line and primary keratinocytes, suggests that the
phenomenon may be a general one amongst keratinocyte cell types.
There are some problems when using the trypan blue exclusion assay to
assess cell death as it has been demonstrated that apoptotic cells can exclude
the dye, however the effect of Se on apoptotic cell death has been
investigated in detail in Chapter 4. Also the trypan blue exclusion method
can give an overestimate of cell survival as cells may exclude the dye but
may not be able to replicate. To avoid this problem some of the key
experiments with primary keratinocytes were repeated with the colony
formation assay. It was demonstrated in keratinocytes that the results from
the trypan blue assay, compared favourably with the results obtained using
the colony formation assay. It should be noted however that with the colony
formation assay a much lower level of UVB exposure must be used, as the
levels of UVB required to kill cells are far greater than the doses required to
prevent cell replication. In the keratinocytes 960 J/m2 was used in the
trypan blue experiments and only 200 J/m2 in the colony formation assay
Fig 3.3a and 3.3b).
Selenium-induced protection from UVB-induced cell death has been
reported by several other groups. The majority of studies have been
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performed using human skin fibroblast supplemented with sodium selenite.
Protection from cell death by UVB radiation (Richard et al, 1990), UVA
radiation (Leccia et al, 1993; Moysan et al, 1995) and a decrease in the number
of sunburn cells in human skin have been demonstrated (La Ruche and
Cesarini, 1991). The concentrations of selenite used in the experiments in the
literature were very high and were non-physiological, with 1.2 |iM sodium
selenite used in a study by Richard et al and 1.3 pM used in another study by
Leccia et al,. Concentrations of sodium selenite over 1 pM produced toxic
effects in fibroblasts in the experiments presented in this thesis. However,
experiments carried out by Moysan et al using fibroblasts and exposure to
UVA to induce cell death, showed significant protection with selenite at
concentrations of 320 nM.
It is widely held that Se exerts many of its biochemical actions through the
expression of specific selenoproteins, in which Se is inserted at specific
selenocysteine residues encoded by a TGA triplet. Insertion of Se at these
TGA-directed sites, requires Se to be presented in a chemically active form
similar to selenide and current evidence indicates that selenite, is a more
potent precursor of selenide than selenomethionine (Sunde, 1990). However,
although whole body turnover studies in man have shown that
selenomethionine is re-utilised by cells more efficiently than inorganic forms,
this appears to arise because selenomethionine can be substituted into
proteins non-specifically for methionine. When replacing methionine
residues in proteins, selenomethionine appears to have no bioactivity
(Waschulewski and Sunde, 1988).
3.3.3 Possible mechanisms of Se protection from UVB-induced cell death.
We have shown that pre-incubation with Se can prevent UVB-induced
damage, the mechanism by which this occurs is not clear. Se did not exert a
protective effect through altering cell growth patterns at the concentrations
which were protective (Fig 3.1a, Table 3.1a, Table 3.2a, and Table 3.3). In
order to demonstrate that the Se compounds were not acting as sunscreens
on the cells, in all of the experiments the cells were washed well and
irradiated in PBS with no Se present (Fig 3.7). However, this did not exclude
the possibility that the cells had free intracellular Se present, which could
absorb the UVB. However when the absorption spectra of the concentrated
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Se solutions made in PBS were measured, it was found that neither Se
compound absorbed in the UVA spectrum and selenomethionine only had a
small level of absorption in the UVB spectrum. The lack of absorption
suggests that cells were not being shielded from UV radiation due to the Se
compounds acting as a sunscreen.
It has been clearly shown that cells need to be pre-incubated with Se before
any protection from UVB-induced damage is achieved (Fig 3.4). As when Se
was added immediately after UVB exposure little protection was achieved
(Fig 3.6).
Overall the data suggests that Se may be acting through incorporation into
selenoproteins, rather than by a direct anti-oxidant chemical action.
Selenomethionine had to be present on the cells for at least 24 hours to obtain
significant protection and 12 hours pre-treatment was required for sodium
selenite (Fig 3.8). The extended period of time required for pre-incubation
with seleno-compounds is probably essential to allow the synthesis of
selenoproteins. Sodium selenite was observed to be more rapid in having an
effect than selenomethionine, probably because selenite has been
demonstrated to be a more suitable precursor to selenide, itself the precursor
of selenocysteine (Sunde, 1990). Also as demonstrated in Fig 1.3 in Chapter
1, selenite requires fewer steps to be converted into selenide than
selenomethionine (Foster and Sumar, 1997). Furthermore, selenomethionine
can be substituted into proteins non-specifically for methionine. The
protective effect Se had against UVB-induced damage increased further with
a 48 hour pre-incubation period with Se.
In an attempt to confirm that selenoprotein synthesis is required for
protection, cycloheximide was added to the cells with the Se. However the
data showed that cycloheximide alone had toxic effects on the cells following
exposure to UVB. The toxic effect of cycloheximide was possibly due to the
cycloheximide inhibiting the production of essential heat shock proteins,
which help the cell respond to toxic insults. Heat shock proteins have been
detected in human skin (Trautinger et al, 1993) and are associated with the
regulation of the cell proliferation, differentiation, the inhibition of sunburn
cell formation and UV-induced cell death (Trautinger et al, 1995; Kane and
Maytin, 1995; Maytin et al, 1994). Thus although the protective effect of Se
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was prevented by cycloheximide, this cannot be regarded as evidence for Se
acting through selenoprotein synthesis.
If Se needs to be incorporated into selenoproteins for it to exert protection
against UVB, possible candidate antioxidant selenoproteins include, the
families of GPXs and TRs.
Labelling of tissues with [75Se]selenite has demonstrated the presence of
more than 30 selenoproteins and the pattern of selenoprotein expression
differs between tissues. It is thought that some of the uncharacterised
selenoproteins may be involved in detoxification reactions and in modifying
cell growth or cell death (Sunde, 1990). In Chapter 8, the effect of Se on the
expression of the GPX and TR proteins will be discussed in more detail.
Proteins of the GPX family are obvious potential candidates for
selenoproteins which may mediate the protective effects of Se, as these
enzymes are capable of detoxifying hydrogen peroxide, lipid
hydroperoxides and phospholipid hydroperoxides which are produced
during UVB exposure. GPX activity is resistant to UV irradiation unlike
SOD and CAT activity which both dramatically fall following irradiation
(Pence and Naylor, 1990; Shindo et al, 1994).
Shisler et al demonstrated that if a GPX-like gene is transfected into HeLa
and HaCaT cells, the cells become resist to UVB-induced cell death. The
induction of cell death in HeLa cells was decreased from 60% to 10%, and in
HaCaT cells from 75% to 20% (Shisler et al, 1998). The reduction in cell
death indicates that GPX has a crucial role in protecting the skin from UVB-
induced damage and that this is due to the antioxidant effects of GPX. The
level of protection reported by Shisler et al is similar to that found in the
present study. In keratinocytes, melanocytes and HaCaT cells the level of
cell death was decreased from 70-80% to 15-25% after Se pretreatment (Fig
3.3a, Table 3.4). The protective actions of the GPX-like protein suggest a role
for GPX in protecting the skin from UVB-induced damage. However the
protection may also be provided by other selenoproteins
TR is a selenoenzyme which has multiple functions, it can reduce oxidised
thioredoxin (Holmgren and Bjornstedt, 1995) and can directly reduce
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hydrogen peroxide, lipid hydroperoxides and superoxide in the presence of
NADPH (Bjornstedt et al, 1995a). Unlike other antioxidant enzymes TR is in
a unique position, as it is located in the cytosol and on the plasma membrane
of skin cells (Schallreuter et al, 1986a; Schallreuter and Wood, 1986).
Schallreuter and Wood have also reported that TR plays an essential role in
the pigmentation of the skin following exposure to UVB, with lighter skin
types containing lower levels of TR in the skin (Schallreuter and Wood, 1989)
Thus TR plays an important role in the reaction of the skin to UV and in
protecting the skin from UVB-induced damage.
Lipid peroxidation is a form of oxidative damage caused by exposure to
UVB. Therefore it can act as an indicator of whether Se is decreasing
oxidative stress, produced by exposure to UVB in the skin. Numerous
antioxidants can decrease the formation of lipid peroxides in the skin
following exposure to UV. The antioxidants which can decrease lipid
peroxidation include; topically applied glutathione, which acts to decrease
the formation of TBARS in irradiated mouse skin (Kobayashi et al, 1996b).
Ascorbic acid injected intraperitoneally or intracutaneously decreases the
formation of TBARS in mouse skin following exposure to UVB (Kobayashi et
al, 1996a). Finally vitamin E added immediately after exposure to UVB is
reported to decrease the formation of TBARS in human skin fibroblasts by at
least 50% (Kondo et al, 1990).
Selenium has also been found to decrease the formation of TBARS in
patients. Patients given Se and then exposed to a solar simulator displayed
decreased levels of TBARS (Pietschmann et al, 1992). Furthermore, cultured
fibroblasts treated with sodium selenite (320 nM) prior to exposure to UVA,
exhibited a 50% decrease in the formation of TBARS (Moysan et al, 1995;
Leccia et al, 1993). Similar results were found in my study with, Se treatment
diminishing the formation of MDA in HaCaT cells following exposure to
UVB. The decrease in MDA formation indicated that Se is indeed decreasing
the oxidative stress induced by UVB. Any decrease in oxidative stress
would increase the cells ability to survive exposure to UVB. As already
alluded to, one mechanism by which Se could decrease the level of oxidative
stress is by the increasing the expression of antioxidant selenoproteins.
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3.3.4 Loss of protection to UVB at high concentrations of Se.
Although both Se compounds displayed concentration-dependent protection
from UVB damage up to approximately 100 nM, when the concentration of
Se was further increased to 1 pM protection appeared to diminish in all cell
types. For selenite, this loss in protection with increasing concentration of
selenite is at least in part due to a direct toxic effect of selenite and its
metabolite selenodiglutathione when present at high concentrations (Stewart
et al, 1999). Selenite has a directly toxic action on cells and a recent study has
shown that the metabolite selenodiglutathione is also a potent cytotoxic
agent (Wu et al, 1995). For selenomethionine the mechanism behind the loss
of protection at higher concentrations is unclear, since selenomethionine was
not toxic at any of the concentrations used (Fig 3.1b, Table 3.1b, Table 3.2b
and Table 3.3). It is possible that UVB exposure might modify
selenomethionine to produce a toxic metabolite, but I could find no evidence
of increased toxicity in solutions of selenomethionine or sodium selenite
irradiated with UVB and incubated on keratinocytes (Fig 3.11).
Alternatively, 1 pM selenomethionine although not toxic on its own, may be
close to a concentration of the compound that was noxious to the cells.
When combined with UVB exposure the two agents may act in concert to
provoke cell death. However, when cells were exposed to higher
concentrations of selenomethionine it was demonstrated that
selenomethionine was only toxic to melanocytes at concentrations of 50 pM
(Fig 3.10b) and to keratinocytes at 1 mM (Fig 3.10a). Concentrations of over
50 pM are much higher than any employed in this study so do not explain
the loss of protection in keratinocytes or melanocytes measured. The loss of
protection seen when using high concentrations of selenomethionine in
HaCaT cells, can be explained, by the fact that it becomes toxic to the cells at
10 pM.
Another possibility is a recent observation in our laboratory using HaCaT
cells, that with increasing concentrations of Se, GPX activity increases, but at
concentrations above 200 nM the GPX activity declines (M Lewin, private
communication). Furthermore TR activity is also inhibited by high
concentrations of selenite (Bjornstedt et al, 1995b). If the decreases in activity
of GPX and TR are caused by increasing the concentration of Se, then this
could explain the loss of the protective effect observed in this study.
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3.3.5 Effect of Se at preventing other forms of oxidative damage.
In order to demonstrate if the loss in protection seen at higher concentrations
of selenomethionine was common to other forms of oxidant insult,
menadione toxicity towards keratinocytes was studied. The experiments
with menadione also provided information on whether Se protected against
other oxidative assaults. Menadione produces free radical-induced damage
including; the production of superoxide, hydrogen peroxide, lipid peroxides
and oxidative damage to DNA (Tzeng et al, 1995; Woods et al, 1997). Cells
were supplemented with Se for 24 hours, and subsequently pulsed with
menadione for 3 hours. As shown in Fig 3.13 it was discovered that sodium
selenite protected keratinocytes from menadione induced cell death (Fig
3.13). Protection was observed with the same concentration range of selenite
(10-100 nM) as was found for UVB-induced cell death (1-200 nM)(Fig 3.3a).
Selenomethionine however did not offer the cells substantial protection from
menadione toxicity, only proving effective at 50 nM. The difference in
protection against menadione elicited by the seleno-compounds highlights
again, the contrasting abilities and properties they exhibit. The toxic
mechanisms of menadione may differ from that of UVB, this may explain
why selenomethionine was not as protective against menadione induced cell
death. Also it can be seen in Fig 3.13 that selenomethionine does indeed lose
it protective effect at high concentrations.
3.3.6 Protection by antioxidants against UVB-induced cell death.
Other antioxidants have also been shown to protect human keratinocytes
from UVB-induced cell death and apoptosis e.g. a-tocopherol decreases
UVB-induced cell death (Malorni et al, 1996; Kondo et al, 1990) and ascorbic
acid has also been demonstrated to decrease UVB-induced cell death in
HaCaT cells (Savini et al, 1998). These studies serve to reinforce the
hypothesis that, UVB exposure produces free radical species in the skin and
that antioxidants such as selenoproteins can protect the skin cells by
inactivating these reactive molecules.
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3.3.7 Susceptibility of skin cells to UVB-induced cell death.
It was found that keratinocytes and HaCaT cells were more resistant to
UVB-induced cell death than melanocytes; typically a UVB dose of 720 J/m2
was required to produce 75% cell death in melanocytes (Table 3.4) whilst 960
J/m2 was required to produce 75-80% cell death in keratinocytes and HaCaT
cells (Fig 3.3a and Table 3.4). Fibroblasts appeared to be more susceptible to
cell destruction by UVB radiation than other skin cells. However, as already
described, this was measured by the more sensitive colony formation assay
and so cannot be directly compared to the trypan blue experiments.
However, on the colony formation assay 150 J/m2 was used to decrease
colony formation for the fibroblasts and 200 J/m2 for the keratinocytes.
3.3.8 Finite levels of antioxidants in the skin.
When the protective effect of Se was studied at higher doses of UVB the
protective effect began to decrease, with increasing UVB dose. This decrease
in protection has been reported before by other groups. Selenium
supplementation can protect fibroblasts and endothelial cells from H2O2-
induced cell death (50 nM sodium selenite), however at higher levels of
H2O2 the protection is lost (Leist et al, 1996). At increasing levels of damage
the cell's antioxidant systems appear to become overwhelmed and any
protective effect is lost. The loss of cellular defence against oxidative insult is
a consequence of the limited capacity of the intracellular antioxidant system.
When confronted with high levels of free radicals a cell can provide a limited
response with its antioxidants, before requiring a recovery period.
3.4 Summary.
I have shown that Se can protect keratinocytes, fibroblasts and melanocytes
from UVB-induced damage and such protection can be achieved using very
low concentrations of Se, particularly when presented as sodium selenite.
The protective effect is not due the Se increasing cell growth or acting as a
sunscreen. Cells need to be pre-incubated with the Se compounds for at
least 24 hours before significant protection is achieved, suggesting that the Se
exerts its effects through synthesis of antioxidant selenoproteins. One
mechanism by which Se may be protecting the cells is by decreasing the level
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of oxidative stress induced by exposure to UVB, presumably by synthesis of
antioxidant enzymes such as TR and GPX. The decrease in oxidative stress
was indicated by a decrease in the formation of lipid peroxides
Our data in isolated cells would suggest that, as in the mouse, (Pence et al,
1994), increasing Se intake could afford protection from the harmful effects
of UVB radiation. Furthermore, our results suggest that if supplements of Se
were to be given, inorganic forms such as selenite may be more potent at
providing this protection than organic forms such as selenomethionine.
However inorganic forms such as selenite are also more toxic than organic
forms.
3.5 Future work.
Specific TR and GPX inhibitors could be employed, to assess which enzyme
system plays an important role in protecting the cells from UVB-induced cell
death. Gold-thioglucose could be utilised as it inhibits selenoproteins,
however this may not prove to be specific. Studies into the levels of
selenoproteins following Se addition might give an indication of which
selenoproteins are important at protecting the cells (Chapter 8). Cells could




Effect Of Se On The Level Of Apoptosis In
Primary Human Keratinocytes Exposed To UVB.
4.1 Introduction.
It is currently understood that there are two mechanisms involved in cell
death, necrosis and apoptosis. Necrosis is caused by an episode of acute and
severe cellular injury, resulting in the loss of the cell membrane integrity and
lysis. Apoptosis in comparison is an active form of cell death with specific
morphological features which differ from necrosis (Kerr et al, 1972). The
mechanisms and pathways of apoptosis, including the role of p53 are
covered in depth in Chapter 1, Section 1.4.1, however some of the main
points are discussed briefly in the following sections.
Many specific biochemical changes occur in apoptotic cells which involve the
activation of catabolic enzymes. The DNA undergoes intranucleosomal
cleavage by endonucleases, which fragment the DNA into approximately
200 base pair multi-mers. This feature of apoptosis can be demonstrated in
cultured cells undergoing apoptosis. The DNA is separated by agarose gel
electrophoresis and a characteristic series of bands called the nucleosomal
ladder can be observed (Wylie et al, 1984).
Apoptotic keratinocytes are characterised by "a condensed, basophilic
nucleus and eosinophilic homogenisation of the cytoplasm" (Young, 1987).
Keratinocytes undergoing apoptosis are often referred to as being
dyskeratotic cells or sunburn cells (Young, 1987). In culture, apoptotic
keratinocytes also lose their cell to cell contacts, round up and develop cell
surface blebs before detaching from the cell monolayer (Malorni et al, 1994).
When induced, apoptosis is mediated by two intracellular pathways, the
Fas/FasL pathway (which is related to the TNF/TNFR pathway) and the
p53 tumour supressor pathway. The discrete pathways are described in
detail in Chapter 1, Section 1.4.1. Keratinocytes can express Fas, FasL, TNFR,
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TNF and p53, therefore apoptosis can be mediated by the Fas or the p53
pathway.
Exposure to UV stimulates both Fas and FasL expression on keratinocytes
and antibodies to anti-FasL, partially block the induction of UV-induced
apoptosis in keratinocytes (Leverkus et al, 1997). Exposure to UV also causes
Fas molecules to cross link on the surface of cells and this can activate
apoptosis (Aragane et al, 1998). This process is thought to involve
superoxide anions and hydroxyl radicals (Gorman et al, 1997). Exposure to
UV induces expression of TNFR and TNF-a production. Moreover,
antibodies to TNF-a partially block UVB-induced apoptosis in keratinocytes
(Schwartz et al, 1995).
The tumour supressor protein p53 is post-translationally stabilised by UV
radiation, prior to the induction of apoptosis in keratinocytes (Henseleit et al,
1997). The level of apoptosis in the epidermis following exposure to UV
radiation, is greatly decreased in p53 knockout mice (Ziegler et al, 1994).
Exposure to UVB causes DNA damage which leads to the induction of p53
(Lu and Lane, 1993). If the amount of DNA damage is limited, then the cell
undergoes G1 cell cycle arrest and the damaged DNA is repaired before the
cell is allowed to progress through the cell cycle (Lane, 1992; Cox and Lane,
1995; Cox et al, 1995). If the damage is severe then the cell will undergo
apoptosis, which will prevent the mutated DNA from being passed on to
daughter cells.
In damaged or stimulated cells the cellular level of p53 protein increases due
to protein stabilisation and this rise is not prevented by RNA or protein
synthesis inhibitors (Maltzman and Czyzyk, 1984). The p53 protein has to be
phosphorylated to become stable and then phosphorylated again to bind
DNA, these events are covered in more detail in Chapter 1, section 1.4.1.
Therefore, the abundance of p53 protein does not correlate with p53 activity,
as the p53 protein has to be activated to bind DNA tightly.
Some of the genes which p53 regulates are p21WAFl/CIPl (EL-Deiry et al,
1994) and GADD45 (Zhan et al, 1994), which are involved in the p53
response to DNA damage and cell cycle arrest. The method of action of
p2iWAFl/CIPl ancj GADD45 are described in Chapter 1, Section 4.3. It has
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been shown that p53 can down regulate Bcl-2 expression and increase Bax
expression, which can lead to the induction of apoptosis (Miyashita et al,
1994, reviewed in Hoffman and Liebermann, 1994).
In many tumours including those of the skin, the regulators of apoptosis
often do not function correctly. Apoptosis inhibitors such as Bcl-2 are
increased, or p53 may be inactivated by mutations. In more than 50% of
human malignancies the gene for p53 is altered, a fact that underlines the
importance of p53 in controlling normal cell growth (Hollstein et al, 1991;
reviewed in Raff, 1998).
Reactive molecules such as H2O2, which induce oxidative stress can
stimulate cells to undergo apoptosis (Lennon et al, 1991). In this context, it
has been shown that TNF-mediated apoptosis can be inhibited in many cell
types by antioxidants such as thioredoxin (Matsuda et al, 1991) or N-
acetylcysteine (Chang et al, 1992). Furthermore, Fas-induced apoptosis is
reduced by the addition of thioredoxin and SOD (Matsuda et al, 1991; Hirose
et al, 1993). Reactive oxygen species-mediated DNA damage has been
demonstrated to lead to the accumulation of p53 (reviewed in Buttke and
Sandstrom, 1994). The antioxidant N-acetylcysteine has been shown to
inhibit the UV activation of p53, suggesting an involvement of oxidative
stress in the activation of p53 (Renzing et al, 1996).
Cellular symptoms of apoptosis such as membrane blebbing in keratinocytes
can be decreased by the addition of antioxidants such as a-tocopherol
(Malorni et al, 1996), glutathione (Godar, 1999), SOD and catalase (Miyachi et
al, 1983).
It has been observed that p53 can activate the antioxidant selenoprotein GPX,
indeed there is a p53 binding site within the promoter for GPX. This may be
a protective mechanism to reduce oxidative damage to the cell while p53
halts the cell cycle to repair DNA damage. The biological importance of
p53's activation of GPX is not fully understood as yet (Tan et al, 1999).
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The aims of this study were to
• Investigate the potential induction of apoptosis by UVB in primary
human keratinocytes.
• Study the effects of Se on the potential induction of apoptosis by UVB.
• Investigate the effect exposure to UVB has on the levels of p53 protein.
• Study the impact of Se on the abundance of p53 protein after exposure to
UVB.
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4.2 Methods and Results.
4.2.1 Induction of apoptosis by UVB in primary human keratinocytes.
4.2.1.1 Quantitated by acridine orange staining.
Apoptosis was quantitated using acridine orange staining. Primary human
keratinocytes were grown to 70% confluence in six well dishes, the media
was replaced with PBS and the cells exposed to 480, 720 or 960 J/m2 UVB.
The original media was replaced and the cells were left for 6,16 or 24 hours,
prior to being stained with acridine orange and counted using fluorescent
microscopy (Chapter 2, section 2.4.1). The percentage of apoptotic cells was
calculated. Each time point consisted of six replicates. Apoptotic cells show
apoptotic body formation and stain very brightly with acridine orange
(Fig4.1b)
Normal cells stained with acridine orange and viewed using a fluorescent
microscope, appear large, circular and green. The nuclei are bright
green/yellow as the dye binds to the DNA, the nuclei also appear large and
diffuse (Fig 4.1a). Apoptotic cells appear to be much brighter than normal
cells and have a shrunken appearance. They also have apoptotic bodies
budding off from the cell, which are bright yellow and the nucleus can no
longer be seen (Fig 4.1b).
The amount of apoptosis induced was dependent on both the dose of UVB
and the time following exposure to UVB (Fig 4.2). The lowest dose of UVB
(480 J/m2) had a peak of apoptosis at 24 hours following exposure to UVB.
The highest dose of UVB (960 J/m2) however caused a peak in apoptosis at 6
hours after exposure, whilst 720 J/m2 caused a peak at 16 hours following
exposure. The greatest number of apoptotic cells was found at 720 J/m2 at
16 hours following exposure to UVB. This time point was selected for the
rest of the study, however a slightly lower dose of UVB (600 J/m2)was
selected for the rest of the study, as it was deemed important not to induce
necrosis of the cells.
Continued on page 4-8
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Figure 4.1: Acridine orange stained normal and apoptotic
keratinocytes.
(a) Unirradiated primary human keratinocytes stained with acridine
orange (x200).
(b) Primary human keratinocytes 16 hours after being exposed to 600 J/m2
UVB (x200).
Figure 4.2: Time course for the induction of apoptosis in
primary human keratinocytes following exposure to
UVB.
Time (hours)
Cells were grown to 70% confluence the media was replaced with PBS and
the cells exposed to UVB. The original media was replaced and the cells
were incubated for 6-24 hours. The cells on the monolayer and supernatant
were harvested separately, resuspended in PBS, stained with acridine orange
and counted using a fluorescent microscopy. The 0 hour cells were
unirradiated. Results are the means of the % apoptosis ± S.E.M, n=6.
Significant difference from unirradiated cells, * = P<0.05.
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4.2.1.2 Confirmation of apoptosis using electron microscopy.
When studying the process of apoptosis it is essential to confirm that the
cells are apoptotic by several methods.
Primary keratinocytes were grown to 70% confluence in 10 cm petri dishes,
the media was removed and replaced with PBS and the cells were exposed to
600 J/m2 UVB. The original media was replaced and the cells were
incubated for 16 hours, before being processed for electron microscopy
(Chapter 2, section 2.4.2). The time point and dose of UVB used were found
to be optimal for the induction apoptosis measured using acridine orange
staining (Fig 4.2). The cells were then studied using an electron microscope
to distinguish any apoptotic features. The irradiated keratinocytes were
demonstrated to be undergoing apoptosis and cells in different stages of
apoptosis could be demonstrated.
• Normal unirradiated cells have a regular round appearance, with a large
diffuse nucleus (Fig 4.3a).
• The cytoplasm of irradiated cells first becomes foamy in appearance and
the chromatin begin to condense (Fig 4.3b).
• The nucleus begins to shrink, with the nuclear membrane remaining
intact (Fig 4.3c).
• The nucleus continues to shrink and the cell begins to form apoptotic
bodies which are membrane bound (Fig 4.3d) and finally the apoptotic
bodies, which are still membrane bound detach from the cell (Fig 4.3e)
4.2.2 Effect of Se on UVB-induced apoptosis.
4.2.2.1 Measured by acridine orange staining.
Six well dishes of primary keratinocytes were incubated with either sodium
selenite or selenomethionine for 24 hours prior to the media being replaced
and the cells exposed to 600 J/m2 UVB. The original Se-containing media *
Continued on page 4-12
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Figure 4.3: Electron microscopy on unirradiated and irradiated
keratinocytes.
(a) Unirradiated primary human keratinocytes (x5000).
(b) Irradiated keratinocytes 16 hours after exposure to UVB (x5000).-The
cytoplasm is foamy, and the chromatin is starting to condense.
(c) Irradiated keratinocytes 16 hours after exposure to UVB (x5000). -The
nucleus has begun to shrink.
(d) Irradiated keratinocytes 16 hours after exposure to UVB (x5000). -The
nucleus is very small and the cell membrane has started to form
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(e) Irradiated keratinocytes 16 hours after exposure to UVB (x28,000). - An
example of a membrane bound apoptotic body.
Primary keratinocytes were grown in 10 cm2 petri dishes, the media was
replaced with PBS and the cells were exposed to 600 J/m2 UVB. The media
was replaced and the cells incubated for 16 hours. The supernatant and
monolayer were harvested separately and dehydrated in alcohol gradients.
The cell pellet was then embedded in araldite and thin sections cut for
electron microscopy. Unirradiated cells are shown in Fig 4.3a and irradiated
cells in Figs 4.3b-e.
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was then returned to the cells and the cells incubated for a further 16 hours.
The cells were then harvested, stained with acridine orange and the
percentage of apoptotic cells was calculated as described previously in
Chapter 2, section 2.4.1. The experiments were carried out with a n of 6,
three times.
Exposure to UVB induced apoptosis in 30% of cells. Control cells showed a
low background level of apoptosis (5%)(Fig 4.4). Selenium decreased the
induction of UVB-induced apoptosis in a dose-dependent manner. Sodium
selenite significantly reduced the level of apoptosis over the concentration
range of 10 nM-1 pM. The concentrations giving best protection were 100-
200 nM sodium selenite. Selenomethionine decreased the levels of apoptosis
with concentrations between 50 nM-1 pM (Fig 4.4). The optimal
concentrations of selenomethionine for decreasing the level of UVB-induced
apoptosis were between 50-200 nM.
4.2.2.2 Confirmation of apoptosis using gel electrophoresis.
Primary keratinocytes grown in 10 cm petri dishes, were incubated with
either sodium selenite or selenomethionine for 24 hours prior to the media
being replaced with PBS and the cells exposed to 600 J/m2 UVB. The
original Se-containing media was then replaced and the cells were incubated
for a further 24 hours. The cells were left for 8 hours longer than when using
the acridine orange staining method, as DNA cleavage is a late event in the
process of apoptosis. The supernatants and the monolayers of cells were
then harvested separately, processed and the DNA run on an agarose gel
(Chapter 2, section 2.4.3). The gel was then visualised on a UV
transilluminator.
As can been seen in Fig 4.5 the supernatants of the irradiated cells contained
apoptotic cells, as DNA ladders were present. This method is not a
quantitative method, so the relative amounts of ladder can not be
quantitatively compared. However it can be seen that the lane with the
supernatant from the unirradiated cells does not contain a DNA ladder.*
Continued on page 4-15
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Figure 4.4: Effect of Se on the UVB-induction of apoptosis in
primary human keratinocytes.
Control 0 1nM 10nM 50nM 100nM 200nM 1uM
Selenium Treatment
Cells were supplemented with either sodium selenite or selenomethionine
for 24 hours prior to the media being replaced with PBS and the cells
exposed to UVB (600 J/m2). The original Se-containing media was replaced
and the cells were incubated for 16 hours. The cells from the monolayers
and supernatants were harvested separately, resuspended in PBS, stained
with acridine orange and counted using fluorescent microscopy. Control
cells were not treated with Se or irradiated. Results are the means of the %
apoptosis ± S.E.M, n=6. Significant difference between control cells and
irradiated cells with no Se treatment, t = P<0.05. Significant difference from
irradiated cells with no Se treatment, * = P<0.05.
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Figure 4.5: Effect of Se and exposure to UVB on the formation of
DNA ladders in primary human keratinocytes.
LaABCDE F GHIJ KLMNOP
Cells were supplemented with either sodium selenite or selenomethionine
for 24 hours prior to the media being replaced with PBS and the cells
exposed to UVB (600 J/m2). The original Se-containing media was replaced
and the cells were incubated for 24 hours. The cells from the monolayers
and supernatants were harvested separately, lysed, proteinase K and RNase
A treated. The DNA was then run on an agarose gel and viewed on a UV
transilluminator. 100 base pair ladder is shown (La). Lanes A-H are
supernatant cells and Lanes I-P are monolayer cells-: A&I- control
unirradiated cells, B&J- irradiated cells with no Se added, C&K- 1 nM
sodium selenite, D&L-10 nM sodium selenite, E&M- 50 nM sodium selenite,
F&N- 50nM selenomethionine, G&O- 100 nM selenomethionine and H&P-
200 nM selenomethionine.
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The supernatants from cells treated with 10 and 50 nM sodium selenite show
less ladder formation than the irradiated control cells. The cells treated with
selenomethionine all show DNA ladders.
The monolayers of all of the cells do not show any DNA ladders and only
show smears of DNA. The presence of DNA ladders are very difficult to
demonstrate, they are only present for a brief period of time during the latter
stages of apoptosis. From seven attempts to demonstrate their presence,
only two were successful.
4.2.3 Effect of exposure to UVB on the levels of p53 protein found in
human primary keratinocytes.
4.2.3.1 Level of protein for p53 measured by western blotting.
Cells were grown to 70% confluence, in six well dishes, the media was
replaced with PBS and the cells exposed to doses of UVB between 200-1000
J/m2. The original media was replaced and the cells were left for 24 hours,
harvested into triple lysis buffer and western blotting performed (Chapter 2
section 2.4.4). The blots were then visualised on XOMAT-XAR film using
ECL and quantitated on a densitometer.
The first two lanes on the western blot are A431's, a human keratinocyte cell
line which express a high level of mutant p53 protein, so were used as a
positive control for the p53 protein (Fig 4.6a). The other lanes in Fig 4.6a
show the effect of exposure to UVB on the levels of p53 protein in primary
keratinocytes, the graph in Fig 4.6b is derived from the western blot in Fig
4.6a.
The protein for p53 increased in a dose dependent manner up to 400 J/m2 of
UVB. However, at doses above 400 J/m2 the protein level remained high
but did not increase further (Fig 4.6 a&b). In further experiments 600 J/m2
UVB has been used again at 24 hours following exposure to UVB.
Continued on page 4-18
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Figure 4.6a: Induction of p53 protein by exposure to UVB, in
primary human keratinocytes, measured by
western blotting.
AB C DE FGH
Cells were grown to 70% confluence the media was replaced with PBS and
the cells exposed to doses of UVB between 200-1000 J/m2. The original
media was replaced and the cells were left for 24 hours, harvested into triple
lysis buffer and western blotting performed for p53. The blots were then
visualised on to XOMAT-XAR film using ECL. Lane A&B- A431 cells, Lane
C- Primary keratinocytes, not exposed to UVB, Lane D-H- Primary
keratinocytes exposed to 200,400, 600, 800 and 1000 J/m2 UVB.
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Figure 4.6b: Induction of p53 protein by exposure to UVB, in
primary human keratinocytes, measured by
western blotting.
Cells were grown to 70% confluence the media was replaced with PBS and
the cells exposed to doses of UVB between 200-1000 J/m2. The original
media was replaced and the cells were left for 24 hours, harvested into triple
lysis buffer and western blotting performed for p53. The blots were then
visualised onto XOMAT-XAR film using ECL and quantitated on a
densitometer. Results are the mean relative densities ± S.E.M, n=2.
Significant differences from the 0 hour, unirradiated cells, * = 0.05%.
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4.2.3.2 Level of protein for p53 demonstrated by immunostaining.
Primary keratinocytes were grown on coverslips and treated as in section
4.2.3.1. After the 24 hour incubation time following exposure to UVB, the
cells were fixed in 1% paraformaldehyde and immunostained for p53
(Chapter 2, Section 2.4.5). They were then studied under the microscope. A
scoring system was devised to grade the intensity of staining.
Normal unirradiated keratinocytes showed a faint nuclear staining for p53
(Fig 4.7a). It was found that 600 J/m2, 24 hours following exposure to UVB
demonstrated again the best induction of p53 (Figure 4.7b). The staining for
p53 was darker in the irradiated cells and remained nuclear. In the control
cells all of the cells show faint staining for p53, then after irradiation this
staining intensifies, this made it difficult to quantitate the staining.
Using the scoring system, exposure to UVB induced an increase, in the
abundance of p53 protein at low levels in cells exposed to 100-300 J/m2
(Table 4.1). This increased in strength in cells exposed to 100-400 J/m2,
however the intensity of staining did not increase further at doses of UVB
above 400 J/m2.
4.2.4 Effect of Se on p53 induction by exposure to UVB in primary
keratinocytes.
4.2.4.1. Measured by western blotting.
The cells were treated with sodium selenite (1-50 nM) or selenomethionine
(50-200 nM) for 24 hours before the media was replaced with PBS and the
cells exposed to 600 J/m2 UVB. The original Se-containing media was
returned and the cells incubated for a further 24 hours. The cells were then
harvested as before and western blotting carried out for p53 (Chapter 2,
section 2.4.4). The experiment was repeated twice and each point was done
in duplicate.
The unirradiated control cells express low background levels of the protein
for p53. The cells exposed to UVB, but not treated with Se, show a four-fold
increase in the abundance of p53 protein. Sodium selenite, did not affect the
4-18
UVB-induced increase in the abundance of the protein for p53 at any
concentration tested (Fig 4.8).
In the second experiment, using selenomethionine, the irradiated cells show
a three fold increase in p53 protein, however due to large variations in the
control unirradiated cells, this did not achieve statistical significance (Fig
4.9). Unfortunately, this occurred in both of the duplicate experiments with
selenomethionine. However, it can be seen that the selenomethionine had
no affect on p53 in irradiated cells at any concentration tested (Fig 4.9).
4.2.4.2 Demonstrated using immunostaining.
Primary keratinocytes were grown on coverslips and treated with either
sodium selenite or selenomethionine for 24 hours prior to the media being
replaced with PBS. The cells were then exposed to 600 J/m2 UVB, the
original Se-containing media was replaced and the cells incubated for a
further 24 hours. After the 24 hour incubation, the cells were fixed in 1%
paraformaldehyde and immunostained for p53 (Chapter 2, section 2.4.5).
They were then studied under the microscope .
As can be seen from Table 4.2, Se did not greatly alter the intensity of
staining for p53. There were indications of slight decreases in staining at 10
nM sodium selenite and 100 and 200 nM selenomethionine. However these
were not consistent in all of the experiments, nor were they large decreases.
Treatment with Se did not alter the location of the p53 within the cell, it
remained nuclear.
4-19
Figure 4.7: Induction of p53 protein by exposure to UVB in
primary human keratinocytes, demonstrated by
immunostaining.
(a) Unirradiated cells (x!60).
(b) Irradiated cells (600 J/m2) (xl60).
% % . |
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Primary keratinocytes were grown on coverslips and treated as in section
4.2.4.1. After the 24 hour incubation time following exposure to UVB the
cells were fixed in 1% paraformaldehyde and immunostained for p53. The
staining intensity was then graded under the microscope.
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Table 4.1: Induction of p53 protein by exposure to UVB in
primary human keratinocytes, measured by
immunostaining.








Primary keratinocytes were grown on coverslips and treated as in section
4.2.4.1. After the 24 hour incubation time following exposure to UVB the
cells were fixed in 1% paraformaldehyde and immunostained for p53. They
were then studied under the microscope, and graded for the intensity of
staining.
- = no staining
+ = faint staining
++ = stronger staining
+++ = very strong dark brown staining
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Figure 4.8: Effect of Se on the UVB-induced increase in p53




The cells were treated with sodium selenite for 24 hours before the media
was replaced with PBS and the cells exposed to 600 J/m2 UVB. The original
Se-containing media was returned and the cells incubated for 24 hours. The
cells were then harvested into triple lysis buffer and western blotting carried
out for p53. The blots were then visualised using ECL and scanned using a
densitometer. Control cells were not treated with Se or exposed to UVB.
Results are the mean densitometer readings ± S.E.M, n=2. Significant
induction compared to 0, unirradiated cells, t = P<0.05%.
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Figure 4.9: Effect of Se on the UVB-induced increase in p53




Control 0 50nM 10OnM 200nM
Selenomethionine
Selenium Treatment
The cells were treated with selenomethionine for 24 hours before the media
was replaced with PBS and the cells exposed to 600 J/m2 UVB. The original
Se-containing media was returned and the cells incubated for 24 hours. The
cells were then harvested into triple lysis buffer and western blotting carried
out for p53. The blots were then visualised using ECL and scanned using a
densitometer. Control cells were not treated with Se or exposed to UVB.
Results are the mean densitometer readings ± S.E.M, n=2.
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Table 4.2: Effect of Se on the UVB-induced increase in the level
of p53 protein in primary keratinocytes, measured by
immunostaining.
Treatment Relative intensity of staining (individual experiments)
Control +/- +/- +



















The cells were treated with sodium selenite or selenomethionine for 24 hours
before the media was replaced with PBS and the cells exposed to 600 J/m2
UVB. The original Se-containing media was returned and the cells incubated
for 24 hours. The cells were then immunostained for p53. Control cells had
not been treated with Se or exposed to UVB. Results are the average
intensity of staining, following the key below, n=3.
- = no staining
+ = faint staining
++ = Stronger staining
+++ = Very strong dark brown staining
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4.3 Discussion.
Following exposure to UVB, skin cells can undergo cell death. Cell death
induced by exposure to UVB was originally considered to be by the process
of necrosis. Necrosis is described as a "passive" form of cell death, during
which the cell swells and lyses, spilling it's cellular contents into the
surrounding tissue and thus induces an inflammatory reaction. However, it
is now accepted that at lower doses of UVB a large proportion of the cell
death is mediated by apoptosis. Apoptosis in comparison to necrosis is an
"active" form of cell death, which is characterised by specific cellular
changes. Cells are observed to shrink and fragment into membrane enclosed
apoptotic bodies, which are then phagocytosed by other cells. The
associated phagocytosis ensures that the cellular contents do not leak,
therefore an inflammatory response does not occur (Kerr et al, 1972).
At the peak induction of apoptosis by UVB, as much as 30% of the
keratinocyte population dies by apoptosis (Baba et al, 1996, Cotton and
Spandau, 1997). Furthermore the optimum time point for the induction of
apoptosis in the skin, has been demonstrated previously to be around 15
hours post exposure to 600 J/m2 UVB. An optimum time of 15 hours
compares well with the results of the present study, were 30% of cells were
induced to undergo apoptosis 16 hours after exposure to 600 J/m2 UVB (Fig
4.1). The level of apoptosis appears to decrease at later time points, this is
because in vivo the apoptotic bodies would have been phagocytosed by other
cells. However, in vitro there are no cells to phagocytose the apoptotic cells
so over time they eventually lyse and the level of apoptosis appears to
decrease. The presence of apoptotic cells was rigorously confirmed by three
separate methods. The use of multiple investigative techniques is important
when studying cell death, due to the similarities between apoptosis and
necrosis. The presence of apoptotic cells was confirmed using acridine
orange staining, where cell shrinkage and the subsequent formation of
apoptotic bodies could be demonstrated (Fig 4.2). The cellular morphology
was then studied by electron microscopy and a series of events leading to
apoptosis was followed. It should be noted that in any given cell population
cells are found at different stages of apoptosis, due to cell to cell variation in
the rate of apoptosis. However cell shrinkage, condensation of the
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chromatin, contraction of the nucleus, and formation of apoptotic bodies
could all be demonstrated in irradiated keratinocytes.
As shown in Figure 4.1 and 4.4 the unirradiated cell population has a low
background level of apoptosis. Therefore apoptosis is one of the mechanisms
by which normal, untreated keratinocytes in culture die. There is much
evidence to suggest that sunburn cells in the epidermis are apoptotic and
that differentiating keratinocytes exhibit many of the features of apoptosis
(Maruoka et al, 1997). These include the activation of endonucleases and
DNA fragmentation (McCall and Cohen, 1991). However there are
differences between terminally differentiating and apoptotic cells.
Terminally differentiating cells can take days and not hours to die. Also
such cells do not fragment and form apoptotic bodies and specific keratin
genes are upregulated in differentiating cells (Gandarillas et al, 1999).
However in culture, normal keratinocytes appear to undergo a low level of
apoptosis, whether this is the case in vivo is unclear.
There is increasing evidence that ROS are involved in the activation of all the
major pathways of apoptosis. Exposure to UV light can induce oxidative
stress. Therefore the effect of Se on the UVB-induction of apoptosis was
studied. It was found that Se, added as sodium selenite or selenomethionine
significantly decreased UVB-induced apoptosis. Both compounds acted in a
dose dependent manner (Fig 4.4). Examination of the results showed that
sodium selenite was protective at slightly lower concentrations (10 nM)
compared to selenomethionine (50 nM). This is in agreement with the
overall cell survival experiments reported in Chapter 3, were sodium selenite
was again found to be protective at slightly lower concentrations (1 nM) than
selenomethionine (10 nM) (Fig 3.3a). The more potent protection offered by
sodium selenite is thought to be a consequence of its increased bioactivity, as
discussed in Chapter 3. The decrease in apoptosis shown differs from the
protection offered against overall cell death. This is because higher
concentrations (1 pM) of both compounds were found to decrease the level
of apoptosis, than the concentrations which where found to reduce overall
cell death (200 nM). It is not known why this should occur, however it
maybe due to the fact that lower doses of UVB were used to induce
apoptosis. Therefore the cells are incurring less damage and can cope more
readily with the extra stress induced by the two seleno-compounds. In
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general terms however, the protection from apoptosis for both compounds is
very similar to the concentrations which afford overall protection from cell
death.
The data in figure 4.5 again demonstrates the protective effects of Se
following cell exposure to UVB. As shown, the formation of nucleosomal
ladders following UVB-exposure was decreased by pre-treatment of the cells
with either 10 or 50 nM sodium selenite. As described in the results section,
this feature of apoptosis is considered a late event and is difficult to detect
and quantitate. However it does serve as a third method for confirming the
presence of apoptosis in keratinocytes following exposure to UVB. Also as
presented in figure 4.5, unirradiated cells do not appear to form nucleosomal
ladders, as none were detected by this assay. However the sensitivity of the
assay may be the limiting factor in detecting any nucleosomal ladder
formation in unirradiated cells.
The apoptosis stimulated by the exposure of cells to UVB appears to be
induced by the activation of several different pathways. It would appear
that the Fas, TNFR and p53 pathways are all involved in UV-induced
apoptosis (Gniadecki et al, 1997).
One of the mechanisms by which apoptosis is induced following exposure to
UVB is via the production of ROS. Apoptosis in keratinocytes following
exposure to UVB can be decreased by the addition of the antioxidants such
as a-tocopherol (Malorni et al, 1996) and glutathione (Godar, 1999).
Therefore Se as a component of the antioxidants GPX or TR may have an
important role in preventing the induction of apoptosis by ROS. Due to time
constraints a full analysis of the three main pathways of apoptosis in
keratinocytes following exposure to UVB could not be completed.
Antioxidants (thioredoxin and N-acetylcysteine) can inhibit the TNF-
mediated pathway of apoptosis (Matsuda et al, 1991; Chang et al, 1992). Both
TNF-a and TNFR are induced by exposure to UVB and antibodies to TNF-a
partially block UVB-induced apoptosis (Schwartz et al, 1995). The effect of Se
on the UVB-stimulation of TNF-a was studied in detail and is covered in
Chapter 6). However it did appear that Se can decrease the UVB-induction
of the mRNA and the protein for TNF-a in primary human keratinocytes.
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Therefore Se could decrease the induction of apoptosis by TNF-a, in
response to UVB by, helping to regulate the cells control of transcription and
translation.
Another pathway involved in the control of apoptosis is the Fas/FasL
signalling pathway. Exposure to UVB induced Fas and FasL on
keratinocytes and it can also induce the Fas molecules to cross link which
can induce apoptosis (Aragane et al, 1998). Cross- linking of Fas molecules is
thought to involve superoxide anions and hydroxyl radicals (Gorman et al,
1997). This pathway can be decreased by the addition of antioxidants such
as thioredoxin and SOD (Matsuda et al, 1991; Hirose et al, 1993). The
Fas/FasL pathway was not examined in this study, however it does appear
to be strongly influenced by ROS and antioxidants do reduce the induction
of apoptosis by this mechanism. Therefore it is certainly a candidate
mechanism for the reduction of apoptosis by Se treatment following
exposure to UVB.
Finally another pathway leading to apoptosis is the p53 pathway. It has
been shown that p53 knock out mice have greatly reduced levels of
apoptosis in the epidermis following exposure to UVB (Ziegler et al, 1994).
Moreover reactive oxygen-mediated DNA damage has been shown to lead
to the accumulation of p53 (reviewed in Buttke and Sandstrom, 1994). In
Chapter 5, Se was found to reduce the formation of oxidative DNA damage.
The ability of Se to prevent oxidative DNA damage is of great importance
since work done using antioxidants points to a role for oxidative stress in the
activation of p53 (Renzing et al, 1996). Antioxidants may act by preventing
the phosphorylation of p53. The N-terminal domain of p53 requires
phosphorylation before the bound mdm-2 is released, the release of mdm-2
stabilises the p53 protein (Midgley and Lane, 1997; Shieh et al, 1997). The
UV-induced protein kinase JNK-1 has been shown to phosphorylates p53 at
the N-terminal (Milne et al, 1995). The C-terminal end of p53 also needs to be
phosphorylated or acetylated to increase it's ability to bind DNA. Indeed
DNA damage induced by exposure to UVB has been shown elicit the
phosphorylation of p53 at the C-terminal (Lu et al, 1998). It has been
demonstrated that the REDOX environment is important for the
conformation of the p53 DNA binding site (Sun and Oberley, 1996).
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Therefore oxidative stress is important in the activation and conformation of
the p53 protein.
The levels of p53 protein were shown to increase 24 hours following
exposure to 600 J/m2 UVB (Fig 4.6a & b). The rise in p53 levels shown here
are in agreement with other reported findings in the literature (Hall et al,
1993). Selenium did not affect the induction of the p53 protein by UVB. The
results suggest that Se does not act by blocking the phosphorylation of the
p53 protein at the N-terminus of the protein, where mdm-2 binds. For there
to be an increase in the abundance of p53, phosphorylation of the N-
terminus must occur allowing the mdm-2 to be released and Se did not block
the increase in the protein. The upregulation of the p53 protein is reported
to be the result of post translational modification and not to an increase in
mRNA levels. However from this study it cannot be distinguished whether
the p53 protein displays an increase in DNA binding ability or stimulates
increased transcription of the genes for effector proteins in the p53 pathway.
It may be that Se alters the transcriptional activation of the p53 target
proteins. Also Se may exert its effects by increasing p53's transcription of
DNA repair pathway proteins or cell cycle arrest proteins such as
p21wAF/CIPl anc[ GADD45. This could be augmented by decreasing the
activation of the apoptotic genes which p53 regulates such as Bax and Bcl-2.
Bcl-2 has antioxidant properties (reviewed in Kroemer, 1997). It is known to
inhibit apoptosis by preventing the release of cytochrome c from
mitochondria. Cytochrome c can act as a co-factor to activate Apaf-1 which
activates caspase 9, an important pro-apoptotic effector.
It has recently been shown that caspase 3, in particular is a key player in the
DNA fragmentation process and other morphological changes associated
with apoptosis. Selenite (100 nM) pre-treatment has been shown to decrease
the level of UVB-induced apoptosis, DNA fragmentation and caspase 3
activation (Park et al, 2000). The inhibition of caspase activity may be a major
mechanism by which primary keratinocytes are protected from UVB-
induced apoptosis.
An interesting recent discovery is
selenoprotein GPX (Tan et al, 1999).
known, however it may be that p53
that p53 can activate the antioxidant
The biological importance of this is not
activates this gene in order to decrease
4-29
the oxidative stress within the cell. Any activation of GPX by p53 would
increase the possibility of the cell recovering from exposure to UVB. If p53
activated the GPX gene in conditions of low Se then the protein would not be
produced optimally. However, supplementation of the cells with extra Se
would allow the cells to produce more functional GPX, thus increasing the
protection of the cell. The effect of Se supplementation in primary
keratinocytes, on the levels of cGPX and phGPX are covered in Chapter 8.
4.4 Further Work.
There is a great deal of further work which could be carried out to discover
how exactly Se decreases the level of apoptosis induced by exposure to UVB.
It would be of interest to study the Fas-mediated pathway of apoptosis and
determine if Se decreases Fas clustering on the surface of cells. Also of
interest is the role of the down stream effector proteins in this pathway. An
investigation into the role Se has on the recruitment of FADD, MORT and
other effectors to the Fas pathway would be very informative.
It could be determined if Se alters the protein levels of any members of the
Bcl-2 family thereby rescuing cells from apoptosis. The levels of activation of
the effector caspases is also a candidate for further examination. Similarly
work could be carried out on the TNF-a pathway to dissect out the mode of
Se's protective effect.
A great deal of work needs to be carried out on the p53 pathway, to
determine which downstream genes are activated by UVB and if Se alters the
transcriptional state of these genes i.e. Bcl-2, Bax, p21WAF/CIP1 and
GADD45. An examination of the phosphorylation pattern of p53 in the
presence or absence of Se would allow greater understanding of the
mechanism of p53 induction. Finally electrophoresis mobility shift assays
could be utilised to determine the DNA binding capability of the p53
protein, in nuclear extracts with and without Se supplementation.
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Chapter 5
The Effect of Se on the Formation and Repair of
UVB-Induced DNA Damage in the Skin.
5.1 Introduction.
5.1.1 Mechanism of Photocarcinogenesis.
As discussed in detail in Chapter 1 it has been established that natural
sunlight is a complete human skin carcinogen, affecting all three stages of
photocarcinogenesis: initiation, promotion and progression (Brash et al,
1996).
At the level of initiation, exposure to UV radiation induces DNA damage,
which may cause mutations within cellular DNA. Exposure to UV radiation
causes DNA mutations and failure to repair these genetic alterations may
lead to unrestrained growth and tumour formation. The importance of UVB
as an initiator of tumourigenesis is thought to result from it's ability to cause
mutations in genes which control the cell cycle. Examples of these genes are
proto-oncogenes such as ras or tumour suppressor genes such as p53 (van
der Schroeff et al, 1990: Brash et al, 1991). There is increasing evidence to link
DNA damage to skin carcinogenesis, the most compelling evidence is that
patients with the hereditary condition xeroderma pigmentosum are 2000 times
more likely than unaffected individuals to develop skin carcinomas
(Lambert et al, 1995). Patients with xeroderma pigmentosum are
characteristically defective in nucleotide excision repair pathways (Cleaver,
1969).
5.1.2 Ultraviolet Radiation-induced DNA damage.
The effects of UV radiation are due to the absorption of radiant energy by an
appropriate molecule (chromophore). The wavelengths of UV that are
carcinogenic for human cells correspond to the absorption spectrum of DNA
(Sutherland et al, 1980). DNA absorbs UV radiation in the range 230-300 nm.
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UV radiation may damage DNA directly, as observed with shorter
wavelengths such as UVC or UVB. Alternatively, damage may be caused
indirectly by longer wavelength UVA, via a photosensitiser and the
formation of reactive oxygen species (Friedberg et al, 1995). The different
lesions are discussed in detail in Chapter 1, however a short summary is
included below:
Direct DNA damage includes the formation of cyclopyrimidine dimers
(CPDs) which are the predominant solar UV photoproduct. The 6-4
pyrimidine-pyrimidone photoproduct is the second most common form of
direct DNA damage caused by solar UV radiation.
There is substantial evidence linking direct types of DNA damage to skin
photocarcinogenesis. Analysis of DNA from human basal and squamous
carcinomas, has revealed that the majority of mutations occur at
dipyrimidine sites.
Indirect forms of DNA damage induced by exposure to UV radiation include
oxidised or hydrated pyrimidines (cytosine photohydrates and thymine
glycols), oxidised purines (8-hydroxyguanosine) (8-OHdg), single-strand
breaks and DNA protein cross-links (Jen et al, 1997). There is some evidence
that indirect DNA damage may be involved in carcinogenesis (van der
Scroeff et al, 1990; Nishigori et al, 1994).
The hydroxyl radical appears to be important in the formation of oxidative
DNA damage (Peak and Peak, 1990). Singlet oxygen has also been shown to
be involved in the formation of 8-OFldg. Oxidised DNA damage has been
reported to occur after exposure of keratinocytes to H2O2, although the
damage is thought to be mediated by the formation of hydroxyl radical
(Beehler et al, 1992; reviewed in Thomas et al, 1998). The damage caused by
exposure of cells to H2O2 includes the formation of oxidised pyrimidines
and single strand breaks (Collins et al, 1995; Duthie and Collins, 1997). Lipid
peroxidation has also been reported to mediate the formation of 8-OHdg
damage (Park and Floyd, 1992). The mutated base 8-OHdg is formed in a
dose-dependent manner following exposure of the skin to UVB (Hattori-
Nakakuki et al, 1994; Hattori et al, 1996).
5-2
5.1.3 Repair of UV-induced DNA damage.
Efficient repair of UV photoproducts is a critical early step in the prevention
of skin cancer. DNA photoproducts will lead to skin cancer only if they
persist long enough in basal cell keratinocytes, to become fixed as permanent
mutations in subsequent rounds of cell division.
Base excision repair removes areas of damaged DNA either as single bases,
or as short oligonucleotides. Nucleotide excision repair (NER), removes both
indirect and direct types of DNA damage. The NER is a general repair
mechanism that removes bulky DNA lesions causing major helical
distortions. These repair mechanisms and other more novel pathways of
DNA repair are covered in more detail in Chapter 1.
5.1.4 Protection from DNA damage by antioxidants.
There is an increasing amount of evidence which suggests that treatment
with antioxidants decreases the levels of oxidative damage to DNA.
Supplementation of human skin fibroblasts with N-acetylcysteine for 4 hours
or zinc for 1 week decreases the DNA damage induced by exposure to UVA.
The type of damage which was decreased was immediate damage such as
single strand breaks and alkali-labile sites (Emonet-Piccardi et al, 1998).
Glutathione has been reported to decrease the formation of 8-OHdg, in a cell
free system following exposure to ionising radiation (Fischer-Nielsen et al,
1994).
5.1.5 Protection from DNA damage by supplementation with Se.
Sodium selenite (600 nM) was found to decrease the formation of single
strand breaks and alkali-labile sites in skin fibroblasts, after exposure to
UVA (Emonet-Piccardi et al, 1998). Pre-treatment with sodium selenite (5
pM) for 48 hours prior to exposure to UVB (500 J/m2) also decreases the
formation of 8-OHdg sites in mouse keratinocytes (Stewart et al, 1996). In the
same report, ascorbic acid and vitamin E also prevented the formation of 8-
OHdg lesions following exposure to UVB. Single strand breaks induced by
exposure of cells to H2O2 can be decreased by supplementation of cells with
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50 nM sodium selenite (Leist et al, 1996). The data presented here suggests
that Se can reduce the formation of oxidative DNA damage.
5.1.6 The Comet assay.
The comet assay (also known as single-cell gel electrophoresis) is a rapid and
sensitive method of measuring DNA strand breaks in mammalian cells. This
assay was first described by Ostling and Johanson (Ostling and Johanson,
1984) and has been developed by Singh and Olive (Singh et al, 1988; Olive et
al, 1990). Methods and applications of this assay have been extensively
reviewed (McKelvey-Martin et al, 1993; Fairbairn et al, 1995; Collins et al,
1997). During the assay cells are embedded in agarose, lysed,
electrophoresed, and stained before DNA damage is visualised using
fluorescent microscopy (Fig 5.1). Breaks in the duplex DNA molecule release
its complex super-coiling and the free DNA migrates toward the anode, so
that the cell resembles a comet with a brightly fluorescent head and a tail
streaming away from it.
The comet assay can distinguish between breakage of the sugar-phosphate
backbone and/or damage to DNA bases. Using time course experiments the
assay can distinguish between direct strand breakage and breakage
occurring as a result of the repair process. Breakage of the DNA due to the
repair process can be measured by the addition of DNA synthesis inhibitors,
which allow the recognition and incision stages of excision repair to proceed,
but which inhibit DNA resynthesis, causing an accumulation of single strand
breaks. Some commonly used inhibitors include; Arabinosyl cytosine (ARA
C) and aphidicolin which act by becoming incorporated into the DNA strand
thereby distorting its shape so that the DNA polymerase detaches. Another
commonly used DNA synthesis inhibitor is hydroxyurea, which inhibits
ribonucleotide reductase activity, therefore blocking the production of all
deoxyribonucleotides and hence DNA synthesis (Fig 5.2). The comet assay
can be easily modified to detect several types of strand breaks and
discriminate between different types of DNA damage by using purified
DNA repair enzymes (Gedik et al, 1992; Collins et al, 1993; Collins et al, 1996).
The Comet assay has been used in vivo and in vitro to assess DNA damage
and repair induced by a variety of physical factors such as: UV radiation
(Arlett et al, 1993; Wollons et al, 1997), chemical agents, cytokines (Delaney et
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al, 1993), exercise (Hartmann et al, 1994), smoking and ageing (Betti et al,
1994; Piperakis et al, 1998).
Other applications of the comet assay include: determination of genotoxicity,
determination of an individual's DNA repair capacity, DNA damage and
repair studies, detection of apoptosis and biomonitoring.
5.1.7 DNA repair enzymes.
In this Chapter DNA repair enzymes have been used in conjunction with the
comet assay to investigate the different types of DNA damage that can be
induced by UVB. These are base excision repair enzymes that incise and
cleave sites containing specific types of DNA damage. These enzymes incise
the DNA at their specific recognition sites to produce single strand breaks in
DNA.
5.1.8 Foramidopyrimidine-DNA Glycosylase (FaPy-glycosylase).
FaPy-glycosylase is an enzyme which catalyses the excision of open-
imidazole ring-structures from DNA and has been isolated from extracts of
E.Coli or mammalian cells. FaPy-glycosylase is a small zinc-containing
protein (31 kDa), which recognises 8-OHdg lesions in DNA (Fig 5.3). The 8-
OHdg lesion is ubiquitous and can result from both endogenous and
exogenous damage to DNA by ROS.
5.1.9 T4 Endonuclease V (pyrimidine dimer DNA glycosylase).
Bacteriophage T4 is the only bacterial virus known to encode an enzyme
specifically for the excision of pyrimidine dimers in DNA (Fig 5.3). The T4
Endonuclease V is a small monomeric protein of 18 kDa with no requirement
for cofactors. The enzyme catalyses the selective incision of DNA at the site
of pyrimidine dimer formation, and is absolutely specific for CPDs in DNA.
The gene product, T4 endonuclease V has been partially purified from T4
infected E.Coli cells (Friedberg, 1971). When applied to the skin in
liposomes, it increases the rate of dimer removal from irradiated mouse skin
(Yarosh et al, 1992).
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The aims of this study were to:
• Study the level of excision repair sites formed in primary keratinocyte
DNA by exposure to UVB.
• Investigate the effect of Se on the formation of excision repair sites in
keratinocyte DNA.
• Monitor the UVB-induction of CPDs and their rate of repair in primary
keratinocytes and primary skin fibroblasts.
• Investigate the effect that Se supplementation has on the formation and
rate of repair of CPDs in primary keratinocytes.
• Monitor the UVB-induction of 8-OHdg lesions and their rate of repair in
primary keratinocytes.
• Study the effect that Se supplementation has on the formation of 8-OHdg
lesions in primary keratinocytes.
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Figure 5.1: Schematic of the comet assay method.
Layer high melting point agarose onto a frosted glass slide
I
Mix cell suspension with low melting point agarose
Layer onto the high melting point agarose on the slide
Excision repair method DNA repair enzyme method
I \
Add DNA repair inhibitor to cells (lhr) Lyse cells (lhr, lysis mix)
i \
Lyse cells (lhr, lysis mix) Neutralise cells (20 mins,
enzyme dilution buffer)
I i
Alkaline electrophoresis buffer Add DNA repair enzyme (lhr)
(40mins, unwinding)
1
Electrophorese cells in alkaline electrophoresis buffer
(20V, 25 mins)
1
Neutralise cells (20 mins, Tris buffer)
1
Stain cells with ethidium bromide
Score on an image analysis system
N.B.- Entire method is carried out in the dark.
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Figure 5.2: Effect of different DNA synthesis inhibitors.









Sites of action of a selection of DNA synthesis inhibitors
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Figure 5.3 Sites of action of the repair enzymes used during the
comet assay
The main repair enzymes of interest are the T4 endonuclease V (T4 endo
V) enzyme which recognises cyclobutane dimers and FaPy-glycolase (Fpg)
which recognises 8-hydroxyguanine
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5.2 Methods and Results.
The experiments in this study were carried out by T. Rafferty at the MRC
Cell Mutation Unit, University of Sussex, Brighton. The UVB source used
was Westinghouse FS-20 broad spectrum UVB lamps. The emission spectra
is similar to the Philips TL-20W/12 lamps which were employed in the
majority of the work described in this thesis. The FS-20 lamps emit slightly
less UVC than the TL-12 lamps. Emission spectra for both lamps are shown
in Chapter 2. Very low levels of UVB were required to induce DNA damage,
therefore Nunclon tissue culture dishes were used as filters to reduce the
outputs of the lamps. The emission spectra for the lamps with and without
filters are shown in Chapter 2.
5.2.1 Induction of excision repair sites in primary keratinocytes.
Primary keratinocytes were harvested and 2xl04 cells were mixed with low
melting point agarose and layered onto slides. Once the agarose had cooled
and solidified the cells were exposed to increasing doses of filtered UVB (5-
20 J/m2). DNA synthesis inhibitors were then added to the cells; ARA C
(100 pM) and hydroxyurea (10 mM) and the cells were incubated for 1 hour.
The slides were then processed using the excision repair comet assay
method, which is shown in Fig 5.1 and described in full in Chapter 2, section
2.5.1 and 2.5.2. The comets were then scored using an image analysis
system, 50 cells were counted per slide with duplicate slides per treatment.
The experiment was carried out in full twice. A full set of control slides were
also counted, which had no ARA C and hydroxyurea treatment, confirming
that the DNA strand breaks were excision repair breaks and not single
strand breaks.
Damage which required excision repair was formed when primary
keratinocytes were exposed to UVB (Fig 5.4). The damage was formed in a
dose-dependent manner. There was substantial DNA damage at 5-10 J/m2
which increased greatly at 20 J/m2. In subsequent experiments 5 J/m2 was
used to induce damage. The control cells with no ARA C and hydroxyurea
treatment, did not show any signs of comet formation, although they had
Continued on page 5-12
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Figure 5.4: Formation of excision repair sites in primary


























Primary keratinocytes were harvested and 2xl04 cells, were mixed with low
melting point agarose, layered onto slides and cells exposed to filtered UVB
(5-20 J/m2). DNA synthesis inhibitors were then added to the slides, ARA C
(100 pM) and hydroxyurea (10 mM) and the cells incubated for 1 hour. The
DNA synthesis inhibitors were added together to the slides. The slides were
then processed using the excision repair comet assay method and comets
scored using an image analysis system, 50 cells were counted per slide with
duplicate slides per treatment. Results are the mean comet lengths ± S.D.,
n=100. * = significant increase in comet length, p<0.05.
5-11
been exposed to UVB, thus confirming that no non-specific DNA damage
was measured. Furthermore unirradiated cells which were exposed to ARA
C/hydroxyurea also had no detectable DNA damage either.
5.2.2 Effect of Se pre-treatment on excision repair sites in primary
keratinocytes.
Primary keratinocytes were supplemented with either 50 nM sodium
selenite or 200 nM selenomethionine, for 24 hours prior to being harvested
and processed as in section 5.2.1, with cells exposed to 5 J/m2 filtered UVB.
The cells were then processed via the excision repair comet assay as
described in Chapter 2, section 2.5.2. The experiment was carried out with
duplicate samples, five times.
Pre-treatment with Se did not alter the formation of excisable DNA damage
(Fig 5.5). The cells untreated with ARA C/hydroxyurea, did not show any
signs of DNA damage and neither did the unirradiated ARA
C/hydroxyurea treated cells. Primary keratinocytes were also treated with
Se only, to ascertain if Se alone induced DNA damage. Neither Se
compound (50 nM sodium selenite or 200 nM selenomethionine) induced
DNA-damage (results not shown).
5.2.3 Formation of CPDs in primary keratinocytes.
Primary keratinocytes were harvested and 2xl04 cells, were mixed with low
melting point agarose and layered onto slides. Once the agarose had
solidified, the cells were exposed to increasing doses of filtered UVB (1-5
J/m2). The cells were then processed via the DNA repair enzyme comet
method which is described in Chapter 2, section 2.5.3 and is illustrated in Fig
5.1. The enzyme used was 50 pL/slide of T4 endonuclease V (5-20 pg/ml),
kindly supplied by L. Mullenders, Leiden, The Netherlands. A full set of
slides were processed without the enzyme to confirm that there was no non¬
specific DNA damage measured by the comet assay. The comets were then
scored using an image analysis system, 50 cells were counted per slide with
duplicate slides per treatment and the experiment was repeated twice. *
Continued on page 5-15
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Figure 5.5: Effect of Se on excision repair in primary
keratinocytes exposed to UVB.
□ -ARA C/hydroxyurea ^
Control UV SS + UV SM + UV
T reatment
Primary keratinocytes were pre-treated with 50 nM sodium selenite (SS) or
200 nM selenomethionine (SM) for 24 hours prior to the cells being
harvested, 2xl04 cells were mixed with low melting point agarose and
layered onto slides. The cells were then exposed to filtered UVB (5 J/m2).
DNA synthesis inhibitors were then added to the slides, ARA C (100 pM)/
hydroxyurea (10 mM) and the cells incubated for 1 hour. The slides were
then processed using the excision repair comet assay method and comets
scored using an image analysis system, 50 cells were counted per slide with
duplicate slides per treatment. Control cells were not exposed to UVB or Se.
Results are the mean comet lengths ± S.D., n=100. * = significant increase in
comet length, p<0.05.
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Figure 5.6: Formation of CPDs in primary keratinocytes
exposed to UVB.
6 0
E2 -T4 endonuclease V

















Primary keratinocytes were harvested and 2xl04 cells were mixed with low
melting point agarose, layered onto slides and cells exposed to filtered UVB
(1-5 J/m2). The cells were then processed via the DNA repair enzyme comet
method. The enzyme used was 50 pL of T4 endonuclease V (5-20 pg/mL).
The comets were scored using an image analysis system, 50 cells were
counted per slide with duplicate slides per treatment. Results are the mean
comet lengths ± S.D., n = 100. * = significant increase in comet length,
p<0.05.
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Very low doses of UVB were required to form CPDs in primary keratinocyte
DNA (Fig 5.6). Exposure to 3 J/m2 UVB, induced the formation of CPDs and
again the level of DNA damage increased with increasing UV exposure. In
subsequent experiments 5 J/m2 UVB, was chosen as the stimulus. The
control cells which were not treated with T4 endonuclease V, did not show
any background DNA damage, nor did the irradiated cells which had been
enzyme treated.
5.2.4 Effect of Se pre-treatment on the formation of CPDs in primary
keratinocytes.
Primary keratinocytes were supplemented with either 50 nM sodium
selenite or 200 nM selenomethionine for 24 hours, prior to being harvested
and processed as in section 5.2.3. The cells were exposed to 5 J/m2 filtered
UVB. The cells were then processed using the T4 endonuclease comet assay,
method from Chapter 2, section 2.5.3. There were duplicate slides per
treatment and the experiment was repeated six times.
Se pre-treatment did not affect the initial formation of thymidine dimers in
primary keratinocyte DNA (Fig 5.7). The control cells which were not
exposed to T4 endonuclease V and the unirradiated enzyme treated cells did
not exhibit any signs of DNA damage. Cells which were treated with the
seleno-compounds alone and not exposed to UVB irradiation, showed no
signs of DNA damage. Therefore neither compound stimulated the
formation of CPDs (results not shown).
5.2.5 Effect of Se pre-treatment on the repair of CPDs in primary
keratinocytes.
Primary keratinocytes were grown in individual 3 cm petri dishes and pre¬
heated with either 50 nM sodium selenite, or 200 nM selenomethionine for
24 hours. The media was then replaced with 1 ml PBS, and the cells exposed
to UVB (5 J/m2), through the bottoms of the tissue culture dishes (this was to
decrease the output of the lamps in order that low levels of UVB were used
Continued on page 5-17
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Figure 5.7: Effect of Se on the formation of CPDs in
primary keratinocytes exposed to UVB.
Treatment □ .74 endonuclease V
□ +T4 endonuclease V
Primary keratinocytes were pre-treated with sodium selenite (50 nM) or
selenomethionine (200 nM) for 24 hours prior to the cells being harvested
and 2xl04 cells were mixed with low melting point agarose, layered onto
slides. The cells were then exposed to filtered UVB (5 J/m2). The cells were
then treated with T4 endonuclease V repair enzyme and processed via the
comet method. The comets were scored using an image analysis system, 50
cells were counted per slide with duplicate slides per treatment. Control
cells were not exposed to UVB or Se. Results are the mean comet lengths ±
S.D., n = 100. * = significant increase in comet length, p<0.05.
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to treat the cells). The original Se-containing media was then replaced and
the cells were harvested, at various time points following irradiation. Once
harvested 2xl04 cells were mixed with low melting point agarose and
layered onto slides. Once the agarose had solidified, the slides were
processed via the T4 endonuclease V repair enzyme comet method, which is
described in Chapter 2, section 2.5.3. A full set of slides were again
processed without the enzyme to confirm that there was no non-specific
DNA damage measured by the comet assay. The comets were then scored
using an image analysis system, 50 cells were counted per slide with
duplicate slides per treatment and the experiment was repeated three times.
Selenium did not alter the rate of repair of CPDs in irradiated primary
keratinocyte DNA (Fig 5.8). Some examples of fluorescent comets are
demonstrated in Figs 5.10a-d. The control cells are compact and there are no
comets present (Fig 5.10a). The irradiated cells in comparison have long tails
which stream out from the cells (Fig 5.10b). Cells which have been incubated
following exposure to UVB to allow time for any DNA repair to occur,
display shorter comets. The cells in Fig 5.10c show cells which have been
incubated for 2 hours, following exposure to UVB and Fig 5.10d cells which
have been incubated for 3 hours. The comets present in Fig 5.10c and d are
very short as the majority of the DNA CPDs have been repaired.
Although Se treatment did not alter the rate of repair of CPDs, in primary
keratinocytes the experiments did infer that primary keratinocytes repair
CPDs rapidly, with most of the damage repaired within 3 hours. The rapid
repair of the CPDs can be more clearly seen in Fig 5.9. The results presented
in Fig 5.9 come from the same experiment as in Fig 5.8, however the data
concerning Se pre-treatment has been removed for clarity. As the primary
keratinocytes repaired the CPDs so quickly, it was decided to compare the
rate of repair of CPDs in primary keratinocytes and fibroblasts.
5.2.6 Rate of repair of CPDs in primary fibroblasts.
The fibroblasts were grown, irradiated (5 J/m2) and processed using the T4
endonuclease V comet assay, in the same manner as the keratinocytes in
section 5.2.5. Again there were duplicate slides per treatment and the
experiment was carried out twice.
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It can be observed in Fig 5.11 that fibroblasts are slower at repairing CPDs
compared to primary keratinocytes (Fig 5.9). The damage appears to
increase slightly at 6 hours and then to decrease slowly over 24 hours until
most of the damage is repaired by 48 hours post exposure to UVB.
5.2.7 Formation of 8-OHdg sites in primary keratinocytes exposed to
UVB.
Primary keratinocytes were harvested and 2xl04 cells were mixed with low
melting point agarose and layered onto slides. Once the agarose had
solidified the cells were exposed to increasing doses of filtered UVB (250-750
J/m2). The cells were then incubated with the FaPy-glycosylase enzyme and
subjected to the comet assay, which is described in Chapter 2, section 2.5.4.
The enzyme used was FaPy-glycosylase, kindly supplied by Dr. A. Collins,
Rowett Institute, Aberdeen, UK. The concentration of enzyme used is
specific for each batch of enzyme. A full set of slides were again processed
without the enzyme, to confirm that there was no non-specific DNA damage
measured by the comet assay. The comets were then scored using an image
analysis system, 50 cells were counted per slide with duplicate slides per
treatment and the experiment was repeated twice.
Exposure to UVB induced the formation of 8-OHdg sites in keratinocyte
DNA (Fig 5.12). The level of DNA damage induced increased in a dose-
dependent manner. The damage present was first significantly induced at
250 J/m2 and increased at doses up to 750 J/m2. There was no detectable
background DNA damage in the unirradiated cells or in the cells not treated
with enzyme. In subsequent experiments a UVB dose of 500 J/m2 was used.
5.2.8 Effect of Se on the formation of 8-hydroxyguanine sites in primary
keratinocytes exposed to UVB.
Primary keratinocytes were pre-treated with either 50 nM sodium selenite or
200 nM selenomethionine for 24 hours prior to being harvested and *
Continued on page 5-24
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Figure 5.8: Effect of Se on rate of repair CPDs in primary
keratinocytes exposed to UVB.
0 J + T4 5 J+T4 5J+SS+T4 5 J +SM + T4
T reatment
Primary keratinocytes were grown in 3 cm2 petri dishes and pre-treated with
either 50 nM sodium selenite (SS) or 200 nM selenomethionine (SM) for 24
hours prior to the media being replaced with 1 ml PBS. The cells were then
exposed to UVB (5 J/m2), through the bottoms of the tissue culture dishes.
The original Se-containing media was then replaced and the cells harvested
at various time points following irradiation. Once harvested 2xl04 cells were
mixed with low melting point agarose, layered onto slides and incubated
with T4 endonuclease V (T4) repair enzyme prior to the comet assay. The
comets were then scored using an image analysis system, 50 cells were
counted per slide with duplicate slides per treatment. Results are the mean
comet lengths ± S.D, n = 100. * = significant increase in comet length, p<0.05.
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Figure 5.9: Rate of repair of CPDs in primary
keratinocytes exposed to UVB.
0 J-T4 0 J + T4 5 J + T4
T reatment
Primary keratinocytes were grown in 3 cm2 petri dishes and the media was
replaced with 1 ml PBS. The cells were then exposed to UVB (5 J/m2),
through the bottoms of the tissue culture dishes. The original media was
then replaced and the cells harvested at various time points following
irradiation. Once harvested 2xl04 cells were mixed with low melting point
agarose, layered onto slides and incubated with T4 endonuclease V (T4)
repair enzyme prior to the comet assay. The comets were then scored using
an image analysis system, 50 cells were counted per slide with duplicate
slides per treatment. Results are the mean comet lengths ± S.D, n = 100. * =
significant increase in comet length, p<0.05.
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Figure 5.10: Visualisation of comet formation during the T4
endonuclease V repair assay using primary
keratinocytes exposed to UVB.
(a) Control cells (xl60).
(b) Irradiated cells, 0 hrs post exposure to UVB (5 J/m2) (xl60).
(c) Irradiated cells, 2 hours post exposure to UVB (5 J/m2) (xl60).
(b) Irradiated cells, 3 hours post exposure to UVB (5 J/m2) (xl60).
Cells were stained with ethidium bromide and visualised using fluorescent
microscopy. The typical structure of the head and tail of the comet can be
seen. The cell body is the "head" of the comet with the DNA streaming out
(to the right) of the cell to form the "tail" of the comet.
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Primary fibroblasts were grown 3 cm2 petri dishes, then the media was
replaced with 1 ml PBS and the cells were exposed to UVB (5 J/m2), through
the bottoms of the tissue culture dishes. The original media was then
replaced and the cells were harvested at various time points following
irradiation. Once harvested 2xl04 cells were mixed with low melting point
agarose, layered onto slides and incubated with T4 endonuclease repair
enzyme prior to the comet assay. The comets were then scored using an
image analysis system, 50 cells were counted per slide with duplicate slides
per treatment. Results are the mean comet lengths ± S.D., n = 100. * =
significant increase in comet length, p<0.05.
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processed as in section 5.2.7, the cells were exposed to 500 J/m2 filtered UVB.
Pre-treatment with sodium selenite or selenomethionine prevented the
formation of 8-OHdg sites in the DNA, following exposure to UVB (Fig 5.13a
and b). Both seleno-compounds decreased the formation of 8-OHdg sites, to
levels equivalent to those found in the unirradiated control cells (Fig 13 a
and b). Again the unirradiated cells and the cells not treated with enzyme
showed no background levels of DNA damage.
5.2.9 Rate of repair of 8-OHdg sites in primary keratinocytes.
Primary keratinocytes were grown in 3 cm petri dishes, prior to the media
being replaced with 1 ml PBS. The cells were then exposed to UVB (150-500
J/m2), through the bottom of the tissue culture dishes. The original media
was then replaced and the cells were harvested at various time points
following irradiation. Once harvested, 2xl04 cells were mixed with low
melting point agarose and layered onto slides. Once the agarose had
solidified, the slides were then processed via the FaPy-glycosylase repair
comet assay method, which is described in Chapter 2, section 2.5.4. A full set
of slides were again processed without enzyme, to confirm that no non¬
specific DNA damage measured by the comet assay. The comets were then
scored using an image analysis system, 50 cells were counted per slide with
duplicate slides per treatment.
It appears from Fig 5.14 that 8-OHdg sites in irradiated DNA are not
repaired even 48 hours following exposure to UVB. However, it cannot be
ascertained if these are genuine 8-OHdg sites, as the control cells which were
not treated with FaPy-glycosylase also showed signs of DNA damage. It
appears that following exposure to 350 J/m2 UVB, or more the cells
accumulate secondary DNA damage, which increases with time. Therefore
damage appears in the cells which have not been treated with the FaPy-
glycosylase enzyme. In the cells treated with FaPy-glycosylase the 350 and
500 J/m2-treated cells have 8-OHdg sites at 0 hours post exposure to UVB,
and the cells not treated with FaPy-glycosylase show no signs of damage.
Therefore the damage measured in cells 0 hour post UVB exposure appears
to be specifically 8-OHdg sites. However, the cells measured at 24 and 48
hours post exposure to UVB show the same level of DNA damage as the
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cells not treated with FaPy-glycosylase. Therefore damage measured at 24
and 48 hours post exposure to UVB, appears to be non-specific DNA
damage.
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Figure 5.12: Formation of 8-OHdg sites in primary


























2 5 0 5 0 0 750
UVB (J/m2)
Primary keratinocytes were harvested and 2xl04 cells were mixed with low
melting point agarose, layered onto slides and the cells exposed to filtered
UVB (250-750 J/m2). The cells were then incubated with FaPy enzyme prior
to comet assay. The comets were scored using an image analysis system, 50
cells were counted per slide with duplicate slides per treatment. Results are
the mean comet lengths ± S.D., n = 100. * = significant increase in comet
length, p<0.05.
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Figure 5.13a: Effect of sodium selenite on the formation of 8-




Con SS + UVtrol UV SS
T reatment
Primary keratinocytes were pre-treated with 50 nM sodium selenite (SS) for
24 hours prior to the cells being harvested, and 2xl04 cells were mixed with
low melting point agarose and layered onto slides. The cells were exposed
to filtered UVB (500 J/m2) and then incubated with FaPy-glycosylase
enzyme prior to the comet assay. The comets were scored using an image
analysis system, 50 cells were counted per slide with duplicate slides per
treatment. Control cells have not been exposed to UVB or Se. Results are the
mean comet lengths ± S.D., n = 100. t = significant increase in comet length,
p<0.05. * = Significant decrease in comet length compared to irradiated,
FaPy-glycosylase treated cells.
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Figure 5.13b: Effect of selenomethionine on the formation of 8-
















Primary keratinocytes were pre-treated with 200 nM selenomethionine (SM)
for 24 hours prior to the cells being harvested, and 2xl04 cells were mixed
with low melting point agarose and layered onto slides. The cells were
exposed to filtered UVB (500 J/m2) and then incubated with FaPy-
glycosylase enzyme prior to the comet assay. The comets were scored using
an image analysis system, 50 cells were counted per slide with duplicate
slides per treatment. Results are the mean comet lengths ± S.D., n = 100. t =
significant increase in comet length, p<0.05. * = Significant decrease in comet
length compared to irradiated, FaPy-glycosylase treated cells.
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Figure 5.14: Rate of repair 8-OHdg sites in primary
keratinocytes exposed to UVB.
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Primary keratinocytes were grown 3 cm2 petri dishes and the media
replaced with 1 ml PBS. The cells were then exposed to UVB (150-500 J/m2),
through the bottoms of the tissue culture dishes. The original media was
then replaced and the cells were harvested at various time points following
irradiation. Once harvested 2xl04 cells were mixed with low melting point
agarose, layered onto slides and incubated with FaPy-glycosylase repair
enzyme prior to the comet assay. The comets were then scored using an
image analysis system, 50 cells were counted per slide with duplicate slides
per treatment. Control cells have not been exposed to UVB or Se. Results




Exposure of cells to all forms of UV radiation induces damage to DNA.
Most of the DNA damage induced by exposure to UV radiation is repaired
efficiently. However, if the damage burden is extensive then, the cells repair
mechanisms may become overwhelmed and mutations within the DNA may
be passed on to daughter cells. Failure to repair any damage to the DNA can
lead to the initiation of carcinogenesis. If the mutated DNA alters the
expression of a tumour suppressor gene, e.g. p53, or a gene which controls
normal cell growth it can lead to unrestrained cell growth.
Exposure to UV radiation can lead to direct or indirect DNA damage. Direct
DNA damage includes the formation of CPDs and 6-4 photoproducts. CPDs
are the most common form of DNA injury, accounting for approximately
85% of the damage, with 6-4 photoproducts accounting for between 10-30%
of observed damage induced by exposure to UVB. Direct forms of DNA
damage are strongly linked to photocarcinogenesis. The analysis of basal
and squamous cell carcinomas has revealed that the majority of mutations
occur at dipyrimidine sites, resulting from direct DNA damage.
To measure the rate of repair of the DNA damage induced by exposure to
UVB, DNA synthesis inhibitors were used in conjunction with the comet
assay. The excision repair comet assay, allows the incision of the DNA at the
site of damage. However the DNA synthesis inhibitors used in the assay,
then prevent the resynthesis of new DNA to rejoin the DNA strands,
therefore leading to an accumulation of single strand breaks in the DNA.
The single strand breaks which accumulate can be specifically measured by
the comet assay. When measuring DNA excision repair, a full set of controls
were also run without the DNA synthesis inhibitors. Therefore any direct
single strand breaks or any other DNA damage which is present can be
detected. It was determined that the broadband UVB lamps used in this
study do not induce many direct single or double strand breaks in DNA. It
was also observed that no comets were detectable in any of the excision
repair comet assay control slides (Fig 5.4 and 5.5).
It is thought that the direct forms of DNA damage detected, comprise the
majority of damage induced by the low doses of UVB used in the excision
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repair comet assay. Also CPDs and 6-4 products are the most abundant
forms of DNA damage induced by exposure to UVB. The number of sites
which were incised during the excision repair comet assay increased in a
dose dependent manner with increasing levels of UVB (Fig 5.4). The low
levels of UVB (5-20 J/m2) required to induce DNA damage, which can be
repaired by the excision repair mechanism, were in agreement with results
reported by other authors. Doses of 1-50 J/m2 UVB have been reported to
induce direct DNA damage (Arlett et al, 1993; Collins et al, 1997). It should
be noted that higher levels of exposure to UVB, will increase the level of
DNA damage and consequently the number of single strand breaks.
However, eventually so many strand breaks are present that the DNA forms
smaller fragments. These smaller fragments of DNA can travel further away
from the cell body, leading to the tail of the comet appearing detached from
the cell body. Eventually the fragments are so small and travel so far that the
resolution of the comet tail is lost. Therefore, the doses of UVB used in this
study were selected in order that the levels of damage induced, formed
comets with a continuous cell body and tail (Fig 5.10).
The results presented in Figure 5.5 display the effect the addition of Se, as
sodium selenite or selenomethionine has on excision repair in primary
keratinocytes. The addition of Se did not affect the degree of DNA damage
which required excision repair. The lack of effect of the Se compounds was
not totally unexpected, as the damage which is measured by the excision
repair comet assay is mainly direct DNA damage. Therefore Se acting as an
active component of antioxidant selenoproteins, would not affect the
induction of direct DNA damage. However, it was thought possible that Se
would perhaps speed up the process of excision repair, as Se is a component
of the selenoprotein TR. Thioredoxin reductase is involved in the electron
transfer chain for ribonucleotide reductase, an enzyme which reduces
ribonucleosides directly to the corresponding deoxyribonucleoside.
Ribonucleotide reductase requires thioredoxin for it's reducing power and
thioredoxin is then recycled, using the selenoprotein thioredoxin reductase.
Therefore, in conditions of low levels of Se, TR may be the rate limiting step
in the production of new deoxyribonucleotides and hence new DNA.
Therefore if excess Se was supplied to cells the optimal levels of TR would be
expressed. Consequently, thioredoxin would be recycled more efficiently,
ribonucleotide reductase would function more effectively, the pools of
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deoxyribonucleotides would increase and so DNA repair would proceed
more rapidly However, this was not observed and the process of excision
repair was not altered by the addition of Se (Fig 5.5). The lack of effect of the
increased levels of Se may be due to there already being sufficient levels of
TR to reduce the thioredoxin present. The primary keratinocyte tissue
culture media contains low levels of Se, this low level may be adequate to
maintain sufficient levels of TR. Also in periods of Se deficiency,
selenoproteins are conserved in some tissues, the selenoproteins which are
conserved appear to be the essential forms. Therefore TR may be one of
these conserved selenoproteins. The levels of TR present in the cells and the
effect of Se supplementation on the levels of TR present in the cells, will be
explored in Chapter 8. Finally it has also been established that other
reductants can replace thioredoxin in the role of reducing ribonucleotide
reductase, for example glutathione. Therefore even in conditions which are
deficient in Se, the ribonucleotide reductase may use alternative reductants
to thioredoxin.
The results concerning the formation and rate of repair of CPDs and the
formation of DNA damage which requires excision repair are in close
agreement. The similarity of results from the two comet assay methods, may
be explained by the fact that CPDs are probably the major lesion which
requires repair by the excision repair method. The CPDs were measured by
incorporating a DNA repair enzyme into the comet assay method. In the
case of CPDs it was T4 endonuclease V. The cells were irradiated, lysed,
then washed with buffer to neutralise the lysis mix, in order that the DNA
repair enzyme was not deactivated when added to the cells. The T4
endonuclease V was then added to the cells, were it selectively recognises
the relevant DNA damage and cuts the DNA at the site of damage.
However, because the cell has already been exposed to lysis buffer, it is no
longer viable and the resynthesis of the damaged DNA can not occur.
Therefore an increase in the number of single strand breaks in the DNA
occurs.
The level of CPDs formed in the DNA increased in a dose-dependent
manner and a dose of 5 J/m2 was chosen to induce comets which were
detectable (Fig 5.6). The dose of UVB used, was identical to the dose used to
induced damage which required excision repair (5 J/m2). It was also found
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that Se did not affect the formation or repair of CPDs (Fig 5.7 and 5.8). The
lack of effect of Se on the repair of CPDs, can probably be explained by the
same reasons as the lack effect of Se on the formation and repair of excision
repair damage. Firstly, because CPDs are a direct form of DNA damage thus
ROS are not involved in their formation. Secondly, the levels of Se do not
appear to altering the rate repair, via TR's actions on ribonucleotide
reductase.
Ffowever, an interesting result was discovered when measuring the rate of
repair of CPDs in primary keratinocytes. It was discovered that primary
keratinocytes repair CPDs very quickly (Fig 5.9). It appeared that 50% of
CPDs were repaired within 2 hours following exposure to UVB, by 3 hours
post exposure only 5-10% of the CPDs remained and the remaining damage
was repaired within 6 hours. Previously in the MRC Cell Mutation Unit in
Brighton the rate of repair of CPDs in primary skin fibroblast had been
shown to be relatively slow. Fibroblast do not appear to have repaired any
of the CPDs present in their DNA by 6 hours post exposure to 5 J/m2 UVB
(Fig 5.11). Indeed it is only 24 hours post exposure to UVB, that the
fibroblast have repaired approximately 50% of the CPDs and even 48 hours
post exposure some damage remains. A longer time course was carried out
by the MRC Cell Mutation Unit and some damage was still detected 72
hours following UVB exposure (Flan et al, 1998). The rapid repair of CPDs in
keratinocytes is an important observation as it suggests that, keratinocytes
have selectively developed a repair pathway for the prompt repair of CPDs.
A fast repair mechanism to deal with CPDs would be crucial for
keratinocytes, as CPDs are the most common type of DNA damage induced
by exposure to UVB radiation. Also keratinocytes are exposed to the highest
levels of UVB, which is the wavelength of UV from the sun which induces
the most CPDs (Kuluncsics et al, 1999). Fibroblasts however, are shielded
from some of the harmful effects of UVB by overlying keratinocytes and
melanocytes, therefore they are exposed to lower levels of UVB and appear
less equipped to repair the damage which it induces.
Few studies have investigated the rate of repair of the major types of direct
DNA damage in the skin. Also most of the investigations have been carried
out using biopsy material, immunostaining and few time points. These
studies do suggest that 6-4 photoproducts are repaired relatively quickly in
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skin, with repair completed within 24 hours following exposure to UVB. The
repair of 6-4 photoproducts has even been reported to be completed within 2
hours following exposure to UVB (McGregor, 1999). The quick repair of 6-4
photoproducts in the skin may suggest a similar rapid pathway of repair to
that for CPDs.
There are conflicting reports in the literature concerning the rate of repair of
CPDs. It has been reported that CPDs appear to be repaired more slowly
than 6-4 photoproducts, with CPDs observed to remain in the skin 24-72
hours following exposure to UV radiation. The presence of CPDs were
measured using immunostaining of skin biopsies from patients exposed to 2
MEDs of UVB (Young et al, 1996; Ahmed et al, 1999). In contrast, it has also
been described that CPDs were repaired in human skin biopsies from
patients exposed to UVB, within 4-12 hours following exposure (Freeman,
1988; Muramatsu et al, 1992; McGregor, 1999; Kinley et al, 1995).
There would appear to be large unresolved differences in the accepted rate
of repair for CPDs in the epidermis, with times for completion of repair,
following exposure to UVB ranging from 4-72 hours. The studies using
human skin biopsies do not clarify, if the damage which remains for long
periods of time is found in the basal keratinocytes, which are still replicating
or is found higher in the epidermis. It may be that the slow rate of repair
found in some of the studies is due to the damage being found in resting or
differentiating keratinocytes. Therefore my study is the first to measure the
rate of excision repair in primary keratinocytes in vitro where most of the
keratinocytes population are basal replicating cells.
The final part of the my study investigated the formation and effect of Se on
indirect DNA damage. Indirect DNA damage has also been reported to be
involved in carcinogenesis (van der Scroeff et al, 1990; Nishigori et al, 1994)
The formation of 8-OHdg was studied using another DNA repair enzyme
called FaPy-glycosylase, which functions along the same principles as T4
endonuclease V. It however recognises 8-OHdg sites in the DNA.
Figure 5.12 indicates that increased levels of UVB are required to induce 8-
OHdg sites in primary keratinocyte DNA (250-750 J/m2), compared to the
levels of radiation required to induce direct DNA damage (1-5 J/m2). The
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higher levels of UVB required to cause indirect DNA damage, indicate that
the broadband UVB lamps used are less effective inducers of this form of
DNA injury.
Selenium supplementation of primary keratinocytes decreased the formation
of 8-OHdg sites in the DNA. Due to the limitations in the number of
samples which could be processed, only one concentration of sodium
selenite (50 nM) and one concentration of selenomethionine (200 nM) could
be investigated. However both of the concentrations of Se investigated
prevented the formation of 8-OHdg sites (Fig 5.13a and b).
Stewart et al have reported that pre-treatment with sodium selenite (5 pM)
for 48 hours can reduce the formation of 8-OHdg sites in murine
keratinocyte DNA following exposure to UVB (500 J/m2) (Stewart et al,
1996). The study by Stewart et al corresponds well to the findings in the my
study, the dose of UVB used was identical to that in the present study (500
J/m2) and the induction of 8-OHdg was almost completely prevented with
Se. However, the concentration of sodium selenite utilised was much higher
(5 pM) than in the present study (50 nM). Indeed I have found that 5 pM
sodium selenite supplementation, for 48 hours would have proven to be
toxic to the keratinocytes (Chapter 3) and is non-physiological.
The 8-OHdg lesions appear to be produced as a consequence of the indirect
production of H2O2 (reviewed in Thomas et al, 1998), hydroxyl radicals
(Peak and Peak, 1990), singlet oxygen and lipid peroxidation (Park and
Floyd, 1992) by UVB which then damage the DNA. Selenium may be
protecting against the formation of 8-OHdg damage to DNA by acting via
antioxidant selenoproteins. The increased levels of Se may increase the
levels of GPX proteins or TR, thereby decreasing the levels of H2O2 and
concomitantly decreasing the formation of the hydroxyl radical. The
reduction in reactive species would then lead to less oxidative DNA damage.
In addition increasing the levels of GPX and TR, would also lead to a
decrease in the levels of lipid peroxidation, which would also diminish the
levels of oxidative DNA damage. The effect of Se supplementation on the
levels of lipid peroxidation induced by exposure to UVB have been
investigated in Chapter 3. Supplementation of keratinocytes with either
sodium selenite or selenomethionine decreased the formation of lipid
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peroxides following exposure to UVB (1000 J/m2). The decrease in lipid
peroxidation may prove to be one of the factors involved in the decrease in
the levels of 8-OHdg in keratinocyte DNA. TR can also act to decrease the
levels of superoxide, which is also another causative factor in the formation
of 8-OHdg damage.
The addition of other antioxidants to cells prior to their exposure to UV has
been reported to decrease the formation of 8-OHdg damage. The
antioxidants include; glutathione, which decreases the formation of 8-OHdg
in DNA following exposure to ionising radiation (Fischer-Neilson et al, 1994).
Ascorbic acid and vitamin E can also decrease the formation of 8-OHdg
damage in keratinocytes exposed to UVB (Stewart et al, 1996).
The formation of other forms of oxidative DNA damage can be decreased by
the addition of Se or other antioxidants. The other forms of oxidative
damage which can be prevented include; single strand breaks induced by the
exposure of fibroblasts to UVA, which can be decreased by the addition of
N-acetylcysteine, sodium selenite (600 nM) or zinc (Emonet-Piccardi et al,
1998). Sodium selenite (50 nM) can also decrease the production of single
strand breaks in DNA, induced in fibroblasts by exposure to H2O2 (Leist et
al, 1996)
Finally the rate of repair of 8-OHdg sites in keratinocytes DNA was
investigated. It was found however that when using 500 J/m2 UVB, the
level of damage increased over 48 hours. Also the level of damage found in
the control slides increased overtime (Fig 5.13). Therefore, it appears that a
chain reaction occurs and secondary or delayed DNA damage occurs in the
cells, which is not specifically 8-OHdg lesions. It is thought that the damage
which appears in the control cells is secondary oxidative damage or that
exhibited by apoptotic cells. The formation of apoptotic cells can be
measured using the comet assay. Cells undergoing the DNA cleavage step
of apoptosis show comets. Indeed the dose of UVB used to cause 8-OHdg
sites in the DNA, 500 J/m2 UVB will induce significant apoptosis as
illustrated in Chapter 4. Due to the irradiated non-enzyme treated cells
becoming DNA damaged when using 500 J/m2 UVB, lower doses of
radiation were used in the time course experiment. However the cells
exposed to 150 J/m2 did not exhibit any 8-OHdg damage and when cells
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were treated with 350 J/m2 UVB, the control slides with no enzyme
treatment showed signs of secondary DNA damage. Consequently a repair
time course for 8-OHdg lesions could not be satisfactorily shown. However
in the literature it is suggested that the rate of repair of 8-OHdg lesions is
slow. It has also been reported that 8-OHdg lesions accumulate up to 24
hours following exposure to UVB and then begin to decline slowly from 48-
96 hours post exposure to UV (Hattori-Nakakuki et al, 1994; Ahmed et al,
1999). Therefore it would appear that whilst 8-OHdg lesions are formed at a
lower rate than direct DNA damage, they appear to exist in the DNA of
keratinocytes for longer than CPDs and are produced at biologically
significant levels of UVB.
5.4 Summary.
Selenium supplementation did not affect the formation or repair of direct
forms of DNA damage. Selenium did however decrease the formation of
indirect DNA damage, in the form of 8-OHdg. The full biological
significance of indirect DNA damage is not known, however it has been
linked to carcinogenesis. Also the 8-OHdg lesions appear to be repaired at a
slower rate, than direct forms of DNA damage and so may be present in
DNA for longer periods of time.
Finally it was also discovered for the first time in vitro that keratinocytes
have a rapid method for the repair of CPDs. This is an important discovery
considering that keratinocytes are exposed to the highest levels of UV
radiation and CPDs are the most common lesion formed after exposure to
UV radiation.
5.5 FurtherWork.
Further investigations need to be carried out on the effect of Se on the
formation and rate of repair of 6-4 photoproducts, these are the second most
common DNA lesion found following exposure to UVB. The levels of TR
and GPX and the effect of Se supplementation, need to investigated in the
epidermis. A greater concentration range of Se needs to be investigated
when studying the formation 8-OHdg sites. The time for complete repair of
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the 8-OHdg sites also needs to be followed. Finally investigations into which
reactive species induce 8-OHdg sites, needs to be undertaken.
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Chapter 6
Effect of Se on cytokine expression in primary
human keratinocytes following exposure to UVB
radiation.
6.1 Introduction.
The cytokine network is central to the immune system in the skin and to the
recruitment of effector cells to the epidermis (the cytokines studied in this
Chapter are summarised in Table 6.1). Many of the cytokines produced by
the skin are thought to be involved in the sunburn reaction which occurs
following exposure to sunlight, these include IL-8, IL-6 and IL-1 (reviewed in
McKenzie and Sauder, 1994). Following exposure to UVB, oedema and
swelling occur in the skin as an inflammatory infiltrate is attracted to the site.
At higher doses of UV, systemic effects, such as fever can occur. The
purpose of this inflammatory reaction following exposure to UV is
unknown. Other cytokines are produced following exposure to UV light,
which are responsible for the induction of immune suppression and include
TNF-a , TGF-(3 and IL-10. Production of these cytokines may form part of a
feed-back loop that helps to reduce the inflammatory reaction. However
they can cause systemic immune suppression, thereby allowing highly
immunogenic skin cancers to develop and evade the immune surveillance
system.
6.1.1 Interleukin-6.
Interleukin-6 is an important mediator of B cell growth and differentiation, it
enhances antibody production, functions as a secondary signal in T cell
activation and induces fever and acute phase proteins (reviewed in Wong
and Clark, 1988). Interleukin-6 can also increase keratinocyte proliferation
(Grossman et al, 1989), and is an inflammatory cytokine which is thought to
be involved in the sunburn reaction. The protein for IL-6 is released into the
circulation following exposure to UVB light (Urbanski et al, 1990) and can be
produced by fibroblast and keratinocytes (Kirnbauer et al, 1991; Wlaschek et
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al, 1993). The peak period of IL-6 mRNA induction following exposure to
UVB is at 6 hours, protein production peaks at 12 hours (de Vos et al, 1994).
6.1.2 Interleukin-8.
Interleukin-8 is a chemoattractant for neutrophils and T cells, and is
produced by keratinocytes, dermal fibroblasts and endothelial cells
(reviewed in Matsushima and Oppenheim, 1989). Interleukin-8 is a
secondary cytokine and its expression is induced by primary cytokines such
as IL-1 and TNF-a. IL-8 production can also be induced directly by the
transcription factors; activator protein-1 (AP-1) (Mukaida et al, 1990) and
nuclear factor kappa B (NFkB). Human keratinocytes produce IL-8, which is
involved in the movement of T cells and neutrophils towards the epidermis
(Barker et al, 1990). Inflammatory infiltrate (Hawk et al, 1988) and oedema
have been demonstrated to be produced in rabbits and humans as a
consequence of injection with IL-8 (Rampart et al, 1989; Leonard et al, 1991).
Interleukin-8 production is also stimulated by exposure to UVB radiation,
with the peak of mRNA production occurring at 6 hours post exposure and
protein production at 24 hours post exposure (Kondo et al, 1993).
6.1.3 Tumour necrosis factor-a.
The pro-inflammatory cytokine TNF-a induces the secretion of IL-1 (Kutsch
et al, 1993), IL-8 and IL-6 by keratinocytes. Furthermore, TNF-a also
stimulates the expression of MHC class II, IL-2 receptor and adhesion
molecules ICAM-2 and E-selectin on endothelial cells. The expression of
endothelial adhesion molecules enables granulocytes, monocytes and
lymphocytes to bind to the vessel walls and subsequently migrate into the
tissues. TNF-a is implicated in the migration of LCs from the epidermis
following exposure to UVB (Cumberbatch and Kimber, 1992; Yoshikawa et
al, 1992). TNF-a has both AP-1 and NFkB binding sites in its promoter
region (Spriggs et al, 1992). Moreover, TNF-a is also implicated in the
induction of apoptosis following UVB exposure (Schwartz et al, 1995) and in
the elicitation of contact hypersensitivity in the skin (Piguet et al, 1991).
Although expressed at low levels in normal skin, TNF-a production by
keratinocytes can be stimulated by exposure to UVB (Kock et al, 1990).
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Induction of mRNA for TNF-a reaches its maximum between 6-12 hours,
with protein production peaking at 24 hours following UVB exposure.
Kibitel et al have demonstrated that TNF-a induction by UVB is linked to
DNA damage. Application of the DNA repair enzyme T4 endonuclease V
reduces the production of TNF-a (Kibitel et al, 1998). It has been reported
that antioxidants and NFkB inhibitors also reduce TNF-a production
following UVB (Corsini et al 1995). This inhibition suggests that free radical
induction of NFkB is a major inducer of TNF-a protein following UVB.
6.1.4 Interleukin-la.
Interleukin-la is a pro-inflammatory cytokine secreted by many cell types
with a pivotal role in epidermal inflammation. It induces adhesion
molecules on endothelial cells and stimulates the secretion of secondary
cytokines such as IL-6 (Chung et al, 1996) and IL-8 (Larsen et al, 1989) from
many cells, including fibroblasts and keratinocytes. Keratinocytes produce
active IL-la and the inactive IL-1 (3 precursor, IL-la also has an NFkB
binding site within the promoter region. Unstimulated keratinocytes store
large amounts of pre-formed IL-la (Sauder et al, 1982), which is released
upon damage to the epidermis (Kondo et al, 1994). The mRNA for IL-la is
only moderately increased at 2 hours post exposure to UVB and by 24 hours
it is suppressed. However the pre-formed IL-la protein is released from
keratinocytes 6 hours after exposure to UVB (Kondo et al, 1994).
6.1.5 Interleukin-10.
Interleukin-10 is regarded as an inhibitory regulator of the immune system
(Moore et al, 1993). It regulates the inflammatory immune response by
inhibiting the synthesis of IL-la, TNF-a, colony stimulating factor (CSF) (de
Waal Malefyt et al 1992) and gamma interferon (y-IFN) production by T cells
and macrophages (Fiorentino et al, 1991; Enk, 1994). In the skin IL-10 is
induced in contact sensitivity responses in mice (Enk and Katz, 1992) and
may have a role in limiting the inflammatory response induced by this
treatment. Furthermore IL-10 can inhibit the ability of LCs to elicit a delayed
type hypersensitivity response to tumour associated antigens (Beissert et al,
1995). Exposure of murine keratinocytes in vitro to UVB induces IL-10
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expression (Rivas and Ullrich, 1992). Interleukin-10 has also been shown to
reduce the production of inducible nitric oxide synthetase (iNOS), nitric
oxide, TNF-a and IL-6 by primary human keratinocytes (Becherel et al, 1995).
However the production of IL-10 in human keratinocytes in vitro remains
controversial since some investigators have identified IL-10 protein and
mRNA in UVB exposed human keratinocytes (Grewe et al, 1995; Enk et al,
1995), whilst others could not (Teunissen et al, 1997). Teunissen has
suggested that the IL-10 found in human skin originates from melanocytes
(Teunissen et al, 1997, Mattei et al, 1994). Melanomas have also been shown
to produce IL-10 and it is thought that this is part of the mechanism by
which they evade the body's immune response (Kruger-Krasagakes et al,
1994). Exposure to UVB stimulates IL-10 mRNA transcription in mouse
keratinocytes 8 hours after irradiation and protein production begins after 24
hours (Enk et al, 1995).
It has also been demonstrated that IL-10 production by mouse keratinocytes
is induced by cyclopyrimidine dimers, caused by UVB irradiation (Nishigori
et al, 1996). When the DNA repair enzyme T4 endonuclease V is applied to
cells following exposure to UVB radiation it helps to repair the cyclobutane
dimers quickly, which leads to a decrease in the production of IL-10.
Consequently there is a reduction in the immune suppressive effects of IL-10.
Recently further work has been carried out, which demonstrates that the
application of T4 endonuclease V containing liposomes to human skin can
prevent the UVB-induction of IL-10 and TNF-a, but not erythema (Wolf et al,
2000). However DNA damage is only one of the mechanisms by which
cytokines are induced in the skin (O'Connor et al, 1996).
6.1.6 Cytokines and Se.
There is some evidence that implies Se can affect the levels of cytokines in
the skin. When inflamed and normal skin are exposed in culture to 800 nM
selenium chloride, sodium selenate or sodium selenite for 2 weeks, IL-la,
TNF-a and IL-6 protein levels were decreased in inflamed skin by the
sodium selenite and selenate. The decrease in cytokine concentrations were
detected by ELISA and immunostaining (Celerier et al, 1995). Selenium can
also affect many other aspects of the immune system, as covered in Chapter
1 (reviewed in McKenzie et al, 1998). Se supplied both topically or in the diet
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can reduce the inflammatory response following UV exposure in humans
(Overvad et al, 1985; Burke et al, 1992a; Burke et al, 1992b) and in mice
(Thorling et al, 1983). Following exposure to UVB there are two possible
mechanisms by which Se may decrease the inflammatory response; by
decreasing the release of inflammatory cytokines or by increasing the release
of immune suppressive cytokines.
6.1.7 Transcription factor activation and Se.
There is a large body of literature to suggest that transcription factors can be
upregulated by free-radicals and that Se can prevent this upregulation.
NFkB is found in the majority of cell types, and is described in detail in
Chapter 1. NFkB can increase IL-6 mRNA production in keratinocytes and is
itself activated by exposure to UVB light and by free radicals (reviewed in
Flohe et al, 1997). Free radical scavengers such as N-acetylcysteine,
pyrrolidine-dithiocarbamate and thioredoxin (Schenk et al, 1994) decrease
NFkB activation by UVB. This decrease in NFkB induction suggests that free
radicals are involved in the induction of NFkB by UVB (Simon et al, 1994).
Overexpression of PHGPX (by transfection of the DNA) in cells
supplemented with 50 nM sodium selenite diminishes the activation of
NFkB by IL-1; and selenite treatment alone for 4 days can also decrease the
level of DNA binding by NFkB (Brigelius-Flohe et al, 1997). This implies that
H2O2 or lipid peroxides are responsible for the activation of NFkB, because
these are the target of PFIGPX.
Another transcription factor which is found in most nucleated cell types is
AP-1, it is also fully described in full in Chapter 1. AP-1 is also regulated by
free radicals as the redox state of the components affects how well the
complex binds to DNA (reviewed in Palmer and Paulson, 1997; Roebuck et
al, 1999). AP-1 is also activated by UV light (Derijard et al, 1994; Devary et al,
1991). Again antioxidants such as N-acetylcysteine and glutathione can
decrease the activation of AP-1 (Devary et al, 1991). Selenite and
selenodigluthione added to nuclear extracts can inhibit AP-1 DNA binding,
however high concentrations of Se, 7.5 pM and 750 nM respectively were
required (Spyrou et al, 1995). The decrease in AP-1 binding was also
confirmed in lymphocytes were cells were incubated with 10 pM selenite for
4 hours and a reduction in DNA binding was shown. The ability of selenite
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to decrease the activation of AP-1 may help to explain the growth inhibitory
effects of selenite at high concentrations.
Table 6.1: Cytokines studied in this chapter.






IL-6 Inflammatory 6 hrs 12 hrs
IL-8 Inflammatory 6 hrs 24 hrs
TNF-a Inflammatory, also
involved in LC migration
6-12 hrs 24 hrs
IL-la Inflammatory 2 hrs 6 hrs
IL-10 Immune suppressive 8 hrs 24 hrs
The aims of the experiments described in this chapter were-:
• To confirm that UVB induces an increase in the levels of mRNA and
protein for IL-6, IL-8, TNF-a, IL-10 and IL-la in keratinocytes.
• To ascertain if Se modifies the induction of mRNA for the above
cytokines following exposure to UVB.
• To determine if Se alters the release of IL-6, IL-8, IL-10 and TNF-a protein
following exposure to UVB.
6-6
6.2 Results and Methods.
6.2.1 Semi Quantitative RT-PCR to measure levels of cytokine mRNA.
6.2.1.1 Optimum cycle number determination.
In order to analyse mRNA expression semi-quantitatively, the optimum
cycle number for each PCR product was determined. A pool of cDNA was
taken from the primary keratinocyte experiments or the Pam 212 cells
(spontaneously transformed mouse keratinocyte cell line) experiments and
were used as the targets for the cycle experiments. Figure 6.1, 6.2, 6.3 and 6.4
demonstrate the cycle numbers used. Forty cycles was the maximum cycle
number used in this study, since above this number the reaction is likely to
plateau due to exhaustion of the DNA polymerase and other reagents. The
full RNA extraction method, RT-PCR and SDS-PAGE electrophoresis
method are described in Chapter 2.
Optimum cycle numbers for each cytokine mRNA were determined. The
optimum cycle numbers for the primary keratinocyte experiments for IL-6
and IL-8 were found to be 32 cycles (Fig 6.1). The optimum cycle number for
TNF-a was 37 cycles, for IL-la 35 cycles and for G3pDH 40 cycles (Fig 6.2).
For the Pam 212 cell experiments the optimum cycle numbers were; for (3-
actin 32 cycles (Fig 6.3a and b), TNF-a 36 cycles and IL-10 40 cycles (Fig 6.4).
These cycle numbers were used for the rest of the mRNA experiments.
6.2.1.2 Effect of UVB on cytokine mRNA levels in primary keratinocytes.
The effect of UVB exposure on primary human keratinocytes in vitro was
examined. Time-course experiments were carried out on primary
keratinocytes. The cells were exposed to UVB (200 J/m2) then incubated for
3-24, hours, the cells were harvested, the RNA extracted and RT-PCR
performed for the cytokines of interest. The house keeping gene G3pDH
was used to normalise the levels of cDNA present. The dose of UVB was
chosen as it has frequently been described in the literature to induce the
Continued on page 6-13
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Figure 6.1: Effect of increasing cycle number on the amount of
PCR product formed for the cytokines IL-6 and IL-8.
Number of Cycles
Primary keratinocyte cDNA from the experiments carried out in sections
6.2.1.2 and 6.2.1.3 were pooled and PCR reactions with 32P-labelled primers
were carried out with increasing cycle numbers. The PCR products were
resolved on SDS-PAGE gels and quantitated using a phosphoimager.
Results are expressed as counts/mm2.
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Figure 6.2: Effect of increasing cycle number on the amount of
PCR product formed for the cytokines TNF-a, IL-la
and G3pDH.
15 20 25 30 35 40 45
Number of Cycles
Primary keratinocyte cDNA from the experiments carried out in sections
6.2.1.2 and 6.2.1.3 were pooled and PCR reactions with 32P-labelled primers
were carried out with increasing cycle numbers. The PCR products were
resolved on SDS-PAGE gels and quantitated using a phosphoimager.
Results are expressed as counts/mm2.
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Figure 6.3a: Effect of increasing cycle number on the amount of















15 20 25 30 35 40 45
Number of cycles
Pam 212 cells cDNA from the experiments carried out in section 6.2.1.5 were
pooled and PCR reactions with 32P-labelled primers were carried out with
increasing cycle numbers. The PCR products were resolved on SDS-PAGE
gels and quantitated using a phosphoimager. Results are expressed as
counts/mm2.
■— (3-actin
i 1 1 1 r
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Figure 6.3b: Effect of increasing cycle number on the amount of
PCR product formed for (3-actin.
(3ACTIN mRNA
15 20 25 30 35
Pam 212 cells cDNA from the experiments carried out in sections 6.2.1.5
were pooled and PCR reactions with 32P-labelled primers were carried out
with increasing cycle numbers. The PCR products were resolved on SDS-
PAGE gels and exposed to autoradiography.
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Figure 6.4: Effect of increasing cycle number on the amount of
PCR product formed for the cytokines TNF-a and
IL-10.
Number of cycles
Pam 212 cells cDNA from the experiments carried out in sections 6.2.1.5
were pooled and PCR reactions with 32P-labelled primers were carried out
with increasing cycle numbers. The PCR products were resolved on SDS-
PAGE gels and quantitated using a phosphoimager. Results are expressed
as counts/mm2.
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release of cytokines in normal human keratinocytes (De Vos et al, 1994;
Kondo et al, 1994; Kondo et al, 1993) also at this dose there was no loss of
viability of the cells (Chapter 3, Fig 3.2a). The time course experiments were
performed in order that the optimum time point for the induction of each
cytokine mRNA, following exposure to UVB could be discovered. This
could then be utilised in further experiments.
Induction of IL-6 mRNA peaked at 6 hours post exposure to UVB, then
declined slowly but was still slightly elevated 24 hours after exposure (Fig
6.5). The mRNA for IL-8 increased at 6 hours post exposure to UVB, then
decreased slowly but was still elevated 24 hours post exposure to UVB (Fig
6.6). The TNF-a mRNA increased at 6 hours but decreased more rapidly
over the 24 hours following exposure to UVB (Fig 6.7). The induction at 6
hours was found not to be significant due to large variation in the replicate
samples. Ffowever significant induction of the mRNA has been
demonstrated with UVB in the literature (Kock et al, 1990) Finally IL-la
mRNA was slightly increased at 6 hours and this had decreased by 12 hours
post exposure to UVB (Fig 6.8). Flowever the increase at 6 hours was not
found to be significant due to the very small increase detected.
6.2.1.3 Effect of Se on the basal levels ofmRNA for IL-6, IL-8, TNL-a and
IL-1 a. in primary keratinocytes.
Primary human keratinocytes were exposed to various concentrations of
sodium selenite or selenomethionine for 24 hours, then the mRNA was
extracted and RT-PCR performed on the samples. The house keeping gene
G3pDH was again used to normalise the levels of cDNA present.
Basal levels of IL-6 mRNA were decreased significantly by 50 nM
selenomethionine only (Fig 6.9). The basal levels of IL-la mRNA were
decreased at only one dose of selenite (1 nM) but not by selenomethionine
(Fig 6.9). In contrast basal mRNA levels for IL-8 were decreased significantly
at concentrations of selenomethionine ranging from 50-200nM and sodium
selenite ranging from 1 nM to 10 nM (Fig 6.9). Finally the basal levels of
TNF-a were not decreased significantly at any of the levels of
Continued on page 6-19
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Figure 6.5: Levels of IL-6 mRNA in primary keratinocytes
















Primary keratinocytes were either exposed to UVB (200 J/m2) or mock
irradiated (control), the cells were incubated for 3-24 hours, prior to being
harvested and the RNA extracted. RT-PCR was then carried out on the
samples using 32P-labelled primers. The PCR products were resolved on
SDS-PAGE gels and quantitated using a phosphoimager. The cytokine
levels were normalised using the housekeeping gene G3pDH. Results are
expressed as the mean ratios ± S.E.M, n=3. Significant difference from the
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Figure 6.6: Levels of IL-8 mRNA in primary keratinocytes
following exposure to UVB.
■— Control
★
• UVB (200 J/m2)
Hours
Primary keratinocytes were either exposed to UVB (200 J/m2) or mock
irradiated (control), the cells were incubated for 3-24 hours, prior to being
harvested and the RNA extracted. RT-PCR was then carried out on the
samples using 32P-labelled primers. The PCR products were resolved on
SDS-PAGE gels and quantitated using a phosphoimager. The cytokine
levels were normalised using the housekeeping gene G3pDH. Results are
expressed as the mean ratios ± S.E.M, n=3. Significant difference from the
control cells, * =P<0.05. The experiment was carried out with triplicate
samples, two times.
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Figure 6.7: Levels of TNF-a mRNA in primary keratinocytes




Primary keratinocytes were either exposed to UVB (200 J/m2) or mock
irradiated (control), the cells were incubated for 3-24 hours, prior to being
harvested and the RNA extracted. RT-PCR was then carried out on the
samples using 32P-labelled primers. The PCR products were resolved on
SDS-PAGE gels and quantitated using a phosphoimager. The cytokine
levels were normalised using the housekeeping gene G3pDH. Results are
expressed as the mean ratios ± S.E.M, n=3. The experiment was carried out
with triplicate samples, two times.
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Figure 6.8: Levels of IL-la mRNA in primary keratinocytes




Primary keratinocytes were either exposed to UVB (200 J/m2) or mock
irradiated (control), the cells were incubated for 3-24 hours, prior to being
harvested and the RNA extracted. RT-PCR was then carried out on the
samples using 32P-labelled primers. The PCR products were resolved on
SDS-PAGE gels and quantitated using a phosphoimager. The cytokine
levels were normalised using the housekeeping gene G3pDH. Results are
expressed as the mean ratios ± S.E.M, n=3. The experiment was carried out
with triplicate samples, two times.
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Figure 6.9: Effect of Se on the basal levels of mRNA for IL-6, IL-
















Control 1nM 10nM 50nM 50nM 100nM 2 0 0 n M
Sodium Seienite Selenomethionine
T reatment
Primary keratinocytes were supplemented with either sodium seienite or
selenomethionine for 24 hours prior to cells being harvested and RNA
extracted. RT-PCR was carried out the samples using 32P-labelled primers.
The PCR products were resolved on SDS-PAGE gels and quantitated using a
phosphoimager. The cytokine levels were normalised using the
housekeeping gene G3pDH. Control cells had no Se added. Results are
expressed as the mean ratios ± S.E.M, n=3. Significant difference from the
control cells, * =P<0.05. The experiment was carried out with triplicate
samples, two times.
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sodium selenite or selenomethionine tested (Fig 6.9).
6.2.1.4 Effect ofSe on the UVB induction ofmRNAfor IL-6,1L-8, TNF-aand
IL-1 a by primary keratinocytes.
The effect of Se on the UVB induction of cytokines by keratinocytes in vitro
was examined. The cells were supplemented with different concentrations
of Se for 24 hours then exposed to UVB (200 J/m2). After a further
incubation of 6 hours, the cells were harvested and RNA extracted,
subsequently RT-PCR was performed to quantify the mRNA for the
cytokines of interest. The RT-PCR reactions were done using the cycle
numbers described in section 6.2.1.1 and at the time points obtained in
section 6.2.1.2.
Selenium supplementation with either selenite (1 nM) or selenomethionine
(50-200 nM) prevented the induction of IL-6 mRNA by UVB which was
observed in the absence of Se. Concentrations of selenite as low as 1 nM
were sufficient to prevent induction of IL-6 mRNA (Fig 6.10a and b).
There was significant UVB induction of the IL-8 mRNA at 6 hours post
exposure to UVB, Se reduced this induction at concentrations between 1-50
nM sodium selenite and at 50 and 200 nM selenomethionine (Fig 6.11a).
Figure 6.11b presents the autoradiographs for IL-8 mRNA and the house
keeping gene G3pDH.
The induction of TNF-a mRNA by UVB was not significantly different
compared to control samples. However it can be seen from Fig 6.12 that the
mRNA levels were significantly lower in irradiated cells treated with 100 nM
and 200 nM selenomethionine, compared to cells which were irradiated but
not pre-treated with Se.
There was no significant induction of IL-la at 6 hours and no significant
reduction of IL-la mRNA at any of the concentrations of Se (Fig 6.13).
Continued on page 6-26
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Figure 6.10a: Effect of Se on the levels of IL-6 mRNA,













1 nM 1 0nM 50nM 50nM 100nM 200nM
Sodium Seienite Selenomethionine
Selenium Treatment
Primary keratinocytes were supplemented with either sodium seienite or
selenomethionine for 24 hours prior to cells being exposed to UVB (200
J/m2). Fresh media was returned to the cells and they were incubated for 6
hours before being harvested. The RNA was extracted and RT-PCR analysis
was carried out on the samples using 32P-labelled primers. The PCR
products were resolved on SDS-PAGE gels and quantitated using a
phosphoimager. The cytokine levels were normalised using the
housekeeping gene G3pDH. Control cells had no Se added and were mock
irradiated. Results are expressed as the mean ratios ± S.E.M, n=3.
Significant difference from the control cells, t = P<0.05, significant difference
from the irradiated cells with no Se added * = P<0.05.
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Figure 6.10b: Autoradiograph showing the effect of Se on the
levels of IL-6 mRNA, following exposure to UVB.
IL-6 mRNA
i
Con UVB InM 200nM
SS SM
G3pDH mRNA
Con UVB InM 200nM
SS SM
Autoradiographs of the SDS-PAGE gels for IL-6 mRNA (Top) and the
housekeeping gene G3pDH (Bottom).
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1n M 1 0 n M 50nM 50nM 100nM 200nM
Sodium Selenite Selenomethionine
Selenium Treatment
Primary keratinocytes were supplemented with either sodium selenite or
selenomethionine for 24 hours prior to cells being exposed to UVB (200
J/m2). Fresh media was returned to the cells and they were incubated for 6
hours before being harvested. The RNA was extracted and RT-PCR analysis
was carried out on the samples using 32P-labelled primers. The PCR
products were resolved on SDS-PAGE gels and quantitated using a
phosphoimager. The cytokine levels were normalised using the
housekeeping gene G3pDH. Control cells had no Se added and were mock
irradiated. Results are expressed as the mean ratios ± S.E.M, n=3.
Significant difference from the control cells, t = P<0.05, significant difference
from the irradiated cells with no Se added * = P<0.05.
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Figure 6.11b: Autoradiograph showing the effect of Se on the
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Autoradiographs of the SDS-PAGE gels for IL-8 mRNA (Top) and the
housekeeping gene G3pDH (Bottom).
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Figure 6.12: Effect of Se on the levels of TNF-a mRNA
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1 n M 10 n M 50nM 50nM 100nM 200nM
Sodium Selenite Selenomethionine
Selenium Treatment
Primary keratinocytes were supplemented with either sodium selenite or
selenomethionine for 24 hours prior to cells being exposed to UVB (200
J/m2). Fresh media was returned to the cells and they were incubated for 6
hours before being harvested. The RNA was extracted and RT-PCR analysis
was carried out on the samples using 32P-labelled primers. The PCR
products were resolved on SDS-PAGE gels and quantitated using a
phosphoimager. The cytokine levels were normalised using the
housekeeping gene G3pDPL Control cells had no Se added and were mock
irradiated. Results are expressed as the mean ratios ± S.E.M, n=3.
Significant difference from the irradiated cells with no Se added * = P<0.05.
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Figure 6.13: Effect of Se on the levels of IL-la mRNA,




















Primary keratinocytes were supplemented with either sodium selenite or
selenomethionine for 24 hours prior to cells being exposed to UVB (200
J/m2). Fresh media was returned to the cells and they were incubated for 6
hours before being harvested. The RNA was extracted and RT-PCR analysis
was carried out on the samples using 32P-labelled primers. The PCR
products were resolved on SDS-PAGE gels and quantitated using a
phosphoimager. The cytokine levels were normalised using the
housekeeping gene G3pDH. Control cells had no Se added and were mock
irradiated. Results are expressed as the mean ratios ± S.E.M, n=3.
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6.2.1.5 Effect of Se on the UVB induction ofmRNA for TNF-cc and
IL-10 by Pant 212 cells.
Pam 212 cells were grown in 6 well dishes and treated with various
concentrations of Se for 24 hours and then exposed to UVB (200 J/m2). After
a further incubation of 6 hours, the cells were harvested and the RNA
extracted and RT-PCR performed to quantify the mRNA for the cytokines of
interest. The RT-PCRs were done using the cycle numbers described in
section 6.2.1.1. The house keeping gene [3-actin was used to normalise the
levels of cDNA.
The mRNA for TNF-a was induced 6 hours following exposure to UVB.
Sodium selenite diminished the induction of the mRNA at concentrations
ranging from 10-200 nM and selenomethionine at concentrations ranging
from 10-50 nM (Fig 6.14a and b).
The mRNA for IL-10 was not significantly induced 6 hours following
exposure to UVB, this was due to the large differences between triplicate
samples (Fig 6.15). Therefore it could not be determined if Se significantly
decreased the mRNA for IL-10.
6.2.2 Cytokine Protein Levels.
6.2.2.1 Effect of Se on basal protein levels ofIL-6, IL-8 and TNF-a from
primary keratinocytes.
The protein levels of IL-6, IL-8 and TNF-a were measured in the media from
primary human keratinocytes using commercial ELISA kits. The cells were
exposed to various concentrations of Se for 24 hours and then the media was
collected and the protein levels in the media were measured by ELISA.
Sodium selenite did not decrease the basal levels of IL-6 protein; however
selenomethionine did decrease the basal levels of IL-6 protein at 50 and 200
nM, however this reduction was not statistically significant (Fig 6.16). The
Continued on page 6-32
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Figure 6.14a: Effect of Se on the levels of TNF-a mRNA in
Pam 212 cells, following exposure to UVB.
Control 0 10nM 50nM 100nM 200nM 1uM
Selenium Treatment
Pam 212 cells were supplemented with either sodium selenite or
selenomethionine for 24 hours prior to cells being exposed to UVB (200
J/m2). Fresh media was returned to the cells and they were incubated for 6
hours before being harvested. The RNA was extracted and RT-PCR analysis
was carried out on the samples using 32P-labelled primers. The PCR
products were resolved on SDS-PAGE gels and quantitated using a
phosphoimager. The cytokine levels were normalised using the
housekeeping gene (3-actin. Control cells had no Se added and were mock
irradiated. Results are expressed as the mean ratios ± S.E.M, n=3.
Significant difference from the control cells, t = P<0.05, significant difference
from the irradiated cells with no Se added * = P<0.05.
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Figure 6.14b: Autoradiograph showing the effect of Se on the
levels of TNF-a mRNA in Pam 212 cells,
following exposure to UVB.
TNFa mRNA
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Autoradiographs of the SDS-PAGE gels for TNF-a mRNA (Top) and the
housekeeping gene (3-actin (Bottom).
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Figure 6.15: Effect of Se on the levels of IL-10 mRNA in Pam
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Selenium Treatment
1 uM
Pam 212 cells were supplemented with either sodium selenite or
selenomethionine for 24 hours prior to cells being exposed to UVB (200
J/m2). Fresh media was returned to the cells and they were incubated for 6
hours before being harvested. The RNA was extracted and RT-PCR analysis
was carried out on the samples using 32P-labelled primers. The PCR
products were resolved on SDS-PAGE gels and quantitated using a
phosphoimager. The cytokine levels were normalised using the
housekeeping gene p-actin. Control cells had no Se added and were mock
irradiated. Results are expressed as the mean ratios ± S.E.M, n=3.
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Sodium Selenite Selenomethionine
Selenium Treatment
Primary keratinocytes were supplemented with either sodium selenite or
selenomethionine for 24 hours prior to the media being collected and the
protein levels measured by ELISA. Control cells had no Se added. Results
are expressed as the mean ratios ± S.E.M, n=3.
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Figure 6.17: Effect of Se on the basal levels of IL-8 protein.


























Primary keratinocytes were supplemented with either sodium selenite or
selenomethionine for 24 hours prior to the media being collected and the
protein levels measured by ELISA. Control cells had no Se added. Results
are expressed as the mean ratios ± S.E.M, n=3. Significant difference from
the control cells, * =P<0.05.
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decrease in basal levels of the protein for IL-6 is in agreement with the effect
of these concentrations of selenomethionine on the basal levels of IL-6
mRNA (Fig 6.9). Selenomethionine at 200 nM and sodium selenite at 50 nM
significantly decreased the levels of IL-8 protein in the supernatants (Fig
6.17). This decrease contrasted with the effect of Se on the basal levels of
mRNA, where all concentrations of Se significantly decreased the IL-8
expression (Fig 6.9).
The basal levels of TNF-a in the media were not affected by Se as there was
no detectable TNF-a in unirradiated cells.
6.2.2.2 Effect of Se on protein levels for IL-6, IL-8 and TNF-afrom primary
keratinocyte cells exposed to UVB.
Exposure to UVB induced the release of IL-6 protein in primary
keratinocytes at 24 hours following exposure. Pre-incubation of cells with
various concentration of Se for 24 hours prior to exposure to UVB (200 J/m2)
did not affect the levels of protein released following exposure to UVB (Fig
6.18). This experiment was repeated three times in triplicate and Se did not
affect the protein levels on any occasion.
There was significant induction of IL-8 protein at 24 hours following
exposure to UVB, again Se did not alter the levels of protein induction. This
experiment was also repeated three times in triplicate with similar results
(Fig 6.19).
There was significant induction of TNF-a protein by exposure to UVB at 24
hours. There was a significant decrease in protein levels at 50 and 100 nM
selenomethionine (Fig 6.20). However this experiment was only done once
with triplicate samples. This was due to severe problems in stabilising the
TNF-a protein during harvesting and storage, it was found that 0.1% foetal
calf serum had to be added back to the media to stabilise the TNF-a protein
in order that it would not deteriorate upon storage. Also the levels of TNF-a
protein released were very low.
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6.2.2.3 Effect of Se on protein levels for TNF-a and IL-10 from Pam 212
cells exposed to UVB.
The protein levels for IL-10 and TNF-a in the murine Pam 212 cells were
investigated. However it was found that both proteins were undetectable
using the currently available ELISA kits. However immunostaining was
carried out on Pam 212 cells for IL-10. Pam 212 cells were cultured on glass
coverslips and treated with various concentrations of Se for 24 hours before
being exposed to 200 J/m2 UVB. The cells were then incubated for a further
24 hours and then immunostained for IL-10. The full method is described in
Chapter 2. The IL-10 staining shows as a brown colour in the cells. As in
Chapter 4 with the p53 staining it was not possible to quantify the staining
because unirradiated cells have low levels of IL- 10 present (Fig 6.21).
Therefore the cells could only be graded for their IL-10 staining.
Exposure to 200 J/m2 UVB increased the intensity of immunostaining for IL-
10 protein in Pam 212 cells. Selenomethionine (50-200 nM) and sodium
selenite (50 nM) were both found to decrease the intensity of
immunostaining for IL-10 protein in Pam 212 cells (Fig 6.21 and Table 6.2).
The largest decrease in immunostaining for IL-10 protein was found in the
cells treated with selenomethionine.
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1n M 1 0 n M 50nM 50nM 100nM 200nM
Sodium Selenite Selenomethionine
Selenium Treatment
Primary keratinocytes were supplemented with either sodium selenite or
selenomethionine for 24 hours prior to cells being exposed to UVB (200
J/m2). Fresh media was returned to the cells and they were incubated for 24
hours prior to the media being collected. ELISA's were carried out on the
samples. Control cells had no Se added and were mock irradiated. Results
are expressed as the mean pg/ml ± S.E.M, n=3. Experiment was repeated in
triplicate. Significant difference from the control cells, for the cells with no
Se, but irradiated, + = P<0.05.
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1n M 10 n M 50nM 50nM 1 00nM 200nM
Sodium Selenite Selenomethionine
Selenium Treatment
Primary keratinocytes were supplemented with either sodium selenite or
selenomethionine for 24 hours prior to cells being exposed to UVB (200
J/m2). Fresh media was returned to the cells and they were incubated for 24
hours prior to the media being collected. ELISA's were carried out on the
samples. Control cells had no Se added and were mock irradiated. Results
are expressed as the mean pg/ml ± S.E.M, n=3. Experiment was repeated in
triplicate. Significant difference from the control cells, for the cells with no
Se but irradiated, t = P<0.05.
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Figure 6.20: Effect of Se on the levels of TNF-a protein,
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Primary keratinocytes were supplemented with either sodium selenite or
selenomethionine for 24 hours prior to cells being exposed to UVB (200
J/m2). Fresh media was returned to the cells and they were incubated for 24
hours prior to the media being collected. ELISA's were carried out on the
samples. Control cells had no Se added and were mock irradiated. Results
are expressed as the mean pg/ml ± S.E.M, n=3. The experiment was only
carried out once. Significant difference from the control cells, for the cells
with no Se but irradiated, t = P<0.05. Significant difference from the
irradiated cells with no Se added * = P<0.05.
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Figure 6.21: Effect of Se on immunostaining for IL-10 protein in
Pam 212 cells.
a) Control cells (magnification xl60)
b) Irradiated cells (200 J/m2)
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c) Cells treated with selenomethionine (200 nM) and irradiated.
d) Cells treated with sodium selenite (50 nM) and irradiated.
6-38
Table 6.2: Effect of Se on the UVB induction of IL-10 protein in
Pam 212 cells, measured by immunostaining.
Treatment Relative intensity of staining (individual
experiments)
Control + + +



















The duplicate cultures were treated with sodium selenite or
selenomethionine for 24 hours prior to the media being replaced and the
cells exposed to 200 J/m2 UVB. The original Se-containing media was then
replaced and the cells incubated for a further 24 hours. The cells were
immunostained for IL-10. Control cells were not treated with Se or
irradiated. Results are the average intensity of staining, n=2, per
experiment.
- = no staining
+ = faint staining
++ = stronger staining





Production IL-6 mRNA was induced by exposure to UVB and peaked at 6
hours (Fig 6.5) whilst the protein production, peaked at 24 hours (Fig 6.18).
This compares well with the literature, however others have reported that
the peak in protein production normally occurs at 12 hours (Wlaschek et al,
1993; Kirnbauer et al, 1991). The basal levels of the mRNA and the protein
were slightly decreased by selenomethionine at 50 and 200 nM (Fig 6.9 and
6.16). The decrease could be mediated by the effects of Se on the AP-1 and
NFkB transcription factors by altering their binding to the IL-6 promoter
region. These transcription factors have been shown to be regulated by the
redox environment. NFkB can activate IL-6 mRNA production in
keratinocytes and is itself activated by exposure to UVB light and can also be
activated by free radicals (reviewed in Flohe et al, 1997). Overexpression of
PHGPX in cells supplemented with 50 nM sodium selenite decreases the
activation of NFkB by IL-1 and selenite treatment for 4 days also diminishes
the level of NFkB DNA binding (Brigelius-Flohe et al, 1997). As Se has been
demonstrated to decrease NFkB activation it is possible that this is the
mechanism for the decrease in the levels of IL-6 mRNA and basal protein
levels. The AP-1 is also activated by UV light (Derijard et al, 1994; Devary et
al, 1991) and by H2O2. Selenite and selenodigluthione added to nuclear
extracts effectively inhibit AP-1 DNA binding (Spyrou et al, 1995). Therefore
this represents another possible mechanism for the decrease in basal levels of
IL-6. However it does not explain why selenomethionine but not selenite
decreases the basal level of IL-6.
When keratinocytes were supplemented with Se and then exposed to UVB
conflicting results arose. The level ofmRNA induced by UVB was decreased
at all the concentrations of selenomethionine used and also at 1 nM sodium
selenite (Fig 6.10a and b). However the levels of protein did not change (Fig
6.18). There are several possible explanations to account for this difference,
the increase in the abundance of mRNA for IL-6 following exposure to UVB
appears to be unimportant. The increase in IL-6 protein appears to be due to
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an increase in mRNA stability and not increased transcription (de Vos et al,
1990). It may be the case that the presence within the IL-6 promoter region
of NFkB and AP-1 binding sites, is not important for the response to UVB.
Furthermore the Se-mediated decrease in transcription factor activation may
not overcome other actions which lead to the stabilisation of the mRNA for
IL-6 . The mRNA for IL-6 has a conserved AU-rich region, found in the 3'
untranslated region, which normally causes destabilisation of the mRNA
(Beelman and Parker, 1995; Caput et al, 1986; Malter, 1989). During
inflammation the mRNA for IL-6 is stabilised through binding of cytosolic
proteins, which specifically recognise the AUUA rich structural elements
and prevent degradation of the mRNA (Malter, 1989). Moreover, it was
reported that UV irradiation enhances the cross-linking between the AU rich
sequence elements and their protective binding proteins (Henics et al, 1995).
It maybe that Se decreases the production of the mRNA for IL-6. However it
is clear that the decrease in mRNA does not lead to a decrease in the level of
IL-6 protein induced following exposure to UVB. Therefore a threshold of
stabilised mRNA may be reached that allows the production of increased
levels of protein. Another possibility is that Se may stabilise the cytokine
proteins, perhaps by inhibiting the action of proteases.
6.3.2 Interleukin-8.
The levels of mRNA and protein for IL-8 were increased by exposure to UVB
6 (Fig 6.6) and 24 hours respectively (Fig 6.19). This increase in both mRNA
and protein following exposure to UVB is in agreement with other reports in
the literature (Kondo et al, 1993). The basal levels of IL-8 protein were
decreased by addition of 200 nM selenomethionine and 50 nM sodium
selenite (Fig 6.17), and the basal level of mRNA was decreased at most
concentrations of Se (Fig 6.9). The decrease in mRNA and protein for IL-8
may be caused by the influence Se has on transcription factors activation and
on ROS-mediated signal transduction. The effect of Se on two of the
transcription factors has been described in section 6.3.1. Protein levels for IL-
8 were not decreased to the same degree as mRNA levels when Se was
added, this may demonstrate the presence of a surplus of IL-8 mRNA in the
cells.
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Again when the cells were supplemented with Se and then exposed to UVB
conflicting results arose. The levels of mRNA induced by UVB were
diminished at 50 nM and 200 nM selenomethionine and at all concentrations
of sodium selenite (Fig 6.11a and b), however the levels of protein did not
decrease (Fig 6.19).
Kondo et al have suggested that the induction of IL-8 mRNA is due to AP-1
activation mainly, because the mRNA is induced within 1 hour and the
proteins c-fos and c-jun which make up the transcription factor AP-1 are also
turned on rapidly by UVB (Shah et al, 1993; Kondo et al, 1993). Most of the
induction of IL-8 following UVB irradiation is due to de novo synthesis of the
protein (Kondo et al, 1993). The induction ofmRNA via AP-1 activation may
explain why the levels of mRNA are induced by UVB and decreased by Se.
However it does not account for the lack of inhibition in protein levels with
Se. There may be sufficient mRNA, encoding for IL-8 even after it is
decreased by Se, to allow efficient production of the protein.
6.3.3 Tumour necrosis factor-a.
The level of mRNA for TNF-a was increased by exposure to UVB at 6 hours
(Fig 6.7), but the induction was not significant, however the protein was
induced significantly at 24 hours (Fig 6.20). The time points for peak
induction agree with those published in the literature (Kock et al, 1990). The
basal level of TNF-a mRNA was not decreased by any of the concentrations
of Se employed (Fig 5.9). Whilst TNF-a does have AP-1 and NFkB binding
sites within it's promoter region (Spriggs et al, 1992); if these sites are
mutated induction of the gene can still occur (Bazzoni et al, 1994). This
would suggest that these transcription factor sites are not absolutely
necessary for induction of the message. Therefore if Se does indeed decrease
the activation of these two transcription factors, this would not necessarily
decrease the level of TNF-a mRNA.
When the primary human keratinocytes were supplemented with Se and
then exposed to UVB, the levels of mRNA induced by UVB were decreased
at 100 and 200 nM selenomethionine. Sodium selenite may have decreased
the mRNA significantly, however there was no significant induction of TNF-
a mRNA (Fig 6.12). The levels of TNF-a protein were also decreased
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significantly at 50 and 100 nM selenomethionine (Fig 6.20). There are several
possible reasons for this, it has been demonstrated that antioxidants and can
reduce the amount of TNF-cc production following exposure to UVB (Corsini
et al, 1995). This suggests that ROS are a major inducer of TNF-a protein
following UVB exposure. If Se lead to an increase in the antioxidant
selenoproteins GPX and TR this would lead to a decrease in ROS-mediated
induction of the mRNA for TNF-a, which in this case appears to lead to a
decrease in the abundance of TNF-a protein. However the TNF-a ELISA
experiment was only carried out once due to problems with the stability of
the protein. The absence of any decrease in TNF-a protein levels after
sodium selenite pretreatment requires further investigation.
The decrease in TNF-a protein is of interest in the context of the skin where
it acts as a pro-inflammatory cytokine which can stimulate IL-1, IL-8 and IL-
6 release by keratinocytes (Kutsch et al, 1993). Therefore if Se reduces the
induction of TNF-a protein within the skin this could lead to a concomitant
abrogation of the inflammatory response. Also TNF-a is implicated in LC
migration from the skin following exposure to UVB. The migration of LCs
from the epidermis leads to local immune suppression, which may allow
altered self antigens and pathogens to evade the immune system. Therefore
any reduction in TNF-a release caused by Se would prevent LCs from
receiving their migratory signal. Indeed, as discussed in Chapter 8 there is a
greater decrease in the numbers of LCs in Se-deficient mice then in Se-replete
mice.
6.3.4 Interleukin-la.
The IL-1 a mRNA was not significantly induced by UVB (Fig 6.8) and Se had
no effect on its basal levels before or after exposure to UVB (Fig 6.9). It was
decided not to pursue an investigation of the protein levels of IL-1 a, which is
released 12 hours following exposure to UVB. The release of IL-1 a is not due
to de novo protein synthesis, de novo transcription or to mRNA stabilisation,
as UVB decreases the half-life of the mRNA (Kondo et al, 1994). The increase
in IL-1 a protein is accounted for by the release of performed IL-1 a.
Therefore it was not thought that Se would affect these protein levels.
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6.4 Pam 212 cell line experiments.
6.4.1 Tumour necrosis factor-a.
In Pam 212 cells the induction of mRNA for TNF-a was significant 6 hours
post exposure to UVB. Selenomethionine at concentrations of 10-50 nM and
sodium selenite at concentration of 10-200 nM significantly decreased this
induction following exposure to UVB (Fig 6.14a and b). As in the case of
human TNF-a this is probably due to a de™3'"'™ *"
Unfortunately TNF-a protein could not ^ Willi V.U11L11I.
commercially available ELISA kits. The role of Se in modulating the
production of murine TNF-a protein could not be investigated.
6.4.2 Interleukin-10.
The increase in IL-10 mRNA following exposure to UVB was found not to be
significant, therefore this prevented a study of the full effects of Se on the
levels of IL-10 mRNA (Fig 6.15). However sodium selenite (1-100 nM) and
selenomethionine at concentrations between 10-100 nM did appear to
decrease the levels of mRNA although this decrease did not reach
significance.
The IL-10 protein was undetectable by the currently commercially available
ELISA kits. However there was a monoclonal antibody available for murine
IL-10 and immunostaining for the protein was carried out. It was found that
selenomethionine at concentrations between 50-200 nM, and sodium selenite
at 50 nM decreased the level of IL-10 protein (Table 6.2). It was also
attempted to carryout western blotting unfortunately the antibody did not
work when using this method.
The decrease in IL-10 protein levels following exposure to UVB, could lead
to a reduction in the level of systemic immune suppression induced by UVB
and a stronger cytotoxic cellular immune response (reviewed in Kondo and
Sauder, 1995). Also IL-10 has been implicated in inhibiting antigen





presentation within the skin and so a decrease in IL-10 would lead to
improved antigen presentation by LCs in the skin (Beissert et al, 1995; Niizeki
and Streilein, 1997; Barr et al, 1999).
6.5 Summary.
There is currently little evidence that Se can affect the levels of cytokines in
the skin. Selenium supplementation can reduce the release of inflammatory
cytokines from the skin (Celerier et al, 1995). The decrease in the protein
levels maybe due to a decrease in the activity of transcription factors and
cellular signalling pathways, such as activation of phospholipases by Se
(Brigelius-Flohe et al, 1997; Spyrou et al, 1995). Previous studies have
demonstrated that a diet deficient in Se is associated with an increased
inflammatory response (reviewed in McKenzie et al, 1998). This increase in
response may be due to the lower level of antioxidant selenoproteins present
leading to an increased level of free-radicals, which could activate
transcription factors and signalling pathways (Devary et al, 1992; Simon et al,
1994). Unfortunately the work presented in this chapter does not really
provide a full explanation for the decrease in inflammation elicited by Se.
While Se does decrease the levels of mRNA for; IL-6, IL-8, TNF-a in human
cells and IL-10, TNF-a in murine cells. Addition of Se only decreased the
levels of UVB-induced TNF-a protein from primary keratinocytes and IL-10
protein from murine cells. The decrease in TNF-a protein is not enough to
explain how the inflammatory response to UVB is diminished by Se. Some
alternative possible mechanisms include a decrease by Se in the production
of inflammatory free-radicals and prostaglandins. Selenium may also lower
the levels of iNOS protein and therefore, nitric oxide release. Keratinocytes
demonstrate enhanced prostaglandin secretion following UVB exposure, in
particular, PGE2 which is also believed to contribute to UVB-induced
inflammation. Selenium supplementation has been reported to decrease the
induction of prostaglandins (reviewed in McKenzie et al, 1998).
The decrease in IL-10 protein release found in the murine cells is of interest
as following UVB exposure, systemic and local immune suppression can be
induced. The immune suppression allows tumour antigens to evade the
immune response, thereby allowing progression of skin tumours.
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6.6 FurtherWork.
There is a great deal of further work which needs to be undertaken in this
area to gain an understanding of how Se affects the immune system. The
TNF-a protein and mRNA experiments need to be repeated as the protein
experiments in the human cells were performed once. The effect of Se on the
activation of transcription factors following exposure to UVB requires
further study. The mechanisms by which the mRNA of cytokines increase
following exposure to UVB needs to be investigated. The effect of Se on
mRNA stabilisation and protein stability. Finally the effect of Se on other




Effect of Selenium on Epidermal Langerhans'
Cell Numbers in Mice.
7.1 Introduction.
7.1.1 Immune suppression.
The phenomenon of UV-induced modulation of tumour immunity was first
noticed by Margaret Kripke and co-workers in 1977, who reported that UV-
induced skin tumours, transplanted to normal syngenic mice, were rejected
by these immunocompetent hosts. However, the tumours grew
progressively if the recipient had been irradiated, with UV radiation at
subcarcinogenic doses, prior to transplantation (Fisher and Kripke, 1977;
Kripke, 1976; Kripke, 1984). Therefore, UVB appears to have a role in both
tumour initiation by causing DNA damage and as a tumour promoter by
inhibiting tumour surveillance and hence, can be described as a complete
carcinogen.
7.1.2 Langerhans' cells.
Langerhans' cells (LCs) are CDla+, MHC class 11+ dendritic cells, derived
from the bone marrow. Langerhans' cells form a semi-continuous network
between epidermal keratinocytes and function as the main antigen
presenting cells (APCs) in the skin. Langerhans' cells are described in more
detail in Chapter 1.
7.1.3 Effect of UVB on Langerhans' cells.
Invading pathogens, contact sensitisers or UVB exposure can all induce LCs
to migrate from the epidermis (Toews et al, 1980, reviewed in Meunier, 1999).
Many cytokines are upregulated by exposure to UVB including IL-1 a, IL-6,
IL-8, IL-10, TNF-a and TGF-(3.
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TNF-a has been proposed to initiate the movement of LCs from the skin to
the draining lymph nodes (Cumberbatch and Kimber, 1995). The encoding
mRNA and the TNF-a protein are upregulated in the epidermis, after
exposure to UVB. Furthermore, intradermal injection of TNF-a causes an
accumulation of dendritic cells in draining lymph nodes (Cumberbatch and
Kimber, 1992) and a decrease in LCs numbers in the epidermis
(Cumberbatch et al, 1994). These effects implicate TNF-a as an important
mediator in LC cell migration. Furthermore, pre-treatment of mice with
neutralising antibodies for TNF-a before UV exposure, prevents the normal
UV-induced accumulation of dendritic cells in the draining lymph nodes.
Interleukin-ip has also been implicated in the migration of LCs to the
draining lymph nodes (Cumberbatch et al, 1997). It is thought that IL-ip is
mainly LC-derived, and it can upregulate epidermal TNF-a (Enk et al, 1993).
As the LCs move to the draining lymph nodes they undergo many changes.
One important change is that LCs express less E-cadherin which is thought
to help LCs bind to keratinocytes (Tang et al, 1993). The down regulation of
E-cadherin may enable LCs to detach from keratinocytes.
Both sub-erythemal and erythemal doses of UVB cause a decrease in the
number of LCs in human skin, this decrease can be between 20-70%
respectively (Cooper et al, 1992). In addition, morphological changes occur
to the LCs including; the loss of dendrites and the alteration of cell surface
markers (Aberer et al, 1981). UVB can reduce the expression of ICAM-1 on
LCs (Tang and Udey, 1991). UVB exposure also affects LC function. For
example it inhibits their ability to stimulate primary alloresponses and their
proliferation in response to mitogens and antigens (Rattis et al, 1995a and b).
Free radicals appear to play a role in UVB-induced damage to LCs. When
SOD is injected intradermally into guinea pigs just prior to their exposure to
UVB, the LC population in the skin is significantly protected (Horio and
Okamoto. 1987). Glutathione has also been reported to preserve the antigen
presenting ability of LCs (Iwai et al, 1999). The protective effect of SOD and
glutathione suggests that oxygen radicals may damage LCs in the skin
following exposure to UVB. Recently it has been established that LCs can
undergo apoptosis following exposure to UVB (Rattis et al, 1998). It has also
been demonstrated that the DNA of LCs can be damaged following
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exposure to UVB. The damage caused is typical of the effects of exposure to
UVB, and includes the formation of thymidine dimers (Sontag et al, 1995).
7.1.4 Effect of Se on the immune system.
Selenium has been demonstrated to play an important role in the immune
system (reviewed in McKenzie et al, 1998). Deficiency of dietary Se is
reported to reduce antibody titres in mice (Spallholz et al, 1973, 1975, 1990).
A more recent study found that Se-deficient rats have lower antibody titres
and a decreased delayed type hypersensitivity reaction (Kukreja and Khan,
1998). Selenium can also upregulate the expression of the T cell high affinity
IL-2 receptor. This increases T cell responsiveness to IL-2 and therefore T
cell proliferation and function (Roy et al, 1995). Cytotoxic T cell function and
natural killer cell activity are also boosted by Se supplementation (Meeker et
al, 1985; Koller et al, 1985; Petrie et al, 1989a and b; Kiremidjian-Schumacher
et al, 1992 and 1996). Erythema induced by exposure to UVB and
inflammatory cytokine expression in inflamed skin in organ cultures, can be
diminished by Se supplementation (Celerier et al, 1995). The role of Se in the
immune system is discussed in more detail in Chapter 1.
Whilst Se does affect the immune system, as yet little is known about how it
modulates cytokine expression, inflammation, UV-induced immune
suppression and antigen presentation.
7.1.5 Measurement of Se Status in vivo.
The most common method for assessing Se status is to measure the activity
of cGPX in erythrocytes or plasma, since GPX activity depends on Se status
(Rotruck et al, 1973). The activity of cGPX decreases in response to Se
deficiency at different rates in different tissues i.e. the endocrine tissues and
brain retain their levels of Se during Se deficiency. This produces a
hierarchy of Se utilisation, such that tissues which retain their Se levels are
thought to utilise it for more essential functions (reviewed in Burk and Hill,
1993; Allan et al, 1999). For example, in the liver cGPX activity can fall to
<1% in Se-deficient animals compared to levels in Se-replete animals, with
no short term adverse health effects. The effect of Se deficiency on lymph
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node and skin levels of cGPX are not known, therefore cGPX measurements
were examined.
The aims of this study were to
• Ensure that the different Se levels in the diets used in this study did not
affect the growth rates of the mice.
• Investigate the effect of exposure to UVB on the numbers of LCs present
in the skin.
• Demonstrate the effect of Se on the number of LCs present in the skin
prior to and following exposure to UVB.
• Study the effect of the different Se dietary intakes on the GPX activity in
the draining lymph nodes, skin and livers of the mice.
• Demonstrate the effect of UVB on the GPX activity in the skin, liver and
lymph nodes of the mice.
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7.2 Methods and Results.
7.2.1 Effect of diets containing different levels of Se on the growth of
mice.
The mice (C3H/HeN) were weaned at 3 weeks, and were maintained on
three different diets, each containing different levels of Se (Oppm, O.lppm
and 2ppm), for 6 weeks prior to the experiments being performed. The
source of the mice and the dietary information is described in full in Chapter
2, section 2.7.1 and 2.7.2. Preliminary experiments were also carried out to
ensure that the mice increased in weight, at a similar rate to mice fed on the
normal animal house diet (Fig 7.1a). During the six weeks the mice were
weighed every week. No differences in weight gain between the three Se
diets were found (Fig 7.1b).
7.2.2 Effect of dietary Se levels on the numbers of LCs present in the
epidermis.
After feeding the mice on one of the three Se diets for six weeks, 4 mice from
each dietary group were irradiated with UVB (1440 J/m2). The mice were
exposed to UVB (TL-20W/12 lamps) in a perspex box, with a maximum of
four mice per box to avoid shielding by litter mates. Twenty-four hours
later, one ear from each mouse was harvested and stained for LCs, by
assessing adenosine triphosphatase (ATPase staining) (see Chapter 2, section
2.7.3 for full methodology). Figure 7.2 illustrates ATPase-stained LCs in the
epidermis. The cells can be distinguished by their dark brown/black
staining and their dendritic appearance.
In Figure 7.3 it can be seen that the level of dietary Se, significantly
modulated the number of LCs found in unirradiated skin. The mice
maintained on the O.lppm Se diet had significantly increased numbers of
LCs present, compared to the Se-deficient mice. The higher levels of LCs
were found in three individual experiments, two of which are illustrated in
Fig 7.3a and 7.3b. The experiments using the diets with 2ppm Se were
performed twice. In the first experiment the mice fed with 2ppm diets had ■
Continued on page 7-11
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Figure 7.1a: Effect of Se diet on weight gain in C3H/HeN mice.
Days on Diet
C3H/HeN mice were weaned at 3 weeks, and were fed on a special diet
containing O.lppm Se or on the normal mouse house facility diet. Fresh food
was given every 2 days. Mice were maintained for 2 weeks and were
weighed daily. Results are the mean weights ± S.E.M (n=6).
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C3H/HeN mice were weaned at 4 weeks, and were fed on three identical
diets, except for the levels of Se present in each diet. Fresh food was given
every 2 days. Mice were maintained for 6 weeks and were weighed once a
week prior to being irradiated. Results are the mean weights ± S.E.M. (n=8).
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Figure 7.2: Langerhans' Cells ATPase stained in mouse
epidermis (xl60).
Control mouse epidermis showing ATPase-stained LCs (xl60). The LCs
stain dark black/brown and can be distinguished by their dendritic
appearance.
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Figure 7.3a: Effect of level of dietary Se on the numbers of LCs
present in the epidermis of C3H/HeN mice, before











Groups of mice were maintained on three different diets each with a
different level of Se for 6 weeks. The mice were subsequently irradiated or
mock irradiated with 1440 J/m2 UVB. After 24 hours the ears were
harvested and ATPase stained for LCs, ten fields from each epidermal sheet
were counted for LCs. Results are the mean number of LCs/mm2 ± S.E.M,
n=4. * = Significant decrease in LC number after exposure to UVB compared
to control mice, P<0.05. t = Significant increase in LC number compared to
irradiated, Se-Oppm mice P<0.05. <P = Significant increase in LC number
compared to control Oppm mice, P<0.05.
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Figure 7.3b: Effect of level of dietary Se on the numbers of LCs
present in the epidermis of C3H/HeN mice, before










Groups of mice were maintained on three different diets each with a
different level of Se for 6 weeks. The mice were subsequently irradiated or
mock irradiated with 1440 J/m2 UVB. After 24 hours the ears were
harvested and ATPase stained for LCs, ten fields from each epidermal sheet
were counted for LCs. Results are the mean number of LCs/mm2 ± S.E.M,
n=4. * = Significant decrease in LC number after exposure to UVB compared
to control mice, P<0.05. t = Significant increase in LC number compared to
irradiated, Se-Oppm mice P<0.05. <P = Significant increase in LC number
compared to control Oppm mice, P<0.05.
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significantly increased numbers of LCs. However, in the second experiment
whilst the numbers of LCs present in the mice fed the diets containing 2ppm
Se, were higher than in the Se-deficient mice, the increase was not
statistically significant (Fig 7.3b).
Following exposure to UVB, there was a decrease in the number of LCs
present in the skin, in the mice maintained on the Se-deficient diet and in the
mice maintained on the O.lppm Se diet (Fig 7.3a & b). In the Se-deficient
mice the decrease was around 10%, but this did not achieve statistical
significance. In the mice fed the diet containing O.Olppm Se, the decrease in
LCs number following exposure to UVB was significant, at around 40%.
There were, however, still significantly more LCs in epidermis of the O.lppm
fed mice after exposure to UVB, than in the Se-deficient mice. These results
were reproducible and each mouse group contained 4 mice and the
experiments were carried out three times. In one experiment, the mice fed
the diet containing 2ppm Se, had an 11% increase in the number of LCs
following exposure to UVB (Fig 7.3a). However, when the experiment was
repeated, whilst there were more LCs present prior to irradiation than in the
deficient mice, there was a large decrease in the number of LC present
following exposure to UVB. The 2ppm Se diet experiments were carried out
on groups of 4 mice twice.
7.2.3 Effect of dietary Se on the GPX activity in the mice.
At the end of the 6 week period of maintenance on the Se diets, when the
ears were removed for LC counts, the livers, draining lymph nodes and one
ear were also harvested and snap frozen in liquid nitrogen. The level of
activity for GPX was measured in these frozen tissues. The measurements of
activity of GPX, were normalised using the protein measurements (Full
methodology for the GPX measurements and the Bradford protein assay are
in Chapter 2 section 2.7.4 and 2.7.5).
The activities of GPX in the livers of the mice varied with the concentration
of Se in the diet. Selenium-deficient mice had GPX levels that were only 10%
of that seen in Se replete mice. Mice fed the 2ppm Se diet, had GPX levels
5% higher than the mice fed on the O.lppm Se diet. UVB had no effect on the
activity of GPX in the livers (Fig 7.4).
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The activity of GPX in the skin of Se-deficient mice was 57% lower ,than the
GPX activities in the skin of the mice fed on the O.lppm diet. There was a
slight decrease in GPX levels in the mice fed on the 2ppm diet, compared to
those fed the O.lppm diet but this was under 10% and not significant. Again
UVB had no effect on the activity of GPX in the skin (Fig 7.5).
Finally GPX activity in the lymph nodes was significantly lower (47%), in the
Se-deficient mice, compared to the mice fed on the O.lppm Se diet. Again
the GPX activities in mice fed either the O.lppm or the 2ppm diets, were not
significantly different. UVB did not affect the activity of GPX in the lymph
nodes (Fig 7.6).
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Figure 7.4: Effect of dietary Se on the activity of GPX in
the livers of C3H/HeN mice.
Oppm 0.1 ppm 2ppm
Se Content of Diets
□ Control
+ UVB
Mice were maintained on one of three diets each with a different level of Se
for 6 weeks. They were then irradiated with 1440 J/m2 UVB or mock
irradiated. After 24 hours the livers were harvested and the activity of GPX
measured. Results are the mean units/g protein ± S.E.M, n=4. * =
Significant difference from Se-deficient control mice, P<0.05.
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Figure 7.5: Effect of dietary Se on the activity of GPX in the










Oppm 0.1 ppm 2ppm
Se Content of Diet
Mice were maintained on one of three diets each with a different level of Se
for 6 weeks. They were then irradiated with 1440 J/m2 UVB or mock
irradiated. After 24 hours the ears were harvested and the activity of GPX
measured. Results are the mean units/g protein ± S.E.M, n=4. * =
Significant difference from Se-deficient control mice, P<0.05.
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Figure 7.6: Effect of dietary Se on the activity of GPX in the










Oppm 0.1 ppm 2ppm
Se Content of Diet
Mice were maintained on three diets each with a different level of Se for 6
weeks. They were then irradiated with 1440 J/m2 UVB or mock irradiated.
After 24 hours the lymph nodes were harvested and the activity of GPX
measured. Results are the mean units/g protein ± S.E.M, n=4. * =
Significant difference from Se-deficient control mice, P<0.05.
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7.3 Discussion.
Dietary Se is essential for many functions in the body, including the immune
system. Selenium can boost B cells, T cells, natural killer and cytotoxic T
cells functions (Spallholz et al, 1973, 1975, 1990; Meeker et al, 1985;
Kiremidjian-Schumacher et al, 1992,1996; Petrie et al, 1989a and b; Koller et al,
1986). Whilst a considerable amount of research has been done to investigate
the importance of Se on the immune system, as yet no work has been carried
out to study the effect of Se on antigen presentation or on LC numbers or
function. In the present study, it was demonstrated that Se can influence LC
populations in the skin (Fig 7.3a & b). The skin is the organ most likely to
encounter foreign antigens. Therefore it is essential that it is equipped to
mount a full and competent immune response to them. It would appear that
a diet containing at least O.lppm Se, was the optimum level of Se for
maintaining maximal numbers of LCs in the epidermis in mice (Fig 7.3a & b).
In mice maintained with the 2ppm Se diet, there is also an elevated level of
epidermal LCs.
There is mounting evidence, to suggest that LCs are very sensitive to
damage caused by exposure to free-radicals (Horio and Okamoto, 1987; Iwai
et al, 1999). It could be argued, therefore, that in Se-deficiency there would
be a decrease in GPX and other selenoenzymes with antioxidant functions.
The decrease in antioxidant selenoenzymes, would increase the
susceptibility of LCs to free radical attack.
Mice fed the diets with different Se content showed no significant difference
in weight gain over the 6 weeks of the experiment, suggesting that there was
no Se toxicity caused by any of the diets (Fig 7.1b). The Se diets were amino
acid based and initial experiments showed that animals fed the Se diets
gained weight, at the same rate as the mice fed on the usual commercial diet
(7.1a).
Following exposure to UVB, the number of LCs present in the skin decreases
(Toews et al, 1980). It is important to maintain the LC population in the skin
following exposure to UVB, as LCs are required to mount an immune
response to any altered self-antigens caused by exposure to UVB. Selenium
proved to be important in maintaining the number of LCs present in the
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epidermis following exposure to UVB (Fig 7.3a & b). It was found that mice
fed the O.lppm Se containing diet retained higher numbers of LCs, compared
to the Se-deficient mice following exposure to UVB.
If immune surveillance is decreased following exposure to UVB, this may
lead to an increased risk of tumour cells not being eliminated by the immune
system. This has been shown to occur by Kripke et al (Fisher and Kripke,
1976; Kripke, 1977; Kripke, 1984). This group have demonstrated that skin
cancers are highly immunogenic, however if a tumour is transplanted into
an irradiated host the tumour can grow, as the UVB induces immune
suppression in the host. This immunosuppression allows the tumour to
evade the host immune response. The immune suppression caused by UVB
also causes the body not to respond to other antigens, such as chemicals and
microbes. Therefore if the body is to prevent tumour growth and infections,
it is essential that antigen presenting ability is not compromised in the skin.
The observation that in mice the number of skin tumours produced by
exposure to UVB is decreased by Se supplementation, may thus be due, in
part, to the maintenance of LC numbers and therefore adequate immune
surveillance (Pence et al, 1994).
The decrease in LC numbers present in the epidermis following exposure to
UVB, is probably accounted for by several mechanisms including: cell death
due to free radical damage (Horio and Okamoto, 1987; Iwai et al, 1999), DNA
damage (Sontag et al, 1995) or death by apoptosis (Rattis et al, 1998).
Furthermore, it may also be due to the LCs binding altered self antigens and
moving to the lymph nodes to present them to T cells. One possible
mechanism for the protection of LCs from UVB-induced damage may be
that, Se decreases the amount of oxidative damage caused by UVB. Other
antioxidants can protect the population of LCs present in the skin from free-
radical damage induced by UVB. These include; glutathione and SOD, both
of which prevent free-radical damage induced by UVB to LCs (Horio and
Okamoto, 1987; Iwai et al, 1999). These studies also demonstrate that
oxidative damage caused by exposure to UVB, is one of the major causes for
LC migration and death following irradiation. In Chapter 3 it was
demonstrated that lipid peroxidation induced by exposure to UVB is
diminished in epidermal keratinocytes, if they are cultured in the presence of
Se. Therefore, if the free-radical stress to LCs could be decreased by the
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presence of Se, this may help to protect them. Similarly the level of apoptotic
cell death (Chapter 4) and oxidative DNA damage (Chapter 5) induced by
exposure to UVB, was decreased in keratinocytes by Se supplementation.
However, further work needs to be carried out to clarify the mechanism by
which Se provides protection against UVB-induced damage. It can be
proposed that if there was less oxidative damage induced in the skin, this
would lead to less DNA damage and therefore fewer of the cells would
undergo cell death by apoptosis. In order to decrease the levels of oxidative
damage, Se would have to increase the levels of antioxidant enzymes such as
GPX and TR. This is certainly true for the levels of GPX found in the liver,
skin and lymph nodes of the mice fed on the diets containing higher levels of
Se; the GPX levels were much higher than in the mice fed with the Se-
deficient diet (Fig 7.4, 5 and 6). This is of particular importance in the skin
where the mice fed the Se replete diets displayed GPX levels, which were
57% higher than in the mice fed with the deficient diets. The increases in
antioxidant enzyme levels correlate with the increased numbers of LCs.
Therefore it may be that LCs which have a higher level of GPX, have a
greater potential to reduce free-radical species and survive exposure to UVB.
In the mice fed the Se-replete diets, it would be expected that in addition to
increased levels of GPX, the levels of other antioxidant selenoproteins would
be increased, such as TR.
The results have clearly shown that in Se-deficiency, the loss of GPX in the
liver was considerably greater than that observed in skin and draining
lymph nodes. It is likely that the differences represent the different degrees
of oxidative stress these tissues are exposed to. The skin is continually
exposed to free radicals induced by exposure to sunlight, pathogens and
chemicals. Thus it may be that the skin and lymph nodes are high in the
hierarchy of tissues for Se retention in times of Se-deficiency. Other organs
which show little change in cGPX activity in Se-deficiency are the brain and
endocrine tissue organs which are subjected to high and continual levels of
oxidative stress (Arthur et al, 1993; Beckett et al, 1993; Bermano et al, 1995;
Thompson et al, 1995).
Exposure to UVB did not decrease the levels of GPX in the skin. Although
only one time point was studied, the results are in agreement with findings
in the literature, where at no time after exposure to UVB do the levels of GPX
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decrease in the skin (Pence and Naylor, 1990; Shindo et al, 1994; Fuchs et al,
1989a and b). Many other antioxidant enzymes decrease in expression
following exposure to UVB, these include SOD and catalase. It maybe that
GPX has a shorter half-life than these other antioxidants, so the levels do not
drop.
The migration of LCs out of the epidermis following exposure to UVB, is due
in part, to the production of TNF-a by keratinocytes (Cumberbatch et al,
1994, Moodycliffe et al, 1994; Cumberbatch and Kimber, 1995). UVB induces
the production of TNF-a from both human and mouse keratinocytes (Kock et
al, 1990). Moreover, the induction of mRNA for TNF-a in both mouse and
human keratinocytes, and the induction of the protein in human
keratinocytes, by exposure to UVB, was demonstrated in Chapter 6 (Figs 6.5
and 6.16). In Chapter 6 the UVB-induction of TNF-a mRNA in human
keratinocytes and the protein for TNF-a were decreased by Se
supplementation (Fig 6.10 and 6.16). In mouse keratinocytes the TNF-a
mRNA was decreased, although the TNF-a protein was not detectable by
ELISA. However, if the protein abundance for TNF-a is decreased by Se,
this could be an explanation for the preservation of the numbers of LCs in
the epidermis.
7.4 Summary.
The results presented in this chapter suggest that Se plays a role in
maintaining the population of LCs in the epidermis. This is of great
importance to the body, as the skin is continually under assault from
pathogens, sunlight and chemicals. Accordingly, the skin must have an
efficient system for the presentation of antigens to the immune system. Also
UVB induces immune suppression in the skin, one mechanism by which it
does this is by loss of epidermal LCs. However in this study, it has been
shown that Se can help to maintain a higher population of LCs in the skin
following exposure to UVB. This would aid the body in dealing with the
carcinogenic effects of UVB, pathogens and chemicals.
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7.5 Further work.
Many experiments could be carried out to clarify how Se is acting in the
mouse epidermis. Further studies could be performed on the levels of other
selenoprotein levels in the skin following Se supplementation, including TR
and the individual members of the GPX family. Whether Se decreases the
levels of free radicals found in the mouse epidermis could be investigated.
Following UVB exposure, experiments could be carried out to measure the
effect of Se on DNA damage, apoptosis, and TNF a production in the
epidermis. Finally the LCs themselves could be investigated, to see if their
antigen presenting ability is modulated following Se supplementation.
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Chapter 8
Selenoprotein Expression In The Skin
8.1 Introduction.
The skin contains many enzyme systems to prevent free radical-induced
damage including; catalase, SOD and the Se-containing GPX and TR.
Catalase and SOD activity are decreased following UVB exposure, whilst
GPX appears to be resistant to the deleterious effects of UVB (Shindo et al,
1994).
There is much evidence to suggest that Se has an important role in protecting
skin from the harmful effects of UVB, this evidence is discussed fully in
Chapters 1 and 3. However briefly, in mice Se supplementation can
substantially decrease the amount of skin damage, tumour formation and
overall mortality following exposure to UVB (Pence et al, 1994; Stewart et al,
1996). Furthermore, cultured skin cells become resistant to UVB damage
following exposure to Se (Rafferty et al, 1998).
All the actions of Se were once thought to be exerted through cGPX, but it is
now recognised and accepted that Se exerts many of its effects through the
expression of a number of selenoproteins. These selenoproteins have Se
covalently linked within the protein, as selenocysteine (Cone et al, 1976). At
least 30 selenoproteins have been identified by SDS-polyacrylamide
electrophoresis of [75Se]-labelled tissue. However, only approximately
fourteen of the detected proteins have been characterised, including cGPX,
PHGPX, EGPX, selenoprotein-P, SP56, protein disulphide isomerase, TR and
the iodothyronine deiodinases (IDI) (Arthur et al, 1996, Burk and Hill, 1993).
The effects of UVB on the expression of these selenoproteins, or indeed their
precise roles in controlling the cells response to UVB are not known. The
family of GPX proteins detoxify a wide range of lipid peroxides (Rotruck et
al, 1973). These enzymes have been implicated in protecting cells from UVB-
induced free radical damage (Moysan et al, 1995). TR is a flavin adenine
dinucleotide-containing enzyme found in all organisms. In conjunction with
it's substrate thioredoxin, TR forms a redox system which has multiple
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functions including detoxification (Holmgren and Bjornstedt, 1995; Tamara
and Stadtman, 1996; Gladyshev et al, 1996). The characteristics of the
individual selenoproteins are discussed in detail in Chapter 2. The
molecular weights of a selection of selenoproteins can be found in Table 8.1.
Table 8.1: Molecular weights of the best known selenoproteins.
Selenoprotein Molecular Mass (kDa) Function
PHGPX 19-21 Antioxidant
TR (3 isoforms) 57-60 Antioxidant
cGPX 22-23 Antioxidant
Type 1IDI 27 Thyroid hormone
metabolism
Selenoprotein-P 42 Antioxidant, Se
transport protein
14 kDa Protein 14 Unknown
Selenoprotein-W 10 Muscle protein
The expression of most selenoproteins is regulated by the bioavailability of
Se (reviewed in Allan, 1999). These include PHGPX, cGPX, Selenoprotein-P
and TR. It has been demonstrated that in most tissues, PHGPX activities are
well conserved in Se deficiency, whilst in contrast cGPX is quickly lost
(Weitzel et al, 1990).
Thus, PHGPX is preferentially retained at the expense of cGPX during
periods of Se-deficiency (Weitzel et al, 1990). PHGPX is thought to be very
important in protecting the cellular membrane as it reduces lipid peroxides
(Ursini et al, 1985). Whilst cGPX is thought to react with soluble
hydroperoxides. It was also found that the levels of TR in many tissues
including the brain appear to be conserved during Se deficiency (Hill et al,
1997).
Labelling experiments with [75Se] have shown clear tissue differences in the
pattern of selenoprotein expression (Behne et al, 1988), but studies have not
been performed on human skin. Such studies may indicate which
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selenoproteins could have a role in protecting skin from the harmful effects
ofUVB.
In the epidermis, keratinocytes normally move up through the epidermis,
differentiate and eventually form the cornified envelope of the skin. In
culture, keratinocytes are maintained in low levels of calcium to prevent
differentiation. However when calcium is added to the media the
keratinocytes will begin to differentiate. The cells can be seen to become
enlarged and more rectangular, with some fragments of cornified material
present in the media. There are reports, which suggest that whilst
undergoing differentiation the activities of intracellular antioxidant enzymes
increase. One of the enzymes which has been shown to increase is GPX
(Vessey et al, 1995). Whereas, TR activity has been shown to diminish when
calcium is added to keratinocytes (Schallreuter et al, 1986b). Therefore the
effect of calcium on the selenoprotein profile of primary keratinocytes was
studied.
The aims of this sudy were to:
• To define the profiles of selenoproteins expressed by cultured human
keratinocytes, melanocytes and fibroblasts.
• Compare the selenoprotein profiles of primary keratinocytes to that
found in epithelial derived cell lines.
• To investigate the effect of exposure to UVB on the selenoprotein profiles
expressed by primary skin cells. Also to study the selenoprotein profile
in differentiating primary keratinocytes.
• Confirm that patients plasma Se levels increase following Se
supplementation.
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8.2 Methods and Results.
8.2.1 Selenoprotein profiles of skin cells.
Primary keratinocytes, melanocytes and fibroblasts were grown until 70%
confluent, in large 75 cm2 tissue culture flasks. They were then labelled for
72 hours with [75Se]-selenite (0.02 MBq/ml). Cells were harvested and the
proteins were then separated by SDS-PAGE and visualised as described in
full in Chapter 2, section 2.8.1.
Primary keratinocytes, melanocytes and fibroblasts were found to have
clearly different selenoprotein profiles (Figs 8.1 and 8.2). Each cell type
showed up to 10 major selenoproteins (molecular mass ranging from
approximately 10 to 60 kDa), but many minor selenoproteins were also
found to be expressed. It is of particular note that between cell types there
was variable expression of the 21 kDa and 60 kDa selenoproteins. Western
blotting identified the 21 kDa and 60 kDa selenoproteins as PHGPX and TR
respectively (This work was carried out by Dr John Arthur, Rowett Research
Institute, Aberdeen) (Rafferty et al, 1998). The 60 kDa [75Se] labelled bands in
each cell line, corresponded exactly in mobility and relative intensity to the
bands revealed by western blotting. The western blot was not sensitive
enough to detect the PHGPX directly, however, a standard of pure PHGPX
had the same mobility as the 21 kDa [75Se]-labelled band. The greatest
expression of TR and PHGPX was found in fibroblasts, with keratinocytes
expressing relatively little of these selenoproteins. The rank order of PHGPX
and TR expression was fibroblasts>melanocytes>keratinocytes.
The selenoprotein bands common to all cell types investigated, were of the
following masses a 60 kDa band, which was identified as TR. The 21 kDa,
which was identified as PHGPX and bands at 27 kDa, 23 kDa, 18 kDa, 16
kDa, and finally 14 kDa which were unknown. A band at 17 kDa was
expressed to a high level in the fibroblasts and was expressed weakly in the
keratinocytes.
The levels of selenoproteins expressed by other epithelial cell lines were also
investigated. The cell types used were labelled with [75Se]-selenite and
separated in the same manner as described for the primary cells. It was
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found that the epithelial cell lines tested, had quite distinct selenoprotein
profiles when compared to primary keratinocytes (Fig 8.3 and 8.4). SiHa
cells (derived from a squamous cell carcinoma of the uterus) (Friedl et al,
1970) expressed higher levels of TR and lower levels of the other lower
molecular weight selenoproteins, when compared to primary keratinocytes.
A431 cells (human epithelial carcinoma cell line) (Giard et al, 1973) were very
similar to primary keratinocytes in their selenoprotein profile, however they
did appear to express less of the 30 and 23 kDa selenoproteins. The
selenoprotein profile in HeLa cells (derived from a carcinoma of the cervix)
(Scherer et al, 1953) was similar to the SiHa cells, in that they overexpressed
TR and exhibited a decreased expression of the lower molecular weight
selenoproteins when compared to primary keratinocytes. Finally, the
HaCaT cells (spontaneously transformed human keratinocyte line)
(Boukamp et al, 1988) expressed more TR and PHGPX than the primary
keratinocytes.
The primary skin cells were also cultured in 10cm petri dishes and labelled
with [75Se] for 24 hours, prior to the media being replaced with PBS and the
cells exposed to 100 J/m2 UVB. The original [75Se]-containing media was
then replaced and the cells incubated for a further 24 hours, before being
harvested and the selenoproteins separated.
Exposure to UVB did not appear to alter the expression of any of the
selenoproteins present (Fig 8.5).
Keratinocytes were treated with 1.5 mM calcium chloride to induce cellular
differentiation. The cells were treated with calcium chloride for 24 hours,
prior to being labelled with [75Se] for a further 48 hours, in the presence of
1.5 mM calcium chloride. The selenoprotein profiles in differentiating
keratinocytes was very similar to that of normal keratinocytes, except that
the protein for TR appears to show a slight decrease in expression.
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Figure 8.1: Selenoprotein expression by primary human skin
cells.










Lane 1 = Melanocytes; Lane 2 = Keratinocytes; Lane 3 = Fibroblasts. Cells
were labelled with [75Se]-selenite for 72 hours and the proteins were
separated by SDS-PAGE and visualised by autoradiography.
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Figure 8.2: Selenoprotein profile analysis of primary human
skin cells.
Molecular Mass (kDa)
A phosphoimager was used to quantify the radioactivity of the
selenoproteins expressed by the primary skin cells. The protein gels were
scanned overnight on a phosphoimager and the profiles of the selenium-
containing proteins were generated. The molecular masses are shown on the
bottom profile.
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Figure 8.3: Selenoprotein expression by primary human
keratinocytes compared to epithelial derived
cell lines.
Selenoprotein Profile ofPrimary




























Lane 1 = Primary human keratinocytes; Lane 2 = SiHa cells; Lane 3 = A431
cells; Lane 4 = HeLa cells. Cells were labelled with [75Se]-selenite for 72
hours and the proteins were separated by SDS-PAGE and visualised by
autoradiography.
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Figure 8.4: Selenoprotein expression in primary human




Lane 1= HaCaT cells; Lane 2 = Primary human keratinocytes. Cells were labelled
with [75Se]-selenite for 72 hours and the proteins were separated by SDS-PAGE and
visualised by autoradiography.
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Figure 8.5 Selenoprotein expression in primary skin cells
exposed to UVB radiation.
Primary Primary Primary











1 2 3 4 5 6 7
Lane 1= keratinocytes; Lane 2 = keratinocytes exposed to 100 J/m2; Lane 3 =
keratinocytes treated with 1.5 mM calcium chloride, Lane 4 = fibroblasts;
Lane 5 = fibroblasts exposed to 100 J/m2; Lane 6 = melanocytes; Lane 7 =
melanocytes exposed to 100 J/m2. Cells were labelled with [75Se]-selenite for
24 hours prior to exposure to 100 J/m2 UVB, after exposure the original
[75Se]-containing media was returned to the cells and they were incubated for
a further 24 hours. The cells were then harvested and the proteins separated
by SDS-PAGE and visualised by autoradiography. The keratinocytes treated
with 1.5 mM calcium chloride were incubated with the calcium chloride for
24 hours prior to being labelled with [75Se] for 48 hours (during the 48 hours
labelling the calcium chloride also present).
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8.2.2 Selenium content of culture media, plasma and skin.
Selenium measurements were carried out by acid digestion and fluorimetry,
the full method can be found in Chapter 2, section 2.2.5.
Selenium content of tissue culture media.
All the culture media used in this project were analysed for their Se content:
Table 8.2: Selenium content of tissue culture media.
Media Selenium Content (nM)
Primary Keratinocyte 8.9
Primary Melanocyte 28
DMEM 5% FCS 0
DMEM 10% FCS 44.7
The tissue culture media contained either very low levels of Se or was too
low to be detected (Table 8.2). Different batches of FCS also demonstrated
variations in Se content (Table 8.2).
The effect of Se supplementation on human plasma Se levels.
A small trial (n=6) with patients was also carried to determine if plasma Se
levels could be increased following Se supplementation. The patients were
part of a larger clinical trial being carried out in the Department of
Dermatology, University of Edinburgh, UK. The patients received 400 jig of
sodium selenite in capsule form, daily for 6 weeks.
The average selenium content of the plasma for these patients prior to Se
supplementation was found to be 89.33 ng/ml ±11.8 (S.E.M). After Se
supplementation for six weeks, the average Se content increased to 104.7
ng/ml ± 9.5 (S.E.M), this represented a 17.2% increase in plasma Se.
Finally the Se content of human skin was measured. To obtain sufficient
material to assay the Se levels, skin from foreskin samples had to be used.
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The foreskins were obtained from The Royal Sick Children's Hospital,
Edinburgh, UK. The level of Se present in the skin was 84.41 ng/g and 89.11
ng/g for both samples tested.
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8.3 Discussion.
The family of GPX proteins and the family of TR proteins, are both clear
candidates for selenoproteins which may mediate the protective effects of Se.
The glutathione peroxidases can detoxify hydrogen peroxide, lipid
hydroperoxides and phospholipid hydroperoxides, which are produced
during UVB exposure. Thioredoxin reductase is a selenoenzyme with
multiple functions, which can act through its ability to reduce oxidised
thioredoxin (Holmgren and Bjornstedt, 1995), or by its ability to directly
reduce hydrogen peroxide and lipid hydroperoxides in the presence of
NADPH (Bjornstedt et al, 1995a). Thus, TR may play an important role in
protecting cells from peroxidative damage. However, labelling of tissues
with [75Se]-selenite has allowed the detection of more than 30 selenoproteins,
with the pattern of selenoprotein expression quite different between tissues.
It is thought that some of these selenoproteins may also be involved in
detoxification reactions and in modifying cell growth or cell death (Sunde,
1990).
The expression of the 21 and 60 kDa selenoproteins showed the most
variability between cell types. These selenoproteins were identified by
western blotting as PHGPX and TR respectively. We found that
keratinocytes expressed much lower levels of TR and PHGPX, when
compared to melanocytes and yet keratinocytes were found to be more
resistant to UVB-induced cell death than melanocytes. A UVB dose of 720
J/m2 was required to produce 80% cell death in melanocytes, whilst 960
J/m2 was required to produce 80% cell death in keratinocytes (Chapter 3).
Furthermore, despite these differences in selenoprotein expression between
the two cell types, keratinocytes and melanocytes showed a similar
concentration requirement for Se in order to obtain maximal protection from
UVB-induced cell death (Chapter 3). Whilst it could be argued that these
observations imply that the selenoproteins TR and PHGPX are not involved
in protection, this is not necessarily the case. The susceptibility of a cell to
UVB-induced damage will depend on the total expression of a wide range of
antioxidant enzymes, DNA repair mechanisms and not necessarily to
differences in the expression of a single specific selenoprotein. Thus
conclusions regarding the protective role of a specific selenoprotein, made by
comparison of the susceptibility of different cell types to UVB-induced cell
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death may be misleading. Experiments which relate to the susceptibility of
a cell to UVB-damage, by modifying the expression of a single selenoprotein
within a single cell type, would provide more conclusive data.
The 23 kDa selenoprotein found in all of the primary cell types may
represent cGPX and the 14 kDa protein maybe a newly identified
selenoprotein protein described by Gladyshev et al, 1998. However, these
observations need to be confirmed by western blotting. The 23 kDa protein
is expressed to a greater degree in keratinocytes than in fibroblasts and
indeed melanocytes express it only weakly. The 14 kDa protein was also
expressed more strongly in keratinocytes than in melanocytes and
fibroblasts. It is known that cGPX is an antioxidant enzyme, furthermore
antioxidant properties have been proposed for the 14 kDa selenoprotein. It
is possible that the 23 and 14 kDa proteins are also involved in protecting
keratinocytes from the harmful effects of UVB radiation.
Primary human keratinocytes only have a short life span in tissue culture,
therefore it is very difficult to obtain large populations of these cells. This
limitation on the number of times keratinocytes divide in culture, greatly
limits the size of the experiments which can be carried out. Therefore, in the
hope that it would be possible to use a epithelial derived cell line for some of
the larger experiments, the selenoprotein profiles of some cell lines were
compared to that of primary keratinocytes. Unfortunately it was
demonstrated that none of the carcinoma derived epithelial cell lines or
spontaneously transformed human keratinocytes, resembled the
selenoprotein expression in primary keratinocyte, sufficiently to allow them
to substitute for primary keratinocytes in experiments. Therefore for the
majority of this thesis primary human keratinocytes were used. This
unfortunately did place some restrictions on the size of some of the
experiments performed. Two of the main differences between primary
keratinocytes and the cell lines were the higher level of expression of the TR
protein and the lower levels of some of the 30-14 kDa selenoproteins. The
higher expression of TR found in the cell lines may have lead to them
responding differently to UVB than the primary keratinocytes. The cell lines
which were closest in selenoprotein expression to primary human
keratinocytes were the A431 cell line and the HaCaT cell line. Consequently
the HaCaT cell line was utilised in two experiments in this thesis which
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required large numbers of cells. During cell survival experiments, following
exposure to UVB the HaCaT cell line responded in an identical manner to
primary keratinocytes, this may be due to the similarities they share in
selenoprotein expression (Chapter 3).
Following exposure to UVB, the activity of some antioxidant enzymes can
decrease. Catalase and SOD activity are decreased following UVB exposure,
whilst GPX appears to be resistant to these effects, this was measured over
several time points up to 24 hours following exposure to UVB (Fuchs et al,
1989a and b; Pence and Naylor, 1990; Shindo et al, 1994). It is thought that
GPX has a shorter half-life than other antioxidant enzymes and so does not
appear to decrease following exposure to UVB. The expression of all visible
selenoproteins was not affected by UVB exposure. This is of interest,
however only one time point, 24 hours following exposure to UVB was
tested. A time course covering more time points, would yield more
informative data on the levels of selenoproteins following exposure to UVB.
It has been reported by Vessey et al, 1995 that the activity of antioxidant
enzymes increase as primary keratinocytes differentiate (this was followed
over 3 days). Calcium chloride was used to induce differentiation of the
primary keratinocytes (over 72 hours) and it was found that the
selenoprotein profiles were similar to untreated keratinocytes (Fig 8.5). The
only difference was a slight decrease in TR expression, this would agree with
the literature, which suggests that TR activity can be decreased in
keratinocytes by calcium (Schallreuter et al, 1986b).
It has been demonstrated that the levels of Se in tissue culture media can
vary considerably. The Se content of FCS can also vary greatly, with values
from zero to 35 pg/L (Leist et al, 1996). Therefore, the level of Se was
determined in all of the tissue culture media used in this study. The levels of
Se in the media were found to be low. The level of protection achieved and
the concentrations of sodium selenite and selenomethionine which provided
protection from UVB-induced damage, were similar in all of the cell types,
despite the different Se content of each media (results from Chapter 3).
Therefore there is a lack of any correlation between the Se contents of the
media and the concentrations at which the sodium selenite and
selenomethionine provide protection. Furthermore, it would appear that the
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Se in the tissue culture media is not readily utilised by the cells, unlike the
supplemented sodium selenite and selenomethionine.
An important question which needed to be investigated was; following Se
supplementation, does the activity of any selenoproteins increase in cells. It
has been shown that TR activity increases, following Se supplementation in
the keratinocyte cell line HaCaT (Marcocci et al, 1997) . The form of Se used
was sodium selenite (40 nM) and the level of TR activity was shown to
increase by 50%. Indeed even 20 nM selenite was shown to increase the TR
activity significantly. The activity of GPX increased dramatically also when
HaCaT cells, were supplemented with 20 nM selenite. The GPX activity
reached a plateau with 20 nM sodium selenite. The TR enzyme also reached
its maximum activity level at 20 nM (Marcocci et al, 1997). It has been
reported in hepatocarcinoma and colon-carcinoma derived cells, that
concentrations as low as 1 nM sodium selenite can increase GPX activity to
its maximal level (Baker et al, 1998). Therefore, it has been demonstrated that
even at low concentrations of Se supplementation, the activity of
selenoproteins can reach a maximal level of activity.
Intake of Se in the United Kingdom has fallen considerably over the past two
decades, until the present when the average intake of Se is only
approximately 40% of the recommended daily allowance (75 pg/day)
(Rayman, 1997). It is possible that a contributing factor to the increase in the
incidence of all types of skin cancer in the United Kingdom (Ko et al, 1994),
may be the decline in Se status. As mentioned in the introduction, the sharp
decrease in plasma Se levels is thought to be a consequence of the reduction
in imports of North American-grown wheat, which are high in Se. The
subsequent increase in imports of European-grown wheat, has introduced
the use of a form of wheat which contains a lower concentration of Se.
Indeed the plasma levels of Se have decreased from 110 pg/L to 70 pg/L in
the period between 1985 to 1994 in the UK (Rayman, 1997). However, it has
been demonstrated that human plasma Se can be increased easily following
Se supplementation (Varo et al, 1988). The successful increase in plasma Se
levels have been best studied in Finland, where a program of nation-wide Se
supplementation (as sodium selenate) in fertilisers has been on going since
1984. It was also shown that the plasma levels in patients in Edinburgh
average 89.33 pg/L, this was slightly higher than the levels found in the
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literature for the UK (70 pg/L) (Rayman, 1997). Following Se
supplementation for 6 weeks the patients' plasma levels had increased to
104.7 pg/L, thus confirming that plasma Se levels are responsive to Se
supplementation. However due to the amount of skin required to
investigate Se levels, no information on whether Se supplemented in the
diet, can reach the skin and increase the levels of selenoproteins present,
could be obtained. However previous work in Chapter 7 using mice showed
that the level of dietary Se can modify the level of GPX in the skin of mice.
Also other groups have demonstrated that the level of dietary Se does
modify the level of GPX and overall Se content of the skin (Burke et al, 1992b;
Pence et al, 1994). Therefore it can be concluded that Se supplements in the
diet can increase the levels of selenoproteins in skin.
8.4 Further Work.
A great deal of further work could be carried out in this area. The effect of
UVB and cellular differentiation on the individual selenoproteins could be
further characterised. When antibodies for more of the selenoproteins
become available, the presence of greater numbers of selenoproteins
expressed by primary skin cells could be confirmed. If an improvement can
be made on the sensitivity of the assays used to investigate selenoprotein
activity, more detailed investigations into the effect of Se supplementation,
on the activity of selenoproteins in primary skin cells could be undertaken.
It would be of interest also to attempt to determine the form of Se present in
tissue culture media. Individual selenoprotein DNAs could be transfected
into skin cells or specifically knocked out, using antisense probes to ascertain
their role in protecting cells from UVB. Finally, it would be of interest to
study further which selenoproteins increase in the skin following Se





Skin cancer is one of the most common malignancies reported in the UK.
The number of cases reported each year has nearly doubled between 1980-
1990, for all three main types of skin cancer (Devessa et al, 1995).
Subsequently, the number of skin cancer related deaths has risen by around
50% over the last 15 years. The number of cases of BCCs are increasing at a
rate of 5% per annum. The number of cases of malignant melanoma are
increasing at a rate of 7% per annum. The major causative factors leading to
the increased number of cases of skin cancer are thought to be; an increase in
the number of people taking sunshine holidays and the decrease in the
ozone layer, resulting in an increase in the amount UV radiation reaching
ground level. The use of sunscreens which filter UVB but not UVA
radiation, may also contribute to skin damage. Another potential factor
resulting in the rise in skin malignancies, may be the low dietary intake of Se
in the UK. The dietary intake of Se in the early 1970's was approximately 60
pg/day, however the current dietary intake of Se in the UK is only
approximately 35-40 pg/day, an intake which falls well below the
recommended intake of 70 pg/day (Rayman, 1997). Subnormal Se status is
associated with a four-fold increased risk of developing skin cancer in
humans, and a poorer prognosis in patients with skin cancer (Reinhold et al,
1989; Combs et al, 1993; Deffaunt et al, 1994).
Previous reports concerning the role of Se in the skin, have highlighted the
need for a greater understanding of the mechanisms of Se action. The first
key studies on the role of Se in the skin, reported that mice supplemented
with Se develop less skin damage, skin tumours and have a lower mortality
rate, than Se-deficient mice following exposure to UVB (Thorling et al, 1983;
Overvad et al, 1985; Pence et al, 1994). Subsequently, it was reported that Se
supplementation in humans could decrease the UVB-induced erythema and
formation of sunburn cells in the epidermis (Burke et al, 1992a and b;
LaRuche and Cesarini, 1991).
9-1
The work presented in this thesis, attempts to investigate the modulatory
effects of Se on various types of UVB-induced damage in the skin. The
starting point was to study the gross effects of UV on skin cells. Cells which
have been heavily irradiated die by either necrosis or apoptosis. Necrotic
cell death occurs at higher levels of UV radiation than apoptosis. It was
found that Se supplementation with sodium selenite, at concentrations
between 1-200 nM or selenomethionine at concentrations between 10 nM-1
pM protected primary human keratinocytes, melanocytes and fibroblasts
from UVB-induced cell death (Fig 3.3a, Table 3.4, Fig 3.5). Cell death
induced by UVB in the experiments described in Chapter 3, was concluded
to occur mainly by necrosis as high levels of UVB were used. It has been
reported that Se supplementation of primary human fibroblasts, decreases
the cell death induced by exposure to UVB (Richard et al, 1990) and UVA
(Leccia et al, 1993; Moysan et al, 1995). Furthermore, transfection of a gene
coding for a selenoprotein with GPX-like activity, into HaCaT cells provides
resistance to UVB-induced cell death (Shisler et al, 1998). The protective
effect of the GPX gene suggests that ROS are involved in the induction of cell
death in skin cells exposed to UVB.
Following the discovery that Se supplementation protects cells from UVB-
induced cell death, the mechanisms behind this protection were investigated.
It was found that protection was not a consequence of Se increasing the
growth rate of the cells (Fig 3.1a and Table 3.1a and Table 3.3). It was also
found that a 24 hour pre-incubation with Se, was required prior to exposure
to UVB to provide significant protection, suggesting that Se acts through
increased expression of selenoproteins (Fig 3.8). The protection provided by
Se supplementation was not due to the Se compounds acting as sunscreens,
as they did not absorb significantly in the UVA and B wavelengths (Fig 3.7).
Many selenoproteins act as antioxidant enzymes. Therefore, the role of Se in
protecting cells from oxidative damage was investigated. Oxidative damage
was induced by treating cells with menadione. Pre-treatment of primary
human keratinocytes with sodium selenite at concentrations ranging
between 1-100 nM and selenomethionine at a concentration of 50 nM,
protected cells from the oxidative damage induced by exposure to
menadione (Fig 3.13). To further investigate the mechanism by which Se
protects from UVB-damage, lipid peroxidation was studied. Exposure to
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UVB radiation produces ROS, which subsequently lead to oxidative
reactions in the cellular membranes, resulting in membrane degradation and
cell death. Sodium selenite and selenomethionine, at concentrations between
1-50 nM and 50-200 nM respectively, significantly decreased the UVB-
induced formation of lipid peroxides in HaCaT cells (Fig 3.16). In the
literature, dietary Se supplementation has been found to decrease the level of
UVB-induced lipid peroxidation in humans (Pietschmann et al, 1992).
Furthermore, the decrease in the formation of lipid peroxides in the presence
of Se supplementation, has also been shown with primary fibroblasts
following exposure to UVA (Moysan et al, 1995; Leccia et al, 1993).
Prevention of oxidative damage induced by exposure to UVB radiation, may
thus be an important mechanism by which Se increases cell survival
following exposure to UVB. The mechanism by which Se prevents lipid
peroxidation and menadione-induced damage is likely to be through
increased expression of antioxidant selenoproteins. Examples of such
selenoproteins are; PHGPX which can reduce lipid peroxides, or TR an
enzyme which is involved in the regeneration of ascorbate, which can in turn
regenerate a-tocopherol, a lipid peroxidation chain breaking antioxidant. TR
may also react with superoxide and hydrogen peroxide and so could
decrease the levels of oxidative stress following exposure to UVB.
Following exposure to UVB, apoptosis also occurs. In the skin exposure to
UVB causes the formation of apoptotic cells (called sunburn cells), which
have a condensed, vacuolated nucleus and a vacuolar cytoplasm (Young,
1987). In the literature, Se supplementation is reported to decrease the UVB-
induced formation of sunburn cells in human skin (LaRuche and Cesarini,
1991). Sodium selenite and selenomethionine at concentrations ranging from
10 nM-1 pM and 50 nM-1 pM respectively, decreased the level of UVB-
induced apoptosis in primary human keratinocytes (Fig 4.4).
To investigate how Se diminished UVB-induced apoptosis, two of the main
pathways of apoptosis were investigated. The first pathway was the p53
pathway. Oxidative stress has been shown to be involved in the activation
of p53 protein (Renzing et al, 1996). However, it was found that neither
sodium selenite or selenomethionine decreased the UVB-induction of the
p53 protein (Fig 4.8 and 4.9). The p53 protein appears to accumulate
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following exposure to UVB, as a consequence of stabilisation of the p53
protein. In order for stabilisation to occur, the p53 protein must be
phosphorylated to prevent the destabilising mdm-2 protein from binding to
it (Midgley and Lane, 1997; Sheih et al, 1997). Following stabilisation of p53,
it must then be phosphorylated again to increase its ability to bind DNA and
activate downstream genes (Lu et al, 1998). It was found in this thesis that
the p53 protein level increased following exposure to UVB and Se
supplementation of cells did not prevent this accumulation. This
observation does not dismiss the possibility, that Se may modulate the
activity of the stabilised p53 protein and therefore decrease DNA binding
and induction of apoptosis.
In the skin it would appear that the p53, Fas and TNF pathways are involved
in the induction of apoptosis following exposure to UVB (Gniadecki et al,
1997). Therefore Se may modulate any one or more of these pathways. It
was not possible to study the Fas pathway, this is unfortunate as the Fas
pathway appears to be activated by ROS, formed following exposure of cells
to UVB (Gorman et al, 1997). However it was possible to investigate the TNF
pathway further, and it was discovered that Se pre-treatment decreased the
UVB induction of TNF-a mRNA (Fig 6.12) and the protein for TNF-a by
primary human keratinocytes (Fig 6.20). Therefore, there may be a decrease
in the TNF-a response to UVB, which may be one mechanism by which Se
decreases the levels of UVB-induced apoptosis (Schwartz, 1995).
Another possible mechanism by which Se may be decreasing cell death,
apoptosis and tumour initiation, is by decreasing the level of UVB-induced
DNA damage. Direct DNA damage in the form of CPDs and 6-4
photoproducts, are the most abundant form of DNA damage induced by
UVB. DNA lesions such as these are linked to skin cancer formation and
analysis of DNA from BCCs and SCCs has revealed that the majority of
mutations occur at these sites. The significance of UVB-induced oxidative
DNA damage in tumourogenesis is not fully known, but it does appear to
contribute to the cells total burden of UVB-induced DNA damage (van der
Scroeff et al, 1990; Nishigori et al, 1994). Selenium supplementation has been
reported to decrease the formation of the oxidative DNA damage lesion 8-
OHdg, in mouse keratinocytes following exposure to UVB (Stewart et al,
1996).
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In my study the influence of Se on both direct and indirect forms of DNA
damage were investigated. First, the impact of Se on the rate of excision
repair of UVB-induced DNA damage was investigated. Selenium
supplementation of primary keratinocytes was found not to alter the overall
rate of excision repair (Fig 5.4). Pre-treatment with Se did not alter the
formation of CPDs or their repair rate (Fig 5.6 and 5.7). However pre-
treatment of primary keratinocytes with 50 nM sodium selenite or 200 nM
selenomethionine, decreased the formation of 8-OHdg sites in irradiated
primary human keratinocytes (Fig 5.12a and b). Therefore, Se
supplementation may decrease the level of UVB-induced apoptosis, by
decreasing the level of UVB-induced oxidative DNA damage. Both the
hydroxyl radical and lipid peroxidation have been reported to mediated the
formation of 8-OHdg sites in DNA (Peak and Peak, 1990; Park and Floyd,
1992). As previously mentioned in Chapter 3, Se can decrease the level of
UVB-induced lipid peroxidation, subsequently this may then lead to a
decrease in the formation of 8-OHdg sites in DNA.
Another significant effect of Se in studies on patients described in the
literature is, the prevention of the inflammatory response following exposure
to UVB (Burke et al, 1992a and b); this has also been reported to occur with
mice (Overvad et al, 1985; Thorling et al, 1983). The effect of Se on the
principal inflammatory cytokines in the skin was investigated. These
include IL-6, IL-8, and IL-1 a. Whilst Se decreased the UVB-inductionmRNA
for IL-6 (Fig 6.10a and b); and mRNA levels for IL-8 (Figs 6.11a and b); such
effects were not repeated in the levels of cytokine proteins (Fig 6.18 and
6.19). The reason for the lack of modulation on the protein levels of these
cytokines was unclear. Se did not alter the levels of IL-1 a mRNA (Fig 6.13).
Thus, despite my work it is still unclear how Se can modulate the
inflammatory response, following exposure to UV. It is possible that Se may
decrease prostaglandin synthesis, through the actions of selenoproteins, or
decrease the levels of intracellular ROS which can act as mediators of
inflammation.
Following initiation of skin neoplasms, the tumour which is highly
immunogenic must evade the host immune response to progress and grow.
Margaret Kripke and co workers were the first to report that UV-induced
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tumours from mice transplanted to normal syngenic mice, which had been
UV-irradiated, led to successful tumour take and growth (Fisher and Kripke,
1977; Kripke 1984). Since then, it has been reported that UV can cause both
local and systemic immune suppression. Immune suppression allows
tumours to progress, therefore the influence of Se on both local and systemic
immune suppression was investigated. The main mediator of systemic
immune suppression is IL-10 (Moore et al, 1993). IL-10 may also have a role
in controlling the inflammatory response, which is induced following
exposure to UVB. Irradiated murine keratinocytes secrete IL-10 protein
(Rivas and Ullrich, 1992), however in human skin the IL-10 protein which is
induced by exposure to UV is thought to be released by melanocytes or from
infiltrating dermal macrophages (Teunissen et al, 1997; Mattei et al, 1994).
Selenium supplementation of mouse keratinocytes decreased the UVB-
induction of the protein for IL-10 (Fig 6.21). This suggests that a Se-mediated
decrease in IL-10 protein, may be a mechanism by which the systemic
immune suppression induced following UVB exposure could be abated, thus
allowing a more effective immune defence to be made against tumour cells.
The IL-10 protein also appears to be involved in local immune suppression,
as it can inhibit antigen presentation within the skin and inhibits
macrophage synthesis of inflammatory cytokines (Beissert et al, 1995; Niizeki
and Streilein, 1997). Thus Se may also be able to modulate local immune
suppression
One of the main inducers of local immune suppression in the skin is TNF-a.
TNF-a is implicated in the migration of LCs from the epidermis, following
exposure to UVB (Cumberbatch and Kimber, 1992; Yoshikawa, 1992;
Cumberbatch and Kimber, 1995). Selenium supplementation of mouse
keratinocytes decreased the UVB-induction of the mRNA for TNF-a. The
UVB-induction of the human TNF-a protein was shown to be decreased
following Se supplementation (Fig 6.20). The decrease in TNF-a protein
levels would perhaps lead to a decrease in local immune suppression, due to
the absence of the associated signal for LCs to migrate from the epidermis
following exposure to UVB. Although it is not clear that there is a straight
forward relationship between LC numbers in the epidermis and APC
capacity, this is due to the presence of other dendritic cells in the skin
(Duthie et al, 1999).
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It was found that increased dietary Se intake in mice, decreased the UVB-
induced loss of epidermal LCs (Fig 7.2). Another possible explanation for
the retention of LCs in the skin is that LCs are susceptible to oxidative
damage (Horio and Okamoto, 1987; Iwai et al, 1999), therefore Se via
selenoprotein augmentation, may provide protection for LCs from oxidative
damage. Finally, LCs have been shown to undergo apoptosis following
exposure to UVB, and in Chapter 4, Se was shown to decrease the level of
UVB-induced apoptosis in keratinocytes, therefore it is possible that Se could
decrease the level of UVB-induced apoptosis in LCs.
Throughout this thesis, it has been proposed that Se exerts its actions via
increased expression of antioxidant selenoproteins. Therefore, it was
decided to investigate the level of selenoproteins found in the skin and to
attempt to study the influence of dietary Se on these selenoproteins. The
major antioxidant selenoproteins are the GPX and TR families. Glutathione
peroxidase consists of a family of selenoproteins, the two most common ones
in the skin are PHGPX and cGPX. Cytoplasmic glutathione peroxidase
detoxifies hydrogen peroxide (Roetruck et al, 1973). Whereas, PHGPX can
metabolise phospholipid hydroperoxides and lipid peroxides (Ursini et al,
1985; Maiorino et al, 1991). Thioredoxin reductase in conjunction with its
substrate thioredoxin, can detoxify hydrogen peroxide (Bjornstedt et al,
1995a) and superoxide (Schallreuter and Wood, 1986). Thioredoxin
reductase can also modulate other antioxidant systems in the skin. It has
been reported to induce superoxide dismutase (Das et al, 1997) and can
regenerate ascorbate (May et al, 1997). The regenerated ascorbate can then
go on to regenerate a-tocopherol (Tamura et al, 1995). Finally TR can also act
as an electron donor for GPX in the reduction of hydroperoxides (Bjornstedt
et al, 1994).
Increasing Se levels in mice lead to increased activity of GPX in the livers
(Fig 7.4), skin (Fig 7.5) and lymph nodes (Fig 7.6). These results demonstrate
that, in mice, dietary Se reaches the skin and increases the levels of
selenoproteins within it. The selenoprotein profiles of the various skin cell
types were also investigated. Primary human keratinocytes, melanocytes
and fibroblasts were shown to each express at least 10 major selenoproteins
(Fig 8.1). All three cell types were confirmed to express PHGPX and TR by
western immunoblotting. Exposure to UVB, did not alter the levels or
9-7
pattern of expression of any of the selenoproteins (Figure 8.5). Other groups
have reported in the literature, that the activity of various selenoproteins
increases in skin cells following Se supplementation. For example TR and
GPX activity increase when 20 nM sodium selenite is added to the media of
keratinocytes (Marcocci et al, 1997). The level of GPX and total Se have been
shown to increase in patient's skin following Se supplementation (Burke et al,
1992a and b) and the same occurs in mouse skin (Pence et al, 1994).
The work presented in this thesis answers some of the questions relating to
the role of Se in the skin. The data reported and discussed here, outlines the
crucial role Se has in protecting the skin from a wide spectrum of UVB and
UVA-induced damage. In a world of increasing exposure to UV radiation,
due to a number of cultural and environmental factors, it is important that
the role of Se in skin function is investigated further. Interesting areas for
further research would be: to investigate the role of GPX and TR in
protecting the skin from the harmful effects of UV, study further the role of
Se in protection from immune suppression, to investigate the mechanism by
which Se is involved in apoptosis, for example; is Se involved in the Fas
pathway, can Se alter the activation of other downstream apoptotic genes
e.g. Bax and Bcl-2 or does it alter the activation of the caspase proteins?
Finally, a very important area of study would be, to look at the effect of Se in
vivo using human trials and monitor if Se modulates the effects of UV on the
skin.
From the work carried out in this thesis, it is not certain that Se
supplementation would decrease the incidence of skin cancers. However, Se
supplementation in vitro does decrease UVB-induced damage to skin cells. It
would appear that sodium selenite is effective at lower concentrations, than
selenomethionine, however selenite is also more toxic than
selenomethionine. Therefore, for Se supplementation in humans
selenomethionine may be preferred. Selenium supplementation has been
shown to improve many other diseases and cancers including; prostate,
colorectal and liver cancers, male infertility and cardiovascular disease.
Therefore there may be a case for intervention to increase the Se intake in the
UK up to at least the recommended level of 70 pg/day.
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Selenium: an essential element for immune function
Roderick C. McKenzie, Teresa S. Rafferty and Geoffrey J. Beckett
3elenium (Se) was discovered in1817 by Jons Jacob Berzeliuswho named it after Selene, theGreek goddess of the moon. It
toxic metaloid with a wide range of
strial applications, including the pro-
on of semiconductors, photocopiers,
less steel and antidandruff shampoos.
•57 it became evident that Se was an
itial trace element that prevented
tic necrosis in vitamin-deficient rats',
omans, clinical signs of toxicity (sel-
s) appear when dietary intake exceeds
ig/day, an intake that can be exceeded
intries where high concentrations of Se
Dund in the soil. A Se intake of up to
.g/day is regarded as safe',
le earliest evidence that Se is involved in
me function came in 1959 with the ob-
tion that dogs injected with 75Se incor-
ed the isotope into a leukocyte protein;
irotein is now known to be cytoplasmic
thione peroxidase (cGPX). In sheep and
ins, Se is concentrated in tissues in-
d in the immune response, such as
a, liver and lymph nodes2. Later it was
•dated that the trace element was essen-
ir normal growth and development and
also prevent myopathies associated
nutritional status in farm animals. In
of China where there is marked Se de-
cy, a severe endemic cardiomyopathy
n as Keshan disease and a deforming
irthritis known as Kashin-Beck disease
und1. Both these diseases respond to Se
ementation. Many studies suggest that
late intake of Se is required to ensure
lal immune function and to preventma-
icy. Various components of the immune
n fail to function correctly if dietary Se
ident2 (Box 1).
e discovery in 1973 that Se was an in-
part of the selenoenzyme cGPX pro-
a mechanism by which Se could exert
ilogical actions; this enzyme detoxifies
ul organic hydroperoxides, as well as
igen peroxide, which are produced
g oxidative metabolism (reviewed in
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The importance of selenium for
optimal immune function is now
apparent. Here, Roddie McKenzie
and colleagues describe how
selenium is involved in the function
of immune cells, and the various
immune deficiencies and diseases
that result from inadequate
dietary intake.
Refs 1-4). However, more-recent work sug¬
gests that cGPX is less important in prevent¬
ing oxidative damage in the absence of
stress and may simply provide a buffer to
ensure a continued Se supply when dietary
intake is limited. Other GPXs and seleno-
enzymes appear to be essential in preventing
oxidative damage to the cell whereas some
selenoproteins, such as the iodothyronine
deiodinases, have roles that are unrelated to
detoxification (reviewed in Refs 1,3,4).
Several studies have suggested that the
incidence ofmalignancy and cardiovascular
disease is inversely related to Se intake, but
the precise means by which Se protects
against these diseases is still unclear1. If Se
does have marked effects on health and
well-being, it is of concern that in many
countries dietary Se intake is well below rec¬
ommended levels5.
Sources of Se
Ultimately, the soil is the source of Se; it
enters the food chain through incorporation
into vegetable protein as the amino acids
selenocysteine and selenomethionine. Thus,
if the animal and human population eat pre¬
dominantly food produced locally, the Se
status of the population will reflect soil lev¬
els. Inmany parts of Europe Se intake is low
(30-40 (xg/day1,5). The recommended dietary
intake (RDI) for Se in the UK is 75 (xg/day for
adult males and 60 pg/day for adult females.
In many parts of the USA, intake is above
the RDI at 90 pLg/day. In Finland, the low Se
status of the livestock and human popu¬
lation, together with the high prevalence
8
of skeletal muscle myopathy in animals,
as well as heart disease and malignancy in
humans, prompted a Se supplementation
programme whereby inorganic Se was
introduced into the food chain via fertiliz¬
ers. This programme has increased Se intake
in the Finnish population to -125 jcg/day.
Food contains organic forms of Se such as
selenomethionine and selenocysteine but
many experiments involving Se supplemen¬
tation have used inorganic forms such as
selenite. Absorption and use of organic and
inorganic Se compounds differ. Organic
forms appear to be re-used by the body more
efficiently than inorganic forms, apparently
because selenomethionine substitutes non-
specifically for methionine residues in pro¬
teins but in such circumstances the Se has no
bioactivity. For bioactivity and synthesis of
specific selenoproteins, the trace element
must be present as a selenide-like intermedi¬
ate that incorporates into specific seleno¬
cysteine residues, usually at the active site of
the selenoprotein1-3-4. Evidence suggests that
selenide is more-readily formed from in¬
organic rather than organic Se. Furthermore,
selenite but not selenomethionine reacts
readily with glutathione in erythrocytes to
form selenodiglutathione6, a compound that
has anticarcinogenic properties and induces
apoptosis of human tumour cells7.
Most Se present in tissues and blood is
incorporated into selenoproteins, leaving
little free Se. Many in vitro experiments have
used selenocompounds at concentrations
that are nonphysiological in that they reflect
total rather than free circulating levels of Se.
Circulating Se levels are low in many dis¬
eases, but this does not imply that Se is
involved in the pathogenesis of the diseases.
In many illnesses, trace elements such as





Selenoproteins are present in every cell
type. At least 20-30 selenoproteins exist, but
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Box I. Effects of Se on immune cell function
>e supplementation .
-i-.
Neutrophil migrationandQ/ activity (cow)
High-affinity 11.-2 receptor (mouse)
T-cell proliferation and function following age-related decline (mouse)
Natural killer cell activity (mouse, human)
Cytotoxic T-cvll activity (mouse)
T-eell response to pokeweedmitpgvn (row)
Lymphokineractivatod killer cell activity
Enhanced delayed-type response due to better antigen presentation (mouse) .
| UV-induced skin cancers and mortality (mouse)
Erythema following UV exposure (human, mouse)
Vaccine-induced immunity to malaria (mice)
t pitTO v,.....-.',' ■_ . . ::i'v ; ;s
HIV long-terminal-repeat activation and HIV replication in T cells (human)
NF kB activation (human)
B-cell lipoxygenase activity (human) . ■ ?;
Antibody responses (primary and secondary) to virus (cow)
Cell death following UV irradiation of skin cells (mouse, human)
DNA damage and lipid peroxidation in UV-exposed skin cells (mouse, human) <#
H.-6,1L-8 and TNF mRNA following UV treatment of skin cells (human)
Cell death following paraquat exposure (human)
Apoptosis in tumours (human, mouse)
Apoptosis induced by UV innormal skin cells (human)
Phytohaemagluttinin response in lymphocytes (human) . .. ;
Killing by macrophages (human)
Target killing by cytotoxic T cells (human)
1
e deficiency
Platelet aggregation and leukotriene synthesis (atopic human)
IgC and lgM titres (human) .
Antibody production by lymphocytes (mouse)
Virulence of Coxsackievirus (mouse)
Neutrophil chemotaxis (goat)
Neutrophil and leukocyte activity (pig)
Cartdidaddal activity by neutrophils (rat)
CD4* T cells, 1 CDS* T cells, i CD4"/CD8~ tliymocytes (mouse)
bbieviations; HIV, human immunodeficiency virus; IL, interleukin; TNF, tumour necrosis factor;
V ultraviolet radiation; t, increase; i, decrease.
about 12 have been either partially or
jletely characterized (reviewed in Refs
4) and most appear to catalyse oxido-
:tion reactions1,3'4. It is widely held that
ges in selenoprotein expression explain
r of the biochemical and clinical mani-
:ions of selenium deficiency, although
t effects of selenium compounds on
cannot be excluded. Immunologically,
bility of selenoproteins to protect the
from oxidative stress is vitally impor¬
tant, since many host defence systems rely on
the microbiocidal effects of macrophage- or
neutrophil-generated free-radical species. Ox¬
idative species are generated through general
metabolism, during the metabolism of xeno-
biotics and during exposure to ultraviolet ra¬
diation (UV) in sunlight. Inflammation as a
process to clear infection and damaged tissue
also generates great oxidative stress. If antiox¬
idant systems are not functioning correctly,
host cells will be damaged.
Much is known about the functions of
the family of GPXs. The membrane-bound
phospholipid hydroperoxide GPX (PHGPX)
detoxifies phospholipid hydroperoxides
and, along with vitamin E, helps prevent
oxidative damage to membranes. The
PHGPX may be more important than the
cGPX in protecting the cell from oxidative
stress. Elimination of peroxides in the extra¬
cellular fluid is dealt with by the extracellu¬
lar or plasma form of GPX. Peroxynitrites,
products of superoxide and nitric oxide, are
produced in skin cells during exposure to
UV and cause single-strand DNA breaks.
The synthetic Se compound ebselen func¬
tions as a GPX and prevents these breaks8.
Ebselen also inhibits the proinflammatory
enzymes nitric oxide synthase and protein
kinase C (Ref. 9). In addition, the GPXs play
a vital role in the synthesis of arachidonic
acid metabolites. The lipoxygenase and
cyclooxygenase pathways produce hydro-
peroxyeicosatetraenoic acids, which must
be reduced for lipoxin, prostaglandin and
leukotriene synthesis2. Eicosanoid synthesis
is depressed in Se deficiency (see Ref. 2).
Furthermore, accumulation of lipoperoxides
impairs prostacyclin synthesis and promotes
thromboxane accumulation, which can in¬
crease platelet aggregation in cardiovascular
disease5.
Other selenoproteins include the
iodothyronine deiodinases (types I, II and
III), which regulate the metabolism of thy¬
roid hormones in all tissues. Clear functions
are still being sought for other seleno¬
proteins such as selenoprotein P and seleno¬
protein YV. The former may be involved in
Se transport; the latter is lost in Se-deficiency-
induced myopathy1-3-4.
The discovery that thioredoxin reductase
(TDR) is a selenoenzyme is of great interest.
One of its substrates is the 12 kDa thiol-
protein thioredoxin10 on which it acts as a
protein disulphide reductase. TDR acting
alone or in conjunction with thioredoxin can
thus affect the redox regulation of a variety
of key enzymes, transcription factors and re¬
ceptors including ribonucleotide reductase,
the glucocorticoid receptor, AP-1 and NF-
kB. Thioredoxin is classified as a T-cell
leukaemia survival factor because it stimu¬
lates expression of the a subunit of the
interleukin 2 (IL-2) receptor10. In addition to
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Se and protection from
UV-induced damage and cancer
UV is the most ubiquitous environmental
carcinogen. Skin exposure leads to DNA,
lipid and protein damage by direct and free-
radical-mediated effects. In mice, dietary Se
supplementation reduces incidence of and
mortality from UV-induced non-melanoma
skin cancers. Se supplementation prevents
DNA adduct accumulation, cell death, lipid
peroxidation and inflammatory cytokine in¬
duction in skin cells in culture following UV
irradiation18. Transfection with a viral GPX
also improves keratinocyte survival follow¬
ing UV exposure19.
An exciting finding is that doses of 200
p.g/day selenomethionine reduce the over¬
all incidence of prostate, lung and gastro¬
intestinal cancers by 39% (Ref. 20). These
effects may result from a number of mecha¬
nisms including preventing oxidative dam¬
age to DNA, maintaining effective immune
defences and inhibiting tumour proliferation.
cing thioredoxin, TDR can break down
operoxide and lipid peroxides in the
;nce of NADPH more efficiently than
can. Some anticarcinogenic effects of
>pear to be mediated via TDR (Ref. 11).
\
cts of Se on immune function
jficiency depresses the effectiveness of
une cells generally, with diverse spe-
effects listed in Box 1. Supplementation
Se appears to boost cellular immunity
iree mechanisms. First, it upregulates
xpression of the T-cell high-affinity IL-
eptor12 and provides a vehicle for en-
ed T-cell responses. Since the T cell is a
:omponent in providing B-cell help for
ody synthesis, this may explain the
llatory effects of Se on antibody pro-
on (Box 1). In fact, age-related de¬
es in cellular immunity can be partially
sed by Se supplementation increasing
insiveness to IL-2 (Ref. 13). Second, it
;nts oxidative-stress-induced damage
mune cells. Third, it alters platelet ag-
ition by decreasing the ratio of throm-
ae to leukotriene production. Human
ses associated with Se deficiency are
i in Box 2 and;below.
Selenium and viral diseases
In mice, the coxsackievirus mutates to a viru¬
lent cardiotoxic form when it is passaged
through Se-deficient hosts14, possibly be¬
cause the host immune system is weakened.
The fact that human Keshan disease is seen
in Se-deficient areas of China led to the hy¬
pothesis that it may be caused by a coxsackie
B virus that mutates to a cardiotoxic form in
Se-deficient hosts. This disease responds to
Se-dietary supplementation. Similarly, in
China, the incidence of hepatitis-B-induced
hepatoma fell after Se supplementation15. In
AIDS patients, Se status is predictive of sur¬
vival times16. There is also the intriguing ob¬
servation that virulent strains of influenza
virus evolve in Se-deficient areas of China
and the suggestion that human immuno¬
deficiency virus (HIV) may have crossed the
species barrier into man in Se-deficient areas
of Africa. Selenite also seems to protect
mouse cells in culture from the transforming
effects of murine mammary tumour virus.
Interestingly several viruses (molluscum
contagiosum, HIV-1, coxsackie B and Ebola)
contain sequences with homology to GPX
(Ref. 17); perhaps these viral GPXs might be
involved in protecting the virus from host-
cell-derived peroxides.
Conclusion
In conclusion, adequate Se is essential for
immune function and can protect the
immune system from oxidative damage.
Dietary Se supplements hold promise as a
means of treating inflammatory conditions
and rejuvenating the ageing immune sys¬
tem, and in protection from carcinogenesis.
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ration of reactive oxygen species has been implicated as
he mechanism responsible for UVB-radiation-induced
rage. In mice, evidence suggests that increased dietary
intake may protect skin from many of the harmful
'
UVB radiation. We sought to determine the seleno-
rofile ofcultured human skin cells and whether selenium
mtation could protect keratinocytes and melanocytes
lethal effects of UVB radiation. Labelling experiments
5e]selenite showed qualitative and quantitative differ-
;elenoprotein expression by human fibroblasts, keratin-
d melanocytes. This wasmost noticeable for thioredoxin
: (60 kDa) and phospholipid glutathione peroxidase
; these proteins were identified by Western blotting,
hese differences, we found that a 24 h preincubation
with sodium selenite or selenomethionine protected both cultured
human keratinocytes and melanocytes from UVB-induced cell
death. With primary keratinocytes, the greatest reduction in cell
death was found with 10 nM sodium selenite (79% cell death
reduced to 21.7%; P < 0.01) and with 50 nM selenomethionine
(79% cell death reduced to 13.2%; P < 0.01). Protection could
be obtained with concentrations as low as 1 nM with sodium
selenite and 10 nM with selenomethionine. When selenium was
added after UVB radiation, little protection could be achieved,
with cell death only being reduced from 88.5 % to about 50 %
with both compounds. In all of the experiments sodium selenite
was more potent than selenomethionine at providing protection
from UVB radiation.
CTI0N
ilence of non-melanoma skin cancer is increasing, and
/e ultraviolet B radiation (UVB) (280-320 nm) dose is
accepted as being one of themost important aetiological
JVB is a complete carcinogen; it can both initiate and
carcinogenesis. Two of its major effects are DNA
ind local and systemic immune suppression [1,2]. The
n of free radicals [3] and cytokines [4] has been
d as being partly responsible for these effects. The skin
many enzyme systems to prevent free-radical-induced
including catalase, superoxide dismutase and selenium
lining glutathione peroxidases (GPXs). Catalase and
le dismutase activity are decreased following UVB
while GPX appears to be resistant to these effects [5].
s much evidence to suggest that Se has an important
utecting skin from the harmful effects of UVB. In mice,
mentation can substantially decrease the amount of
ige, tumour formation and overall mortality following
isure [6,7]. In humans, subnormal Se status is associated
a a 4-fold increased risk of developing skin cancer [8],
al Se application, as selenomethionine, has been shown
t subjects from acute skin damage following UVB
[9].
actions of Se were once thought to be exerted through
GPX, but it is now recognized that Se exerts many of
through the expression of a number of selenoproteins,
Se is covalently linked within the protein as seleno-
10]. At least 30 selenoproteins have been identified by
3E of 75Se-labelled tissue. However, only approximately
14 have been characterized, including cytosolic GPX, phos¬
pholipid hydroperoxide GPX (PHGPX), extracellular GPX,
selenoprotein-P, SP56, protein disulphide isomerase, thioredoxin
reductase (TR) and the iodothyronine deiodinases [11,12]. The
effects of UVB on the expression of these selenoproteins, or
indeed their precise roles in influencing the cells' response to
UVB, are not known. The family of GPXs detoxifies a wide
range of lipid peroxides [13], and these enzymes have been
implicated in protecting cells from UVB-induced free-radical
damage. TR is an FAD-containing enzyme found in all organisms
which, in conjunction with its substrate thioredoxin, forms a
redox system which has multiple functions, including detoxifi¬
cation reactions [14-16].
Labelling experiments with 75Se have shown clear tissue
differences in the pattern of selenoprotein expression [17], but
studies have not been performed on human skin. Such studies
may indicate which selenoproteins have a role in protecting skin
from the harmful effects of UVB.
Both inorganic and organic forms of Se are commonly used as
Se supplements in experiments, although dietary Se is found
predominantly as the organic forms selenomethionine and seleno-
cysteine [18]. In humans, whole-body turnover studies indicate
that selenomethionine and selenocysteine are re-utilized more
efficiently than inorganic forms such as sodium selenite [19]. This
occurs because selenomethionine can be substituted non-specifi-
cally into proteins at methionine residues. However, inorganic
forms of Se may provide a more bioactive form of the trace
element than selenomethionine and, in cultured thyrocytes,
sodium selenite is retained and utilized by an energy-dependent
process [20]. Studies have not been performed to compare the
Hons used: UVB, ultraviolet B radiation; GPX, glutathione peroxidase; PHGPX, phospholipid hydroperoxide glutathione peroxidase; TR.
reductase; DMEM, Dulbecco's modified Eagle's medium; EBSS, Earle's balanced salt solution.
Dm correspondence should be addressed (e-mail tr@srv1.med.ed.ac.uk).
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ency of sodium selenite and selenomethionine in protecting
tured human skin cells from UVB.
Jere, for the first time, we define the profiles of selenoproteins
iressed by cultured human keratinocytes, melanocytes and
oblasts. We also show that sodium selenite and seleno-
thionine supplementation protects human melanocytes and
atinocytes in vitro from UVB-induced cell death.
rERIALS AND METHODS
lerials
Ibecco's modified Eagle's medium (DMEM), penicillin/
ptomycin, glutamine, dispase, trypsin, sodium pyruvate,
atinocyte serum-free medium, Earle's balanced salt solution
ISS) and the culture vessels were purchased from Gibco BRL,
sley, Renfrewshire, Scotland, U.K. [75Se]Selenite (33 MBq/
I was purchased from the University of Missouri, Columbia,
), U.S.A. All other chemicals and reagents and themelanocyte
ure media were purchased from Sigma-Aldrich, Poole,
"set, U.K. Antibodies to rat liver TR and rat PHGPX were
ed in rabbits using proteins purified as described previously
21].
ue culture
tures of the spontaneously transformed keratinocyte line
3aT [22] (a gift from Professor N. Fusenig, Differenzierung
Carcinogenese, Deutsches Krebsforschungszentrum, Heidel-
l, Germany), were grown in DMEM supplemented with 5 %
r) foetal calf serum, 100 units/ml penicillin and 100 /tg/ml
ptomycin in a humidified 5 % COa atmosphere at 37 °C.
lary fibroblasts were cultured from forearm biopsies [23],
vn out from underneath coverslips and cultured until con-
it. These were grown in DMEM as above, but with 10%
al calf serum.
-imary human keratinocytes and melanocytes were cultured
l neonatal foreskins as described previously [24], Briefly, the
skin samples were incubated overnight in 0.1% dispase/
EM. The epidermis was removed and dispersed in trypsin
g/1) and EDTA (6.8 /tM) for 15 min. Cells were then plated
in fibronectin-coated plates and grown in either keratinocyte
lelanocyte medium. After two passages, the cultures were
posed predominantly (>95%) of either keratinocytes or
mocytes respectively. The cells were used at passages 3 or 4.
Se content of each culture medium was determined by acid
stion followed by fluorimetric analysis [25] and the following
Its found: melanocyte medium, 28 nM; keratinocyte me-
l, 8.9 nM. No Se was detected in the DMEM with 5 or 10%
il calf serum added.
loaded on to SDS/PAGE (12 % gels) and proteins were separated
by electrophoresis. The gels were dried and the labelled seleno¬
proteins were quantified using a molecular Phosphorlmager
(model GS-525; Bio-Rad, Hemel Hempstead, Herts., U.K.) and
visualized by autoradiography using Kodak X-OMAT XAR-5
film. Selenoprotein profiles were also determined in primary
melanocytes, keratinocytes and fibroblasts which had either (1)
been prelabelled with 75Se for 24 h prior to being exposed to
200 J/m2 UVB and then harvested 24 h post-exposure, or (2)
been exposed to 200 J/m2 UVB, then labelled with 75Se and
harvested 24 h later.
Western blot analysis was used to identify TR and PHGPX.
The proteins were separated by SDS/PAGE and were transferred
to Immobilon P membranes. The blot was probed with affinity-
purified polyclonal antibodies to rat liver TR and developed
using chemiluminescence or coupled alkaline phosphatase re¬
agents [27], The blots were also probed with purified antibodies
to rat PHGPX.
Protein determination
The protein content of the sonicated samples was determined
using the Bradford dye-binding method [28] adapted for use on
a Cobras Fara centrifugal analyser (Roche Diagnostics, Welwyn
Garden City, U.K.).
UV irradiation
To determine the lethal UVB dose for the various cell types, cells
were grown to 70% confluence; the medium was then removed
and set aside, and the monolayer was covered with 1 ml of PBS.
Then the cells were irradiated with broadband UVB from a bank
of two TL-20W/12 lamps (Philips, Croydon, U.K.) with an
output range of 270-350 nm (peak at 308 nm). The irradiance
was 80 mW/cm2 at a distance of 30 cm [24]. To determine the
UVB dose that killed 80% of the cells, doses of between 480 and
1200 J/m2 were given. The original medium was replaced, and
cell viability was determined by cell counts on a haemocytometer
using Trypan Blue (0.4%, w/v) exclusion, 48 h after irradiation.
Effects of selenium supplementation on cell viability and growth
Cells grown in six-well dishes to 70 % confluence were treated
with sodium selenite or selenomethionine (1 nM-10 //M) and
incubated for 72 h. The toxicity of these compounds was de¬
termined by assessing cell viability using Trypan Blue exclusion.
Growth stimulation was assessed by counting cells using a
Coulter counter (model DN; Coulter Electronics Ltd., Harpen-
den, U.K.).
rmination of selenoprotein profiles
les of selenoproteins expressed by the various primary skin
were determined by radiolabelling with [75Se]selenite as
"ibed previously [26], Briefly, confluent cultures of cells in
n2 flasks were labelled with 0.02 MBq/ml [75Se]selenite by
lation for 72 h. Previous studies have shown that 75Se
ke and incorporation into selenoproteins by cells reaches a
au at approx. 24 h, and therefore cells were labelled for 72 h
lsure that a steady state had been reached. Medium was
ited and cells were washed twice with EBSS before being
:sted into EBSS by scraping, followed by centrifugation at
g for 10 min. Cells were resuspended in 60 mM Tris buffer,
.8, containing 1 mM dithiothreitol and 1 mM EDTA, and
by sonication. Equal amounts of protein (25 /tg) were
Protective effect of selenium supplementation on cells treated
with UVB
Cells cultured in six-well dishes until 70% confluent were treated
with sodium selenite or selenomethionine (1 nM-1 /tM), and
incubated for 24 h. The medium was removed and set aside, and
1 ml of PBS was added to each well immediately prior to the cells
being exposed to UVB. Typically the cells were exposed to UVB
for 1.5-2 min (720-960 J/m2; the dose given depended on the cell
type used), which resulted in approx. 80 % cell death 48 h post-
irradiation, in cultures where no sodium selenite or seleno¬
methionine had been added. After UVB exposure, PBS was
removed and the original culture medium was replaced. Viability
was determined by Trypan Blue exclusion 48 h post-UVB ex¬
posure.
Protection by selenium from UVB-induced cell death 233
iecond series of experiments, cells were treated with
selenite or selenomethionine immediately after UVB
(without the 24 h pretreatment with Se). The rest of the
;nt was performed as above.
periments were carried out twice (with similar results),
plicate samples for each data point. ANOVA and the
test Bonferroni were used to analyse the data; values for
were deemed to be significant. To compare the dif-
jetween sodium selenite and selenomethionine, ANOVA
ost hoc test Scheffe were used; again values for P < 0.05
med significant.
itein profiles in cultured melanocytes, fibroblasts and
ytes
keratinocytes, melanocytes and fibroblasts were found
learly different selenoprotein profiles (Figures 1 and 2).
type showed up to 10 major selenoproteins (molecular
ging from approx. 10 kDa to 60 kDa), but many minor
iteins were also expressed. Of particular note was the
:xpression between cell types of the 21 kDa and 60 kDa
iteins. Western blotting identified the 21 kDa and
elenoproteins as being PHGPX and TR respectively
ot shown). The 60 kDa 75Se-labelled bands in each cell
sponded exactly inmobility and relative intensity to the
'ealed by Western blotting. The Western blot was not
tnough to detect PHGPX directly; however, a standard
'HGPX had exactly the same mobility as the 21 kDa
led band. The greatest expression of TR and PHGPX
in fibroblasts, with keratinocytes expressing relatively
hese selenoproteins. PHGPX and TR expression was
melanocytes than keratinocytes, but not as great as in
s. At 24 h following exposure to UVB, no change in the
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Figure 2 Selenoprotein profile analysis of primary human skin cells
A Phosphorlmager was used to quantify the radioactivity of the selenoproteins expressed by the
primary skin cells. The protein gels were scanned overnight on an imager and the profiles of











Table 1 Effects of sodium selenite and selenomethionine on the viability
of primary human keratinocytes
Primary human keratinocytes were incubated with sodium selenite or selenomethionine for 72 h,
and the viable cells were counted using a haemocytometer and Trypan Blue exclusion. Control
cells had no Se added to them. At least 100 cells were counted. Results are means+ S.E.M.




















ielenoprotein expression by primary human skin cells
ocytes; lane 2, keratinocytes: lane 3, fibroblasts. Cells were labelled with
0.02 MBq) for 72 h, and the proteins were separated by SDS/PAGE and
utoradiography.
Effect of Se supplementation on cell growth and cell viability
In cultured primary keratinocytes, sodium selenite or seleno¬
methionine had no apparent growth-stimulating activity (results
not shown), and sodium selenite was only significantly toxic at
concentrations of 1 /iM or above (Table 1). Selenomethioninewas
not found to be toxic at concentrations up to 10 fiM (Table 1).















re 3 Effect of sodium selenite or selenomethionine pretreatment on
/iability of primary human keratinocytes after exposure to UVB
ry keratinocytes were pretreated with sodium selenite or selenomethionine for 24 h; then
edium was replaced with PBS and the cells were exposed to a dose of UVB {960 J/m2).
riginal medium was returned and the cells were incubated for 48 h before cell counts were
med using a haemocytometer and Trypan Blue exclusion. Control cells received no UVB
supplement. At least 100 cells were counted. Results are given as percentage cell death
is ± S.E.M., n = 3). Significant difference from cells not treated with Se, but exposed to
*P<0.05; "P < 0.01. Significant differences between the sodium selenite and
imethionine results are indicated by tP < 0.05.
ilar results were found in primary melanocytes and HaCaT
(not shown).
:t of selenium in decreasing UVB-induced cell death
dose of UVB used (960 J/m2) produced 80 % cell death in
lary keratinocytes 48 h after exposure. The addition of
um selenite or selenomethionine, prior to exposure to UVB,
ented a significant amount of cell death, but the protective
:t was significantly different between the two compounds
ure 3). A protective effect with sodium selenite was seen with
:s from 1 to 200 nM, with an optimal protective dose of
M. Selenomethionine was less potent than sodium selenite in
ecting cells from UVB-induced damage, with a higher
:entration of selenomethionine than sodium selenite being
ired to give significant protection from UVB-induced dam-
No significant protective effect of selenomethionine was
rved below 10 nM. Maximal protection using seleno-
lionine was found at 50 nM, with concentrations in the
e 10 nM-1 /<M offering significant protection. As with
am selenite, the protection afforded by selenomethionine
ed to decrease at 1 //M.
elanocytes were more sensitive to UVB than were keratin-
es, and a UVB dose of 720 J/m2 was sufficient to kill 80%
le cells. With melanocytes, the effects of Se were similar to
5 seen with keratinocytes, with maximal protection being
:ved for sodium selenite and selenomethionine at concen-
3ns of 10 nM and 100 nM respectively, with little or no
:ction found at 1 /<M (Table 2). In the keratinocyte cell line
aT, a dose of 960 J/m2 UVB was required to kill 80 % of the
and maximal protection with Se was found at 10 nM
lm selenite and 100 nM selenomethionine (Table 2).
experiments in which sodium selenite or selenomethionine
Table 2 Effects of selenomethionine and sodium selenite pretreatment on
the viability of primary human melanocytes and the human keratinocyte cell
line HaCaT after exposure to UVB
Primary melanocytes and HaCaT cells were pretreated with sodium selenite or selenomethionine
for 24 h prior to the medium being replaced with PBS and the cells being exposed to a dose
of UVB (melanocytes, 720 J/m2; HaCaT cells, 960 J/m2). The original medium was returned
and the cells incubated for 48 h before cell counts were performed using a haemocytometer
and Trypan Blue exclusion. Control cells received no UVB or Se supplement. At least 100 cells
were counted. Results are the means+ S.E.M. (n — 3). Significant differences from cells not
treated with Se, but exposed to UVB :*P< 0.05; "P < 0.01. Significant differences between




Melanocytes HaCaT cells Melanocytes HaCaT cells
Control 7.7 + 1.6 4.3 + 4.3 7.7 + 1.6 4.3 + 4.3
0 82.6 + 1.4 86.8 + 1.1 82.6 + 1.4 86.8 + 1.1
1 57.7 + 6.4*t 57.6 ± 2.9*t 79.3 + 1.7 79.4 + 3.8
10 10.3±0.9"t 19.5+ 1.4"f 72.4 + 2.3* 64.3 + 2.2*
50 22.5 + 1.5**t 35.4 + 1.9" 26.9 + 1.5" 23.8 + 4.5"
100 29.2 + 1.1" 45.2 + 2.8* 14.3 + 4.9" 11 6±3.9"t
200 34.4 + 3.5" 60.4 + 2.2* 30.3 + 3.4" 39.5 +3.1 **t




Figure 4 Effects of sodium selenite or selenomethionine added after the
exposure of primary human keratinocytes to UVB
The medium on primary keratinocytes was replaced with PBS prior to the cells being exposed
to a dose of UVB (960 J/m2). Then the original medium was returned, with either sodium
selenite or selenomethionine added, and the cells were incubated for 48 h before cell counts
were performed using a haemocytometer and Trypan Blue exclusion. Control cells received no
UVB or Se supplement. Results are given as percentage cell death (means + S.E.M., n= 3).
Significant differences from cells not treated with Se, but exposed to UVB: "P < 0.05, "P <
0.01.
was added to primary keratinocytes immediately after UVB
exposure, protection was still achieved, but the protection was
modest and required higher doses of Se compared with protection
achieved by adding sodium selenite or selenomethionine to cells
24 h prior to UVB exposure (Figure 4). Maximal protection was
achieved at 50 nM sodium selenite and 200 nM selenomethionine.
The level of protection was much less (2-3-fold decrease in cell
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ells pretreated with Se for 24 h (5-6-fold decrease in
1) (Figures 3 and 4).
ION
Its presented here show that preincubation of primary
of keratinocytes, melanocytes or the HaCaT cell line
3r 24 h can provide all of these cell types with significant
n from UVB-induced cell death (Figure 3; Table 2). The
form of Se added to cells was an important factor in
ing the minimal and optimal doses of Se required to
nrotection from UVB. Selenite was more potent than
thionine at conferring protection, illustrated by the
hat, in melanocytes, keratinocytes and HaCaT cells,
it protection was achieved with a dose of 1 nM
whereas no significant protection was achieved with
thionine below concentrations of 10 nM. Concen-
i>f Se that conferred maximal protection to cells also
ith the chemical form of Se. With selenite, maximal
n was achieved at a concentration of 10 nM in all cell
ereas, with selenomethionine, maximal protection was
at concentrations of 50 nM, 100 nM and 100 nM for
ytes, HaCaT cells and melanocytes respectively (Figure
2). The observation that a similar degree of protection
by Se addition was found with the HaCaT keratinocyte
ad primary keratinocytes suggests that the phenomenon
al one among skin cell types.
1 not investigate the effects of Se on fibroblasts, as
cies in the skin arise from keratinocytes and melanocytes
wever, Richard et al. [29] have shown that fibroblasts
otected from broadband UVB by selenium,
lely held that Se exerts many of its biochemical actions
he expression of specific selenoproteins in which Se is
is specific selenocysteine residues encoded by a TGA
sertion of Se at these TGA-directed sites requires Se to
ted in a chemically active form similar to selenide, and
idence indicates that selenite is a more potent precursor
e than is selenomethionine [30]. Furthermore, although
iy turnover studies in humans have shown that seleno-
te is re-utilized by cells more efficiently than inorganic
is appears to arise because selenomethionine can be
d into proteins non-specifically for methionine. When
methionine residues, selenomethionine appears to have
vity [31]. Further evidence for the increased bioactivity
: over selenomethionine comes from the observation
ite, but not selenomethionine, can be converted within
:o selenodiglutathione, a form of Se which appears able
e apoptosis [32],
*h selenite was more potent than selenomethionine at
; protection from UVB damage, our data clearly
lat selenite was much more toxic to cells than was
hionine. Thus 1 /iM selenite killed approx. 25 % of
at a dose of 10 /tM more than 50 % of the cells were
; this contrasts with selenomethionine, which showed
f at any of the doses used in the study (Table 1). While
ay itself be directly toxic to cells, a study has shown
etabolite selenodiglutathione is also a potent cytotoxic
j. Although both Se compounds conferred dose-de-
rotection from UVB damage up to approx. 100 nM,
i appeared to be diminished in all cell types when the
was further increased to 1 /iM. This loss of protection
asing concentration of selenite is most likely to be due
:t toxic effect of selenite and its metabolite seleno-
me when present at high concentrations. For seleno-
e, the mechanism behind the loss of protection at
higher doses is unknown, since selenomethionine was not toxic at
any of the concentrations used (Table 1). It is possible that UVB
exposure might modify selenomethionine to produce a toxic
metabolite, but we could find no evidence of increased toxicity in
a solution of selenomethionine irradiated with UVB (results not
shown).
We have shown that preincubation with Se can prevent UVB-
induced damage; the mechanism by which this occurs is not
clear. Se did not exert a protective effect through altering cell
growth patterns at the doses that were protective. If Se was
added immediately after UVB exposure, some protection was
achieved, but this effect was small compared with the protection
achieved if the cells were preincubated with the trace element
(Figure 4). These data suggest that Se may be acting through
incorporation into selenoproteins rather than by a direct anti¬
oxidant chemical action.
The family of GPXs are clearly potential candidates for
selenoproteins that may mediate the protective effects of Se, since
these enzymes are capable of detoxifying hydrogen peroxide,
lipid hydroperoxides and phospholipid hydroperoxides which
are produced during UVB exposure. TR is a selenoenzyme which
has multiple functions and can act through its ability to reduce
oxidized thioredoxin [14] or its ability to directly reduce hydrogen
peroxide and lipid hydroperoxides in the presence of NADPH
[33]. Thus TR may play an important role in protecting cells
from peroxidative damage. However, labelling of tissues with
[,5Se]selenite has revealed more than 30 selenoproteins, and the
pattern of selenoprotein expression is quite different between
tissues. It is thought that some of these selenoproteins may also
be involved in detoxification reactions and in modifying cell
growth or cell death [30].
The expression of the 21 and 60 kDa selenoproteins showed
the most diversity between cell types. These selenoproteins were
identified by Western blotting to be PHGPX and TR. We
found that keratinocytes expressed much lower levels of TR
and PHGPX than melanocytes, and yet keratinocytes were
found to be more resistant to UVB-induced cell death than
melanocytes; typically, a UVB dose of 720 J/m2 was required to
produce 80 % cell death in melanocytes, while a dose of 960 J/m2
was required to produce 80% cell death in keratinocytes.
Furthermore, despite these differences in selenoprotein ex¬
pression between the two cell types, keratinocytes and melan¬
ocytes showed a similar dose requirement for selenium to obtain
maximal protection. While it could be argued that these obser¬
vations imply that the selenoproteins TR and PHGPX are not
involved in protection, this is not necessarily the case. The
susceptibility of a cell to UVB-induced damage will depend on
the total expression of a wide range of antioxidant enzymes and
DNA repair mechanisms, and not necessarily on differences in
the expression ofa single specific selenoprotein. Thus conclusions
regarding the protective role of a specific selenoprotein made on
the basis of comparison of the susceptibility of different cell types
to UVB-induced cell death may be misleading; experiments that
relate to the susceptibility of a cell to UVB-damage after
modifying the expression of a single selenoprotein within a single
cell type would provide more conclusive data.
We have shown that Se can protect both keratinocytes and
melanocytes from UVB-induced damage, and such protection
can be achieved using very low concentrations of Se, particularly
when presented as sodium selenite. Intake of Se in the U.K. has
fallen considerably over the past two decades; at present, the
average intake is only about 40% of the recommended daily
allowance (75 /tg/day) [34], It is possible that a contributing
factor to the increase in the incidence of skin cancer of all types
seen in the U.K. [35] may, in part, be due to this decline in Se
T. S. Rafferty and others
us. Our data from isolated cells would suggest that, as in the
use [6], increasing the Se intake of humans could afford
tection from the harmful effects of UVB radiation. Fur-
rmore, our results suggest that, if supplements of Se were to
pven, inorganic forms such as selenite may be more potent at
viding this protection than organic forms such as seleno-
hionine.
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Expression Of Selenoproteins In Human Skin Cells And Protection
From Ultraviolet B Radiation-Induced Cell Death By Selenium
Supplementation
Teresa S. Rafferty, Roderick C. McKenzie, John A.A. Hunter, A.
Forbes Howie*, John R. Arthur**, Fergus Nicol ** & Geoff J.
Beckett*
Departments of Dermatology & *Clinical Biochemistry, University
of Edinburgh, Edinburgh EH3 9YW and **Rowett Research
Institute, Bucksburn, Aberdeen AB21 9SB.
INTRODUCTION
The prevalence of non-melanoma skin cancer is increasing and
cumulative ultraviolet B radiation (UVB) (280-320nm) dose is accepted to be
one of the most important factors in the aetiology of the disease. The
generation of free radicals [1] and cytokines [2] have been implicated as being
partly responsible for these effects. Selenium (Se) has an important role in
protecting skin from the harmful effects of UVB. In mice Se supplementation
can substantially decrease the amount of skin damage, tumour formation and
overall mortality following UVB exposure [3]. In humans low serum Se
levels are associated with an increased risk of developing skin cancer [4] and
topical Se application, as selenomethionine protects subjects from acute skin
damage following UVB exposure [5].
Selenium is thought to act predominantly through the action of
selenoproteins and at least 30 selenoproteins have been identified by SDS-
75
polyacrylamide electrophoresis of [Se]-labelled tissue. However,
approximately only 14 have been characterised, including cytoplasmic
glutathione peroxidase (cyGPX), phospholipid hydroperoxide GPX (PHGPX),
extracellular GPX, selenoprotein-P, AP56, thioredoxin reductase (TR) and the
iodothyronine deiodinases [6,7].
Here we define the profiles of selenoproteins expressed by cultured
human keratinocytes, fibroblasts and melanocytes. We also show that sodium
selenite and selenomethionine supplementation protects human melanocytes
and keratinocytes in vitro from UVB-induced cell death.
METHODS
The protective effect of Se on cells was determined as previously
described [8]. Briefly cells were treated with sodium selenite or
selenomethionine (InM - lpM) for 24 hours. The media was removed and set
aside and phosphate buffered saline (PBS) added to each well immediately
prior to the cells being exposed to broadband UVB. Typically the
keratinocytes were exposed to 960J/m2 of UVB and the melanocytes to
*
I
720J/m , which resulted in approximately 80% cell death in cultures where no
sodium selenite or selenomethionine had been added. After UVB exposure
PBS was removed and the original culture media was replaced. Viability was
determined by trypan blue exclusion 48 hours post UVB exposure. In a
second series of experiments, cells were treated with sodium selenite or
selenomethionine immediately after UVB exposure (without the 24 hour pre-
treatment with Se). The rest of the experiment was performed as above.
Profiles of selenoproteins expressed by the various primary skin cells
*7 C
were determined by radiolabelling with [ Se]-selenite as described previously
[9].
All experiments were carried out twice (with similar results), using
triplicate samples for each data point. ANOVA and the posthoc test

















































FIGURE 1 : The effect of Se pre-treatment on the viability of
primary human keratinocytes after exposure to UVB.
Cells were pre-treated with sodium selenite or selenomethionine for 24
■j
hours prior to being exposed to UVB (960J/m ). Cell counts were performed
using a haemocytometer and trypan blue exclusion 48 hours after UVB
exposure. Control cells received no UVB or Se supplement. Results are the
means of the percentage cell death ± S.E.M, (n - 3). Significant difference
from cells not treated with Se, but exposed to UVB (* = p < 0.05).
The dose of UVB used (960J/m2) produced 80% cell death in primary
keratinocytes 48 hours after exposure, and pre-incubation of keratinocytes or
melanocytes with Se for 24 hours provided both cell types with significant
protection from UVB-induced cell death (Fig 1: data for melanocytes is not
shown). Selenite was more potent than selenomethionine at conferring
protection as illustrated by the finding that significant protection was achieved
with a dose of selenite of InM, whilst no significant protection was achieved
with selenomethionine until a concentration of 50nM was present. With
selenite maximal protection was achieved at a concentration of lOnM in all cell
types whilst with selenomethionine maximal protection was achieved at
concentrations of lOOnM for keratinocytes and melanocytes.
Although both Se compounds displayed dose-dependant protection from
UVB damage up to approximately lOOnM, when the dose of Se was further
increased protection appeared to diminish until at a dose of lpM no significant
protective effect on cell death was found. For selenite this loss in protection
with increasing concentration of selenite appeared to be due to a direct toxic
effect of selenite at high concentrations (Fig 2). For selenomethionine the
mechanism leading to the loss of protection at higher doses is less clear since
selenomethionine was not toxic at any of the concentrations used (Fig 2).
Treatment
Figure 2 : The toxic effect of Se on the viability of primary human
keratinocytes.
Cells were treated with sodium selenite or selenomethionine for 72 hours.
Cells counts were performed using a heamocytometer and trypan blue
exclusion. Control cells received no Se. Results are the means of the
percentage cell death ± S.E.M, (n =3). Significant difference from cells not
treated with Se (* = p < 0.05)
Pre-incubation with Se was required to prevent UVB-induced damage.
If Se was added immediately after UVB exposure little protection was
achieved. This suggests that Se is acting through incorporation into
selenoproteins rather than by a direct chemical action.
The family of GPXs and TR are clearly potential candidates for
selenoproteins which may mediate the protective effects of Se since these
enzymes are capable of detoxifying hydrogen peroxide, lipid hydroperoxides
and phospholipid hydroperoxides which are produced during UVB exposure.
Primary keratinocytes, melanocytes and fibroblasts were found to have
clearly different selenoprotein profiles (Fig. 3). Each cell type showed up to
ten major selenoproteins (molecular mass ranging from approximately lOkDa
to 60kDa), but many minor selenoproteins were also expressed. The
expression of the 21kDa and the 60kDa selenoproteins showed the most
diversity between cell types. These selenoproteins were identified by Western
blotting as PHGPX and TR. We found that keratinocytes expressed much
lower levels of TR and PHGPX than melanocytes and yet keratinocytes were
found to be more resistant to UVB-induced cell death than melanocytes;
typically a UVB dose of 720J/m was required to produce 80% cell death in
9
melanocytes whilst 960 J/m was required to produce 80% cell death in
keratinocytes. However, the susceptibility of a cell to UVB damage will
depend on the total expression of a wide range of antioxidant enzymes and
DNA repair mechanisms and not necessarily differences in the expression of a
single specific selenoprotein.
Figure 3 : Selenoprotein expression by primary human skin cells.
Cells were labelled with [75Se]-selenite [0.02 MBq] for 72 hours, the proteins
were separated by SDS-PAGE and visualised by autoradiography.
We have shown that Se can protect both keratinocytes and melanocytes
from UVB-induced damage and such protection can be achieved using very
low concentrations of Se particularly when presented as sodium selenite.
Intake of Se in the United Kingdom has fallen considerably over the past two
decades such that, the average intake is now only about 40% of the
recommended daily allowance (75pg/day) [10]. It is possible that a
contributing factor to the increase in the incidence of skin cancer of all types
seen in the United Kingdom may, in part, be due to this decline in Se status.
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EXPRESSION OF SELENOPROTEINS BY SKIN CELLS AND
PROTECTION FROM UVB INDUCED CELL DEATH BY
SELENOMETHIONINE.
T S Rqffertv. R C McKenzie, A F Howie and G J Beckett.
Departments of Dermatology and Clinical Biochemistry,
University of Edinburgh, Lauriston Place Edinburgh EH3 9YW
Selenoproteins are thought to help prevent free radical induced
damage. Although the functions of these selenoproteins are
unknown, it has been shown in mice that selenium supplementation
reduces ultraviolet-B radiation (UVB)-induced skin tumours.
We have characterised the expression of these selenoproteins by
labelling skin cell cultures with %e. We have found that primary
keratinocytes, melanocytes and fibroblasts ail express unique
patterns of selenoproteins. Each cell type expresses between 7-9
species of selenoprotein. The major species are 56kd, 26kd, 21 kd
and 14kd. Keratinocyte cell lines had very similar patterns to the
primary cells. As a role has been suggested for these proteins in
protection from oxidative stress, we looked to see if selenium
supplementation protected keratinocytes from UVB damage. We
supplemented cells in culture with selenomethionine for 24h, gave a
dose of UVB sufficient to kill 50% of the cells and determined viability
after 48h. We found that lOOnm selenomethionine gave the best
protective effect, reducing the rate of cell death to 23%.
This is the first characterisation of selenoprotein expression in skin
cells. These results suggest that selenium may protect cells from UV
induced damage.
EXPRESSION OF SELENOPROTEINS BY SKIN CELLS AND
PROTECTION FROM UVB-INDUCED CELL DEATH BY SELENIUM
SUPPLEMENTATION.
T S Rqfferty, R C McKenzie, A F Howie and G J Beckett.
Departments of Dermatology and Clinical Biochemistry,
University of Edinburgh, Lauriston Place , Edinburgh EH3 9YW
Cells contain many different selenoproteins, however the
functions of most of these selenoproteins are unknown. It has
been shown in mice that selenium supplementation reduces
ultraviolet-B radiation (UVB)-induced skin tumours. One
possible mechanism to explain selenium's importance could
be that some selenoproteins help prevent free radical-
induced damage.
We have characterised the expression of skin cell
selenoproteins by labelling cultures with 75Se followed by SDS
polyacrylamide gel electrophoresis. We found that primary
keratinocytes, melanocytes and fibroblasts all express unique
patterns of selenoproteins. Each cell type expresses between
7-9 species of selenoprotein. The major species are 56kd,
26kd, 21 kd and 14kd. Keratinocyte cell lines had very similar
patterns to the primary cultures. As a role has been
suggested for these proteins in protection from oxidative
stress, we determined if selenium supplementation protected
keratinocytes from UVB damage. We supplemented cells in
culture with selenomethionine and sodium selenite for 24h,
gave a dose of UVB sufficient to kill 50% of the cells
(120J/m2/min) and determined viability after 48h. We found
that lOOnm selenomethionine and 50nm sodium selenite gave
the best protective effect, reducing the rate of cell death to
19% and 27% respectively. We are repeating these survival
experiments with UVA radiation, and determining the
mechanism of this protective effect.
This is the first characterisation of selenoprotein expression
in skin cells. These results suggest that selenium may protect
cells from UV induced damage.
SELENIUM COMPOUNDS INHIBIT ULTRAVIOLET-B (UVB)-INDUCED
KERATINOCYTE CYTOKINE PRODUCTION AND CELL DEATH BY
APOPTOSIS.
T S Rafferty, G J Beckett*, J A A Hunter and R C McKenzie.
University Departments of Dermatology and *Clinical
Biochemistry, The Royal Infirmary , Edinburgh EH3 9YW.
Ultraviolet radiation (UVR) can induce cell death by
oxidative damage to cell lipids, proteins and DNA. UVR can
also cause immunosuppression, by damage to Langerhans
cells and induction of cytokines. It has been demonstrated
that direct damage to DNA causes the release of
immunosuppressive cytokines (O'Connor et al, J. Immunol
1996;! 57:271-278) and that addition of selenium (Se) has been
demonstrated to reduce the formation of DNA adducts in
keratinocytes. We have previously reported that Se protects
keratinocytes and melanocytes from UVB-induced cell death,
presumably by acting as an antioxidant.
We sought to determine whether Se could prevent apoptotic
cell death in keratinocytes, a indirect consequence of DNA
damage. Apoptosis was maximal (30%) 16h after 680J/m2 UVB.
Pre-incubation with sodium selen'rte or selenomethione (10-
200nM) for 24h decreased the level of apoptosis to 10%
[p<0.05, n=6].
As DNA damage is implicated in cytokine production, we
determined whether Se could prevent UVB-induced cytokine
synthesis. Using RT-PCR, we looked at the effect of sodium
selenite and selenomethionine on the production of mRNA for
TNFa and IL-8. In human keratinocytes we found a two-fold
induction of TNFa mRNA after 200J/ m2 UVB. Pre-incubation
with sodium selenrte for 24h (1-1 OnM) decreased this
induction by 50% and selenomethionine (50-200nM) by 60%.
Four-fold induction of IL-8 was seen after 6h. Sodium selenite
(50nm) decreased induction by 100% and selenomethionine
(50-200nM) by 40%-85%. This effect was reproducible in
mouse keratinocytes, where we found a 3-fold induction of
TNFa 6h post UVB, sodium selenite (10-50nM) decreased this
induction by 70%, and selenomethionine (10-50nM) by 50%
[p<0.05, n=3].
This suggests thatSe may protect the skin from UVB induced
damage by reducing DNA damage and inflammatory
cytokine production.
SELENIUM COMPOUNDS INHIBIT ULTRAVIOLET-B (UVB)-INDUCED KERATINOCYTE
CYTOKINE PRODUCTION AND CELL DEATH BY APOPTOSIS. TS Raffertv, GJ
Beckett*, JA Hunter and RC McKenzle, Departments of Dermatology and
*Cllnlcal Biochemistry, The University of Edinburgh, Scotland
Ultraviolet radiation (UVR) can Induce cell death by oxidative damage
and cause Immune suppression by damage to Langerhans cells. Others
have demonstrated that damage to DNA causes the release of TNF-a and
IL-10 (O'Connor et al, J. bmmunol 1996,157: 271-278). Addition of selenium (Se)
decreases the formation of DNA adducts In UVB-treated keratinocytes (KC)
and protects KC and melanocytes fromUVB-lnduced cell death. We sought
to determine whether Se could prevent apoptotlc cell death, an indirect
consequence of DNA damage, in human KC. Apoptosis was maximal (30%)
16h after 680J/m2 UVB. Pre-incubatlon with sodium selenlte (SS) or
selenomethionine (SM) (10-200nM) for24h decreased the level of apoptosis
to 10% [p<0.05, n=6]. As DNA damage is implicated in cytokine production,
we determined whether Se could prevent UVB-lnduced cytokine synthesis.
Using RT-PCR, we examined effects of SS and SM on the production of TNFa
and IL-8 mRNA. In KC we found a two-fold Induction of TNFa mRNA 6h after
200J/ rrf UVB. Pre-incubation with SS for 24h (l-10nM) decreased this
Induction by 50% and SM (50-200nM) by 60%. Four-fold induction of IL-8 was
seen after 6h. The SS (50nm) decreased induction by 100% and SM (50-
200nM) by 40%-85%. This effect was reproducible In mouse KC, where we
found a 3-fold Induction of TNFa 6h post UVB, SS (10-50nM) decreased this
induction by 70%, and SM (10-50nM) by 50% [p<0.05, n=3]. These data
suggest that Se may protect the skin from UVB-induced damage by
reducing DNA damage and Inflammatory cytokine production.
SELENIUM PROTECTION AGAINST UVB-INDUCED
APOPTOSIS OF EPIDERMAL CELLS MAY BE A
CONSEQUENCE OF ITS ABILTY TO REDUCE p53
TRANSACnYATION. N.J.Traynor, N.K.Gibbs, *T.S. Rafferty,
^.C. Bisset, 2J. Blavdes, 3Q.J. Beckett and ^.C. McKenzie.
Photobiology Unit and Molecular and Cellular Pathology, University
of Dundee Medical School, DDI 9SY and 3Dermatology and
4Clinical Biochemistry, University ofEdinburgh, EH8 9AG.
Ultraviolet radiation produces DNA damage including pyrimidine
dimers (PyroPyr) and oxidised bases such as 8-hydroxy-guanine (8-
OH-G). The tumour suppressor protein p53 is post-translationally
activated by UVB radiation and acts as a transcription factor for
downstream loci involved in cell cycle arrest (e.g. p21WAF/CIP1) or
apoptosis.(e.g. bax, PIG2). We have previously shown that low levels
of selenomethionine (SM) protect cells from UVB-induced cell death
and apoptosis (Rafferty et al. Biochem. J. 1998; 332:231-236). We
have also reported that SM protected against 8-OH-G formation but
not from PyroPyr in the DNA of UVB irradiated cells. We now
assess whether there is a connection between SM protection against
UVB-induced apoptosis and p53 transactivation.
An amelanotic melanoma cell line expressing wild type p53 was
stably transfected with the pRGCz)fos-lacZ p53-dependent reporter
construct (clone Arn8). Toxicity testing by the MTT assay revealed
that SM doses of up to 100 pM for 24 h did not impair cell survival.
After irradiation with TL12 broadband (-270-350nm) UVB lamps
(0-30 mJ/cm2) the percentage of cells with transcriptionally active
p53 (detected by X-gal substrate) increased dose-dependently up to
10 mJ/cm2, thereafter the response curve flattened, falling after 20
J/m2. Incubation with 50 uM SM for 24 h pre- and post-irradiation
significantly diminished p53 transactivation by 1.5-1.9 fold across the
UV dose range (p<0.011; n=5 independent experiments).
We now have evidence that SM protects against both UVB-induced
apoptosis and p53 transactivation, which may suggest a causal link
between the the two processes. The fact that SM protected against 8-
OH-G, but not PyroPyr formation in epidermal cells, suggests that
8-OH-G may be an important UVB-induced DNA lesion in p53
transactivation and the subsequent apoptotic response.
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unirradiated skin, measured using a reflectance instrument, was
plotted afainst log UV dose. Sigmoidal curves fitted to these data
[GraphPad PRISM software) were used to calculate for each lamp and
at each time of measurement the UV doses required to cause a AE of
3-025 (Do-025 - equivalent to just perceptible erythema) and AE of
3-1 (D0 i - equivalent to moderate erythema). Sufficient data to
:onstruct full dose-response curves for were obtained in 12 patients.
A measure of curve steepness was made by calculating the D0 i:D0 o25
ratio. The mean ratios at 24 h were 1-73 (95%CI 1-36-2-10) for
TL-01 and 1-83 (1-52-2-14) for TL-12 (P = 0-64. paired t-test). At
72 h the mean ratios were 1-64 (1-34-1-95) for TL-01 and 1-73
)1 -51—1-94) for TL-12 (P = 0-47). Persistence of erythema was
measured by substituting the 24 h D0.i into the 72 h dose-response
rurve and calculating the AE that would have resulted from this dose,
fhe mean calculated 72 h AE was 0-063 (0-043-0-084) for TL-01
ind 0-068 (0-045-0-080) for TL-12 (P = 0-94).
Our results have shown no difference in the steepness of the
iose-response or persistence of erythema induced by TL-01 or TL-12
amps. Therefore, at least in terms of erythema, no evidence has been
ound for a difference in burning potential for the two lamp types.
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Effects of narrow band UVB (TLOl) 311 nm on the
ion-lesional skin of psoriatics
3.D.DE SILVA. T.S.RAFFERTY,* M.NORVAL,* J.A.A.HUNTER* AND
l.C.McKENZIE*
department ofDermatology, the Royal Infirmary ofEdinburgh, Edinburgh,
'J.K.
'Department of Medical and Radiological Sciences. University of
Edinburgh. Edinburgh EH3 9YW, U.K.
Phototherapy with narrow band UVB is an effective treatment for
isoriasis. However, exposure to UVB causes erythema. DNA damage,
mmunosupression and lipid peroxidation We studied the effects of
whole body irradiation with TLOl in patients with psoriasis.
18 subjects (8 male, 10 female, median age 41 (range 17-69)
tears) with psoriasis were randomly selected from those attending
or TLOl treatment at the phototherapy department. The Royal
nfirmary of Edinburgh. Scotland. Peripheral blood samples were
:ollected at baseline and 48 h after the twelfth treatment for
:stimation of (1) natural killer cell activity by Chromium 51 (5lCr)
abelled tumour target cell assay and (2) lipid peroxidation by
:olourimetric assay. 4 mm punch biopsies were obtained under local
maesthetic from non-lesional buttock skin at baseline and after 12
reatments. These were immunostained with antibodies to p53
indicative of DNA damage) and CDla for Langerhans cells (LC).
Statistical analysis was by Student's t-test.
All the patients had mild to moderate psoriasis with mean PASI
core 6-5 (range 3-6-18-4). None were using topical tars or
lithranol or had evidence of immunosuppressive disorder. There
vas no significant difference in the NK activity between the baseline
ind the post TLOl samples. Additionally lipid peroxidation was not
;ignificantly different in the post irradiation samples at 48 h. P53
mmunostaining was increasedby TLOl exposure (unirradiated
t-34 ± 0-93 cells/mm of epidermis vs. irradiated 29-56 ± 7-73.
3 = 0-0089). There was a 26% reduction in the number of epidermal
X post TLOl (n = 11. unirradiated 17-03 ± 3-22 cells/mm of
ipidermis vs. irradiated 12-42 ± 2-99. P = 0-006).
TLOl caused DNA damage as shown by induction of p53 in the
ipidermis of these subjects with psoriasis. This has been demonstrated
vith broad band UVB and UVA but not as far as we are aware in
luman skin with TLOl exposure. In agreement with previous studies
El-Ghorr et ai). The effect of chronic low dose UVB radiation on
^angerhans cells, sunburn cells, urocanic acid isomers, contact
hypersensitivity and serum immunoglobulins in mice. Photochem.
Photobiol.. 1995. 62. 326—332.) we have shown a smaller reduction
in epidermal LC post TLOl than with broadband UVB irradiation.
However, no significant reduction in NK activity or systemic oxidative
damage occurred in these subjects.
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Susceptibility of xeroderma pigmentosum keratinocytes from
different complementation groups to ultraviolet B-induced
apoptosis
C.PETIT-FRERE*, E.CAPULAS. J.E.LOWE. L.KOULU.t R.J.MARTTILA4
N.G.J.JASPERS.H P.H.CLINGEN.** M.H.L.GREENtt AND
C.F.ARLETT
MRC Cell Mutation Unit, University of Sussex. Brighton BN1 9RR. U.K.
"Division of. Clinical Immunology. Karolinska Institute. S-141 86
Huddinge. Sweden
tDepartment of Dermatology and %Department of Neurology.
University of Turku, FIN-20520. Turku. Finland
HDepartment of Cell Biology and Genetics. Erasmus University.
Rotterdam, PO Box 1738. NL-3000 DR, Rotterdam, the Netherlands
"CRC Drug-DNA Interaction Research Group. Department of Oncology.
UCL Medical School, 91 Riding House Street, London W1P 8BT. U.K.
tfSchooI of Pharmacological and Biomolecular Sciences,
University of Brighton. Brighton BN2 4G], U.K. — *
DNA damage induced by the ultraviolet component of sunlight plays
an important role in the aetiology of skin cancer. Induction of cancer
may be related not simply to the mutagenicity of sunlight, but to its
ability to induce apoptosis, immunomodulation or cytokine release. If
the endpoints other than mutagenesis are also mediated by DNA
damage, then they should be altered in cases where DNA repair is
defective. Patients from the UV repair deficiency syndrome xeroderma
pigmentosum (XP) show enormously increased susceptibility to skin
cancer, but other DNA repair syndromes are not necessarily cancer-
prone. Resistance or susceptibility to apoptosis might affect the pool of
UV-mutated skin cells available to progress to cancers in these
syndromes. We have therefore measured UVB-induced apoptosis in
keratinocytes grown out from fragments of skin biopsy from repair-
deficient individuals. XP group A (3 biopsies) and XP group D (1
biopsy) keratinocytes were at least 6 times more sensitive than
normal cells (2 biopsies) to UVB-induced apoptosis. XP variant
keratinocytes (2 biopsies) showed intermediate susceptibility. XP
group C keratinocytes (3 biopsies) proved heterogeneous, one sample
showed high sensitivity to apoptosis. whereas two showed near
normal susceptibility. Cockayne syndrome patients are defective in
the repair of UV-induced DNA damage but not cancer-prone. The
keratinocytes from 1 biopsy showed a similar susceptibility to that
of XP groups A and D. Our work extends and partially confirms the
work of Ljungman and Zhang1 and suggests that relationships
between repair deficiency, apoptosis and susceptibility to skin cancer
are complex.
Reference
1 Ljungman M. Zhang F. Blockage of RNA polymerase as a possible
trigger for U.V. light-induced apoptosis. Oncogene 1996: 13:
823-831.
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Differential repair kinetics of ultravioIet-B radiation
' (UVB)-induced DNA damage in human keratinocytes (KC) and
' fibroblasts (FIBS) and protection from oxidative damage by
selenium
T.S.RAFFERTY, M.H.L.GREEN.* J.E.LOWE.* C.ARLETT.*
J.A.A.HUNTER, G.J.BECKETTt AND R.C.McKENZIE
5 2000 British Association of Dermatologists. British Journal of Dermatology, 142. 599-627
EFFECTS OF SELENIUM DIETARY SUPPLEMENTS ON DNA
DAMAGE AND IMMUNE FUNCTION IN NORMAL
INDIVIDUALS AND PSORIASIS PATIENTS UNDERGOING
PHOTOTHERAPY. B. de Silva, *G.J.Beckett, 2M. Norval, R.J.
Langley, TS.Rafferty. Y.C. Bissett, C.Walker, J.A.A. Hunter, R.C.
McKenzie. Departments ofDermatology, 1Clinical Biochemistry,
and ^Medical Microbiology, University of Edinburgh EH3 9YW.
Selenium (Se) can protect skin cells in culture from UVB-induced
cell death by preventing DNA damage.
Similar studies have not yet been performed in human subjects. The
present investigation examined the effects of supplementing the diet
with daily capsules of 400 ug/day sodium selenite on the extent of
DNA damage induced by irradiating lymphocytes in vitro with UVB,
and on p53 expression and Langerhans cell (LC) numbers in the skin
during phototherapy. Lymphocytes were purified from the blood of 6
normal subjects and irradiated with 40 J/m2 broadband UVB (Philips
TL12). The DNA damage was assessed by the alkaline comet assay.
The comet score [undamaged (1) to extensive damage (4)] in
unirradiated cells before supplementation was 0.50±0.06 which rose
to 2.910.00 in irradiated cells (p<0.001). After one week of selenite,
the basal score was 0.9510.06 (p<0.0001) and the score after
irradiation was 2.210.00, significantly lower than the score before
the supplementation (p=0.0059). The phototherapy group consisted
of 10 psoriatic patients taking selenium supplementation and 9 taking
a placebo, randomly allocated and assessed blindly. Biopsies were
taken before the supplements were started and after 12 narrowband
UVB exposures (Philips TL01) Epidermal LC numbers and cells
expressing p53 were counted after immunostaining. Sunburn cells
were assessed in H&E stained sections. The reduction in LCs as a
result of phototherapy did not differ between the 2 groups, but
keratinocytes expressing p53 increased 23-fold in the Se group
compared with 6-fold in the placebo group (p<0.05). Sunburn cells
were 4-fold fewer in the Se group following irradiation. Therefore Se
supplementation modulated the effects ofUVB on several parameters
which are likely to influence immune function.
DIFFERENTIAL REPAIR KINETICS OF ULTRAVIOLET -B
RADIATION (UVB)-INDUCED DNA DAMAGE IN HUMAN
KERATINOCYTES (KC) AND FIBROBLASTS (FIBS) AND
PROTECTION FROM OXIDATIVE DAMAGE BY SELENIUM.
T. RafFerty, M.H.L.Green* , J.E. Lowe *, C. Arlett*, JAA Hunter, G.J.
Beckettt, RC McKenzie. Departments of Dermatology and tciinical
Biochemistry, University of Edinburgh and *MRC Cell Mutation Unit,
University of Sussex, UK.
Ultraviolet radiation is the most ubiquitous environmental genotoxic agent
and the skin is the major target in humans for UVB-induced DNA damage.
The trace element selenium (Se) is covalently incorporated into enzymes of
the glutathione peroxidase and thioredoxin reductase families, which
scavenge free radicals. We compared the ability of human KC and FIBS to
repair cyclobutane dimers (CBD) and the effects of Se on DNA damage.
Primary KC and FIBS were irradiated with 5 J/m^ from FS20 lamps and
subjected to T4 endonuclease treatment and comet assay 2h -72 h post UVB.
Comet tail length increased from 43±8 pm to 82±200 pm. After 2h, 54% of
this damage remained, 21% after 3h and only 10 % after 6h. In contrast, in
FIBS comet length increased from 18±1 pm to 56±3 pm and this damage
increased to 117% after 4h, dropping slowly with over 65% damage
remaining after 24 h , 45% after 48 h and 30 % remaining after 72h (n=4).
Treatment with up to 200 nM selenomethionine (SM) had no effect on CPD
formation or rates of repair. In contrast, Se did protect against oxidative
DNA damage measured by formation of Foramidopyrimidine glycosylase-
sensitive (FaPy) sites, which are indicative of 8-hydroxydeoxyguanosme
photoproduct formation. Irradiation of KC increased comet length from 54±
9 pm to 85± 17 pm. Pre-incubation for 24 h with 50 nM sodium selenite
abolished UVB-induced increase in comet length (P<0.001). Pre¬
incubation with 10-200 nM SM dose-dependently protected KC from UVB-
induced apoptosis 16 h after 600 J/m^; 200 nM SM completely abolished
UVB-induced apoptosis. Thus KC are more efficient than FIBS at repair of
CBD and Se protects KC from UVB-induced oxidative damage and
apoptosis, but not CPD formation.
SELENIUM INHIBITS ULTRAVIOLET RADIATION-INDUCED
P53 ACTIVATION OF P53-RESPONSIVE ELEMENTS BUT
DOES NOT PREVENT ACCUMULATION OF P53 PROTEIN IN
EPIDERMAL CELLS. NJ.Travnor. N.K.Gibbs, ]T.S. Rafferty,
lY.C. Bisset, 2 J. Blaydes, ^G.J. JBeckett and iR.C. McKenzie,.
Photobiology Unit and 2 Molecular and Cellular Pathology,
University ofDundee Medical School, Dundee and Depts. of
^Dermatology and 3 Clinical Biochemistry, University ofEdinburgh.
Ultraviolet radiation damages DNA by several mechanisms
including thymidine dimerisation and oxidative damage. The wild
type p53 protein is a transcription factor which is activated in
response; to DNA damage; pre-existing p53 is stabilised and activated
by post-translational modifications. The activated protein can then
transactivate genes involved in cell cycle arrest in G1 or initiating
apoptosis.(p21, bax, mdm2). Low levels of sodium selenite (SS) or
selenomethionine (SM) protects cells from UVB-induced cell death
and apoptosis (Rafferty et al. Biochem. J. 1998; 332:231-236). Since
SM protect cells from oxidative DNA damage-but not thymidine
dimers- we determined whether SM or SS affected p53 protein
activation and accumulation.
An amelanotic melanoma cell line expressing wild type p53 was
stably transfected with the pRGCAfos-lacZ p53-dependent reporter
construct (clone Arn8). After irradiation with FS12 broadband UVB
lamps (0-30 mJ/cm2) the percentage of cells with transcriptionally
active p53 (detected by X-gal substrate) increased dose-dependently
up to 25 mJ/cm2. Incubation with 50 nM SM for 24 h post
irradiation significantly diminished p53 activation by 1.9-1.5 fold
across the UV dose range (p=0.0014 to 0.0101, n=5 independent
experiments). Western blotting of Arn8 protein from parallel
experiments showed that p53 abundance increased despite the
presence of SM. We conclude that Se diminishes p53 activation but
not protein accumulation; suggesting that oxidative DNA damage,
not thymidine dimers, mediate p53 transactivation.
